PL206576B1 - Izolowany polinukleotyd, wektor zawierający ten polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca izolowany polipeptyd lub chimeryczny polipeptyd oraz terapeutyczne zastosowanie tej kompozycji w zakażeniach paciorkowcem - Google Patents
Izolowany polinukleotyd, wektor zawierający ten polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca izolowany polipeptyd lub chimeryczny polipeptyd oraz terapeutyczne zastosowanie tej kompozycji w zakażeniach paciorkowcemInfo
- Publication number
- PL206576B1 PL206576B1 PL349777A PL34977799A PL206576B1 PL 206576 B1 PL206576 B1 PL 206576B1 PL 349777 A PL349777 A PL 349777A PL 34977799 A PL34977799 A PL 34977799A PL 206576 B1 PL206576 B1 PL 206576B1
- Authority
- PL
- Poland
- Prior art keywords
- bvh
- polypeptide
- sequence
- streptococcus
- amino acid
- Prior art date
Links
- 241000194017 Streptococcus Species 0.000 title claims abstract description 17
- 108091007433 antigens Proteins 0.000 title abstract description 25
- 102000036639 antigens Human genes 0.000 title abstract description 25
- 239000000427 antigen Substances 0.000 title description 22
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 37
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 37
- 239000002157 polynucleotide Substances 0.000 claims abstract description 37
- 229960005486 vaccine Drugs 0.000 claims abstract description 26
- 208000015181 infectious disease Diseases 0.000 claims abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 143
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 141
- 229920001184 polypeptide Polymers 0.000 claims description 137
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 52
- 238000000034 method Methods 0.000 claims description 29
- 239000002773 nucleotide Substances 0.000 claims description 26
- 125000003729 nucleotide group Chemical group 0.000 claims description 26
- 239000013598 vector Substances 0.000 claims description 23
- 239000002671 adjuvant Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 18
- 206010061372 Streptococcal infection Diseases 0.000 claims description 16
- 230000027455 binding Effects 0.000 claims description 11
- 241000193998 Streptococcus pneumoniae Species 0.000 claims description 9
- 230000028993 immune response Effects 0.000 claims description 9
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 6
- 208000031729 Bacteremia Diseases 0.000 claims description 5
- 201000009906 Meningitis Diseases 0.000 claims description 5
- 206010033078 Otitis media Diseases 0.000 claims description 5
- 206010035664 Pneumonia Diseases 0.000 claims description 5
- 241000193985 Streptococcus agalactiae Species 0.000 claims description 5
- 241000193996 Streptococcus pyogenes Species 0.000 claims description 5
- 150000001720 carbohydrates Chemical class 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 5
- 241000194042 Streptococcus dysgalactiae Species 0.000 claims description 4
- 241000194054 Streptococcus uberis Species 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 229940115920 streptococcus dysgalactiae Drugs 0.000 claims description 4
- 229940115922 streptococcus uberis Drugs 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 241001505901 Streptococcus sp. 'group A' Species 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims description 3
- 230000003248 secreting effect Effects 0.000 claims description 3
- 241000193990 Streptococcus sp. 'group B' Species 0.000 claims description 2
- 238000004113 cell culture Methods 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 230000008105 immune reaction Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 140
- 102000004169 proteins and genes Human genes 0.000 abstract description 75
- 230000000890 antigenic effect Effects 0.000 abstract description 7
- 241001465754 Metazoa Species 0.000 abstract description 2
- 238000003556 assay Methods 0.000 abstract description 2
- 238000011321 prophylaxis Methods 0.000 abstract description 2
- 238000010188 recombinant method Methods 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 235000013351 cheese Nutrition 0.000 description 1058
- 241000282326 Felis catus Species 0.000 description 117
- 108010065920 Insulin Lispro Proteins 0.000 description 78
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 73
- 108020004414 DNA Proteins 0.000 description 72
- 235000018102 proteins Nutrition 0.000 description 71
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 70
- 238000003752 polymerase chain reaction Methods 0.000 description 58
- 108010057821 leucylproline Proteins 0.000 description 55
- 108010077245 asparaginyl-proline Proteins 0.000 description 47
- 241000699670 Mus sp. Species 0.000 description 44
- 239000013615 primer Substances 0.000 description 44
- 108091034117 Oligonucleotide Proteins 0.000 description 43
- 108010050848 glycylleucine Proteins 0.000 description 43
- 108010005233 alanylglutamic acid Proteins 0.000 description 40
- 108010038633 aspartylglutamate Proteins 0.000 description 39
- 108010047495 alanylglycine Proteins 0.000 description 38
- SUIAHERNFYRBDZ-GVXVVHGQSA-N Glu-Lys-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O SUIAHERNFYRBDZ-GVXVVHGQSA-N 0.000 description 36
- 108010064235 lysylglycine Proteins 0.000 description 36
- 108010073969 valyllysine Proteins 0.000 description 36
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 34
- 108010049041 glutamylalanine Proteins 0.000 description 33
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 32
- GADKFYNESXNRLC-WDSKDSINSA-N Asn-Pro Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GADKFYNESXNRLC-WDSKDSINSA-N 0.000 description 31
- 108010047857 aspartylglycine Proteins 0.000 description 31
- 239000012634 fragment Substances 0.000 description 30
- 108010036413 histidylglycine Proteins 0.000 description 30
- 108010009298 lysylglutamic acid Proteins 0.000 description 30
- 239000000047 product Substances 0.000 description 29
- 108010093581 aspartyl-proline Proteins 0.000 description 28
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 28
- 108010092114 histidylphenylalanine Proteins 0.000 description 28
- 108010017391 lysylvaline Proteins 0.000 description 28
- PGUYEUCYVNZGGV-QWRGUYRKSA-N Asp-Gly-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PGUYEUCYVNZGGV-QWRGUYRKSA-N 0.000 description 27
- QTMKFZAYZKBFRC-BZSNNMDCSA-N His-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N)O QTMKFZAYZKBFRC-BZSNNMDCSA-N 0.000 description 27
- LGYZYFFDELZWRS-DCAQKATOSA-N Glu-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O LGYZYFFDELZWRS-DCAQKATOSA-N 0.000 description 26
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 26
- 108010034529 leucyl-lysine Proteins 0.000 description 26
- 108010003700 lysyl aspartic acid Proteins 0.000 description 26
- ULWBBFKQBDNGOY-RWMBFGLXSA-N Pro-Lys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)O ULWBBFKQBDNGOY-RWMBFGLXSA-N 0.000 description 25
- DUAWRXXTOQOECJ-JSGCOSHPSA-N Gly-Tyr-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O DUAWRXXTOQOECJ-JSGCOSHPSA-N 0.000 description 24
- OEROYDLRVAYIMQ-YUMQZZPRSA-N His-Gly-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O OEROYDLRVAYIMQ-YUMQZZPRSA-N 0.000 description 24
- MQVFHOPCKNTHGT-MELADBBJSA-N Phe-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O MQVFHOPCKNTHGT-MELADBBJSA-N 0.000 description 24
- 241001122767 Theaceae Species 0.000 description 24
- 150000001413 amino acids Chemical class 0.000 description 24
- VTJUNIYRYIAIHF-IUCAKERBSA-N Leu-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O VTJUNIYRYIAIHF-IUCAKERBSA-N 0.000 description 23
- FRKBNXCFJBPJOL-GUBZILKMSA-N Pro-Glu-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FRKBNXCFJBPJOL-GUBZILKMSA-N 0.000 description 23
- FMBWLLMUPXTXFC-SDDRHHMPSA-N Glu-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)N)C(=O)O FMBWLLMUPXTXFC-SDDRHHMPSA-N 0.000 description 22
- RZXLZBIUTDQHJQ-SRVKXCTJSA-N Leu-Lys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O RZXLZBIUTDQHJQ-SRVKXCTJSA-N 0.000 description 22
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 22
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 21
- VOZIBWWZSBIXQN-SRVKXCTJSA-N Pro-Glu-Lys Chemical compound NCCCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O VOZIBWWZSBIXQN-SRVKXCTJSA-N 0.000 description 20
- 239000013612 plasmid Substances 0.000 description 20
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 19
- SVABRQFIHCSNCI-FOHZUACHSA-N Asp-Gly-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SVABRQFIHCSNCI-FOHZUACHSA-N 0.000 description 19
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 19
- 108010037850 glycylvaline Proteins 0.000 description 19
- 108010061238 threonyl-glycine Proteins 0.000 description 19
- 108010003137 tyrosyltyrosine Proteins 0.000 description 19
- SWTQDYFZVOJVLL-KKUMJFAQSA-N Asp-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N)O SWTQDYFZVOJVLL-KKUMJFAQSA-N 0.000 description 18
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 18
- OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 18
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 18
- RVQDZELMXZRSSI-IUCAKERBSA-N Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 RVQDZELMXZRSSI-IUCAKERBSA-N 0.000 description 18
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 18
- 108020001507 fusion proteins Proteins 0.000 description 18
- 102000037865 fusion proteins Human genes 0.000 description 18
- 108010089804 glycyl-threonine Proteins 0.000 description 18
- OLVIPTLKNSAYRJ-YUMQZZPRSA-N Asn-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N OLVIPTLKNSAYRJ-YUMQZZPRSA-N 0.000 description 17
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 17
- HQUXQAMSWFIRET-AVGNSLFASA-N Leu-Glu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HQUXQAMSWFIRET-AVGNSLFASA-N 0.000 description 17
- RUCNAYOMFXRIKJ-DCAQKATOSA-N Val-Ala-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RUCNAYOMFXRIKJ-DCAQKATOSA-N 0.000 description 17
- 108010070643 prolylglutamic acid Proteins 0.000 description 17
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 16
- JEPNYDRDYNSFIU-QXEWZRGKSA-N Asn-Arg-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(N)=O)C(O)=O JEPNYDRDYNSFIU-QXEWZRGKSA-N 0.000 description 16
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 16
- 241000588724 Escherichia coli Species 0.000 description 16
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 16
- TUTIHHSZKFBMHM-WHFBIAKZSA-N Glu-Asn Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O TUTIHHSZKFBMHM-WHFBIAKZSA-N 0.000 description 16
- IOWJRKAVLALBQB-IWGUZYHVSA-N Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O IOWJRKAVLALBQB-IWGUZYHVSA-N 0.000 description 16
- 108010054155 lysyllysine Proteins 0.000 description 16
- KUTPGXNAAOQSPD-LPEHRKFASA-N Glu-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O KUTPGXNAAOQSPD-LPEHRKFASA-N 0.000 description 15
- IWWMPCPLFXFBAF-SRVKXCTJSA-N Lys-Asp-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O IWWMPCPLFXFBAF-SRVKXCTJSA-N 0.000 description 15
- HJOSVGCWOTYJFG-WDCWCFNPSA-N Thr-Glu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O HJOSVGCWOTYJFG-WDCWCFNPSA-N 0.000 description 15
- AAZOYLQUEQRUMZ-GSSVUCPTSA-N Thr-Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O AAZOYLQUEQRUMZ-GSSVUCPTSA-N 0.000 description 15
- VSCIANXXVZOYOC-AVGNSLFASA-N Val-Pro-His Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N VSCIANXXVZOYOC-AVGNSLFASA-N 0.000 description 15
- 238000010367 cloning Methods 0.000 description 15
- KXEVYGKATAMXJJ-ACZMJKKPSA-N Ala-Glu-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KXEVYGKATAMXJJ-ACZMJKKPSA-N 0.000 description 14
- RJONUNZIMUXUOI-GUBZILKMSA-N Glu-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N RJONUNZIMUXUOI-GUBZILKMSA-N 0.000 description 14
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 14
- IMAKMJCBYCSMHM-AVGNSLFASA-N Lys-Glu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN IMAKMJCBYCSMHM-AVGNSLFASA-N 0.000 description 14
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 14
- BXNGIHFNNNSEOS-UWVGGRQHSA-N Phe-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 BXNGIHFNNNSEOS-UWVGGRQHSA-N 0.000 description 14
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 14
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 13
- NLYYHIKRBRMAJV-AEJSXWLSSA-N Ala-Val-Pro Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N NLYYHIKRBRMAJV-AEJSXWLSSA-N 0.000 description 13
- SJUXYGVRSGTPMC-IMJSIDKUSA-N Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O SJUXYGVRSGTPMC-IMJSIDKUSA-N 0.000 description 13
- UKGGPJNBONZZCM-WDSKDSINSA-N Asp-Pro Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O UKGGPJNBONZZCM-WDSKDSINSA-N 0.000 description 13
- IRDASPPCLZIERZ-XHNCKOQMSA-N Glu-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N IRDASPPCLZIERZ-XHNCKOQMSA-N 0.000 description 13
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 13
- IOUQWHIEQYQVFD-JYJNAYRXSA-N Glu-Leu-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IOUQWHIEQYQVFD-JYJNAYRXSA-N 0.000 description 13
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 13
- XUORRGAFUQIMLC-STQMWFEESA-N Gly-Arg-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)O XUORRGAFUQIMLC-STQMWFEESA-N 0.000 description 13
- UXJHNZODTMHWRD-WHFBIAKZSA-N Gly-Asn-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O UXJHNZODTMHWRD-WHFBIAKZSA-N 0.000 description 13
- YEIYAQQKADPIBJ-GARJFASQSA-N Lys-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)N)C(=O)O YEIYAQQKADPIBJ-GARJFASQSA-N 0.000 description 13
- RIJCHEVHFWMDKD-SRVKXCTJSA-N Lys-Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RIJCHEVHFWMDKD-SRVKXCTJSA-N 0.000 description 13
- FPQMQEOVSKMVMA-ACRUOGEOSA-N Lys-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CCCCN)N)O FPQMQEOVSKMVMA-ACRUOGEOSA-N 0.000 description 13
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 13
- DFQZDQPLWBSFEJ-LSJOCFKGSA-N Val-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DFQZDQPLWBSFEJ-LSJOCFKGSA-N 0.000 description 13
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 13
- 108010085059 glutamyl-arginyl-proline Proteins 0.000 description 13
- 108010087823 glycyltyrosine Proteins 0.000 description 13
- NPDLYUOYAGBHFB-WDSKDSINSA-N Asn-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NPDLYUOYAGBHFB-WDSKDSINSA-N 0.000 description 12
- FHETWELNCBMRMG-HJGDQZAQSA-N Asn-Leu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FHETWELNCBMRMG-HJGDQZAQSA-N 0.000 description 12
- UQBGYPFHWFZMCD-ZLUOBGJFSA-N Asp-Asn-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O UQBGYPFHWFZMCD-ZLUOBGJFSA-N 0.000 description 12
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 12
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 12
- HKTRDWYCAUTRRL-YUMQZZPRSA-N Glu-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 HKTRDWYCAUTRRL-YUMQZZPRSA-N 0.000 description 12
- LLXVQPKEQQCISF-YUMQZZPRSA-N Gly-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN LLXVQPKEQQCISF-YUMQZZPRSA-N 0.000 description 12
- VBOFRJNDIOPNDO-YUMQZZPRSA-N His-Gly-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N VBOFRJNDIOPNDO-YUMQZZPRSA-N 0.000 description 12
- FBTYOQIYBULKEH-ZFWWWQNUSA-N His-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CNC=N1 FBTYOQIYBULKEH-ZFWWWQNUSA-N 0.000 description 12
- XBBKIIGCUMBKCO-JXUBOQSCSA-N Leu-Ala-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XBBKIIGCUMBKCO-JXUBOQSCSA-N 0.000 description 12
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 12
- JGAMUXDWYSXYLM-SRVKXCTJSA-N Lys-Arg-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O JGAMUXDWYSXYLM-SRVKXCTJSA-N 0.000 description 12
- GCMWRRQAKQXDED-IUCAKERBSA-N Lys-Glu-Gly Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)N[C@@H](CCC([O-])=O)C(=O)NCC([O-])=O GCMWRRQAKQXDED-IUCAKERBSA-N 0.000 description 12
- ATIPDCIQTUXABX-UWVGGRQHSA-N Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ATIPDCIQTUXABX-UWVGGRQHSA-N 0.000 description 12
- LJADEBULDNKJNK-IHRRRGAJSA-N Lys-Leu-Val Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LJADEBULDNKJNK-IHRRRGAJSA-N 0.000 description 12
- ZJSZPXISKMDJKQ-JYJNAYRXSA-N Lys-Phe-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(O)=O)CC1=CC=CC=C1 ZJSZPXISKMDJKQ-JYJNAYRXSA-N 0.000 description 12
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 12
- 101100228799 Schizosaccharomyces pombe (strain 972 / ATCC 24843) gem6 gene Proteins 0.000 description 12
- 108010064997 VPY tripeptide Proteins 0.000 description 12
- HHSILIQTHXABKM-YDHLFZDLSA-N Val-Asp-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O HHSILIQTHXABKM-YDHLFZDLSA-N 0.000 description 12
- GIAZPLMMQOERPN-YUMQZZPRSA-N Val-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GIAZPLMMQOERPN-YUMQZZPRSA-N 0.000 description 12
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 12
- 108010015792 glycyllysine Proteins 0.000 description 12
- 108010040030 histidinoalanine Proteins 0.000 description 12
- 230000003053 immunization Effects 0.000 description 12
- 238000002649 immunization Methods 0.000 description 12
- 108010079317 prolyl-tyrosine Proteins 0.000 description 12
- RCFGLXMZDYNRSC-CIUDSAMLSA-N Asn-Lys-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O RCFGLXMZDYNRSC-CIUDSAMLSA-N 0.000 description 11
- GKKUBLFXKRDMFC-BQBZGAKWSA-N Asn-Pro-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O GKKUBLFXKRDMFC-BQBZGAKWSA-N 0.000 description 11
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 11
- UHVIQGKBMXEVGN-WDSKDSINSA-N Glu-Gly-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UHVIQGKBMXEVGN-WDSKDSINSA-N 0.000 description 11
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 11
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 11
- FELJDCNGZFDUNR-WDSKDSINSA-N Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FELJDCNGZFDUNR-WDSKDSINSA-N 0.000 description 11
- ABSSTGUCBCDKMU-UWVGGRQHSA-N Pro-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H]1CCCN1 ABSSTGUCBCDKMU-UWVGGRQHSA-N 0.000 description 11
- OIDKVWTWGDWMHY-RYUDHWBXSA-N Pro-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 OIDKVWTWGDWMHY-RYUDHWBXSA-N 0.000 description 11
- JHDZONWZTCKTJR-KJEVXHAQSA-N Tyr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JHDZONWZTCKTJR-KJEVXHAQSA-N 0.000 description 11
- JXWGBRRVTRAZQA-ULQDDVLXSA-N Val-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N JXWGBRRVTRAZQA-ULQDDVLXSA-N 0.000 description 11
- 108010041407 alanylaspartic acid Proteins 0.000 description 11
- 108010054813 diprotin B Proteins 0.000 description 11
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 11
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 11
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 11
- 108010012581 phenylalanylglutamate Proteins 0.000 description 11
- GSCLWXDNIMNIJE-ZLUOBGJFSA-N Ala-Asp-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GSCLWXDNIMNIJE-ZLUOBGJFSA-N 0.000 description 10
- XSPKAHFVDKRGRL-DCAQKATOSA-N Arg-Pro-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XSPKAHFVDKRGRL-DCAQKATOSA-N 0.000 description 10
- SLKLLQWZQHXYSV-CIUDSAMLSA-N Asn-Ala-Lys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O SLKLLQWZQHXYSV-CIUDSAMLSA-N 0.000 description 10
- VFUXXFVCYZPOQG-WDSKDSINSA-N Asp-Glu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VFUXXFVCYZPOQG-WDSKDSINSA-N 0.000 description 10
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 10
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 10
- OCDLPQDYTJPWNG-YUMQZZPRSA-N Gly-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN OCDLPQDYTJPWNG-YUMQZZPRSA-N 0.000 description 10
- VHOLZZKNEBBHTH-YUMQZZPRSA-N His-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 VHOLZZKNEBBHTH-YUMQZZPRSA-N 0.000 description 10
- UXSATKFPUVZVDK-KKUMJFAQSA-N His-Lys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CN=CN1)N UXSATKFPUVZVDK-KKUMJFAQSA-N 0.000 description 10
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 10
- WSGXUIQTEZDVHJ-GARJFASQSA-N Leu-Ala-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O WSGXUIQTEZDVHJ-GARJFASQSA-N 0.000 description 10
- ZURHXHNAEJJRNU-CIUDSAMLSA-N Leu-Asp-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZURHXHNAEJJRNU-CIUDSAMLSA-N 0.000 description 10
- BTEMNFBEAAOGBR-BZSNNMDCSA-N Leu-Tyr-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BTEMNFBEAAOGBR-BZSNNMDCSA-N 0.000 description 10
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 10
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 description 10
- 241001644525 Nastus productus Species 0.000 description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 description 10
- FYQSMXKJYTZYRP-DCAQKATOSA-N Pro-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FYQSMXKJYTZYRP-DCAQKATOSA-N 0.000 description 10
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 10
- VTVVYQOXJCZVEB-WDCWCFNPSA-N Thr-Leu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O VTVVYQOXJCZVEB-WDCWCFNPSA-N 0.000 description 10
- NDXSOKGYKCGYKT-VEVYYDQMSA-N Thr-Pro-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O NDXSOKGYKCGYKT-VEVYYDQMSA-N 0.000 description 10
- WCRFXRIWBFRZBR-GGVZMXCHSA-N Thr-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WCRFXRIWBFRZBR-GGVZMXCHSA-N 0.000 description 10
- LVRFMARKDGGZMX-IZPVPAKOSA-N Thr-Tyr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=C(O)C=C1 LVRFMARKDGGZMX-IZPVPAKOSA-N 0.000 description 10
- ZMDCGGKHRKNWKD-LAEOZQHASA-N Val-Asn-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZMDCGGKHRKNWKD-LAEOZQHASA-N 0.000 description 10
- CVIXTAITYJQMPE-LAEOZQHASA-N Val-Glu-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CVIXTAITYJQMPE-LAEOZQHASA-N 0.000 description 10
- ZXYPHBKIZLAQTL-QXEWZRGKSA-N Val-Pro-Asp Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N ZXYPHBKIZLAQTL-QXEWZRGKSA-N 0.000 description 10
- DVLWZWNAQUBZBC-ZNSHCXBVSA-N Val-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N)O DVLWZWNAQUBZBC-ZNSHCXBVSA-N 0.000 description 10
- 108010087924 alanylproline Proteins 0.000 description 10
- 108010070783 alanyltyrosine Proteins 0.000 description 10
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 10
- 108010092854 aspartyllysine Proteins 0.000 description 10
- 239000012472 biological sample Substances 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 10
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 10
- 108010020688 glycylhistidine Proteins 0.000 description 10
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 10
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 9
- BTYTYHBSJKQBQA-GCJQMDKQSA-N Ala-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)O BTYTYHBSJKQBQA-GCJQMDKQSA-N 0.000 description 9
- MAISCYVJLBBRNU-DCAQKATOSA-N Arg-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N MAISCYVJLBBRNU-DCAQKATOSA-N 0.000 description 9
- UPKMBGAAEZGHOC-RWMBFGLXSA-N Arg-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O UPKMBGAAEZGHOC-RWMBFGLXSA-N 0.000 description 9
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 9
- OOWSBIOUKIUWLO-RCOVLWMOSA-N Asn-Gly-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O OOWSBIOUKIUWLO-RCOVLWMOSA-N 0.000 description 9
- JRCASHGTXZYSPW-XIRDDKMYSA-N Asn-His-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CC(=O)N)N JRCASHGTXZYSPW-XIRDDKMYSA-N 0.000 description 9
- GIQCDTKOIPUDSG-GARJFASQSA-N Asn-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)N)C(=O)O GIQCDTKOIPUDSG-GARJFASQSA-N 0.000 description 9
- WSOKZUVWBXVJHX-CIUDSAMLSA-N Asp-Arg-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O WSOKZUVWBXVJHX-CIUDSAMLSA-N 0.000 description 9
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 9
- MYLZFUMPZCPJCJ-NHCYSSNCSA-N Asp-Lys-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MYLZFUMPZCPJCJ-NHCYSSNCSA-N 0.000 description 9
- VHUKCUHLFMRHOD-MELADBBJSA-N Asp-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O VHUKCUHLFMRHOD-MELADBBJSA-N 0.000 description 9
- JJKKWYQVHRUSDG-GUBZILKMSA-N Glu-Ala-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O JJKKWYQVHRUSDG-GUBZILKMSA-N 0.000 description 9
- SBCYJMOOHUDWDA-NUMRIWBASA-N Glu-Asp-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SBCYJMOOHUDWDA-NUMRIWBASA-N 0.000 description 9
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 9
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 9
- RMWAOBGCZZSJHE-UMNHJUIQSA-N Glu-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N RMWAOBGCZZSJHE-UMNHJUIQSA-N 0.000 description 9
- GGEJHJIXRBTJPD-BYPYZUCNSA-N Gly-Asn-Gly Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GGEJHJIXRBTJPD-BYPYZUCNSA-N 0.000 description 9
- FMNHBTKMRFVGRO-FOHZUACHSA-N Gly-Asn-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN FMNHBTKMRFVGRO-FOHZUACHSA-N 0.000 description 9
- PDAWDNVHMUKWJR-ZETCQYMHSA-N Gly-Gly-His Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 PDAWDNVHMUKWJR-ZETCQYMHSA-N 0.000 description 9
- YIWFXZNIBQBFHR-LURJTMIESA-N Gly-His Chemical compound [NH3+]CC(=O)N[C@H](C([O-])=O)CC1=CN=CN1 YIWFXZNIBQBFHR-LURJTMIESA-N 0.000 description 9
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 9
- CVFOYJJOZYYEPE-KBPBESRZSA-N Gly-Lys-Tyr Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CVFOYJJOZYYEPE-KBPBESRZSA-N 0.000 description 9
- NIKBMHGRNAPJFW-IUCAKERBSA-N His-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 NIKBMHGRNAPJFW-IUCAKERBSA-N 0.000 description 9
- NOQPTNXSGNPJNS-YUMQZZPRSA-N His-Asn-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O NOQPTNXSGNPJNS-YUMQZZPRSA-N 0.000 description 9
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 9
- OBVCYFIHIIYIQF-CIUDSAMLSA-N Pro-Asn-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OBVCYFIHIIYIQF-CIUDSAMLSA-N 0.000 description 9
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 9
- XFFIGWGYMUFCCQ-ULQDDVLXSA-N Pro-His-Tyr Chemical compound C1=CC(O)=CC=C1C[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H]1[NH2+]CCC1)CC1=CN=CN1 XFFIGWGYMUFCCQ-ULQDDVLXSA-N 0.000 description 9
- IURWWZYKYPEANQ-HJGDQZAQSA-N Pro-Thr-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O IURWWZYKYPEANQ-HJGDQZAQSA-N 0.000 description 9
- AIOWVDNPESPXRB-YTWAJWBKSA-N Pro-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2)O AIOWVDNPESPXRB-YTWAJWBKSA-N 0.000 description 9
- YHUBAXGAAYULJY-ULQDDVLXSA-N Pro-Tyr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O YHUBAXGAAYULJY-ULQDDVLXSA-N 0.000 description 9
- NOWXWJLVGTVJKM-PBCZWWQYSA-N Thr-Asp-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O NOWXWJLVGTVJKM-PBCZWWQYSA-N 0.000 description 9
- AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 9
- WXVIGTAUZBUDPZ-DTLFHODZSA-N Thr-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 WXVIGTAUZBUDPZ-DTLFHODZSA-N 0.000 description 9
- OSXNCKRGMSHWSQ-ACRUOGEOSA-N Tyr-His-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OSXNCKRGMSHWSQ-ACRUOGEOSA-N 0.000 description 9
- DDRBQONWVBDQOY-GUBZILKMSA-N Val-Ala-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DDRBQONWVBDQOY-GUBZILKMSA-N 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 9
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 9
- 230000004083 survival effect Effects 0.000 description 9
- 108010020532 tyrosyl-proline Proteins 0.000 description 9
- WQVFQXXBNHHPLX-ZKWXMUAHSA-N Ala-Ala-His Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O WQVFQXXBNHHPLX-ZKWXMUAHSA-N 0.000 description 8
- SHYYAQLDNVHPFT-DLOVCJGASA-N Ala-Asn-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SHYYAQLDNVHPFT-DLOVCJGASA-N 0.000 description 8
- JDIQCVUDDFENPU-ZKWXMUAHSA-N Ala-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CNC=N1 JDIQCVUDDFENPU-ZKWXMUAHSA-N 0.000 description 8
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 8
- AENHOIXXHKNIQL-AUTRQRHGSA-N Ala-Tyr-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]([NH3+])C)CC1=CC=C(O)C=C1 AENHOIXXHKNIQL-AUTRQRHGSA-N 0.000 description 8
- HXWUJJADFMXNKA-BQBZGAKWSA-N Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O HXWUJJADFMXNKA-BQBZGAKWSA-N 0.000 description 8
- NSTBNYOKCZKOMI-AVGNSLFASA-N Asn-Tyr-Glu Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O NSTBNYOKCZKOMI-AVGNSLFASA-N 0.000 description 8
- BLQBMRNMBAYREH-UWJYBYFXSA-N Asp-Ala-Tyr Chemical compound N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O BLQBMRNMBAYREH-UWJYBYFXSA-N 0.000 description 8
- GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 8
- RDRMWJBLOSRRAW-BYULHYEWSA-N Asp-Asn-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O RDRMWJBLOSRRAW-BYULHYEWSA-N 0.000 description 8
- CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 description 8
- QCLHLXDWRKOHRR-GUBZILKMSA-N Asp-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N QCLHLXDWRKOHRR-GUBZILKMSA-N 0.000 description 8
- YRBGRUOSJROZEI-NHCYSSNCSA-N Asp-His-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(O)=O YRBGRUOSJROZEI-NHCYSSNCSA-N 0.000 description 8
- KKZHXOOZHFABQQ-UWJYBYFXSA-N Cys-Ala-Tyr Chemical compound SC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KKZHXOOZHFABQQ-UWJYBYFXSA-N 0.000 description 8
- 239000003298 DNA probe Substances 0.000 description 8
- CKRUHITYRFNUKW-WDSKDSINSA-N Glu-Asn-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CKRUHITYRFNUKW-WDSKDSINSA-N 0.000 description 8
- PHONAZGUEGIOEM-GLLZPBPUSA-N Glu-Glu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PHONAZGUEGIOEM-GLLZPBPUSA-N 0.000 description 8
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 8
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 8
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 8
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 8
- WDEHMRNSGHVNOH-VHSXEESVSA-N Gly-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)CN)C(=O)O WDEHMRNSGHVNOH-VHSXEESVSA-N 0.000 description 8
- VDCRBJACQKOSMS-JSGCOSHPSA-N Gly-Phe-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O VDCRBJACQKOSMS-JSGCOSHPSA-N 0.000 description 8
- HTOOKGDPMXSJSY-STQMWFEESA-N His-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 HTOOKGDPMXSJSY-STQMWFEESA-N 0.000 description 8
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 8
- WGNOPSQMIQERPK-GARJFASQSA-N Leu-Asn-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N WGNOPSQMIQERPK-GARJFASQSA-N 0.000 description 8
- LESXFEZIFXFIQR-LURJTMIESA-N Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(O)=O LESXFEZIFXFIQR-LURJTMIESA-N 0.000 description 8
- PJWOOBTYQNNRBF-BZSNNMDCSA-N Leu-Phe-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)O)N PJWOOBTYQNNRBF-BZSNNMDCSA-N 0.000 description 8
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 8
- HKCCVDWHHTVVPN-CIUDSAMLSA-N Lys-Asp-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O HKCCVDWHHTVVPN-CIUDSAMLSA-N 0.000 description 8
- OWRUUFUVXFREBD-KKUMJFAQSA-N Lys-His-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O OWRUUFUVXFREBD-KKUMJFAQSA-N 0.000 description 8
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 8
- AIXUQKMMBQJZCU-IUCAKERBSA-N Lys-Pro Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O AIXUQKMMBQJZCU-IUCAKERBSA-N 0.000 description 8
- CNGOEHJCLVCJHN-SRVKXCTJSA-N Lys-Pro-Glu Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O CNGOEHJCLVCJHN-SRVKXCTJSA-N 0.000 description 8
- YSPZCHGIWAQVKQ-AVGNSLFASA-N Lys-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN YSPZCHGIWAQVKQ-AVGNSLFASA-N 0.000 description 8
- YQAIUOWPSUOINN-IUCAKERBSA-N Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN YQAIUOWPSUOINN-IUCAKERBSA-N 0.000 description 8
- VKCPHIOZDWUFSW-ONGXEEELSA-N Lys-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN VKCPHIOZDWUFSW-ONGXEEELSA-N 0.000 description 8
- DMEYUTSDVRCWRS-ULQDDVLXSA-N Phe-Lys-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 DMEYUTSDVRCWRS-ULQDDVLXSA-N 0.000 description 8
- SJRQWEDYTKYHHL-SLFFLAALSA-N Phe-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=CC=C3)N)C(=O)O SJRQWEDYTKYHHL-SLFFLAALSA-N 0.000 description 8
- YXHYJEPDKSYPSQ-AVGNSLFASA-N Pro-Leu-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 YXHYJEPDKSYPSQ-AVGNSLFASA-N 0.000 description 8
- FZXSYIPVAFVYBH-KKUMJFAQSA-N Pro-Tyr-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O FZXSYIPVAFVYBH-KKUMJFAQSA-N 0.000 description 8
- GNHRVXYZKWSJTF-HJGDQZAQSA-N Thr-Asp-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GNHRVXYZKWSJTF-HJGDQZAQSA-N 0.000 description 8
- KBBRNEDOYWMIJP-KYNKHSRBSA-N Thr-Gly-Thr Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KBBRNEDOYWMIJP-KYNKHSRBSA-N 0.000 description 8
- KZURUCDWKDEAFZ-XVSYOHENSA-N Thr-Phe-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O KZURUCDWKDEAFZ-XVSYOHENSA-N 0.000 description 8
- GQEXFCQNAJHJTI-IHPCNDPISA-N Trp-Phe-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N GQEXFCQNAJHJTI-IHPCNDPISA-N 0.000 description 8
- HPYDSVWYXXKHRD-VIFPVBQESA-N Tyr-Gly Chemical compound [O-]C(=O)CNC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 HPYDSVWYXXKHRD-VIFPVBQESA-N 0.000 description 8
- KCPFDGNYAMKZQP-KBPBESRZSA-N Tyr-Gly-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O KCPFDGNYAMKZQP-KBPBESRZSA-N 0.000 description 8
- CTDPLKMBVALCGN-JSGCOSHPSA-N Tyr-Gly-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O CTDPLKMBVALCGN-JSGCOSHPSA-N 0.000 description 8
- KLQPIEVIKOQRAW-IZPVPAKOSA-N Tyr-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O KLQPIEVIKOQRAW-IZPVPAKOSA-N 0.000 description 8
- CXWJFWAZIVWBOS-XQQFMLRXSA-N Val-Lys-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N CXWJFWAZIVWBOS-XQQFMLRXSA-N 0.000 description 8
- UOUIMEGEPSBZIV-ULQDDVLXSA-N Val-Lys-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UOUIMEGEPSBZIV-ULQDDVLXSA-N 0.000 description 8
- 108010013835 arginine glutamate Proteins 0.000 description 8
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 8
- 108010085325 histidylproline Proteins 0.000 description 8
- 108010038320 lysylphenylalanine Proteins 0.000 description 8
- 108010025826 prolyl-leucyl-arginine Proteins 0.000 description 8
- 108010077112 prolyl-proline Proteins 0.000 description 8
- 108010029020 prolylglycine Proteins 0.000 description 8
- 108091008146 restriction endonucleases Proteins 0.000 description 8
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 7
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 7
- VQAVBBCZFQAAED-FXQIFTODSA-N Ala-Pro-Asn Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N VQAVBBCZFQAAED-FXQIFTODSA-N 0.000 description 7
- BTRULDJUUVGRNE-DCAQKATOSA-N Ala-Pro-Lys Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O BTRULDJUUVGRNE-DCAQKATOSA-N 0.000 description 7
- XAXMJQUMRJAFCH-CQDKDKBSSA-N Ala-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 XAXMJQUMRJAFCH-CQDKDKBSSA-N 0.000 description 7
- DGFXIWKPTDKBLF-AVGNSLFASA-N Arg-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCN=C(N)N)N DGFXIWKPTDKBLF-AVGNSLFASA-N 0.000 description 7
- UZGFHWIJWPUPOH-IHRRRGAJSA-N Arg-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UZGFHWIJWPUPOH-IHRRRGAJSA-N 0.000 description 7
- XTWSWDJMIKUJDQ-RYUDHWBXSA-N Arg-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XTWSWDJMIKUJDQ-RYUDHWBXSA-N 0.000 description 7
- BKFXFUPYETWGGA-XVSYOHENSA-N Asn-Phe-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BKFXFUPYETWGGA-XVSYOHENSA-N 0.000 description 7
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 7
- VGRHZPNRCLAHQA-IMJSIDKUSA-N Asp-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O VGRHZPNRCLAHQA-IMJSIDKUSA-N 0.000 description 7
- PZXPWHFYZXTFBI-YUMQZZPRSA-N Asp-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PZXPWHFYZXTFBI-YUMQZZPRSA-N 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 7
- 241000701022 Cytomegalovirus Species 0.000 description 7
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 7
- SVZIKUHLRKVZIF-GUBZILKMSA-N Glu-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N SVZIKUHLRKVZIF-GUBZILKMSA-N 0.000 description 7
- YBAFDPFAUTYYRW-YUMQZZPRSA-N Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O YBAFDPFAUTYYRW-YUMQZZPRSA-N 0.000 description 7
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 7
- YTSVAIMKVLZUDU-YUMQZZPRSA-N Gly-Leu-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YTSVAIMKVLZUDU-YUMQZZPRSA-N 0.000 description 7
- XBGGUPMXALFZOT-VIFPVBQESA-N Gly-Tyr Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-VIFPVBQESA-N 0.000 description 7
- JCOSMKPAOYDKRO-AVGNSLFASA-N His-Glu-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N JCOSMKPAOYDKRO-AVGNSLFASA-N 0.000 description 7
- GNBHSMFBUNEWCJ-DCAQKATOSA-N His-Pro-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O GNBHSMFBUNEWCJ-DCAQKATOSA-N 0.000 description 7
- PYNPBMCLAKTHJL-SRVKXCTJSA-N His-Pro-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O PYNPBMCLAKTHJL-SRVKXCTJSA-N 0.000 description 7
- HIJIJPFILYPTFR-ACRUOGEOSA-N His-Tyr-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HIJIJPFILYPTFR-ACRUOGEOSA-N 0.000 description 7
- CZCSUZMIRKFFFA-CIUDSAMLSA-N Leu-Ala-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O CZCSUZMIRKFFFA-CIUDSAMLSA-N 0.000 description 7
- XIRYQRLFHWWWTC-QEJZJMRPSA-N Leu-Ala-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XIRYQRLFHWWWTC-QEJZJMRPSA-N 0.000 description 7
- APFJUBGRZGMQFF-QWRGUYRKSA-N Leu-Gly-Lys Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN APFJUBGRZGMQFF-QWRGUYRKSA-N 0.000 description 7
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 7
- VULJUQZPSOASBZ-SRVKXCTJSA-N Leu-Pro-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O VULJUQZPSOASBZ-SRVKXCTJSA-N 0.000 description 7
- KWLWZYMNUZJKMZ-IHRRRGAJSA-N Leu-Pro-Leu Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O KWLWZYMNUZJKMZ-IHRRRGAJSA-N 0.000 description 7
- NTBFKPBULZGXQL-KKUMJFAQSA-N Lys-Asp-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NTBFKPBULZGXQL-KKUMJFAQSA-N 0.000 description 7
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 7
- ISHNZELVUVPCHY-ZETCQYMHSA-N Lys-Gly-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O ISHNZELVUVPCHY-ZETCQYMHSA-N 0.000 description 7
- UQRZFMQQXXJTTF-AVGNSLFASA-N Lys-Lys-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O UQRZFMQQXXJTTF-AVGNSLFASA-N 0.000 description 7
- OBZHNHBAAVEWKI-DCAQKATOSA-N Lys-Pro-Asn Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O OBZHNHBAAVEWKI-DCAQKATOSA-N 0.000 description 7
- WGILOYIKJVQUPT-DCAQKATOSA-N Lys-Pro-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WGILOYIKJVQUPT-DCAQKATOSA-N 0.000 description 7
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 7
- WPTYDQPGBMDUBI-QWRGUYRKSA-N Phe-Gly-Asn Chemical compound N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O WPTYDQPGBMDUBI-QWRGUYRKSA-N 0.000 description 7
- PMKIMKUGCSVFSV-CQDKDKBSSA-N Phe-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=CC=C2)N PMKIMKUGCSVFSV-CQDKDKBSSA-N 0.000 description 7
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 7
- APKRGYLBSCWJJP-FXQIFTODSA-N Pro-Ala-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O APKRGYLBSCWJJP-FXQIFTODSA-N 0.000 description 7
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 7
- QHSSUIHLAIWXEE-IHRRRGAJSA-N Pro-Tyr-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O QHSSUIHLAIWXEE-IHRRRGAJSA-N 0.000 description 7
- ZSPQUTWLWGWTPS-HJGDQZAQSA-N Thr-Lys-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZSPQUTWLWGWTPS-HJGDQZAQSA-N 0.000 description 7
- VGYVVSQFSSKZRJ-OEAJRASXSA-N Thr-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CC=CC=C1 VGYVVSQFSSKZRJ-OEAJRASXSA-N 0.000 description 7
- PALLCTDPFINNMM-JQHSSLGASA-N Trp-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N PALLCTDPFINNMM-JQHSSLGASA-N 0.000 description 7
- CKKFTIQYURNSEI-IHRRRGAJSA-N Tyr-Asn-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CKKFTIQYURNSEI-IHRRRGAJSA-N 0.000 description 7
- SQUMHUZLJDUROQ-YDHLFZDLSA-N Tyr-Val-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O SQUMHUZLJDUROQ-YDHLFZDLSA-N 0.000 description 7
- PQPWEALFTLKSEB-DZKIICNBSA-N Tyr-Val-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PQPWEALFTLKSEB-DZKIICNBSA-N 0.000 description 7
- SZTTYWIUCGSURQ-AUTRQRHGSA-N Val-Glu-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SZTTYWIUCGSURQ-AUTRQRHGSA-N 0.000 description 7
- XWYUBUYQMOUFRQ-IFFSRLJSSA-N Val-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N)O XWYUBUYQMOUFRQ-IFFSRLJSSA-N 0.000 description 7
- XPKCFQZDQGVJCX-RHYQMDGZSA-N Val-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N)O XPKCFQZDQGVJCX-RHYQMDGZSA-N 0.000 description 7
- 239000011543 agarose gel Substances 0.000 description 7
- 108010010096 glycyl-glycyl-tyrosine Proteins 0.000 description 7
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- YAXNATKKPOWVCP-ZLUOBGJFSA-N Ala-Asn-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O YAXNATKKPOWVCP-ZLUOBGJFSA-N 0.000 description 6
- XEXJJJRVTFGWIC-FXQIFTODSA-N Ala-Asn-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XEXJJJRVTFGWIC-FXQIFTODSA-N 0.000 description 6
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 6
- HHRAXZAYZFFRAM-CIUDSAMLSA-N Ala-Leu-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O HHRAXZAYZFFRAM-CIUDSAMLSA-N 0.000 description 6
- BLTRAARCJYVJKV-QEJZJMRPSA-N Ala-Lys-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O BLTRAARCJYVJKV-QEJZJMRPSA-N 0.000 description 6
- YEBZNKPPOHFZJM-BPNCWPANSA-N Ala-Tyr-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O YEBZNKPPOHFZJM-BPNCWPANSA-N 0.000 description 6
- ASQKVGRCKOFKIU-KZVJFYERSA-N Arg-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ASQKVGRCKOFKIU-KZVJFYERSA-N 0.000 description 6
- DDBMKOCQWNFDBH-RHYQMDGZSA-N Arg-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O DDBMKOCQWNFDBH-RHYQMDGZSA-N 0.000 description 6
- LEFKSBYHUGUWLP-ACZMJKKPSA-N Asn-Ala-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LEFKSBYHUGUWLP-ACZMJKKPSA-N 0.000 description 6
- CBWCQCANJSGUOH-ZKWXMUAHSA-N Asn-Val-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O CBWCQCANJSGUOH-ZKWXMUAHSA-N 0.000 description 6
- UGKZHCBLMLSANF-CIUDSAMLSA-N Asp-Asn-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UGKZHCBLMLSANF-CIUDSAMLSA-N 0.000 description 6
- JDHOJQJMWBKHDB-CIUDSAMLSA-N Asp-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N JDHOJQJMWBKHDB-CIUDSAMLSA-N 0.000 description 6
- IVPNEDNYYYFAGI-GARJFASQSA-N Asp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N IVPNEDNYYYFAGI-GARJFASQSA-N 0.000 description 6
- NVFSJIXJZCDICF-SRVKXCTJSA-N Asp-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N NVFSJIXJZCDICF-SRVKXCTJSA-N 0.000 description 6
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 6
- DINOVZWPTMGSRF-QXEWZRGKSA-N Asp-Pro-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O DINOVZWPTMGSRF-QXEWZRGKSA-N 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 6
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 6
- YBTCBQBIJKGSJP-BQBZGAKWSA-N Glu-Pro Chemical compound OC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O YBTCBQBIJKGSJP-BQBZGAKWSA-N 0.000 description 6
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 6
- IEFJWDNGDZAYNZ-BYPYZUCNSA-N Gly-Glu Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(O)=O IEFJWDNGDZAYNZ-BYPYZUCNSA-N 0.000 description 6
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 6
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 6
- LYCVKHSJGDMDLM-LURJTMIESA-N His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1 LYCVKHSJGDMDLM-LURJTMIESA-N 0.000 description 6
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 6
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 6
- MUXNCRWTWBMNHX-SRVKXCTJSA-N Lys-Leu-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O MUXNCRWTWBMNHX-SRVKXCTJSA-N 0.000 description 6
- QQPSCXKFDSORFT-IHRRRGAJSA-N Lys-Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN QQPSCXKFDSORFT-IHRRRGAJSA-N 0.000 description 6
- BOJYMMBYBNOOGG-DCAQKATOSA-N Lys-Pro-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O BOJYMMBYBNOOGG-DCAQKATOSA-N 0.000 description 6
- GIKFNMZSGYAPEJ-HJGDQZAQSA-N Lys-Thr-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O GIKFNMZSGYAPEJ-HJGDQZAQSA-N 0.000 description 6
- SEPNOAFMZLLCEW-UBHSHLNASA-N Phe-Ala-Val Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O SEPNOAFMZLLCEW-UBHSHLNASA-N 0.000 description 6
- WGXOKDLDIWSOCV-MELADBBJSA-N Phe-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O WGXOKDLDIWSOCV-MELADBBJSA-N 0.000 description 6
- RMODQFBNDDENCP-IHRRRGAJSA-N Pro-Lys-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O RMODQFBNDDENCP-IHRRRGAJSA-N 0.000 description 6
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 6
- 101100460200 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) NEW1 gene Proteins 0.000 description 6
- 101100167780 Schizosaccharomyces pombe (strain 972 / ATCC 24843) coa2 gene Proteins 0.000 description 6
- 101100172625 Schizosaccharomyces pombe (strain 972 / ATCC 24843) erh1 gene Proteins 0.000 description 6
- 101100460198 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new14 gene Proteins 0.000 description 6
- 101100273916 Schizosaccharomyces pombe (strain 972 / ATCC 24843) wip1 gene Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- SWIKDOUVROTZCW-GCJQMDKQSA-N Thr-Asn-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O SWIKDOUVROTZCW-GCJQMDKQSA-N 0.000 description 6
- LMMDEZPNUTZJAY-GCJQMDKQSA-N Thr-Asp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O LMMDEZPNUTZJAY-GCJQMDKQSA-N 0.000 description 6
- MFEBUIFJVPNZLO-OLHMAJIHSA-N Thr-Asp-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O MFEBUIFJVPNZLO-OLHMAJIHSA-N 0.000 description 6
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 6
- YRJOLUDFVAUXLI-GSSVUCPTSA-N Thr-Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O YRJOLUDFVAUXLI-GSSVUCPTSA-N 0.000 description 6
- FYBFTPLPAXZBOY-KKHAAJSZSA-N Thr-Val-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O FYBFTPLPAXZBOY-KKHAAJSZSA-N 0.000 description 6
- ZWZOCUWOXSDYFZ-CQDKDKBSSA-N Tyr-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ZWZOCUWOXSDYFZ-CQDKDKBSSA-N 0.000 description 6
- QHONGSVIVOFKAC-ULQDDVLXSA-N Tyr-Pro-His Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O QHONGSVIVOFKAC-ULQDDVLXSA-N 0.000 description 6
- PAPWZOJOLKZEFR-AVGNSLFASA-N Val-Arg-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N PAPWZOJOLKZEFR-AVGNSLFASA-N 0.000 description 6
- KTEZUXISLQTDDQ-NHCYSSNCSA-N Val-Lys-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KTEZUXISLQTDDQ-NHCYSSNCSA-N 0.000 description 6
- NZGOVKLVQNOEKP-YDHLFZDLSA-N Val-Phe-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N NZGOVKLVQNOEKP-YDHLFZDLSA-N 0.000 description 6
- QWCZXKIFPWPQHR-JYJNAYRXSA-N Val-Pro-Tyr Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QWCZXKIFPWPQHR-JYJNAYRXSA-N 0.000 description 6
- 108010010430 asparagine-proline-alanine Proteins 0.000 description 6
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 230000002163 immunogen Effects 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- RVLOMLVNNBWRSR-KNIFDHDWSA-N (2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O RVLOMLVNNBWRSR-KNIFDHDWSA-N 0.000 description 5
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 5
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 5
- MKZCBYZBCINNJN-DLOVCJGASA-N Ala-Asp-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MKZCBYZBCINNJN-DLOVCJGASA-N 0.000 description 5
- OMMDTNGURYRDAC-NRPADANISA-N Ala-Glu-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OMMDTNGURYRDAC-NRPADANISA-N 0.000 description 5
- BLIMFWGRQKRCGT-YUMQZZPRSA-N Ala-Gly-Lys Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN BLIMFWGRQKRCGT-YUMQZZPRSA-N 0.000 description 5
- BUQICHWNXBIBOG-LMVFSUKVSA-N Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)N BUQICHWNXBIBOG-LMVFSUKVSA-N 0.000 description 5
- ZJLORAAXDAJLDC-CQDKDKBSSA-N Ala-Tyr-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O ZJLORAAXDAJLDC-CQDKDKBSSA-N 0.000 description 5
- PAPSMOYMQDWIOR-AVGNSLFASA-N Arg-Lys-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PAPSMOYMQDWIOR-AVGNSLFASA-N 0.000 description 5
- STHNZYKCJHWULY-AVGNSLFASA-N Arg-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O STHNZYKCJHWULY-AVGNSLFASA-N 0.000 description 5
- ZJBUILVYSXQNSW-YTWAJWBKSA-N Arg-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ZJBUILVYSXQNSW-YTWAJWBKSA-N 0.000 description 5
- QMQZYILAWUOLPV-JYJNAYRXSA-N Arg-Tyr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CC1=CC=C(O)C=C1 QMQZYILAWUOLPV-JYJNAYRXSA-N 0.000 description 5
- RJUHZPRQRQLCFL-IMJSIDKUSA-N Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O RJUHZPRQRQLCFL-IMJSIDKUSA-N 0.000 description 5
- WQLJRNRLHWJIRW-KKUMJFAQSA-N Asn-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N)O WQLJRNRLHWJIRW-KKUMJFAQSA-N 0.000 description 5
- QYRMBFWDSFGSFC-OLHMAJIHSA-N Asn-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QYRMBFWDSFGSFC-OLHMAJIHSA-N 0.000 description 5
- XLDMSQYOYXINSZ-QXEWZRGKSA-N Asn-Val-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N XLDMSQYOYXINSZ-QXEWZRGKSA-N 0.000 description 5
- CBHVAFXKOYAHOY-NHCYSSNCSA-N Asn-Val-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O CBHVAFXKOYAHOY-NHCYSSNCSA-N 0.000 description 5
- JHFNSBBHKSZXKB-VKHMYHEASA-N Asp-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(O)=O JHFNSBBHKSZXKB-VKHMYHEASA-N 0.000 description 5
- ORRJQLIATJDMQM-HJGDQZAQSA-N Asp-Leu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O ORRJQLIATJDMQM-HJGDQZAQSA-N 0.000 description 5
- JZDHUJAFXGNDSB-WHFBIAKZSA-N Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O JZDHUJAFXGNDSB-WHFBIAKZSA-N 0.000 description 5
- PBEQPAZRHDVJQI-SRVKXCTJSA-N Glu-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N PBEQPAZRHDVJQI-SRVKXCTJSA-N 0.000 description 5
- VPKBCVUDBNINAH-GARJFASQSA-N Glu-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O VPKBCVUDBNINAH-GARJFASQSA-N 0.000 description 5
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 5
- HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 5
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 5
- ZJFNRQHUIHKZJF-GUBZILKMSA-N Glu-His-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O ZJFNRQHUIHKZJF-GUBZILKMSA-N 0.000 description 5
- HRBYTAIBKPNZKQ-AVGNSLFASA-N Glu-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O HRBYTAIBKPNZKQ-AVGNSLFASA-N 0.000 description 5
- SITLTJHOQZFJGG-XPUUQOCRSA-N Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O SITLTJHOQZFJGG-XPUUQOCRSA-N 0.000 description 5
- MFVQGXGQRIXBPK-WDSKDSINSA-N Gly-Ala-Glu Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFVQGXGQRIXBPK-WDSKDSINSA-N 0.000 description 5
- GAFKBWKVXNERFA-QWRGUYRKSA-N Gly-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 GAFKBWKVXNERFA-QWRGUYRKSA-N 0.000 description 5
- OLIFSFOFKGKIRH-WUJLRWPWSA-N Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CN OLIFSFOFKGKIRH-WUJLRWPWSA-N 0.000 description 5
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 5
- GWCJMBNBFYBQCV-XPUUQOCRSA-N Gly-Val-Ala Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O GWCJMBNBFYBQCV-XPUUQOCRSA-N 0.000 description 5
- TXLQHACKRLWYCM-DCAQKATOSA-N His-Glu-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O TXLQHACKRLWYCM-DCAQKATOSA-N 0.000 description 5
- QOOWRKBDDXQRHC-BQBZGAKWSA-N L-lysyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN QOOWRKBDDXQRHC-BQBZGAKWSA-N 0.000 description 5
- HASRFYOMVPJRPU-SRVKXCTJSA-N Leu-Arg-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HASRFYOMVPJRPU-SRVKXCTJSA-N 0.000 description 5
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 5
- WXUOJXIGOPMDJM-SRVKXCTJSA-N Leu-Lys-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O WXUOJXIGOPMDJM-SRVKXCTJSA-N 0.000 description 5
- GZRABTMNWJXFMH-UVOCVTCTSA-N Leu-Thr-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZRABTMNWJXFMH-UVOCVTCTSA-N 0.000 description 5
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 5
- NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 5
- CIOWSLJGLSUOME-BQBZGAKWSA-N Lys-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O CIOWSLJGLSUOME-BQBZGAKWSA-N 0.000 description 5
- KPJJOZUXFOLGMQ-CIUDSAMLSA-N Lys-Asp-Asn Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N KPJJOZUXFOLGMQ-CIUDSAMLSA-N 0.000 description 5
- GJJQCBVRWDGLMQ-GUBZILKMSA-N Lys-Glu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O GJJQCBVRWDGLMQ-GUBZILKMSA-N 0.000 description 5
- MDDUIRLQCYVRDO-NHCYSSNCSA-N Lys-Val-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN MDDUIRLQCYVRDO-NHCYSSNCSA-N 0.000 description 5
- UGCIQUYEJIEHKX-GVXVVHGQSA-N Lys-Val-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O UGCIQUYEJIEHKX-GVXVVHGQSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 108700026244 Open Reading Frames Proteins 0.000 description 5
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 5
- KYYMILWEGJYPQZ-IHRRRGAJSA-N Phe-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KYYMILWEGJYPQZ-IHRRRGAJSA-N 0.000 description 5
- ZLGQEBCCANLYRA-RYUDHWBXSA-N Phe-Gly-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O ZLGQEBCCANLYRA-RYUDHWBXSA-N 0.000 description 5
- GTMSCDVFQLNEOY-BZSNNMDCSA-N Phe-Tyr-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N GTMSCDVFQLNEOY-BZSNNMDCSA-N 0.000 description 5
- VJLJGKQAOQJXJG-CIUDSAMLSA-N Pro-Asp-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VJLJGKQAOQJXJG-CIUDSAMLSA-N 0.000 description 5
- UUHXBJHVTVGSKM-BQBZGAKWSA-N Pro-Gly-Asn Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UUHXBJHVTVGSKM-BQBZGAKWSA-N 0.000 description 5
- VWXGFAIZUQBBBG-UWVGGRQHSA-N Pro-His-Gly Chemical compound C([C@@H](C(=O)NCC(=O)[O-])NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 VWXGFAIZUQBBBG-UWVGGRQHSA-N 0.000 description 5
- YDTUEBLEAVANFH-RCWTZXSCSA-N Pro-Val-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 YDTUEBLEAVANFH-RCWTZXSCSA-N 0.000 description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 description 5
- 108010025216 RVF peptide Proteins 0.000 description 5
- 101100460204 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new4 gene Proteins 0.000 description 5
- 101100322386 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new8 gene Proteins 0.000 description 5
- 101100460205 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new9 gene Proteins 0.000 description 5
- VPZKQTYZIVOJDV-LMVFSUKVSA-N Thr-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(O)=O VPZKQTYZIVOJDV-LMVFSUKVSA-N 0.000 description 5
- YOSLMIPKOUAHKI-OLHMAJIHSA-N Thr-Asp-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O YOSLMIPKOUAHKI-OLHMAJIHSA-N 0.000 description 5
- XDARBNMYXKUFOJ-GSSVUCPTSA-N Thr-Asp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XDARBNMYXKUFOJ-GSSVUCPTSA-N 0.000 description 5
- BIYXEUAFGLTAEM-WUJLRWPWSA-N Thr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(O)=O BIYXEUAFGLTAEM-WUJLRWPWSA-N 0.000 description 5
- XFTYVCHLARBHBQ-FOHZUACHSA-N Thr-Gly-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XFTYVCHLARBHBQ-FOHZUACHSA-N 0.000 description 5
- MXNAOGFNFNKUPD-JHYOHUSXSA-N Thr-Phe-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MXNAOGFNFNKUPD-JHYOHUSXSA-N 0.000 description 5
- QOLYAJSZHIJCTO-VQVTYTSYSA-N Thr-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O QOLYAJSZHIJCTO-VQVTYTSYSA-N 0.000 description 5
- JAJOFWABAUKAEJ-QTKMDUPCSA-N Thr-Pro-His Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O JAJOFWABAUKAEJ-QTKMDUPCSA-N 0.000 description 5
- CKHWEVXPLJBEOZ-VQVTYTSYSA-N Thr-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])[C@@H](C)O CKHWEVXPLJBEOZ-VQVTYTSYSA-N 0.000 description 5
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 5
- RCLOWEZASFJFEX-KKUMJFAQSA-N Tyr-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RCLOWEZASFJFEX-KKUMJFAQSA-N 0.000 description 5
- NQJDICVXXIMMMB-XDTLVQLUSA-N Tyr-Glu-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O NQJDICVXXIMMMB-XDTLVQLUSA-N 0.000 description 5
- NZFCWALTLNFHHC-JYJNAYRXSA-N Tyr-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NZFCWALTLNFHHC-JYJNAYRXSA-N 0.000 description 5
- GZWPQZDVTBZVEP-BZSNNMDCSA-N Tyr-Tyr-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O GZWPQZDVTBZVEP-BZSNNMDCSA-N 0.000 description 5
- YKBUNNNRNZZUID-UFYCRDLUSA-N Tyr-Val-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YKBUNNNRNZZUID-UFYCRDLUSA-N 0.000 description 5
- HNWQUBBOBKSFQV-AVGNSLFASA-N Val-Arg-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N HNWQUBBOBKSFQV-AVGNSLFASA-N 0.000 description 5
- WITCOKQIPFWQQD-FSPLSTOPSA-N Val-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O WITCOKQIPFWQQD-FSPLSTOPSA-N 0.000 description 5
- YDPFWRVQHFWBKI-GVXVVHGQSA-N Val-Glu-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N YDPFWRVQHFWBKI-GVXVVHGQSA-N 0.000 description 5
- UEHRGZCNLSWGHK-DLOVCJGASA-N Val-Glu-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UEHRGZCNLSWGHK-DLOVCJGASA-N 0.000 description 5
- RWOGENDAOGMHLX-DCAQKATOSA-N Val-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N RWOGENDAOGMHLX-DCAQKATOSA-N 0.000 description 5
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 5
- MIKHIIQMRFYVOR-RCWTZXSCSA-N Val-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)N)O MIKHIIQMRFYVOR-RCWTZXSCSA-N 0.000 description 5
- 125000000539 amino acid group Chemical group 0.000 description 5
- 108010036533 arginylvaline Proteins 0.000 description 5
- 210000004899 c-terminal region Anatomy 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 238000003018 immunoassay Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 101150066555 lacZ gene Proteins 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 5
- 238000002255 vaccination Methods 0.000 description 5
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 5
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 4
- OAIGZYFGCNNVIE-ZPFDUUQYSA-N Ala-Val-Asp-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O OAIGZYFGCNNVIE-ZPFDUUQYSA-N 0.000 description 4
- XNSKSTRGQIPTSE-ACZMJKKPSA-N Arg-Thr Chemical compound C[C@@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O XNSKSTRGQIPTSE-ACZMJKKPSA-N 0.000 description 4
- PSUXEQYPYZLNER-QXEWZRGKSA-N Arg-Val-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PSUXEQYPYZLNER-QXEWZRGKSA-N 0.000 description 4
- AKEBUSZTMQLNIX-UWJYBYFXSA-N Asn-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N AKEBUSZTMQLNIX-UWJYBYFXSA-N 0.000 description 4
- HAJWYALLJIATCX-FXQIFTODSA-N Asn-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N HAJWYALLJIATCX-FXQIFTODSA-N 0.000 description 4
- VKCOHFFSTKCXEQ-OLHMAJIHSA-N Asn-Asn-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VKCOHFFSTKCXEQ-OLHMAJIHSA-N 0.000 description 4
- KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 4
- FFMIYIMKQIMDPK-BQBZGAKWSA-N Asn-His Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 FFMIYIMKQIMDPK-BQBZGAKWSA-N 0.000 description 4
- GLWFAWNYGWBMOC-SRVKXCTJSA-N Asn-Leu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GLWFAWNYGWBMOC-SRVKXCTJSA-N 0.000 description 4
- FTSAJSADJCMDHH-CIUDSAMLSA-N Asn-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N FTSAJSADJCMDHH-CIUDSAMLSA-N 0.000 description 4
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 4
- FRYULLIZUDQONW-IMJSIDKUSA-N Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FRYULLIZUDQONW-IMJSIDKUSA-N 0.000 description 4
- HSPSXROIMXIJQW-BQBZGAKWSA-N Asp-His Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 HSPSXROIMXIJQW-BQBZGAKWSA-N 0.000 description 4
- MVRGBQGZSDJBSM-GMOBBJLQSA-N Asp-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)N MVRGBQGZSDJBSM-GMOBBJLQSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 102100021277 Beta-secretase 2 Human genes 0.000 description 4
- 101710150190 Beta-secretase 2 Proteins 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 description 4
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 4
- ZPASCJBSSCRWMC-GVXVVHGQSA-N Glu-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N ZPASCJBSSCRWMC-GVXVVHGQSA-N 0.000 description 4
- MFNUFCFRAZPJFW-JYJNAYRXSA-N Glu-Lys-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFNUFCFRAZPJFW-JYJNAYRXSA-N 0.000 description 4
- SWDNPSMMEWRNOH-HJGDQZAQSA-N Glu-Pro-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWDNPSMMEWRNOH-HJGDQZAQSA-N 0.000 description 4
- HZISRJBYZAODRV-XQXXSGGOSA-N Glu-Thr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O HZISRJBYZAODRV-XQXXSGGOSA-N 0.000 description 4
- UMZHHILWZBFPGL-LOKLDPHHSA-N Glu-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O UMZHHILWZBFPGL-LOKLDPHHSA-N 0.000 description 4
- SOYWRINXUSUWEQ-DLOVCJGASA-N Glu-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O SOYWRINXUSUWEQ-DLOVCJGASA-N 0.000 description 4
- FUESBOMYALLFNI-VKHMYHEASA-N Gly-Asn Chemical compound NCC(=O)N[C@H](C(O)=O)CC(N)=O FUESBOMYALLFNI-VKHMYHEASA-N 0.000 description 4
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 4
- DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 4
- AFWYPMDMDYCKMD-KBPBESRZSA-N Gly-Leu-Tyr Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 AFWYPMDMDYCKMD-KBPBESRZSA-N 0.000 description 4
- WSDOHRLQDGAOGU-BQBZGAKWSA-N His-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 WSDOHRLQDGAOGU-BQBZGAKWSA-N 0.000 description 4
- WMKXFMUJRCEGRP-SRVKXCTJSA-N His-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N WMKXFMUJRCEGRP-SRVKXCTJSA-N 0.000 description 4
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 4
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 4
- QLROSWPKSBORFJ-BQBZGAKWSA-N L-Prolyl-L-glutamic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 QLROSWPKSBORFJ-BQBZGAKWSA-N 0.000 description 4
- YKNBJXOJTURHCU-DCAQKATOSA-N Leu-Asp-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKNBJXOJTURHCU-DCAQKATOSA-N 0.000 description 4
- YVKSMSDXKMSIRX-GUBZILKMSA-N Leu-Glu-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O YVKSMSDXKMSIRX-GUBZILKMSA-N 0.000 description 4
- BIZNDKMFQHDOIE-KKUMJFAQSA-N Leu-Phe-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 BIZNDKMFQHDOIE-KKUMJFAQSA-N 0.000 description 4
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 4
- VJGQRELPQWNURN-JYJNAYRXSA-N Leu-Tyr-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O VJGQRELPQWNURN-JYJNAYRXSA-N 0.000 description 4
- FBNPMTNBFFAMMH-AVGNSLFASA-N Leu-Val-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-AVGNSLFASA-N 0.000 description 4
- VHXMZJGOKIMETG-CQDKDKBSSA-N Lys-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCCCN)N VHXMZJGOKIMETG-CQDKDKBSSA-N 0.000 description 4
- FACUGMGEFUEBTI-SRVKXCTJSA-N Lys-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN FACUGMGEFUEBTI-SRVKXCTJSA-N 0.000 description 4
- ZXEUFAVXODIPHC-GUBZILKMSA-N Lys-Glu-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZXEUFAVXODIPHC-GUBZILKMSA-N 0.000 description 4
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 4
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 4
- HVAUKHLDSDDROB-KKUMJFAQSA-N Lys-Lys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HVAUKHLDSDDROB-KKUMJFAQSA-N 0.000 description 4
- PLDJDCJLRCYPJB-VOAKCMCISA-N Lys-Lys-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PLDJDCJLRCYPJB-VOAKCMCISA-N 0.000 description 4
- BXPHMHQHYHILBB-BZSNNMDCSA-N Lys-Lys-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BXPHMHQHYHILBB-BZSNNMDCSA-N 0.000 description 4
- QCZYYEFXOBKCNQ-STQMWFEESA-N Lys-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QCZYYEFXOBKCNQ-STQMWFEESA-N 0.000 description 4
- QVTDVTONTRSQMF-WDCWCFNPSA-N Lys-Thr-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CCCCN QVTDVTONTRSQMF-WDCWCFNPSA-N 0.000 description 4
- OZVXDDFYCQOPFD-XQQFMLRXSA-N Lys-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N OZVXDDFYCQOPFD-XQQFMLRXSA-N 0.000 description 4
- 101100301239 Myxococcus xanthus recA1 gene Proteins 0.000 description 4
- QPVFUAUFEBPIPT-CDMKHQONSA-N Phe-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QPVFUAUFEBPIPT-CDMKHQONSA-N 0.000 description 4
- SFKOEHXABNPLRT-KBPBESRZSA-N Phe-His-Gly Chemical compound N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NCC(O)=O SFKOEHXABNPLRT-KBPBESRZSA-N 0.000 description 4
- DBALDZKOTNSBFM-FXQIFTODSA-N Pro-Ala-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DBALDZKOTNSBFM-FXQIFTODSA-N 0.000 description 4
- VCYJKOLZYPYGJV-AVGNSLFASA-N Pro-Arg-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VCYJKOLZYPYGJV-AVGNSLFASA-N 0.000 description 4
- TXPUNZXZDVJUJQ-LPEHRKFASA-N Pro-Asn-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N2CCC[C@@H]2C(=O)O TXPUNZXZDVJUJQ-LPEHRKFASA-N 0.000 description 4
- KIPIKSXPPLABPN-CIUDSAMLSA-N Pro-Glu-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 KIPIKSXPPLABPN-CIUDSAMLSA-N 0.000 description 4
- SXMSEHDMNIUTSP-DCAQKATOSA-N Pro-Lys-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O SXMSEHDMNIUTSP-DCAQKATOSA-N 0.000 description 4
- AWJGUZSYVIVZGP-YUMQZZPRSA-N Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 AWJGUZSYVIVZGP-YUMQZZPRSA-N 0.000 description 4
- 101100255212 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rsa3 gene Proteins 0.000 description 4
- 101100210181 Schizosaccharomyces pombe (strain 972 / ATCC 24843) vts1 gene Proteins 0.000 description 4
- 238000012300 Sequence Analysis Methods 0.000 description 4
- 241000680505 Streptococcus pneumoniae WU2 Species 0.000 description 4
- MQCPGOZXFSYJPS-KZVJFYERSA-N Thr-Ala-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MQCPGOZXFSYJPS-KZVJFYERSA-N 0.000 description 4
- PQLXHSACXPGWPD-GSSVUCPTSA-N Thr-Asn-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PQLXHSACXPGWPD-GSSVUCPTSA-N 0.000 description 4
- PZVGOVRNGKEFCB-KKHAAJSZSA-N Thr-Asn-Val Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N)O PZVGOVRNGKEFCB-KKHAAJSZSA-N 0.000 description 4
- SCSVNSNWUTYSFO-WDCWCFNPSA-N Thr-Lys-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O SCSVNSNWUTYSFO-WDCWCFNPSA-N 0.000 description 4
- WTXQBCCKXIKKHB-JYJNAYRXSA-N Tyr-Arg-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WTXQBCCKXIKKHB-JYJNAYRXSA-N 0.000 description 4
- ONWMQORSVZYVNH-UWVGGRQHSA-N Tyr-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ONWMQORSVZYVNH-UWVGGRQHSA-N 0.000 description 4
- QZOSVNLXLSNHQK-UWVGGRQHSA-N Tyr-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QZOSVNLXLSNHQK-UWVGGRQHSA-N 0.000 description 4
- PDSLRCZINIDLMU-QWRGUYRKSA-N Tyr-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PDSLRCZINIDLMU-QWRGUYRKSA-N 0.000 description 4
- NVJCMGGZHOJNBU-UFYCRDLUSA-N Tyr-Val-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N NVJCMGGZHOJNBU-UFYCRDLUSA-N 0.000 description 4
- UPJONISHZRADBH-XPUUQOCRSA-N Val-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UPJONISHZRADBH-XPUUQOCRSA-N 0.000 description 4
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 4
- IJGPOONOTBNTFS-GVXVVHGQSA-N Val-Lys-Glu Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O IJGPOONOTBNTFS-GVXVVHGQSA-N 0.000 description 4
- WMRWZYSRQUORHJ-YDHLFZDLSA-N Val-Phe-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WMRWZYSRQUORHJ-YDHLFZDLSA-N 0.000 description 4
- NHXZRXLFOBFMDM-AVGNSLFASA-N Val-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C NHXZRXLFOBFMDM-AVGNSLFASA-N 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 108010060035 arginylproline Proteins 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 108010053037 kyotorphin Proteins 0.000 description 4
- 239000013600 plasmid vector Substances 0.000 description 4
- 108010004914 prolylarginine Proteins 0.000 description 4
- 108010053725 prolylvaline Proteins 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- ALBODLTZUXKBGZ-JUUVMNCLSA-N (2s)-2-amino-3-phenylpropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 ALBODLTZUXKBGZ-JUUVMNCLSA-N 0.000 description 3
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 3
- GFBLJMHGHAXGNY-ZLUOBGJFSA-N Ala-Asn-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GFBLJMHGHAXGNY-ZLUOBGJFSA-N 0.000 description 3
- NWVVKQZOVSTDBQ-CIUDSAMLSA-N Ala-Glu-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NWVVKQZOVSTDBQ-CIUDSAMLSA-N 0.000 description 3
- QUIGLPSHIFPEOV-CIUDSAMLSA-N Ala-Lys-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O QUIGLPSHIFPEOV-CIUDSAMLSA-N 0.000 description 3
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 3
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 3
- CHFFHQUVXHEGBY-GARJFASQSA-N Ala-Lys-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N CHFFHQUVXHEGBY-GARJFASQSA-N 0.000 description 3
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 3
- YCTIYBUTCKNOTI-UWJYBYFXSA-N Ala-Tyr-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCTIYBUTCKNOTI-UWJYBYFXSA-N 0.000 description 3
- SKTGPBFTMNLIHQ-KKUMJFAQSA-N Arg-Glu-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SKTGPBFTMNLIHQ-KKUMJFAQSA-N 0.000 description 3
- SSZGOKWBHLOCHK-DCAQKATOSA-N Arg-Lys-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N SSZGOKWBHLOCHK-DCAQKATOSA-N 0.000 description 3
- LQJAALCCPOTJGB-YUMQZZPRSA-N Arg-Pro Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O LQJAALCCPOTJGB-YUMQZZPRSA-N 0.000 description 3
- WOZDCBHUGJVJPL-AVGNSLFASA-N Arg-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WOZDCBHUGJVJPL-AVGNSLFASA-N 0.000 description 3
- FXGMURPOWCKNAZ-JYJNAYRXSA-N Arg-Val-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FXGMURPOWCKNAZ-JYJNAYRXSA-N 0.000 description 3
- HZYFHQOWCFUSOV-IMJSIDKUSA-N Asn-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O HZYFHQOWCFUSOV-IMJSIDKUSA-N 0.000 description 3
- JREOBWLIZLXRIS-GUBZILKMSA-N Asn-Glu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JREOBWLIZLXRIS-GUBZILKMSA-N 0.000 description 3
- OLGCWMNDJTWQAG-GUBZILKMSA-N Asn-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(N)=O OLGCWMNDJTWQAG-GUBZILKMSA-N 0.000 description 3
- JQSWHKKUZMTOIH-QWRGUYRKSA-N Asn-Gly-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N JQSWHKKUZMTOIH-QWRGUYRKSA-N 0.000 description 3
- NLRJGXZWTKXRHP-DCAQKATOSA-N Asn-Leu-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NLRJGXZWTKXRHP-DCAQKATOSA-N 0.000 description 3
- NYGILGUOUOXGMJ-YUMQZZPRSA-N Asn-Lys-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O NYGILGUOUOXGMJ-YUMQZZPRSA-N 0.000 description 3
- OVPHVTCDVYYTHN-AVGNSLFASA-N Asp-Glu-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OVPHVTCDVYYTHN-AVGNSLFASA-N 0.000 description 3
- WYOSXGYAKZQPGF-SRVKXCTJSA-N Asp-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC(=O)O)N WYOSXGYAKZQPGF-SRVKXCTJSA-N 0.000 description 3
- KPSHWSWFPUDEGF-FXQIFTODSA-N Asp-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(O)=O KPSHWSWFPUDEGF-FXQIFTODSA-N 0.000 description 3
- BWJZSLQJNBSUPM-FXQIFTODSA-N Asp-Pro-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O BWJZSLQJNBSUPM-FXQIFTODSA-N 0.000 description 3
- NTQDELBZOMWXRS-IWGUZYHVSA-N Asp-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O NTQDELBZOMWXRS-IWGUZYHVSA-N 0.000 description 3
- 108020003215 DNA Probes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- NCWOMXABNYEPLY-NRPADANISA-N Glu-Ala-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O NCWOMXABNYEPLY-NRPADANISA-N 0.000 description 3
- GLWXKFRTOHKGIT-ACZMJKKPSA-N Glu-Asn-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GLWXKFRTOHKGIT-ACZMJKKPSA-N 0.000 description 3
- QJCKNLPMTPXXEM-AUTRQRHGSA-N Glu-Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O QJCKNLPMTPXXEM-AUTRQRHGSA-N 0.000 description 3
- OCJRHJZKGGSPRW-IUCAKERBSA-N Glu-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O OCJRHJZKGGSPRW-IUCAKERBSA-N 0.000 description 3
- JRDYDYXZKFNNRQ-XPUUQOCRSA-N Gly-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN JRDYDYXZKFNNRQ-XPUUQOCRSA-N 0.000 description 3
- OGCIHJPYKVSMTE-YUMQZZPRSA-N Gly-Arg-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O OGCIHJPYKVSMTE-YUMQZZPRSA-N 0.000 description 3
- SCCPDJAQCXWPTF-VKHMYHEASA-N Gly-Asp Chemical compound NCC(=O)N[C@H](C(O)=O)CC(O)=O SCCPDJAQCXWPTF-VKHMYHEASA-N 0.000 description 3
- LIXWIUAORXJNBH-QWRGUYRKSA-N Gly-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN LIXWIUAORXJNBH-QWRGUYRKSA-N 0.000 description 3
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 3
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 3
- HQSKKSLNLSTONK-JTQLQIEISA-N Gly-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 HQSKKSLNLSTONK-JTQLQIEISA-N 0.000 description 3
- RYAOJUMWLWUGNW-QMMMGPOBSA-N Gly-Val-Gly Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O RYAOJUMWLWUGNW-QMMMGPOBSA-N 0.000 description 3
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 3
- KWBISLAEQZUYIC-UWJYBYFXSA-N His-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CN=CN2)N KWBISLAEQZUYIC-UWJYBYFXSA-N 0.000 description 3
- STOOMQFEJUVAKR-KKUMJFAQSA-N His-His-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CNC=N1 STOOMQFEJUVAKR-KKUMJFAQSA-N 0.000 description 3
- VYUXYMRNGALHEA-DLOVCJGASA-N His-Leu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O VYUXYMRNGALHEA-DLOVCJGASA-N 0.000 description 3
- CZVQSYNVUHAILZ-UWVGGRQHSA-N His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 CZVQSYNVUHAILZ-UWVGGRQHSA-N 0.000 description 3
- LPBWRHRHEIYAIP-KKUMJFAQSA-N His-Tyr-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LPBWRHRHEIYAIP-KKUMJFAQSA-N 0.000 description 3
- 102000002265 Human Growth Hormone Human genes 0.000 description 3
- 108010000521 Human Growth Hormone Proteins 0.000 description 3
- 239000000854 Human Growth Hormone Substances 0.000 description 3
- KWTVLKBOQATPHJ-SRVKXCTJSA-N Leu-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N KWTVLKBOQATPHJ-SRVKXCTJSA-N 0.000 description 3
- IIKJNQWOQIWWMR-CIUDSAMLSA-N Leu-Cys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)N IIKJNQWOQIWWMR-CIUDSAMLSA-N 0.000 description 3
- NFNVDJGXRFEYTK-YUMQZZPRSA-N Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O NFNVDJGXRFEYTK-YUMQZZPRSA-N 0.000 description 3
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 3
- OTXBNHIUIHNGAO-UWVGGRQHSA-N Leu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN OTXBNHIUIHNGAO-UWVGGRQHSA-N 0.000 description 3
- IBSGMIPRBMPMHE-IHRRRGAJSA-N Leu-Met-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O IBSGMIPRBMPMHE-IHRRRGAJSA-N 0.000 description 3
- INCJJHQRZGQLFC-KBPBESRZSA-N Leu-Phe-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O INCJJHQRZGQLFC-KBPBESRZSA-N 0.000 description 3
- BTSXLXFPMZXVPR-DLOVCJGASA-N Lys-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCCN)N BTSXLXFPMZXVPR-DLOVCJGASA-N 0.000 description 3
- ABHIXYDMILIUKV-CIUDSAMLSA-N Lys-Asn-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ABHIXYDMILIUKV-CIUDSAMLSA-N 0.000 description 3
- UGTZHPSKYRIGRJ-YUMQZZPRSA-N Lys-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UGTZHPSKYRIGRJ-YUMQZZPRSA-N 0.000 description 3
- NCZIQZYZPUPMKY-PPCPHDFISA-N Lys-Ile-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NCZIQZYZPUPMKY-PPCPHDFISA-N 0.000 description 3
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 3
- YXPJCVNIDDKGOE-MELADBBJSA-N Lys-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N)C(=O)O YXPJCVNIDDKGOE-MELADBBJSA-N 0.000 description 3
- ALEVUGKHINJNIF-QEJZJMRPSA-N Lys-Phe-Ala Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 ALEVUGKHINJNIF-QEJZJMRPSA-N 0.000 description 3
- UDXSLGLHFUBRRM-OEAJRASXSA-N Lys-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N)O UDXSLGLHFUBRRM-OEAJRASXSA-N 0.000 description 3
- ZOKVLMBYDSIDKG-CSMHCCOUSA-N Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ZOKVLMBYDSIDKG-CSMHCCOUSA-N 0.000 description 3
- PPNCMJARTHYNEC-MEYUZBJRSA-N Lys-Tyr-Thr Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)CC1=CC=C(O)C=C1 PPNCMJARTHYNEC-MEYUZBJRSA-N 0.000 description 3
- HMZPYMSEAALNAE-ULQDDVLXSA-N Lys-Val-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMZPYMSEAALNAE-ULQDDVLXSA-N 0.000 description 3
- 101100205189 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-5 gene Proteins 0.000 description 3
- QCHNRQQVLJYDSI-DLOVCJGASA-N Phe-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 QCHNRQQVLJYDSI-DLOVCJGASA-N 0.000 description 3
- HWMGTNOVUDIKRE-UWVGGRQHSA-N Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 HWMGTNOVUDIKRE-UWVGGRQHSA-N 0.000 description 3
- PEFJUUYFEGBXFA-BZSNNMDCSA-N Phe-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 PEFJUUYFEGBXFA-BZSNNMDCSA-N 0.000 description 3
- RBRNEFJTEHPDSL-ACRUOGEOSA-N Phe-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 RBRNEFJTEHPDSL-ACRUOGEOSA-N 0.000 description 3
- BSKMOCNNLNDIMU-CDMKHQONSA-N Phe-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O BSKMOCNNLNDIMU-CDMKHQONSA-N 0.000 description 3
- MSSXKZBDKZAHCX-UNQGMJICSA-N Phe-Thr-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O MSSXKZBDKZAHCX-UNQGMJICSA-N 0.000 description 3
- SSSFPISOZOLQNP-GUBZILKMSA-N Pro-Arg-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O SSSFPISOZOLQNP-GUBZILKMSA-N 0.000 description 3
- IHCXPSYCHXFXKT-DCAQKATOSA-N Pro-Arg-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O IHCXPSYCHXFXKT-DCAQKATOSA-N 0.000 description 3
- ZSKJPKFTPQCPIH-RCWTZXSCSA-N Pro-Arg-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZSKJPKFTPQCPIH-RCWTZXSCSA-N 0.000 description 3
- GLEOIKLQBZNKJZ-WDSKDSINSA-N Pro-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 GLEOIKLQBZNKJZ-WDSKDSINSA-N 0.000 description 3
- CLJLVCYFABNTHP-DCAQKATOSA-N Pro-Leu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O CLJLVCYFABNTHP-DCAQKATOSA-N 0.000 description 3
- FDMKYQQYJKYCLV-GUBZILKMSA-N Pro-Pro-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 FDMKYQQYJKYCLV-GUBZILKMSA-N 0.000 description 3
- CXGLFEOYCJFKPR-RCWTZXSCSA-N Pro-Thr-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O CXGLFEOYCJFKPR-RCWTZXSCSA-N 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 3
- JXKMXEBNZCKSDY-JIOCBJNQSA-N Thr-Asp-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O JXKMXEBNZCKSDY-JIOCBJNQSA-N 0.000 description 3
- IQHUITKNHOKGFC-MIMYLULJSA-N Thr-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IQHUITKNHOKGFC-MIMYLULJSA-N 0.000 description 3
- MUAFDCVOHYAFNG-RCWTZXSCSA-N Thr-Pro-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MUAFDCVOHYAFNG-RCWTZXSCSA-N 0.000 description 3
- XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 3
- BCYUHPXBHCUYBA-CUJWVEQBSA-N Thr-Ser-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O BCYUHPXBHCUYBA-CUJWVEQBSA-N 0.000 description 3
- VBMOVTMNHWPZJR-SUSMZKCASA-N Thr-Thr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VBMOVTMNHWPZJR-SUSMZKCASA-N 0.000 description 3
- PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 3
- TVOGEPLDNYTAHD-CQDKDKBSSA-N Tyr-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TVOGEPLDNYTAHD-CQDKDKBSSA-N 0.000 description 3
- AYPAIRCDLARHLM-KKUMJFAQSA-N Tyr-Asn-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O AYPAIRCDLARHLM-KKUMJFAQSA-N 0.000 description 3
- GAYLGYUVTDMLKC-UWJYBYFXSA-N Tyr-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GAYLGYUVTDMLKC-UWJYBYFXSA-N 0.000 description 3
- YIKDYZDNRCNFQB-KKUMJFAQSA-N Tyr-His-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O YIKDYZDNRCNFQB-KKUMJFAQSA-N 0.000 description 3
- BSCBBPKDVOZICB-KKUMJFAQSA-N Tyr-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BSCBBPKDVOZICB-KKUMJFAQSA-N 0.000 description 3
- PWKMJDQXKCENMF-MEYUZBJRSA-N Tyr-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O PWKMJDQXKCENMF-MEYUZBJRSA-N 0.000 description 3
- LNYOXPDEIZJDEI-NHCYSSNCSA-N Val-Asn-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N LNYOXPDEIZJDEI-NHCYSSNCSA-N 0.000 description 3
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 3
- ZRSZTKTVPNSUNA-IHRRRGAJSA-N Val-Lys-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(O)=O ZRSZTKTVPNSUNA-IHRRRGAJSA-N 0.000 description 3
- YLRAFVVWZRSZQC-DZKIICNBSA-N Val-Phe-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N YLRAFVVWZRSZQC-DZKIICNBSA-N 0.000 description 3
- 108010028939 alanyl-alanyl-lysyl-alanine Proteins 0.000 description 3
- 108010070944 alanylhistidine Proteins 0.000 description 3
- 108010011559 alanylphenylalanine Proteins 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 108010062796 arginyllysine Proteins 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 239000007330 chocolate agar Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 108010009297 diglycyl-histidine Proteins 0.000 description 3
- 238000012869 ethanol precipitation Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 108010028295 histidylhistidine Proteins 0.000 description 3
- 210000004408 hybridoma Anatomy 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 108010012058 leucyltyrosine Proteins 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 208000022218 streptococcal pneumonia Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- -1 synthetic multimers) Polymers 0.000 description 3
- 108010071097 threonyl-lysyl-proline Proteins 0.000 description 3
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 3
- 108010051110 tyrosyl-lysine Proteins 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- AUXMWYRZQPIXCC-KNIFDHDWSA-N (2s)-2-amino-4-methylpentanoic acid;(2s)-2-aminopropanoic acid Chemical compound C[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O AUXMWYRZQPIXCC-KNIFDHDWSA-N 0.000 description 2
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 2
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 2
- SKHCUBQVZJHOFM-NAKRPEOUSA-N Ala-Arg-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SKHCUBQVZJHOFM-NAKRPEOUSA-N 0.000 description 2
- CCUAQNUWXLYFRA-IMJSIDKUSA-N Ala-Asn Chemical compound C[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC(N)=O CCUAQNUWXLYFRA-IMJSIDKUSA-N 0.000 description 2
- XCVRVWZTXPCYJT-BIIVOSGPSA-N Ala-Asn-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N XCVRVWZTXPCYJT-BIIVOSGPSA-N 0.000 description 2
- WXERCAHAIKMTKX-ZLUOBGJFSA-N Ala-Asp-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O WXERCAHAIKMTKX-ZLUOBGJFSA-N 0.000 description 2
- YSMPVONNIWLJML-FXQIFTODSA-N Ala-Asp-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O YSMPVONNIWLJML-FXQIFTODSA-N 0.000 description 2
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 2
- VHVVPYOJIIQCKS-QEJZJMRPSA-N Ala-Leu-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VHVVPYOJIIQCKS-QEJZJMRPSA-N 0.000 description 2
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 2
- WPWUFUBLGADILS-WDSKDSINSA-N Ala-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WPWUFUBLGADILS-WDSKDSINSA-N 0.000 description 2
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 2
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 2
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 2
- LSMDIAAALJJLRO-XQXXSGGOSA-N Ala-Thr-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O LSMDIAAALJJLRO-XQXXSGGOSA-N 0.000 description 2
- DEAGTWNKODHUIY-MRFFXTKBSA-N Ala-Tyr-Trp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O DEAGTWNKODHUIY-MRFFXTKBSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OOBVTWHLKYJFJH-FXQIFTODSA-N Arg-Ala-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O OOBVTWHLKYJFJH-FXQIFTODSA-N 0.000 description 2
- HPKSHFSEXICTLI-CIUDSAMLSA-N Arg-Glu-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HPKSHFSEXICTLI-CIUDSAMLSA-N 0.000 description 2
- PNQWAUXQDBIJDY-GUBZILKMSA-N Arg-Glu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNQWAUXQDBIJDY-GUBZILKMSA-N 0.000 description 2
- AUFHLLPVPSMEOG-YUMQZZPRSA-N Arg-Gly-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AUFHLLPVPSMEOG-YUMQZZPRSA-N 0.000 description 2
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 2
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 2
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 2
- FSNVAJOPUDVQAR-AVGNSLFASA-N Arg-Lys-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FSNVAJOPUDVQAR-AVGNSLFASA-N 0.000 description 2
- IZSMEUDYADKZTJ-KJEVXHAQSA-N Arg-Tyr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IZSMEUDYADKZTJ-KJEVXHAQSA-N 0.000 description 2
- SWLOHUMCUDRTCL-ZLUOBGJFSA-N Asn-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N SWLOHUMCUDRTCL-ZLUOBGJFSA-N 0.000 description 2
- PPMTUXJSQDNUDE-CIUDSAMLSA-N Asn-Glu-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PPMTUXJSQDNUDE-CIUDSAMLSA-N 0.000 description 2
- OPEPUCYIGFEGSW-WDSKDSINSA-N Asn-Gly-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OPEPUCYIGFEGSW-WDSKDSINSA-N 0.000 description 2
- QEQVUHQQYDZUEN-GUBZILKMSA-N Asn-His-Glu Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N QEQVUHQQYDZUEN-GUBZILKMSA-N 0.000 description 2
- ACKNRKFVYUVWAC-ZPFDUUQYSA-N Asn-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ACKNRKFVYUVWAC-ZPFDUUQYSA-N 0.000 description 2
- PNHQRQTVBRDIEF-CIUDSAMLSA-N Asn-Leu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)N PNHQRQTVBRDIEF-CIUDSAMLSA-N 0.000 description 2
- DJIMLSXHXKWADV-CIUDSAMLSA-N Asn-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O DJIMLSXHXKWADV-CIUDSAMLSA-N 0.000 description 2
- QJMCHPGWFZZRID-BQBZGAKWSA-N Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O QJMCHPGWFZZRID-BQBZGAKWSA-N 0.000 description 2
- ZYPWIUFLYMQZBS-SRVKXCTJSA-N Asn-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ZYPWIUFLYMQZBS-SRVKXCTJSA-N 0.000 description 2
- ZUFPUBYQYWCMDB-NUMRIWBASA-N Asn-Thr-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZUFPUBYQYWCMDB-NUMRIWBASA-N 0.000 description 2
- PUUPMDXIHCOPJU-HJGDQZAQSA-N Asn-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O PUUPMDXIHCOPJU-HJGDQZAQSA-N 0.000 description 2
- WUQXMTITJLFXAU-JIOCBJNQSA-N Asn-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N)O WUQXMTITJLFXAU-JIOCBJNQSA-N 0.000 description 2
- YQPSDMUGFKJZHR-QRTARXTBSA-N Asn-Trp-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)N)N YQPSDMUGFKJZHR-QRTARXTBSA-N 0.000 description 2
- CNKAZIGBGQIHLL-GUBZILKMSA-N Asp-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N CNKAZIGBGQIHLL-GUBZILKMSA-N 0.000 description 2
- XACXDSRQIXRMNS-OLHMAJIHSA-N Asp-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N)O XACXDSRQIXRMNS-OLHMAJIHSA-N 0.000 description 2
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 2
- KYQNAIMCTRZLNP-QSFUFRPTSA-N Asp-Ile-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O KYQNAIMCTRZLNP-QSFUFRPTSA-N 0.000 description 2
- KGHLGJAXYSVNJP-WHFBIAKZSA-N Asp-Ser-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O KGHLGJAXYSVNJP-WHFBIAKZSA-N 0.000 description 2
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 2
- JJQGZGOEDSSHTE-FOHZUACHSA-N Asp-Thr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JJQGZGOEDSSHTE-FOHZUACHSA-N 0.000 description 2
- RSMZEHCMIOKNMW-GSSVUCPTSA-N Asp-Thr-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RSMZEHCMIOKNMW-GSSVUCPTSA-N 0.000 description 2
- NALWOULWGHTVDA-UWVGGRQHSA-N Asp-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NALWOULWGHTVDA-UWVGGRQHSA-N 0.000 description 2
- 101100289888 Caenorhabditis elegans lys-5 gene Proteins 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 241000672609 Escherichia coli BL21 Species 0.000 description 2
- VAZZOGXDUQSVQF-NUMRIWBASA-N Glu-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N)O VAZZOGXDUQSVQF-NUMRIWBASA-N 0.000 description 2
- PCBBLFVHTYNQGG-LAEOZQHASA-N Glu-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N PCBBLFVHTYNQGG-LAEOZQHASA-N 0.000 description 2
- NKLRYVLERDYDBI-FXQIFTODSA-N Glu-Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKLRYVLERDYDBI-FXQIFTODSA-N 0.000 description 2
- OAGVHWYIBZMWLA-YFKPBYRVSA-N Glu-Gly-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)NCC(O)=O OAGVHWYIBZMWLA-YFKPBYRVSA-N 0.000 description 2
- HILMIYALTUQTRC-XVKPBYJWSA-N Glu-Gly-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HILMIYALTUQTRC-XVKPBYJWSA-N 0.000 description 2
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 2
- NJCALAAIGREHDR-WDCWCFNPSA-N Glu-Leu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NJCALAAIGREHDR-WDCWCFNPSA-N 0.000 description 2
- RXESHTOTINOODU-JYJNAYRXSA-N Glu-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCC(=O)O)N RXESHTOTINOODU-JYJNAYRXSA-N 0.000 description 2
- MIIGESVJEBDJMP-FHWLQOOXSA-N Glu-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 MIIGESVJEBDJMP-FHWLQOOXSA-N 0.000 description 2
- HMJULNMJWOZNFI-XHNCKOQMSA-N Glu-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N)C(=O)O HMJULNMJWOZNFI-XHNCKOQMSA-N 0.000 description 2
- JSIQVRIXMINMTA-ZDLURKLDSA-N Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O JSIQVRIXMINMTA-ZDLURKLDSA-N 0.000 description 2
- HBMRTXJZQDVRFT-DZKIICNBSA-N Glu-Tyr-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O HBMRTXJZQDVRFT-DZKIICNBSA-N 0.000 description 2
- YPHPEHMXOYTEQG-LAEOZQHASA-N Glu-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O YPHPEHMXOYTEQG-LAEOZQHASA-N 0.000 description 2
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 2
- QSDKBRMVXSWAQE-BFHQHQDPSA-N Gly-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN QSDKBRMVXSWAQE-BFHQHQDPSA-N 0.000 description 2
- JLXVRFDTDUGQEE-YFKPBYRVSA-N Gly-Arg Chemical compound NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N JLXVRFDTDUGQEE-YFKPBYRVSA-N 0.000 description 2
- JPXNYFOHTHSREU-UWVGGRQHSA-N Gly-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN JPXNYFOHTHSREU-UWVGGRQHSA-N 0.000 description 2
- HDNXXTBKOJKWNN-WDSKDSINSA-N Gly-Glu-Asn Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O HDNXXTBKOJKWNN-WDSKDSINSA-N 0.000 description 2
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 2
- UQJNXZSSGQIPIQ-FBCQKBJTSA-N Gly-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)CN UQJNXZSSGQIPIQ-FBCQKBJTSA-N 0.000 description 2
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 2
- IKAIKUBBJHFNBZ-LURJTMIESA-N Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CN IKAIKUBBJHFNBZ-LURJTMIESA-N 0.000 description 2
- CUVBTVWFVIIDOC-YEPSODPASA-N Gly-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CN CUVBTVWFVIIDOC-YEPSODPASA-N 0.000 description 2
- FNXSYBOHALPRHV-ONGXEEELSA-N Gly-Val-Lys Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN FNXSYBOHALPRHV-ONGXEEELSA-N 0.000 description 2
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
- KZTLOHBDLMIFSH-XVYDVKMFSA-N His-Ala-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O KZTLOHBDLMIFSH-XVYDVKMFSA-N 0.000 description 2
- YPLYIXGKCRQZGW-SRVKXCTJSA-N His-Arg-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YPLYIXGKCRQZGW-SRVKXCTJSA-N 0.000 description 2
- ZPVJJPAIUZLSNE-DCAQKATOSA-N His-Arg-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O ZPVJJPAIUZLSNE-DCAQKATOSA-N 0.000 description 2
- PMWSGVRIMIFXQH-KKUMJFAQSA-N His-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1NC=NC=1)C1=CN=CN1 PMWSGVRIMIFXQH-KKUMJFAQSA-N 0.000 description 2
- FHGVHXCQMJWQPK-SRVKXCTJSA-N His-Lys-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O FHGVHXCQMJWQPK-SRVKXCTJSA-N 0.000 description 2
- DGLAHESNTJWGDO-SRVKXCTJSA-N His-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N DGLAHESNTJWGDO-SRVKXCTJSA-N 0.000 description 2
- MRVZCDSYLJXKKX-ACRUOGEOSA-N His-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CN=CN3)N MRVZCDSYLJXKKX-ACRUOGEOSA-N 0.000 description 2
- LVQDUPQUJZWKSU-PYJNHQTQSA-N Ile-Arg-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LVQDUPQUJZWKSU-PYJNHQTQSA-N 0.000 description 2
- NKRJALPCDNXULF-BYULHYEWSA-N Ile-Asp-Gly Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O NKRJALPCDNXULF-BYULHYEWSA-N 0.000 description 2
- DGTOKVBDZXJHNZ-WZLNRYEVSA-N Ile-Thr-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N DGTOKVBDZXJHNZ-WZLNRYEVSA-N 0.000 description 2
- DLEBSGAVWRPTIX-PEDHHIEDSA-N Ile-Val-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)[C@@H](C)CC DLEBSGAVWRPTIX-PEDHHIEDSA-N 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- HFKJBCPRWWGPEY-BQBZGAKWSA-N L-arginyl-L-glutamic acid Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HFKJBCPRWWGPEY-BQBZGAKWSA-N 0.000 description 2
- RNKSNIBMTUYWSH-YFKPBYRVSA-N L-prolylglycine Chemical compound [O-]C(=O)CNC(=O)[C@@H]1CCC[NH2+]1 RNKSNIBMTUYWSH-YFKPBYRVSA-N 0.000 description 2
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 2
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 2
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 2
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 2
- FMEICTQWUKNAGC-YUMQZZPRSA-N Leu-Gly-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O FMEICTQWUKNAGC-YUMQZZPRSA-N 0.000 description 2
- SEMUSFOBZGKBGW-YTFOTSKYSA-N Leu-Ile-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SEMUSFOBZGKBGW-YTFOTSKYSA-N 0.000 description 2
- KFKWRHQBZQICHA-STQMWFEESA-N Leu-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 2
- JIHDFWWRYHSAQB-GUBZILKMSA-N Leu-Ser-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JIHDFWWRYHSAQB-GUBZILKMSA-N 0.000 description 2
- LRKCBIUDWAXNEG-CSMHCCOUSA-N Leu-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRKCBIUDWAXNEG-CSMHCCOUSA-N 0.000 description 2
- AEDWWMMHUGYIFD-HJGDQZAQSA-N Leu-Thr-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O AEDWWMMHUGYIFD-HJGDQZAQSA-N 0.000 description 2
- LFSQWRSVPNKJGP-WDCWCFNPSA-N Leu-Thr-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O LFSQWRSVPNKJGP-WDCWCFNPSA-N 0.000 description 2
- KLSUAWUZBMAZCL-RHYQMDGZSA-N Leu-Thr-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O KLSUAWUZBMAZCL-RHYQMDGZSA-N 0.000 description 2
- XZNJZXJZBMBGGS-NHCYSSNCSA-N Leu-Val-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XZNJZXJZBMBGGS-NHCYSSNCSA-N 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 2
- KNKHAVVBVXKOGX-JXUBOQSCSA-N Lys-Ala-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KNKHAVVBVXKOGX-JXUBOQSCSA-N 0.000 description 2
- IRNSXVOWSXSULE-DCAQKATOSA-N Lys-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN IRNSXVOWSXSULE-DCAQKATOSA-N 0.000 description 2
- VHNOAIFVYUQOOY-XUXIUFHCSA-N Lys-Arg-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VHNOAIFVYUQOOY-XUXIUFHCSA-N 0.000 description 2
- DGAAQRAUOFHBFJ-CIUDSAMLSA-N Lys-Asn-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O DGAAQRAUOFHBFJ-CIUDSAMLSA-N 0.000 description 2
- DNEJSAIMVANNPA-DCAQKATOSA-N Lys-Asn-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DNEJSAIMVANNPA-DCAQKATOSA-N 0.000 description 2
- LMVOVCYVZBBWQB-SRVKXCTJSA-N Lys-Asp-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LMVOVCYVZBBWQB-SRVKXCTJSA-N 0.000 description 2
- CANPXOLVTMKURR-WEDXCCLWSA-N Lys-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN CANPXOLVTMKURR-WEDXCCLWSA-N 0.000 description 2
- IGRMTQMIDNDFAA-UWVGGRQHSA-N Lys-His Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IGRMTQMIDNDFAA-UWVGGRQHSA-N 0.000 description 2
- KKFVKBWCXXLKIK-AVGNSLFASA-N Lys-His-Glu Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCCN)N KKFVKBWCXXLKIK-AVGNSLFASA-N 0.000 description 2
- OVAOHZIOUBEQCJ-IHRRRGAJSA-N Lys-Leu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OVAOHZIOUBEQCJ-IHRRRGAJSA-N 0.000 description 2
- NJNRBRKHOWSGMN-SRVKXCTJSA-N Lys-Leu-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O NJNRBRKHOWSGMN-SRVKXCTJSA-N 0.000 description 2
- LUTDBHBIHHREDC-IHRRRGAJSA-N Lys-Pro-Lys Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O LUTDBHBIHHREDC-IHRRRGAJSA-N 0.000 description 2
- VWPJQIHBBOJWDN-DCAQKATOSA-N Lys-Val-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O VWPJQIHBBOJWDN-DCAQKATOSA-N 0.000 description 2
- DRRXXZBXDMLGFC-IHRRRGAJSA-N Lys-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN DRRXXZBXDMLGFC-IHRRRGAJSA-N 0.000 description 2
- TXTZMVNJIRZABH-ULQDDVLXSA-N Lys-Val-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TXTZMVNJIRZABH-ULQDDVLXSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- HXSUFWQYLPKEHF-IHRRRGAJSA-N Phe-Asn-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N HXSUFWQYLPKEHF-IHRRRGAJSA-N 0.000 description 2
- LDSOBEJVGGVWGD-DLOVCJGASA-N Phe-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 LDSOBEJVGGVWGD-DLOVCJGASA-N 0.000 description 2
- ZZVUXQCQPXSUFH-JBACZVJFSA-N Phe-Glu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 ZZVUXQCQPXSUFH-JBACZVJFSA-N 0.000 description 2
- DZVXMMSUWWUIQE-ACRUOGEOSA-N Phe-His-Tyr Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N DZVXMMSUWWUIQE-ACRUOGEOSA-N 0.000 description 2
- KXUZHWXENMYOHC-QEJZJMRPSA-N Phe-Leu-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O KXUZHWXENMYOHC-QEJZJMRPSA-N 0.000 description 2
- GMWNQSGWWGKTSF-LFSVMHDDSA-N Phe-Thr-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMWNQSGWWGKTSF-LFSVMHDDSA-N 0.000 description 2
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- JQOHKCDMINQZRV-WDSKDSINSA-N Pro-Asn Chemical compound NC(=O)C[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 JQOHKCDMINQZRV-WDSKDSINSA-N 0.000 description 2
- UVKNEILZSJMKSR-FXQIFTODSA-N Pro-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1 UVKNEILZSJMKSR-FXQIFTODSA-N 0.000 description 2
- WWAQEUOYCYMGHB-FXQIFTODSA-N Pro-Asn-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1 WWAQEUOYCYMGHB-FXQIFTODSA-N 0.000 description 2
- SFECXGVELZFBFJ-VEVYYDQMSA-N Pro-Asp-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SFECXGVELZFBFJ-VEVYYDQMSA-N 0.000 description 2
- LHALYDBUDCWMDY-CIUDSAMLSA-N Pro-Glu-Ala Chemical compound C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O LHALYDBUDCWMDY-CIUDSAMLSA-N 0.000 description 2
- VPFGPKIWSDVTOY-SRVKXCTJSA-N Pro-Glu-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O VPFGPKIWSDVTOY-SRVKXCTJSA-N 0.000 description 2
- LGSANCBHSMDFDY-GARJFASQSA-N Pro-Glu-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O LGSANCBHSMDFDY-GARJFASQSA-N 0.000 description 2
- BEPSGCXDIVACBU-IUCAKERBSA-N Pro-His Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1NCCC1)C1=CN=CN1 BEPSGCXDIVACBU-IUCAKERBSA-N 0.000 description 2
- AQSMZTIEJMZQEC-DCAQKATOSA-N Pro-His-Ser Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CO)C(=O)O AQSMZTIEJMZQEC-DCAQKATOSA-N 0.000 description 2
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 2
- XQPHBAKJJJZOBX-SRVKXCTJSA-N Pro-Lys-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O XQPHBAKJJJZOBX-SRVKXCTJSA-N 0.000 description 2
- FNGOXVQBBCMFKV-CIUDSAMLSA-N Pro-Ser-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O FNGOXVQBBCMFKV-CIUDSAMLSA-N 0.000 description 2
- GZNYIXWOIUFLGO-ZJDVBMNYSA-N Pro-Thr-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZNYIXWOIUFLGO-ZJDVBMNYSA-N 0.000 description 2
- CWZUFLWPEFHWEI-IHRRRGAJSA-N Pro-Tyr-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O CWZUFLWPEFHWEI-IHRRRGAJSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 101100390985 Schizosaccharomyces pombe (strain 972 / ATCC 24843) fmc1 gene Proteins 0.000 description 2
- 101100221189 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new16 gene Proteins 0.000 description 2
- 101100460203 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new2 gene Proteins 0.000 description 2
- CAJFZCICSVBOJK-SHGPDSBTSA-N Thr-Ala-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAJFZCICSVBOJK-SHGPDSBTSA-N 0.000 description 2
- WFUAUEQXPVNAEF-ZJDVBMNYSA-N Thr-Arg-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CCCN=C(N)N WFUAUEQXPVNAEF-ZJDVBMNYSA-N 0.000 description 2
- QGXCWPNQVCYJEL-NUMRIWBASA-N Thr-Asn-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QGXCWPNQVCYJEL-NUMRIWBASA-N 0.000 description 2
- BECPPKYKPSRKCP-ZDLURKLDSA-N Thr-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O BECPPKYKPSRKCP-ZDLURKLDSA-N 0.000 description 2
- VGYBYGQXZJDZJU-XQXXSGGOSA-N Thr-Glu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VGYBYGQXZJDZJU-XQXXSGGOSA-N 0.000 description 2
- LGNBRHZANHMZHK-NUMRIWBASA-N Thr-Glu-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O LGNBRHZANHMZHK-NUMRIWBASA-N 0.000 description 2
- LCCSEJSPBWKBNT-OSUNSFLBSA-N Thr-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N LCCSEJSPBWKBNT-OSUNSFLBSA-N 0.000 description 2
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 2
- YKRQRPFODDJQTC-CSMHCCOUSA-N Thr-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN YKRQRPFODDJQTC-CSMHCCOUSA-N 0.000 description 2
- WFAUDCSNCWJJAA-KXNHARMFSA-N Thr-Lys-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(O)=O WFAUDCSNCWJJAA-KXNHARMFSA-N 0.000 description 2
- NYQIZWROIMIQSL-VEVYYDQMSA-N Thr-Pro-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O NYQIZWROIMIQSL-VEVYYDQMSA-N 0.000 description 2
- MROIJTGJGIDEEJ-RCWTZXSCSA-N Thr-Pro-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 MROIJTGJGIDEEJ-RCWTZXSCSA-N 0.000 description 2
- IVDFVBVIVLJJHR-LKXGYXEUSA-N Thr-Ser-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IVDFVBVIVLJJHR-LKXGYXEUSA-N 0.000 description 2
- JAWUQFCGNVEDRN-MEYUZBJRSA-N Thr-Tyr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N)O JAWUQFCGNVEDRN-MEYUZBJRSA-N 0.000 description 2
- OGOYMQWIWHGTGH-KZVJFYERSA-N Thr-Val-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O OGOYMQWIWHGTGH-KZVJFYERSA-N 0.000 description 2
- KPMIQCXJDVKWKO-IFFSRLJSSA-N Thr-Val-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KPMIQCXJDVKWKO-IFFSRLJSSA-N 0.000 description 2
- JXNRXNCCROJZFB-RYUDHWBXSA-N Tyr-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JXNRXNCCROJZFB-RYUDHWBXSA-N 0.000 description 2
- AYHSJESDFKREAR-KKUMJFAQSA-N Tyr-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AYHSJESDFKREAR-KKUMJFAQSA-N 0.000 description 2
- QNJYPWZACBACER-KKUMJFAQSA-N Tyr-Asp-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O QNJYPWZACBACER-KKUMJFAQSA-N 0.000 description 2
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 2
- QSFJHIRIHOJRKS-ULQDDVLXSA-N Tyr-Leu-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QSFJHIRIHOJRKS-ULQDDVLXSA-N 0.000 description 2
- MVFQLSPDMMFCMW-KKUMJFAQSA-N Tyr-Leu-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O MVFQLSPDMMFCMW-KKUMJFAQSA-N 0.000 description 2
- KSCVLGXNQXKUAR-JYJNAYRXSA-N Tyr-Leu-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KSCVLGXNQXKUAR-JYJNAYRXSA-N 0.000 description 2
- PMHLLBKTDHQMCY-ULQDDVLXSA-N Tyr-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMHLLBKTDHQMCY-ULQDDVLXSA-N 0.000 description 2
- VNYDHJARLHNEGA-RYUDHWBXSA-N Tyr-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 VNYDHJARLHNEGA-RYUDHWBXSA-N 0.000 description 2
- ZZDYJFVIKVSUFA-WLTAIBSBSA-N Tyr-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ZZDYJFVIKVSUFA-WLTAIBSBSA-N 0.000 description 2
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 2
- NMANTMWGQZASQN-QXEWZRGKSA-N Val-Arg-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N NMANTMWGQZASQN-QXEWZRGKSA-N 0.000 description 2
- UDNYEPLJTRDMEJ-RCOVLWMOSA-N Val-Asn-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N UDNYEPLJTRDMEJ-RCOVLWMOSA-N 0.000 description 2
- CWSIBTLMMQLPPZ-FXQIFTODSA-N Val-Cys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)N CWSIBTLMMQLPPZ-FXQIFTODSA-N 0.000 description 2
- NXRAUQGGHPCJIB-RCOVLWMOSA-N Val-Gly-Asn Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O NXRAUQGGHPCJIB-RCOVLWMOSA-N 0.000 description 2
- XXROXFHCMVXETG-UWVGGRQHSA-N Val-Gly-Val Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXROXFHCMVXETG-UWVGGRQHSA-N 0.000 description 2
- BNQVUHQWZGTIBX-IUCAKERBSA-N Val-His Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC1=CN=CN1 BNQVUHQWZGTIBX-IUCAKERBSA-N 0.000 description 2
- CHWRZUGUMAMTFC-IHRRRGAJSA-N Val-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CNC=N1 CHWRZUGUMAMTFC-IHRRRGAJSA-N 0.000 description 2
- XXWBHOWRARMUOC-NHCYSSNCSA-N Val-Lys-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O)N XXWBHOWRARMUOC-NHCYSSNCSA-N 0.000 description 2
- DLRZGNXCXUGIDG-KKHAAJSZSA-N Val-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O DLRZGNXCXUGIDG-KKHAAJSZSA-N 0.000 description 2
- BGTDGENDNWGMDQ-KJEVXHAQSA-N Val-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N)O BGTDGENDNWGMDQ-KJEVXHAQSA-N 0.000 description 2
- SSKKGOWRPNIVDW-AVGNSLFASA-N Val-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N SSKKGOWRPNIVDW-AVGNSLFASA-N 0.000 description 2
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 2
- STTYIMSDIYISRG-UHFFFAOYSA-N Valyl-Serine Chemical compound CC(C)C(N)C(=O)NC(CO)C(O)=O STTYIMSDIYISRG-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009435 amidation Effects 0.000 description 2
- 238000007112 amidation reaction Methods 0.000 description 2
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 2
- 108010068380 arginylarginine Proteins 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- 238000009640 blood culture Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 108010045126 glycyl-tyrosyl-glycine Proteins 0.000 description 2
- STKYPAFSDFAEPH-LURJTMIESA-N glycylvaline Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CN STKYPAFSDFAEPH-LURJTMIESA-N 0.000 description 2
- 108010018006 histidylserine Proteins 0.000 description 2
- 238000003119 immunoblot Methods 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 108010057952 lysyl-phenylalanyl-lysine Proteins 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000007479 molecular analysis Methods 0.000 description 2
- 210000004897 n-terminal region Anatomy 0.000 description 2
- 229960001973 pneumococcal vaccines Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108010031719 prolyl-serine Proteins 0.000 description 2
- 108010090894 prolylleucine Proteins 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000012134 supernatant fraction Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- ZZIZZTHXZRDOFM-XFULWGLBSA-N tamsulosin hydrochloride Chemical compound [H+].[Cl-].CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 ZZIZZTHXZRDOFM-XFULWGLBSA-N 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- ZNAIHAPCDVUWRX-DUCUPYJCSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-t Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1.C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O ZNAIHAPCDVUWRX-DUCUPYJCSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 101710117373 92 kDa protein Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- CVGNCMIULZNYES-WHFBIAKZSA-N Ala-Asn-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CVGNCMIULZNYES-WHFBIAKZSA-N 0.000 description 1
- NJPMYXWVWQWCSR-ACZMJKKPSA-N Ala-Glu-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NJPMYXWVWQWCSR-ACZMJKKPSA-N 0.000 description 1
- HMRWQTHUDVXMGH-GUBZILKMSA-N Ala-Glu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HMRWQTHUDVXMGH-GUBZILKMSA-N 0.000 description 1
- ROLXPVQSRCPVGK-XDTLVQLUSA-N Ala-Glu-Tyr Chemical compound N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O ROLXPVQSRCPVGK-XDTLVQLUSA-N 0.000 description 1
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 1
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 1
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 1
- AJBVYEYZVYPFCF-CIUDSAMLSA-N Ala-Lys-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O AJBVYEYZVYPFCF-CIUDSAMLSA-N 0.000 description 1
- XRUJOVRWNMBAAA-NHCYSSNCSA-N Ala-Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 XRUJOVRWNMBAAA-NHCYSSNCSA-N 0.000 description 1
- XWFWAXPOLRTDFZ-FXQIFTODSA-N Ala-Pro-Ser Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O XWFWAXPOLRTDFZ-FXQIFTODSA-N 0.000 description 1
- IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 1
- IETUUAHKCHOQHP-KZVJFYERSA-N Ala-Thr-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(O)=O IETUUAHKCHOQHP-KZVJFYERSA-N 0.000 description 1
- BGGAIXWIZCIFSG-XDTLVQLUSA-N Ala-Tyr-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O BGGAIXWIZCIFSG-XDTLVQLUSA-N 0.000 description 1
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- JSHVMZANPXCDTL-GMOBBJLQSA-N Arg-Asp-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JSHVMZANPXCDTL-GMOBBJLQSA-N 0.000 description 1
- BNODVYXZAAXSHW-IUCAKERBSA-N Arg-His Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 BNODVYXZAAXSHW-IUCAKERBSA-N 0.000 description 1
- XUGATJVGQUGQKY-ULQDDVLXSA-N Arg-Lys-Phe Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XUGATJVGQUGQKY-ULQDDVLXSA-N 0.000 description 1
- SYFHFLGAROUHNT-VEVYYDQMSA-N Arg-Thr-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O SYFHFLGAROUHNT-VEVYYDQMSA-N 0.000 description 1
- QJWLLRZTJFPCHA-STECZYCISA-N Arg-Tyr-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QJWLLRZTJFPCHA-STECZYCISA-N 0.000 description 1
- RZVVKNIACROXRM-ZLUOBGJFSA-N Asn-Ala-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N RZVVKNIACROXRM-ZLUOBGJFSA-N 0.000 description 1
- CMLGVVWQQHUXOZ-GHCJXIJMSA-N Asn-Ala-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CMLGVVWQQHUXOZ-GHCJXIJMSA-N 0.000 description 1
- XWGJDUSDTRPQRK-ZLUOBGJFSA-N Asn-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O XWGJDUSDTRPQRK-ZLUOBGJFSA-N 0.000 description 1
- DAPLJWATMAXPPZ-CIUDSAMLSA-N Asn-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O DAPLJWATMAXPPZ-CIUDSAMLSA-N 0.000 description 1
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 1
- PIWWUBYJNONVTJ-ZLUOBGJFSA-N Asn-Asp-Asn Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)C(=O)N PIWWUBYJNONVTJ-ZLUOBGJFSA-N 0.000 description 1
- XSGBIBGAMKTHMY-WHFBIAKZSA-N Asn-Asp-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O XSGBIBGAMKTHMY-WHFBIAKZSA-N 0.000 description 1
- MSBDSTRUMZFSEU-PEFMBERDSA-N Asn-Glu-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MSBDSTRUMZFSEU-PEFMBERDSA-N 0.000 description 1
- DMLSCRJBWUEALP-LAEOZQHASA-N Asn-Glu-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O DMLSCRJBWUEALP-LAEOZQHASA-N 0.000 description 1
- HYQYLOSCICEYTR-YUMQZZPRSA-N Asn-Gly-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O HYQYLOSCICEYTR-YUMQZZPRSA-N 0.000 description 1
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 1
- ODBSSLHUFPJRED-CIUDSAMLSA-N Asn-His-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N ODBSSLHUFPJRED-CIUDSAMLSA-N 0.000 description 1
- FBODFHMLALOPHP-GUBZILKMSA-N Asn-Lys-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O FBODFHMLALOPHP-GUBZILKMSA-N 0.000 description 1
- QDXQWFBLUVTOFL-FXQIFTODSA-N Asn-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)N)N QDXQWFBLUVTOFL-FXQIFTODSA-N 0.000 description 1
- RAUPFUCUDBQYHE-AVGNSLFASA-N Asn-Phe-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RAUPFUCUDBQYHE-AVGNSLFASA-N 0.000 description 1
- YUOXLJYVSZYPBJ-CIUDSAMLSA-N Asn-Pro-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O YUOXLJYVSZYPBJ-CIUDSAMLSA-N 0.000 description 1
- VHQSGALUSWIYOD-QXEWZRGKSA-N Asn-Pro-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O VHQSGALUSWIYOD-QXEWZRGKSA-N 0.000 description 1
- VWADICJNCPFKJS-ZLUOBGJFSA-N Asn-Ser-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O VWADICJNCPFKJS-ZLUOBGJFSA-N 0.000 description 1
- HCZQKHSRYHCPSD-IUKAMOBKSA-N Asn-Thr-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HCZQKHSRYHCPSD-IUKAMOBKSA-N 0.000 description 1
- WQAOZCVOOYUWKG-LSJOCFKGSA-N Asn-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC(=O)N)N WQAOZCVOOYUWKG-LSJOCFKGSA-N 0.000 description 1
- XBQSLMACWDXWLJ-GHCJXIJMSA-N Asp-Ala-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XBQSLMACWDXWLJ-GHCJXIJMSA-N 0.000 description 1
- RGKKALNPOYURGE-ZKWXMUAHSA-N Asp-Ala-Val Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O RGKKALNPOYURGE-ZKWXMUAHSA-N 0.000 description 1
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 1
- TVVYVAUGRHNTGT-UGYAYLCHSA-N Asp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O TVVYVAUGRHNTGT-UGYAYLCHSA-N 0.000 description 1
- VILLWIDTHYPSLC-PEFMBERDSA-N Asp-Glu-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VILLWIDTHYPSLC-PEFMBERDSA-N 0.000 description 1
- DGKCOYGQLNWNCJ-ACZMJKKPSA-N Asp-Glu-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O DGKCOYGQLNWNCJ-ACZMJKKPSA-N 0.000 description 1
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 1
- JOCQXVJCTCEFAZ-CIUDSAMLSA-N Asp-His-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O JOCQXVJCTCEFAZ-CIUDSAMLSA-N 0.000 description 1
- CYCKJEFVFNRWEZ-UGYAYLCHSA-N Asp-Ile-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O CYCKJEFVFNRWEZ-UGYAYLCHSA-N 0.000 description 1
- SPWXXPFDTMYTRI-IUKAMOBKSA-N Asp-Ile-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SPWXXPFDTMYTRI-IUKAMOBKSA-N 0.000 description 1
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 1
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
- OAMLVOVXNKILLQ-BQBZGAKWSA-N Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O OAMLVOVXNKILLQ-BQBZGAKWSA-N 0.000 description 1
- LIVXPXUVXFRWNY-CIUDSAMLSA-N Asp-Lys-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O LIVXPXUVXFRWNY-CIUDSAMLSA-N 0.000 description 1
- GWIJZUVQVDJHDI-AVGNSLFASA-N Asp-Phe-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GWIJZUVQVDJHDI-AVGNSLFASA-N 0.000 description 1
- ZKAOJVJQGVUIIU-GUBZILKMSA-N Asp-Pro-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ZKAOJVJQGVUIIU-GUBZILKMSA-N 0.000 description 1
- VNXQRBXEQXLERQ-CIUDSAMLSA-N Asp-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N VNXQRBXEQXLERQ-CIUDSAMLSA-N 0.000 description 1
- UTLCRGFJFSZWAW-OLHMAJIHSA-N Asp-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O UTLCRGFJFSZWAW-OLHMAJIHSA-N 0.000 description 1
- JDDYEZGPYBBPBN-JRQIVUDYSA-N Asp-Thr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JDDYEZGPYBBPBN-JRQIVUDYSA-N 0.000 description 1
- WAEDSQFVZJUHLI-BYULHYEWSA-N Asp-Val-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WAEDSQFVZJUHLI-BYULHYEWSA-N 0.000 description 1
- XMKXONRMGJXCJV-LAEOZQHASA-N Asp-Val-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O XMKXONRMGJXCJV-LAEOZQHASA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000726103 Atta Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010060123 Conjugate Vaccines Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
- AVZHGSCDKIQZPQ-CIUDSAMLSA-N Glu-Arg-Ala Chemical compound C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AVZHGSCDKIQZPQ-CIUDSAMLSA-N 0.000 description 1
- DIXKFOPPGWKZLY-CIUDSAMLSA-N Glu-Arg-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O DIXKFOPPGWKZLY-CIUDSAMLSA-N 0.000 description 1
- AFODTOLGSZQDSL-PEFMBERDSA-N Glu-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N AFODTOLGSZQDSL-PEFMBERDSA-N 0.000 description 1
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 1
- QQLBPVKLJBAXBS-FXQIFTODSA-N Glu-Glu-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QQLBPVKLJBAXBS-FXQIFTODSA-N 0.000 description 1
- IQACOVZVOMVILH-FXQIFTODSA-N Glu-Glu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O IQACOVZVOMVILH-FXQIFTODSA-N 0.000 description 1
- CUXJIASLBRJOFV-LAEOZQHASA-N Glu-Gly-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUXJIASLBRJOFV-LAEOZQHASA-N 0.000 description 1
- KRGZZKWSBGPLKL-IUCAKERBSA-N Glu-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)N KRGZZKWSBGPLKL-IUCAKERBSA-N 0.000 description 1
- QLPYYTDOUQNJGQ-AVGNSLFASA-N Glu-His-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N QLPYYTDOUQNJGQ-AVGNSLFASA-N 0.000 description 1
- VGOFRWOTSXVPAU-SDDRHHMPSA-N Glu-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)O)N)C(=O)O VGOFRWOTSXVPAU-SDDRHHMPSA-N 0.000 description 1
- CXRWMMRLEMVSEH-PEFMBERDSA-N Glu-Ile-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O CXRWMMRLEMVSEH-PEFMBERDSA-N 0.000 description 1
- LGYCLOCORAEQSZ-PEFMBERDSA-N Glu-Ile-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O LGYCLOCORAEQSZ-PEFMBERDSA-N 0.000 description 1
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 1
- YGLCLCMAYUYZSG-AVGNSLFASA-N Glu-Lys-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 YGLCLCMAYUYZSG-AVGNSLFASA-N 0.000 description 1
- BFEZQZKEPRKKHV-SRVKXCTJSA-N Glu-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O BFEZQZKEPRKKHV-SRVKXCTJSA-N 0.000 description 1
- BIYNPVYAZOUVFQ-CIUDSAMLSA-N Glu-Pro-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O BIYNPVYAZOUVFQ-CIUDSAMLSA-N 0.000 description 1
- UQHGAYSULGRWRG-WHFBIAKZSA-N Glu-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(O)=O UQHGAYSULGRWRG-WHFBIAKZSA-N 0.000 description 1
- QCMVGXDELYMZET-GLLZPBPUSA-N Glu-Thr-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QCMVGXDELYMZET-GLLZPBPUSA-N 0.000 description 1
- JLCYOCDGIUZMKQ-JBACZVJFSA-N Glu-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)O)N JLCYOCDGIUZMKQ-JBACZVJFSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- DUYYPIRFTLOAJQ-YUMQZZPRSA-N Gly-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN DUYYPIRFTLOAJQ-YUMQZZPRSA-N 0.000 description 1
- GRIRDMVMJJDZKV-RCOVLWMOSA-N Gly-Asn-Val Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O GRIRDMVMJJDZKV-RCOVLWMOSA-N 0.000 description 1
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 1
- XTQFHTHIAKKCTM-YFKPBYRVSA-N Gly-Glu-Gly Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O XTQFHTHIAKKCTM-YFKPBYRVSA-N 0.000 description 1
- INLIXXRWNUKVCF-JTQLQIEISA-N Gly-Gly-Tyr Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 INLIXXRWNUKVCF-JTQLQIEISA-N 0.000 description 1
- UTYGDAHJBBDPBA-BYULHYEWSA-N Gly-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN UTYGDAHJBBDPBA-BYULHYEWSA-N 0.000 description 1
- IUZGUFAJDBHQQV-YUMQZZPRSA-N Gly-Leu-Asn Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IUZGUFAJDBHQQV-YUMQZZPRSA-N 0.000 description 1
- LRQXRHGQEVWGPV-NHCYSSNCSA-N Gly-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN LRQXRHGQEVWGPV-NHCYSSNCSA-N 0.000 description 1
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 1
- PTIIBFKSLCYQBO-NHCYSSNCSA-N Gly-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN PTIIBFKSLCYQBO-NHCYSSNCSA-N 0.000 description 1
- YHYDTTUSJXGTQK-UWVGGRQHSA-N Gly-Met-Leu Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(O)=O YHYDTTUSJXGTQK-UWVGGRQHSA-N 0.000 description 1
- YOBGUCWZPXJHTN-BQBZGAKWSA-N Gly-Ser-Arg Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YOBGUCWZPXJHTN-BQBZGAKWSA-N 0.000 description 1
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 1
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 1
- LLWQVJNHMYBLLK-CDMKHQONSA-N Gly-Thr-Phe Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLWQVJNHMYBLLK-CDMKHQONSA-N 0.000 description 1
- KOYUSMBPJOVSOO-XEGUGMAKSA-N Gly-Tyr-Ile Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KOYUSMBPJOVSOO-XEGUGMAKSA-N 0.000 description 1
- DNAZKGFYFRGZIH-QWRGUYRKSA-N Gly-Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 DNAZKGFYFRGZIH-QWRGUYRKSA-N 0.000 description 1
- SBVMXEZQJVUARN-XPUUQOCRSA-N Gly-Val-Ser Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O SBVMXEZQJVUARN-XPUUQOCRSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- FRJIAZKQGSCKPQ-FSPLSTOPSA-N His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CN=CN1 FRJIAZKQGSCKPQ-FSPLSTOPSA-N 0.000 description 1
- FDQYIRHBVVUTJF-ZETCQYMHSA-N His-Gly-Gly Chemical compound [O-]C(=O)CNC(=O)CNC(=O)[C@@H]([NH3+])CC1=CN=CN1 FDQYIRHBVVUTJF-ZETCQYMHSA-N 0.000 description 1
- YXXKBPJEIYFGOD-MGHWNKPDSA-N His-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CN=CN2)N YXXKBPJEIYFGOD-MGHWNKPDSA-N 0.000 description 1
- CSRRMQFXMBPSIL-SIXJUCDHSA-N His-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CN=CN3)N CSRRMQFXMBPSIL-SIXJUCDHSA-N 0.000 description 1
- VLDVBZICYBVQHB-IUCAKERBSA-N His-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])CC1=CN=CN1 VLDVBZICYBVQHB-IUCAKERBSA-N 0.000 description 1
- SYPULFZAGBBIOM-GVXVVHGQSA-N His-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N SYPULFZAGBBIOM-GVXVVHGQSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- KIMHKBDJQQYLHU-PEFMBERDSA-N Ile-Glu-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KIMHKBDJQQYLHU-PEFMBERDSA-N 0.000 description 1
- SJLVSMMIFYTSGY-GRLWGSQLSA-N Ile-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SJLVSMMIFYTSGY-GRLWGSQLSA-N 0.000 description 1
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 1
- IDMNOFVUXYYZPF-DKIMLUQUSA-N Ile-Lys-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N IDMNOFVUXYYZPF-DKIMLUQUSA-N 0.000 description 1
- UDBPXJNOEWDBDF-XUXIUFHCSA-N Ile-Lys-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O)N UDBPXJNOEWDBDF-XUXIUFHCSA-N 0.000 description 1
- HQEPKOFULQTSFV-JURCDPSOSA-N Ile-Phe-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)O)N HQEPKOFULQTSFV-JURCDPSOSA-N 0.000 description 1
- IIWQTXMUALXGOV-PCBIJLKTSA-N Ile-Phe-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N IIWQTXMUALXGOV-PCBIJLKTSA-N 0.000 description 1
- IITVUURPOYGCTD-NAKRPEOUSA-N Ile-Pro-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IITVUURPOYGCTD-NAKRPEOUSA-N 0.000 description 1
- NLZVTPYXYXMCIP-XUXIUFHCSA-N Ile-Pro-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O NLZVTPYXYXMCIP-XUXIUFHCSA-N 0.000 description 1
- MLSUZXHSNRBDCI-CYDGBPFRSA-N Ile-Pro-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)O)N MLSUZXHSNRBDCI-CYDGBPFRSA-N 0.000 description 1
- PZWBBXHHUSIGKH-OSUNSFLBSA-N Ile-Thr-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PZWBBXHHUSIGKH-OSUNSFLBSA-N 0.000 description 1
- YCKPUHHMCFSUMD-IUKAMOBKSA-N Ile-Thr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCKPUHHMCFSUMD-IUKAMOBKSA-N 0.000 description 1
- WCNWGAUZWWSYDG-SVSWQMSJSA-N Ile-Thr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O)N WCNWGAUZWWSYDG-SVSWQMSJSA-N 0.000 description 1
- FXJLRZFMKGHYJP-CFMVVWHZSA-N Ile-Tyr-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N FXJLRZFMKGHYJP-CFMVVWHZSA-N 0.000 description 1
- YJRSIJZUIUANHO-NAKRPEOUSA-N Ile-Val-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)O)N YJRSIJZUIUANHO-NAKRPEOUSA-N 0.000 description 1
- RQZFWBLDTBDEOF-RNJOBUHISA-N Ile-Val-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N RQZFWBLDTBDEOF-RNJOBUHISA-N 0.000 description 1
- YHFPHRUWZMEOIX-CYDGBPFRSA-N Ile-Val-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)N YHFPHRUWZMEOIX-CYDGBPFRSA-N 0.000 description 1
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- MLTRLIITQPXHBJ-BQBZGAKWSA-N Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O MLTRLIITQPXHBJ-BQBZGAKWSA-N 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 1
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 1
- HYMLKESRWLZDBR-WEDXCCLWSA-N Leu-Gly-Thr Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HYMLKESRWLZDBR-WEDXCCLWSA-N 0.000 description 1
- HNDWYLYAYNBWMP-AJNGGQMLSA-N Leu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N HNDWYLYAYNBWMP-AJNGGQMLSA-N 0.000 description 1
- JLWZLIQRYCTYBD-IHRRRGAJSA-N Leu-Lys-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JLWZLIQRYCTYBD-IHRRRGAJSA-N 0.000 description 1
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 1
- CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 1
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 1
- JGKHAFUAPZCCDU-BZSNNMDCSA-N Leu-Tyr-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=C(O)C=C1 JGKHAFUAPZCCDU-BZSNNMDCSA-N 0.000 description 1
- XOEDPXDZJHBQIX-ULQDDVLXSA-N Leu-Val-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XOEDPXDZJHBQIX-ULQDDVLXSA-N 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- MPGHETGWWWUHPY-CIUDSAMLSA-N Lys-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN MPGHETGWWWUHPY-CIUDSAMLSA-N 0.000 description 1
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 1
- JPNRPAJITHRXRH-BQBZGAKWSA-N Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O JPNRPAJITHRXRH-BQBZGAKWSA-N 0.000 description 1
- QYOXSYXPHUHOJR-GUBZILKMSA-N Lys-Asn-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QYOXSYXPHUHOJR-GUBZILKMSA-N 0.000 description 1
- ZQCVMVCVPFYXHZ-SRVKXCTJSA-N Lys-Asn-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN ZQCVMVCVPFYXHZ-SRVKXCTJSA-N 0.000 description 1
- GKFNXYMAMKJSKD-NHCYSSNCSA-N Lys-Asp-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GKFNXYMAMKJSKD-NHCYSSNCSA-N 0.000 description 1
- WGLAORUKDGRINI-WDCWCFNPSA-N Lys-Glu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGLAORUKDGRINI-WDCWCFNPSA-N 0.000 description 1
- HGNRJCINZYHNOU-LURJTMIESA-N Lys-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(O)=O HGNRJCINZYHNOU-LURJTMIESA-N 0.000 description 1
- NNKLKUUGESXCBS-KBPBESRZSA-N Lys-Gly-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NNKLKUUGESXCBS-KBPBESRZSA-N 0.000 description 1
- KYNNSEJZFVCDIV-ZPFDUUQYSA-N Lys-Ile-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O KYNNSEJZFVCDIV-ZPFDUUQYSA-N 0.000 description 1
- WRODMZBHNNPRLN-SRVKXCTJSA-N Lys-Leu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O WRODMZBHNNPRLN-SRVKXCTJSA-N 0.000 description 1
- AZOFEHCPMBRNFD-BZSNNMDCSA-N Lys-Phe-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=CC=C1 AZOFEHCPMBRNFD-BZSNNMDCSA-N 0.000 description 1
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 1
- MYTOTTSMVMWVJN-STQMWFEESA-N Lys-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 MYTOTTSMVMWVJN-STQMWFEESA-N 0.000 description 1
- NYTDJEZBAAFLLG-IHRRRGAJSA-N Lys-Val-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O NYTDJEZBAAFLLG-IHRRRGAJSA-N 0.000 description 1
- ONGCSGVHCSAATF-CIUDSAMLSA-N Met-Ala-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O ONGCSGVHCSAATF-CIUDSAMLSA-N 0.000 description 1
- UZVWDRPUTHXQAM-FXQIFTODSA-N Met-Asp-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O UZVWDRPUTHXQAM-FXQIFTODSA-N 0.000 description 1
- SBFPAAPFKZPDCZ-JYJNAYRXSA-N Met-Pro-Tyr Chemical compound [H]N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O SBFPAAPFKZPDCZ-JYJNAYRXSA-N 0.000 description 1
- KZKVVWBOGDKHKE-QTKMDUPCSA-N Met-Thr-His Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 KZKVVWBOGDKHKE-QTKMDUPCSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- LSXGADJXBDFXQU-DLOVCJGASA-N Phe-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 LSXGADJXBDFXQU-DLOVCJGASA-N 0.000 description 1
- HTTYNOXBBOWZTB-SRVKXCTJSA-N Phe-Asn-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N HTTYNOXBBOWZTB-SRVKXCTJSA-N 0.000 description 1
- LNIIRLODKOWQIY-IHRRRGAJSA-N Phe-Asn-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O LNIIRLODKOWQIY-IHRRRGAJSA-N 0.000 description 1
- MGBRZXXGQBAULP-DRZSPHRISA-N Phe-Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGBRZXXGQBAULP-DRZSPHRISA-N 0.000 description 1
- ONORAGIFHNAADN-LLLHUVSDSA-N Phe-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N ONORAGIFHNAADN-LLLHUVSDSA-N 0.000 description 1
- RFCVXVPWSPOMFJ-STQMWFEESA-N Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RFCVXVPWSPOMFJ-STQMWFEESA-N 0.000 description 1
- SMFGCTXUBWEPKM-KBPBESRZSA-N Phe-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 SMFGCTXUBWEPKM-KBPBESRZSA-N 0.000 description 1
- WEQJQNWXCSUVMA-RYUDHWBXSA-N Phe-Pro Chemical compound C([C@H]([NH3+])C(=O)N1[C@@H](CCC1)C([O-])=O)C1=CC=CC=C1 WEQJQNWXCSUVMA-RYUDHWBXSA-N 0.000 description 1
- FSXRLASFHBWESK-HOTGVXAUSA-N Phe-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 FSXRLASFHBWESK-HOTGVXAUSA-N 0.000 description 1
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 1
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 1
- SGCZFWSQERRKBD-BQBZGAKWSA-N Pro-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 SGCZFWSQERRKBD-BQBZGAKWSA-N 0.000 description 1
- PULPZRAHVFBVTO-DCAQKATOSA-N Pro-Glu-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PULPZRAHVFBVTO-DCAQKATOSA-N 0.000 description 1
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 1
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 1
- LXVLKXPFIDDHJG-CIUDSAMLSA-N Pro-Glu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O LXVLKXPFIDDHJG-CIUDSAMLSA-N 0.000 description 1
- AFXCXDQNRXTSBD-FJXKBIBVSA-N Pro-Gly-Thr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AFXCXDQNRXTSBD-FJXKBIBVSA-N 0.000 description 1
- JRQCDSNPRNGWRG-AVGNSLFASA-N Pro-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]2CCCN2 JRQCDSNPRNGWRG-AVGNSLFASA-N 0.000 description 1
- ZKQOUHVVXABNDG-IUCAKERBSA-N Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 ZKQOUHVVXABNDG-IUCAKERBSA-N 0.000 description 1
- MHHQQZIFLWFZGR-DCAQKATOSA-N Pro-Lys-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O MHHQQZIFLWFZGR-DCAQKATOSA-N 0.000 description 1
- WFIVLLFYUZZWOD-RHYQMDGZSA-N Pro-Lys-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WFIVLLFYUZZWOD-RHYQMDGZSA-N 0.000 description 1
- GNADVDLLGVSXLS-ULQDDVLXSA-N Pro-Phe-His Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O GNADVDLLGVSXLS-ULQDDVLXSA-N 0.000 description 1
- RWCOTTLHDJWHRS-YUMQZZPRSA-N Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RWCOTTLHDJWHRS-YUMQZZPRSA-N 0.000 description 1
- SNGZLPOXVRTNMB-LPEHRKFASA-N Pro-Ser-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N2CCC[C@@H]2C(=O)O SNGZLPOXVRTNMB-LPEHRKFASA-N 0.000 description 1
- GVUVRRPYYDHHGK-VQVTYTSYSA-N Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 GVUVRRPYYDHHGK-VQVTYTSYSA-N 0.000 description 1
- GBUNEGKQPSAMNK-QTKMDUPCSA-N Pro-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@@H]2CCCN2)O GBUNEGKQPSAMNK-QTKMDUPCSA-N 0.000 description 1
- VVAWNPIOYXAMAL-KJEVXHAQSA-N Pro-Thr-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VVAWNPIOYXAMAL-KJEVXHAQSA-N 0.000 description 1
- FUOGXAQMNJMBFG-WPRPVWTQSA-N Pro-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FUOGXAQMNJMBFG-WPRPVWTQSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101100460197 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new13 gene Proteins 0.000 description 1
- 101100460199 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new15 gene Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 1
- HBZBPFLJNDXRAY-FXQIFTODSA-N Ser-Ala-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O HBZBPFLJNDXRAY-FXQIFTODSA-N 0.000 description 1
- OOKCGAYXSNJBGQ-ZLUOBGJFSA-N Ser-Asn-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OOKCGAYXSNJBGQ-ZLUOBGJFSA-N 0.000 description 1
- UBRXAVQWXOWRSJ-ZLUOBGJFSA-N Ser-Asn-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N)C(=O)N UBRXAVQWXOWRSJ-ZLUOBGJFSA-N 0.000 description 1
- WXWDPFVKQRVJBJ-CIUDSAMLSA-N Ser-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N WXWDPFVKQRVJBJ-CIUDSAMLSA-N 0.000 description 1
- DKKGAAJTDKHWOD-BIIVOSGPSA-N Ser-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)C(=O)O DKKGAAJTDKHWOD-BIIVOSGPSA-N 0.000 description 1
- OHKLFYXEOGGGCK-ZLUOBGJFSA-N Ser-Asp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OHKLFYXEOGGGCK-ZLUOBGJFSA-N 0.000 description 1
- QGAHMVHBORDHDC-YUMQZZPRSA-N Ser-His-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 QGAHMVHBORDHDC-YUMQZZPRSA-N 0.000 description 1
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 1
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 1
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 1
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 1
- UBTNVMGPMYDYIU-HJPIBITLSA-N Ser-Tyr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UBTNVMGPMYDYIU-HJPIBITLSA-N 0.000 description 1
- ANOQEBQWIAYIMV-AEJSXWLSSA-N Ser-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N ANOQEBQWIAYIMV-AEJSXWLSSA-N 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 1
- DGDCHPCRMWEOJR-FQPOAREZSA-N Thr-Ala-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DGDCHPCRMWEOJR-FQPOAREZSA-N 0.000 description 1
- HYLXOQURIOCKIH-VQVTYTSYSA-N Thr-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N HYLXOQURIOCKIH-VQVTYTSYSA-N 0.000 description 1
- YLXAMFZYJTZXFH-OLHMAJIHSA-N Thr-Asn-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O YLXAMFZYJTZXFH-OLHMAJIHSA-N 0.000 description 1
- NIEWSKWFURSECR-FOHZUACHSA-N Thr-Gly-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O NIEWSKWFURSECR-FOHZUACHSA-N 0.000 description 1
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 1
- GVMXJJAJLIEASL-ZJDVBMNYSA-N Thr-Pro-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O GVMXJJAJLIEASL-ZJDVBMNYSA-N 0.000 description 1
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 1
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 1
- XHWCDRUPDNSDAZ-XKBZYTNZSA-N Thr-Ser-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O XHWCDRUPDNSDAZ-XKBZYTNZSA-N 0.000 description 1
- DSGIVWSDDRDJIO-ZXXMMSQZSA-N Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DSGIVWSDDRDJIO-ZXXMMSQZSA-N 0.000 description 1
- KZTLZZQTJMCGIP-ZJDVBMNYSA-N Thr-Val-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KZTLZZQTJMCGIP-ZJDVBMNYSA-N 0.000 description 1
- ILDJYIDXESUBOE-HSCHXYMDSA-N Trp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N ILDJYIDXESUBOE-HSCHXYMDSA-N 0.000 description 1
- DKKHULUSOSWGHS-UWJYBYFXSA-N Tyr-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N DKKHULUSOSWGHS-UWJYBYFXSA-N 0.000 description 1
- GFHYISDTIWZUSU-QWRGUYRKSA-N Tyr-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GFHYISDTIWZUSU-QWRGUYRKSA-N 0.000 description 1
- ZQOOYCZQENFIMC-STQMWFEESA-N Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=C(O)C=C1 ZQOOYCZQENFIMC-STQMWFEESA-N 0.000 description 1
- PRONOHBTMLNXCZ-BZSNNMDCSA-N Tyr-Leu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PRONOHBTMLNXCZ-BZSNNMDCSA-N 0.000 description 1
- AOLHUMAVONBBEZ-STQMWFEESA-N Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AOLHUMAVONBBEZ-STQMWFEESA-N 0.000 description 1
- JXGUUJMPCRXMSO-HJOGWXRNSA-N Tyr-Phe-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 JXGUUJMPCRXMSO-HJOGWXRNSA-N 0.000 description 1
- MFEVVAXTBZELLL-GGVZMXCHSA-N Tyr-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MFEVVAXTBZELLL-GGVZMXCHSA-N 0.000 description 1
- NZBSVMQZQMEUHI-WZLNRYEVSA-N Tyr-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NZBSVMQZQMEUHI-WZLNRYEVSA-N 0.000 description 1
- JAQGKXUEKGKTKX-HOTGVXAUSA-N Tyr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 JAQGKXUEKGKTKX-HOTGVXAUSA-N 0.000 description 1
- UUJHRSTVQCFDPA-UFYCRDLUSA-N Tyr-Tyr-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 UUJHRSTVQCFDPA-UFYCRDLUSA-N 0.000 description 1
- VKYDVKAKGDNZED-STECZYCISA-N Tyr-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)N VKYDVKAKGDNZED-STECZYCISA-N 0.000 description 1
- JFAWZADYPRMRCO-UBHSHLNASA-N Val-Ala-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JFAWZADYPRMRCO-UBHSHLNASA-N 0.000 description 1
- QRZVUAAKNRHEOP-GUBZILKMSA-N Val-Ala-Val Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O QRZVUAAKNRHEOP-GUBZILKMSA-N 0.000 description 1
- WKWJJQZZZBBWKV-JYJNAYRXSA-N Val-Arg-Tyr Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WKWJJQZZZBBWKV-JYJNAYRXSA-N 0.000 description 1
- UBTBGUDNDFZLGP-SRVKXCTJSA-N Val-Arg-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)O)N UBTBGUDNDFZLGP-SRVKXCTJSA-N 0.000 description 1
- IDKGBVZGNTYYCC-QXEWZRGKSA-N Val-Asn-Pro Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O IDKGBVZGNTYYCC-QXEWZRGKSA-N 0.000 description 1
- HZYOWMGWKKRMBZ-BYULHYEWSA-N Val-Asp-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HZYOWMGWKKRMBZ-BYULHYEWSA-N 0.000 description 1
- WPSXZFTVLIAPCN-WDSKDSINSA-N Val-Cys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CS)C(O)=O WPSXZFTVLIAPCN-WDSKDSINSA-N 0.000 description 1
- VCAWFLIWYNMHQP-UKJIMTQDSA-N Val-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N VCAWFLIWYNMHQP-UKJIMTQDSA-N 0.000 description 1
- WFENBJPLZMPVAX-XVKPBYJWSA-N Val-Gly-Glu Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O WFENBJPLZMPVAX-XVKPBYJWSA-N 0.000 description 1
- SDUBQHUJJWQTEU-XUXIUFHCSA-N Val-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)N SDUBQHUJJWQTEU-XUXIUFHCSA-N 0.000 description 1
- LYERIXUFCYVFFX-GVXVVHGQSA-N Val-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LYERIXUFCYVFFX-GVXVVHGQSA-N 0.000 description 1
- JKHXYJKMNSSFFL-IUCAKERBSA-N Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN JKHXYJKMNSSFFL-IUCAKERBSA-N 0.000 description 1
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
- CKTMJBPRVQWPHU-JSGCOSHPSA-N Val-Phe-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)N CKTMJBPRVQWPHU-JSGCOSHPSA-N 0.000 description 1
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 1
- LTTQCQRTSHJPPL-ZKWXMUAHSA-N Val-Ser-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N LTTQCQRTSHJPPL-ZKWXMUAHSA-N 0.000 description 1
- PQSNETRGCRUOGP-KKHAAJSZSA-N Val-Thr-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O PQSNETRGCRUOGP-KKHAAJSZSA-N 0.000 description 1
- GVNLOVJNNDZUHS-RHYQMDGZSA-N Val-Thr-Lys Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O GVNLOVJNNDZUHS-RHYQMDGZSA-N 0.000 description 1
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 1
- IOUPEELXVYPCPG-UHFFFAOYSA-N Valylglycine Chemical compound CC(C)C(N)C(=O)NCC(O)=O IOUPEELXVYPCPG-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000007818 agglutination assay Methods 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000935 anti-streptococcal effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940031670 conjugate vaccine Drugs 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 101150089730 gly-10 gene Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 238000012872 hydroxylapatite chromatography Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- DVCSNHXRZUVYAM-BQBZGAKWSA-N leu-asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O DVCSNHXRZUVYAM-BQBZGAKWSA-N 0.000 description 1
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 108010063431 methionyl-aspartyl-glycine Proteins 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000001254 nonsecretory effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 101150022503 phoR gene Proteins 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 230000020978 protein processing Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960000814 tetanus toxoid Drugs 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 101150057627 trxB gene Proteins 0.000 description 1
- 108010084932 tryptophyl-proline Proteins 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940125575 vaccine candidate Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
Opis wynalazku
Wynalazek dotyczy antygenów, bardziej szczegółowo białkowych patogennych antygenów paciorkowca zapalenia płuc, które są stosowane do leczenia i/lub profilaktyki jako składniki szczepionek.
S. pneumoniae jest ważnym czynnikiem chorobotwórczym u człowieka, zwłaszcza u niemowląt, ludzi starszych i osób mających obniżoną odporność. Jest to bakteria często izolowana od pacjentów cierpiących na choroby inwazyjne o wysokiej chorobowości i śmiertelności na całym świecie, takie jak: bakteriemia/ posocznica, zapalenie płuc, zapalenie opon. Nawet przy odpowiedniej terapii antybiotykowej, infekcje paciorkowcami nadal prowadzą do wielu zgonów. Pomimo, że rozwój chorób przeciwko drobnoustrojom zmniejszył ogólną śmiertelność w wyniku chorób wywołanych przez paciorkowce, obecność odpornych organizmów paciorkowców stała się obecnie głównym problemem na świecie. Skuteczne szczepionki przeciwko paciorkowcom mogą mieć ogromny wpływ na chorobowość i śmiertelność związaną z chorobami wywołanymi S. pneumoniae. Szczepionki takie mogłyby być również stosowane do zapobiegania zapaleniom ucha środkowego u niemowląt i małych dzieci.
Wysiłki skierowane na opracowanie szczepionki przeciwko paciorkowcom koncentrowały się na tworzeniu odpowiedzi immunologicznej na pneumokokowy polisacharyd otoczkowy. Na podstawie różnic antygenowych zidentyfikowano ponad 80 serotypów pneumokokowych polisacharydów otoczkowych. Dostępne obecnie szczepionki pneumokokowe, zawierające 23 polisacharydy otoczkowe, które najczęściej powodują choroby, mają znaczącą wadę związaną przede wszystkim ze słabą immunogennością niektórych polisacharydów otoczkowych, różnorodnością serotypów i różnic w rozmieszczeniu serotypów w czasie, obszarach geograficznych i grupach wiekowych. W szczególności zawodność w zabezpieczaniu młodych dzieci przeciwko wszystkim serotypom istniejących szczepionek i szczepionek zawierających koniugaty otoczkowe, które są obecnie intensywnie badane zachęca do badania przydatności innych składników S. pneumoniae. Pomimo, że immunogenność polisacharydów otoczkowych może być poprawiona, specyficzność serotypowa nadal jest głównym ograniczeniem szczepionek opartych na polisacharydach. Zastosowanie antygenowo konserwowanych immunogennych pneumokokowych antygenów białkowych zarówno samych jak i w połączeniu z dodatkowymi składnikami, stwarza możliwość do stworzenia szczepionek pneumokokowych opartych na białkach.
Opis patentowy PCT nr publikacji WO 98/18930 opublikowanej 7 maja 1998 zatytułowany „Streptococcus Pneumoniae antigenes i vaccines” opisuje pewne polipeptydy, które zgodnie z zastrzeżeniami są antygenowe. Jednakże, nie stwierdzono żadnej aktywności biologicznej tych polipeptydów.
Dlatego nadal pozostaje niezrealizowana potrzeba opracowania antygenów paciorkowców, które mogłyby być używane jako składniki szczepionki w profilaktyce i/lub leczeniu zakażeń paciorkowcami.
Przedmiotem wynalazku jest izolowany polinukleotyd wybrany spośród (a) izolowanego polinukleotydu kodującego polipeptyd zawierający sekwencję aminokwasów identyczną w co najmniej 95% z sekwencją aminokwasów nr 4, 14, 58, 60, 62, 63, 73, 74, 77 lub 79, przy czym polipeptyd ten jest zdolny do wytwarzania przeciwciała wykazującego specyficzność wiązania wobec polipeptydu zawierającego sekwencję aminokwasów nr 4 lub 14, oraz polipeptyd ten jest zdolny do wywoływania u osobnika reakcji immunologicznej na paciorkowce;
(b) izolowanego polinukleotydu kodującego polipeptyd zawierający sekwencją aminokwasów nr 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79;
(c) izolowanego polinukleotydu zawierającego sekwencję nukleotydową identyczną w co najmniej 95% z sekwencją nukleotydową nr 3, 12 lub 13, przy czym polinukleotyd ten koduje polipeptyd zdolny do wytwarzania przeciwciała wykazującego specyficzność wiązania wobec polipeptydu zawierającego sekwencję aminokwasów nr 4 lub 14, oraz ten izolowany polipeptyd jest zdolny do wywoływania u osobnika reakcji immunologicznej na paciorkowce;
(d) izolowanego polinukleotydu zawierającego sekwencję nukleotydową nr 3, 12 lub 13; lub (e) izolowanego polinukleotydu komplementarnego z polinukleotydem określonym w którymkolwiek z punktów (a)-(d) powyżej.
W jednym z korzystnych wariantów realizacji wynalazku polinukleotyd ma postać DNA. W innym korzystnym wariancie realizacji wynalazku polinukleotyd ma postać RNA.
Przedmiotem wynalazku jest także wektor zawierający polinukleotyd według wynalazku funkcjonalnie połączony z regionem kontroli ekspresji.
Ponadto, przedmiotem wynalazku jest komórka gospodarza transfekowana lub transformowana za pomocą wektora według wynalazku.
PL 206 576 B1
Przedmiotem wynalazku jest także sposób wytwarzania polipeptydu kodowanego przez polinukleotyd według wynalazku, przy czym sposób ten obejmuje hodowlę komórek gospodarza według wynalazku w warunkach odpowiednich do uzyskania ekspresji tego polipeptydu. W jednym z korzystnych wariantów realizacji sposób według wynalazku obejmuje ponadto izolowanie polipeptydu z hodowli komórek gospodarza. W innym korzystnym wariancie realizacji sposobu według wynalazku polipeptyd jest polipeptydem rekombinowanym.
Przedmiotem wynalazku jest również izolowany polipeptyd zawierający (a) sekwencję aminokwasów identyczną w co najmniej 95% z sekwencją aminokwasów nr 4, 14, 58, 60, 63, 73, 74, 77 lub 79, przy czym ten izolowany polipeptyd ten jest zdolny do wytwarzania przeciwciała wykazującego specyficzność wiązania wobec polipeptydu zawierającego sekwencję aminokwasów nr 4 lub 14, oraz polipeptyd ten jest zdolny do wywoływania u osobnika reakcji immunologicznej na paciorkowce; lub (b) sekwencję aminokwasów nr 4, 14, 58, 60, 62, 63, 68, 72, 73, 74, 77 lub 79.
W jednym z korzystnych wariantów izolowanego polipeptydu według wynalazku z sekwencji nr 4 lub 14 usunięta jest N-terminalna reszta metioninowa. W innym korzystnym wariancie izolowanego polipeptydu według wynalazku z sekwencji nr 4 lub 14 usunięta jest wydzielnicza sekwencja aminokwasów. W kolejnym korzystnym wariancie izolowany polipeptyd według wynalazku jest przyłączony do sacharydu. W następnym korzystnym wariancie izolowanego polipeptydu według wynalazku paciorkowiec jest wybrany spośród Streptococcus pneumoniae, grupy A Streptococcus (Streptococcus pyogenes), grupy B Streptococcus (Streptococcus agalactiae), Streptococcus dysgalactiae, lub Streptococcus uberis. W szczególnie korzystnym przypadku paciorkowcem jest Streptococcus pneumoniae.
Ponadto, przedmiotem wynalazku jest chimeryczny polipeptyd wybrany spośród (a) chimerycznego polipeptydu zawierającego dwa lub większą liczbę polipeptydów, przy czym sekwencja aminokwasów każdego z dwóch lub większej liczby peptydów zawiera sekwencję aminokwasów wybraną spośród sekwencji nr 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79, zaś dwa lub większa liczba polipeptydów jest połączona z utworzeniem chimerycznego polipeptydu;
(b) chimerycznego polipeptydu zawierającego dwa lub większą liczbę polipeptydów, przy czym sekwencja aminokwasów każdego z dwóch lub większej liczby peptydów zawiera sekwencję aminokwasów wybraną spośród sekwencji nr 58, 60, 62, 67, 68, 72, 74 lub 77, zaś dwa lub większa liczba polipeptydów jest połączona z utworzeniem chimerycznego polipeptydu;
(c) chimerycznego polipeptydu o wzorze (I):
A-(B)m-(C)n-D (I) w którym: m oznacza 0 lub 1, n oznacza 0 lub 1,
A jest wybrane spoś ród sekwencji nr: 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79;
B jest wybrane spoś ród sekwencji nr: 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79;
C jest wybrane spoś ród sekwencji nr: 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79; oraz
D jest wybrane spoś ród sekwencji nr: 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79; lub (d) chimerycznego polipeptydu o wzorze (I):
A-(B)m-(C)n-D (I) w którym: m oznacza 0 lub 1, n oznacza 0 lub 1,
A jest wybrane spoś ród sekwencji nr: 58, 60, 62, 67, 68, 72, 74 lub 77;
B jest wybrane spoś ród sekwencji nr: 58, 60, 62, 67, 68, 72, 74 lub 77;
C jest wybrane spoś ród sekwencji nr: 58, 60, 62, 67, 68, 72, 74 lub 77; oraz
D jest wybrane spoś ród sekwencji nr: 58, 60, 62, 67, 68, 72, 74 lub 77.
W jednym z korzystnych wariantów realizacji chimerycznego polipeptydu według wynalazku izolowany polipeptyd jest przyłączony do sacharydu.
Kolejnym przedmiotem wynalazku jest kompozycja do szczepionek zawierająca (a) skuteczną profilaktycznie lub terapeutycznie ilość izolowanego polipeptydu według wynalazku, oraz farmaceutycznie akceptowalny nośnik lub rozcieńczalnik; lub (b) skuteczną profilaktycznie lub terapeutycznie ilość chimerycznego polipeptydu według wynalazku, oraz farmaceutycznie akceptowalny nośnik lub rozcieńczalnik. W jednym z korzystnych wariantów realizacji kompozycja według wynalazku zawiera ponadto farmaceutycznie akceptowalny adiuwant.
PL 206 576 B1
W innym korzystnym wariancie realizacji kompozycja według wynalazku jest przeznaczona do zastosowania w zapobieganiu lub leczeniu zakażenia osobnika paciorkowcem.
Przedmiotem wynalazku jest także zastosowanie kompozycji według wynalazku do wytwarzania leku do leczenia lub zapobiegania zakażeniu osobnika paciorkowcem. W jednym z korzystnych przypadków zastosowania według wynalazku zakażenie paciorkowcem obejmuje zapalenie opon, zapalenie ucha środkowego, bakteriemię lub zapalenie płuc. W szczególnie korzystnym przypadku zastosowania według wynalazku osobnikiem jest ssak, a zwłaszcza człowiek. W innym korzystnym przypadku zastosowania według wynalazku zakażenie paciorkowcem jest wywołane przez Streptococcus pneumoniae, grupę A paciorkowców (Streptococcus pyogenes), grupę B paciorkowców (Streptococcus agalactiae), Streptococcus dysgalactiae lub Streptococcus uberis, a zwłaszcza - przez Streptococcus pneumoniae.
Przedmiot wynalazku w przykładach wykonania został przedstawiony na rysunku, na którym:
fig. 3 przedstawia sekwencję DNA genu BVH-11; Sekwencja nr 3.
fig. 4 przedstawia sekwencję aminokwasową białka BVH-11; Sekwencja nr 4.
fig. 12 przedstawia porównanie przewidywanej sekwencji aminokwasowej otwartych ramek odczytu BVH-11 ze szczepów S. pneumoniae WU2, Rx1, JNR.7/87, SP64, P4241, A66 i SP63 stosując program Clustal W z oprogramowania do analizy sekwencyjnej MacVector (wersja 6.5). Poniżej wersów zawierających sekwencje, znajduje się wiersz określający zgodność, gdzie symbole* i. oznaczają odpowiednio identyczne i podobne reszty aminokwasowe.
fig. 13 przedstawia porównanie przewidywanej sekwencji aminokwasowej białek BVH-11 z różnych szczepów S. pneumoniae. Stopień identyczności (I) i podobieństwa (S) wyznaczono stosując program Clustal W z oprogramowania do analizy sekwencyjnej MacVector (wersja 6.5).
fig. 15 przedstawia sekwencję DNA zawierającą cały gen BVH-11 (ORF zlokalizowana od nukleotydu 45 do 2567); Sekwencja nr 12.
fig. 16 przedstawia sekwencję DNA zawierającą cały gen BVH-11-2 (ORF zlokalizowana od nukleotydu 114 do 2630); Sekwencja nr 13.
fig. 17 przedstawia sekwencję aminokwasową białka BVH-11-2; Sekwencja nr 14.
fig. 23 przedstawia sekwencję aminokwasową białka NEW12; Sekwencja nr 58.
fig. 25 przedstawia sekwencję aminokwasową białka BVH-11M; Sekwencja nr 60.
fig. 26 przedstawia sekwencję aminokwasową białka BVH-11A; Sekwencja nr 61.
fig. 27 przedstawia sekwencję aminokwasową białka BVH-11B (zwanego również New13); Sekwencja nr 62.
fig. 28 przedstawia sekwencję aminokwasową białka BVH-11C; Sekwencja nr 63.
fig. 32 przedstawia sekwencję aminokwasową białka NEW4; Sekwencja nr 67.
fig. 33 przedstawia sekwencję aminokwasową białka NEW5; Sekwencja nr 68.
fig. 34 przedstawia sekwencję aminokwasową białka NEW6; Sekwencja nr 69.
fig. 35 przedstawia sekwencję aminokwasową białka NEW7; Sekwencja nr 70.
fig. 36 przedstawia sekwencję aminokwasową białka NEW8; Sekwencja nr 71.
fig. 37 przedstawia sekwencję aminokwasową białka NEW9; Sekwencja nr 72.
fig. 38 przedstawia sekwencję aminokwasową białka BVH-11-2M; Sekwencja nr 73.
fig. 39 przedstawia sekwencję aminokwasową białka NEW10; Sekwencja nr 74.
fig. 40 przedstawia sekwencję aminokwasową białka NEW11; Sekwencja nr 75.
fig. 41 przedstawia sekwencję DNA genu NEW12; Sekwencja nr 76.
fig. 42 przedstawia sekwencję aminokwasową białka NEW14; Sekwencja nr 77. fig. 44 przedstawia sekwencję aminokwasową białka NEW16; Sekwencja nr 79.
Przeciwciało, które „ma specyficzność wiązania” jest o przeciwciało, które rozpoznaje i wiąże się z wybranym polipeptydem, ale które zasadniczo nie rozpoznaje i nie wiąże się z innymi cząsteczkami w próbce, np. próbce biologicznej, która z natury swojej zawiera wybrany peptyd. Specyficzne wiązanie może być mierzone stosując test ELISA, w którym wybrany polipeptyd jest stosowany jako antygen.
Jeśli nie zdefiniowano inaczej, wszystkie techniczne i naukowe określenia stosowane w niniejszym opisie mają takie samo znaczenie jak ogólnie zrozumiałe dla specjalisty w dziedzinie, do której należy niniejszy wynalazek. Wszystkie publikacje, zgłoszenia patentowe, patenty i inne odnośniki wymienione w opisie są zawarte w całości jako literatura. W przypadku niezgodności niniejszy opis wynalazku włącznie z definicjami będzie wiążący. Ponadto materiały, sposoby i przykłady stanowią jedynie ilustrację i nie mają ograniczać zakresu wynalazku.
PL 206 576 B1
Zgodnie z niniejszym opisem, „fragmenty”, „analogi” lub „pochodne” polipeptydów według wynalazku obejmują te polipeptydy, w których jedna lub większa liczba reszt aminokwasowych jest podstawiona konserwowanymi lub nie-konserwowanymi resztami aminokwasowymi (korzystnie konserwowanymi) i które mogą być naturalne lub nie będące pochodzenia naturalnego. W jednym z wariantów rozwiązania według wynalazku, pochodne i analogi polipeptydów według wynalazku mają mniej niż około 20 podstawień, modyfikacji lub delecji reszt aminokwasowych i korzystniej mniej niż 10. Korzystnymi podstawieniami są te, w które są znane specjalistom w dziedzinie jako konserwowane to jest podstawione reszty wykazują takie same fizyczne lub chemiczne właściwości takie jak hydrofobowość, wielkość, ładunek lub grupy funkcyjne.
Wynalazkiem objęte są również polipeptydy które zostały połączone z innymi związkami, które zmieniają biologiczne lub farmakologiczne właściwości polipeptydów to jest poli(glikolem etylenowym) (PEG), w celu zwiększenia półokresu trwania; aminokwasowymi sekwencjami liderowymi lub wydzielniczymi, w celu ułatwienia oczyszczania, i sekwencjami prepro- i pro-; i (poli)sacharydami.
Ponadto, w tych sytuacjach, w których jak stwierdzono, regiony aminokwasowe są polimorficzne, może być pożądana zmiana jednego lub większej liczby poszczególnych aminokwasów, w celu zwiększenia skuteczności naśladowania różnych epitopów różnych szczepów paciorkowców.
Ponadto, polipeptydy według niniejszego wynalazku mogą być modyfikowane poprzez acylację końca -NH2 (np. przez acetylowanie, lub amidowanie kwasem tioglikolowym, amidowanie końca karboksylowego, np. amoniakiem lub metyloaminą) w celu zapewnienia stabilności, zwiększenia hydrofobowości w wiązaniu lub połączeniu z podłożem lub z inną cząsteczką.
Przedmiotem wynalazku są również hetero- i homo polipeptydowe multimery fragmentów polipeptydowych, analogi i pochodne. Te polimerowe postaci obejmują, na przykład, jeden lub większą liczbę polipeptydów, które zostały usieciowane z cząsteczkami sieciującymi, takimi jak awidyna/biotyna, gluteraldehyd lub dimetylo-superimidan. Takie polimerowe postaci obejmują również polipeptydy zawierające dwa lub większą liczbę tandemowych lub odwróconych przylegających sekwencji, otrzymane z multicistronowych mRNA wytworzonych technikami rekombinacyjnego DNA.
Korzystnie fragment, analog lub pochodna polipeptydu według wynalazku zawiera przynajmniej jeden obszar antygenowy to jest przynajmniej jeden epitop.
W celu uzyskania tworzenia się polimerów antygenowych (to jest multimerów syntetycznych), mogą być wykorzystane polipeptydy mające grupy bishalogenoacetylowe, nitroarylohaloidki, i tym podobne, w których odczynniki są specyficzne dla grup tiolowych. Dlatego połączenie pomiędzy dwoma grupami merkaptolowymi różnych peptydów może być wiązaniem pojedynczym lub może być złożone z grupy wiążącej złożonej zazwyczaj z co najmniej czterech, a nie więcej niż 16, ale zazwyczaj nie więcej niż 14 atomów węgla.
W szczególnym rozwiązaniu, fragmenty polipeptydowe, analogi i pochodne według wynalazku nie zawierają zaczynającej reszty metioninowej (Met). Korzystnie, polipeptydy nie będą zawierały sekwencji liderowej lub wydzielniczej (sekwencji sygnałowej). Część sygnałowa polipeptydu według wynalazku może być określona według ustalonych technik biologii molekularnej. Ogólnie, polipeptyd według wynalazku, może być izolowany z hodowli paciorkowców, a następnie sekwencjonowany w celu określenia reszty początkowej dojrzałego białka i w wyniku tego sekwencji dojrzałego polipeptydu.
Jak wskazano powyżej wynalazek dotyczy również kompozycji do szczepionek zawierającej jeden lub większą liczbę polipeptydów według wynalazku w mieszaninie z farmaceutycznie dopuszczalnym nośnikiem, rozcieńczalnikiem lub adiuwantem. Odpowiednie adiuwanty obejmują oleje takie jak pełny i częściowy adiuwant Freunda; sole to jest AlK(SO4)2, AlNa(SO4)2, AINH4(SO4)2, krzemiany, kaolin, polinukleotydy węglowe to jest poli IC i poli AU. Korzystne adjuwanty obejmują QuilA i Alhydrogel. Szczepionki według wynalazku mogą być podawane pozajelitowo przez iniekcję, szybki wlew, absorpcję nosowo-gardłową, absorpcję skórną, lub policzkową, lub doustną. Nośniki dopuszczalne farmakologicznie obejmują również anatoksynę tężca.
Kompozycje do szczepionek według wynalazku są stosowane do leczenia lub profilaktyki zakażeń paciorkowcami i/lub chorób i zespołów w których uczestniczy zakażenie paciorkowcami, jak opisano w P.R. Murray (Ed, in chief), E.J. Baron, M.A. Pfaller, F.C. Tenover i R.H. Yolken. Manual of Clinical Microbiology, ASM Press, Washington, D.C. szóste wyd., 1995, str. 1482, które są zamieszczone jako odnośniki. Kompozycja do szczepionek według wynalazku może być wykorzystywana m.in. w profilaktyce lub leczeniu zapalenia opon, zapalenia ucha środkowego, bakteriemii lub zapalenia płuc. W szczególnym rozwiązaniu, szczepionki są podawane tym osobnikom które są zagrożone ryzykiem infekcji paciorkowcami takie jak niemowlęta, osoby starsze i osoby o osłabionej odporności.
PL 206 576 B1
Kompozycje do szczepionek są korzystnie w dawce jednostkowej od około 0,001 do 100 μg/kg (antygen/masę ciała) i korzystniej 0,01 do 10 μg/kg i najkorzystniej 0,1 do 1 μg/kg 1 do 3 razy z przerwami około 1 do 6 tygodni pomiędzy immunizacjami.
W jednym rozwiązaniu, polinukleotydy zostały przestawione w Sekwencji nr: 3, 12, 13 i 76, które obejmują otwarte ramki odczytu (ORF), kodujące polipeptydy według wynalazku. Jest jasne, że sekwencje polinukleotydowe przedstawione na rysunku mogą być zmienione przez zdegenerowane kodony, jednak nadal kodując polipeptydy według wynalazku. Zgodnie z powyższym, niniejszy wynalazek obejmuje polinukleotyd, który hybrydyzuje z sekwencjami polinukleotydami jak opisano powyżej (lub całkowitymi sekwencjami tych polinukleotydów).
Niniejszy wynalazek obejmuje również polinukleotydy kodujące polipeptydy według wynalazku, lub fragmenty, analogi lub pochodne tych polipeptydów, które mogą być stosowane w immunizacji DNA. To jest mogą one być włączone do wektora, który ulega replikacji i ekspresji po iniekcji i przez to powoduje produkcję antygenowego polipeptydu in vivo. Na przykład polinukleotydy mogą być włączone do wektora plazmidowego pod kontrolą promotora CMV, który jest funkcjonalny w komórkach eukariotycznych. Korzystnie wektor jest wprowadzany zastrzykiem domięśniowym.
Jak wskazano powyżej, wynalazek dotyczy m.in. sposobu otrzymywania polipeptydu według wynalazku technikami rekombinacyjnymi w wyniku ekspresji polinukleotydu kodującego ten polipeptyd w komórce gospodarza i odzyskiwania produktu polipeptydowego uzyskanego w wyniku ekspresji. W innym rozwiązaniu, polipeptydy mogą być otrzymywane zgodnie z ustalonymi technikami syntezy chemicznej to jest synteza oligopeptydów w fazie płynnej lub stałej, które są ligowane w celu otrzymania całego polipeptydu (ligacja blokowa).
Ogólnie sposoby otrzymywania i oszacowania polinukleotydów i polipeptydów są opisane w następujących odnośnikach: Sambrook i wsp., Molecular Cloning: A Laboratory Manual, II wyd., Cold Spring Harbor, N.Y., 1989; Current Protocols in Molecular Biology, Edited by Ausubel F.M. i wsp., John Wiley i Sons, Inc. New York; PCR Klonowanie Protocols, from Molecular Klonowanie to Genetic Engineering, Edited by White B.A., Humana Press, Totowa, New Jersey, 1997, strona 490; Białko Oczyszczanie, Principles i Practices, Scopes R.K., Springer-Verlag, New York, III wyd., 1993, strona 380; Current Protocols in Immunology, Edited by Coligan J.E. i wsp., John Wiley & Sons Inc., New York, które są zamieszczone jako odnośniki.
Do produkcji w wyniku rekombinacji, komórki gospodarza są transfekowane wektorami, które kodują polipeptyd, a następnie są one hodowane w pożywce pokarmowej zmodyfikowanej odpowiednio do aktywacji promotorów, selekcji transformantów lub amplifikacji genów. Odpowiednie wektory, które są żywotne i ulegają replikacji w wybranym gospodarzu i obejmują chromosomalnie, nie-chromosomalne i syntetyczne sekwencje DNA np. plazmidy bakteryjne, fagi DNA, bakulowirusy, plazmidy drożdżowe, wektory pochodzące z połączeń plazmidów i fagów DNA. Sekwencje polipeptydowe mogą być włączane do wektora w odpowiednim miejscu stosując enzymy restrykcyjne w taki sposób, że jest on funkcjonalnie połączony z regionem kontroli ekspresji zawierającym promotor, miejsce wiązania rybosomu (region zgodności lub sekwencja Shine-Dalgarno), i ewentualnie operator (element kontroli). Możliwe jest wybranie poszczególnych składników regionu kontroli ekspresji, które są odpowiednie dla danego gospodarza i wektora według ustalonych zasad biologii molekularnej (Sambrook i wsp., Molecular Cloning: A Laboratory Manual, wyd. II, Cold Spring Harbor, N.Y., 1989; Current Protocols in Molecular Biology, Edited by Ausubel F.M. i wsp., John Wiley i Sons, Inc. New York załączone w niniejszym opisie jako odnośnik). Odpowiednie promotory obejmują między innymi promotory LTR lub SV40, E.coli lac, tac lub trp i promotory faga lambda PL. Wektory korzystnie zawierają początek replikacji jak i markery selekcyjne to jest gen odporności na ampicylinę. Odpowiednie wektory bakteryjne obejmują pET, pQE70, pQE60, pQE-9, pbs, pD10 phagescript, psiX174, pbluescript SK, pbsks, pNH8A, pNH16a, pNH18A, pNH46A, ptrc99a, pKK223-3, pKK233-3, pDR540, pRIT5 i wektory eukariotyczne pBlueBacIII, pWLNEO, pSV2CAT, pOG44, pXT1, pSG, pSVK3, pBPV, pMSG i pSVL. Komórki gospodarza mogą być bakteryjne to jest E.coli, Bacillus subtilis, Streptomyces; grzybowe to jest Aspergillus niger, Aspergillus nidulins; drożdżowe to jest Saccharomyces lub eukariotyczne to jest CHO, COS.
W wyniku ekspresji polipeptydu w hodowli, komórki są zazwyczaj zbierane przez wirowanie następnie rozerwanie środkami fizycznymi lub chemicznymi (jeśli ekspresja polipeptydu prowadzi do otrzymania peptydu, który nie jest wydzielany do pożywki) i otrzymuje się surowy ekstrakt zatrzymany do przeprowadzenia wyodrębnienia żądanego polipeptydu. Oczyszczanie polipeptydu z pożywki hodowlanej lub lizatu może być uzyskany znanymi technikami w zależności od właściwości polipeptydu
PL 206 576 B1 to jest stosując strącanie siarczanem amonowym lub etanolem, ekstrakcję kwasem, chromatografię anionowo- lub kationowo- wymienną, chromatografii na złożu fosfocelulozowym, chromatografii oddziaływań hydrofobowych, chromatografię na hydroksyloapatycie i chromatografii lecytynowej. Końcowe oczyszczanie może być przeprowadzone z wykorzystaniem HPLC.
Polipeptyd może ulegać ekspresji z lub bez sekwencji liderowej lub wydzielniczej. W poprzednim przypadku, lider może być usuwany w trakcie obróbki post-translacyjnej (patrz opisy patentowe US 4,431,739; US 4,425,437; i US 4,338,397 załączone w niniejszym opisie jako odnośniki) lub może być usuwany chemicznie po oczyszczeniu polipeptydu uzyskanego w wyniku ekspresji.
Polipeptydy według wynalazku mogą być stosowane w testach diagnostycznych w zakażeniach paciorkowcami, w szczególności w zakażeniach S. pneumoniae. Możliwe jest zastosowanie kilku sposobów diagnostycznych, na przykład wykrywanie organizmów paciorkowców w próbce biologicznej. W tym celu moż e być wykorzystana procedura opisana poniż ej:
a) uzyskiwanie próbki biologicznej od pacjenta;
b) inkubacja przeciwciała lub jego fragmentu reagującego z polipeptydem paciorkowców według wynalazku z próbką biologiczną do utworzenia mieszaniny; oraz
c) wykrywanie przeciwciała specyficznie związanego lub związanego fragmentu w mieszaninie, co wskazuje na obecność paciorkowców.
W innym rozwiązaniu, sposób wykrywania przeciwciała specyficznego względem antygenu paciorkowców w próbce biologicznej, w której podejrzewa się lub zakłada obecność tego przeciwciała, może być przeprowadzony następująco:
a) uzyskiwanie próbki biologicznej od pacjenta;
b) inkubacja jednego lub większej liczby polipeptydów według wynalazku lub jego fragmentów z próbką biologiczn ą do utworzenia mieszaniny; oraz
c) wykrywanie specyficznie związanego antygenu lub związanego fragmentu w mieszaninie, co wskazuje na obecność przeciwciała specyficznego względem paciorkowców.
Specjalista w dziedzinie zrozumie, że te diagnostyczne testy mogą mieć kilka postaci, włącznie z testami immunologicznymi, takimi jak test immunoabsorpcji enzymozależ nej (ELISA), test radioimmunologiczny (przy użyciu radioaktywnie znakowanych przeciwciał) lub test aglutynacji lateksowej, zasadniczo do określania czy specyficzne przeciwciała przeciwko białkom są obecne w organizmie.
Sekwencje DNA kodujące polipeptydy według wynalazku mogą również być stosowane do projektowania sond DNA do stosowania przy wykrywaniu obecności paciorkowców w próbce biologicznej, które jak się przypuszcza zawierają takie bakterie. Sposób wykrywania według niniejszego wynalazku obejmuje:
a) uzyskiwanie próbki biologicznej od pacjenta;
b) inkubację jednej lub większej liczby sond DNA o sekwencji DNA kodującej polipeptyd według wynalazku lub jego fragmentów z próbką biologiczną do utworzenia mieszaniny; oraz
c) wykrywanie specyficznie związanej sondy DNA w mieszaninie, co wskazuje na obecność bakterii paciorkowców.
Sondy DNA przygotowane z wykorzystaniem niniejszego wynalazku mogą również być stosowane do wykrywania krążących paciorkowców to jest kwasów nukleinowych S. pneumoniae w próbce, na przykład stosując reakcję łańcuchową polimerazy, jako sposobu diagnozowania infekcji paciorkowcami. Sonda może być syntetyzowana stosując tradycyjne techniki i może być unieruchomiona na stałym podłożu, lub może być znakowana znacznikiem, który może być wykryty. Korzystna sonda DNA przygotowana z wykorzystaniem niniejszego wynalazku to oligomer o sekwencji komplementarnej do co najmniej około 6 sąsiadujących nukleotydów kodujących polipeptydy paciorkowców zapalenia płuc według wynalazku.
Inny sposób diagnostyczny wykrywania paciorkowców u pacjenta obejmuje:
a) znakowanie przeciwciała reagujące z polipeptydem według wynalazku lub jego fragmentem za pomocą wykrywalnego znacznika;
b) podawanie znakowanego przeciwciała lub znakowanego fragmentu pacjentowi; oraz
c) wykrywanie specyficznie związanego znakowanego przeciwciała lub znakowanego fragmentu u pacjenta, co wskazuje na obecność paciorkowców.
Kolejny aspekt wykorzystania niniejszego wynalazku stanowi zastosowanie polipeptydów paciorkowców według wynalazku jako immunogenów do otrzymywania specyficznych przeciwciał do diagnostyki i w szczególności do leczenia infekcji paciorkowcami. Odpowiednie przeciwciała mogą być określane przy użyciu odpowiednich sposobów przeszukiwania, na przykład przez pomiar zdolności
PL 206 576 B1 poszczególnego przeciwciała do biernej ochrony przeciwko infekcjom paciorkowcami w modelach testowych. Jednym przykładem modelu zwierzęcego jest model mysi opisany w poniższych przykładach. Przeciwciało może być całym przeciwciałem lub jego fragmentem wiążącym antygen i może należeć do dowolnej klasy immunoglobulin. Przeciwciało lub jego fragment może pochodzić od zwierzęcia, specyficznie od ssaka a bardziej szczegółowo od myszy, szczura lub człowieka. Może to być naturalne przeciwciało lub jego fragment, lub jeśli jest to pożądane, zrekombinowane przeciwciało lub fragment przeciwciała. Określenie zrekombinowane przeciwciało lub fragment przeciwciała oznacza przeciwciało lub fragment przeciwciała, który otrzymano w wyniku zastosowania technik biologii molekularnej. Przeciwciało lub fragment przeciwciała może być poliklonalne, lub korzystnie monoklonalne. Może one być specyficzne ze względu na ilość epitopów związanych z polipeptydami paciorkowców zapalenia płuc, ale korzystnie są one specyficzne względem jednego epitopu.
Jak opisano powyżej, przedmiotem wynalazku są nowe antygeny oznaczone jako BVH-11 i BVH-11-2, obcięte polipeptydy zawierające fragmenty antygenów BVH-11 i BVH-11-2 oraz chimeryczne polipeptydy zawierające fragmenty antygenów BVH-11 i BVH-11-2.
Poniżej przedstawiono tabelę zawierającą odnośniki podsumowującą zależności pomiędzy antygenami według niniejszego wynalazku:
| Rodzina | Nr sekwencji nukleotydowej | Nr sekwencji aminokwasowej |
| BVH-11 | ||
| BVH-11-1 | 3, 12 | 4 |
| BVH-11-2 | 13 | 14 |
| BVH-11M | 60 | |
| BVH-11A | 61 | |
| BVH-11B również oznaczany jako NEW13 | 62 | |
| BVH-11C | 63 | |
| New4 | 67 | |
| New5 | 68 | |
| New6 | 69 | |
| New7 | 70 | |
| New8 | 71 | |
| New9 | 72 | |
| BVH-11-2M | 73 | |
| New10 | 74 | |
| New11 | 75 | |
| New12 | 76 | 58 |
| New14 | 77 | |
| New16 | 79 |
Treść poniższych przykładów zachowano w zakresie pierwotnego zgłoszenia PCT/CA99/01218. Wprawdzie częściowo treść przykładów odnosi się do rozwiązań stanowiących przedmiot zgłoszeń wydzielonych z niniejszego zgłoszenia (w szczególności w zakresie BVH-3 i BVH-28), ale uznano, że dla zachowania spójności i kompletności informacji korzystniejsze będzie pozostawienie w niniejszym opisie treści przykładów w formie niezmienionej. Znawca w dziedzinie wynalazku będzie w stanie na podstawie tych przykładów zrealizować wynalazek w całym zastrzeganym zakresie.
PL 206 576 B1
P r z y k ł a d 1
Niniejszy przykład przedstawia klonowanie genów S. pneumoniae.
Region kodujący genu S. pneumoniae BVH-3 (Sekwencja nr 1) i region kodujący genu S. pneumoniae BVH-28 (Sekwencja nr 5) amplifikowano metodą PCR (DNA Thermal Cycler GeneAmp PCR system 2400 Perkin Elmer, San Jose, CA) z genomowego DNA z grupy surowiczej 6 Szczepu S. pneumoniae SP64 stosując oligonukleotydy, które zawierały końcówki nici odpowiednie do dodania miejsc restrykcyjnych Bglll (AGATCT) i Xbal (TCTAGA). Produkty PCR oczyszczano z żelu agarozowego stosując zestaw do ekstrakcji z żelu QIAquick z firmy QIAgen (Chatsworth, CA), trawiono BglII-XbaI (Pharmacia Canada Inc, Baie d'Urfe, Kanada), ekstrahowano fenolem:chloroformem i wytrącano etanolem. Wektor Superlinker pSL301 (Invitrogen, San Diego, CA) trawiono Bglll i Xbal i oczyszczano z ż elu agarozowego stosują c zestaw do ekstrakcji z ż elu QIAquick z firmy QIAgen (Chatsworth, CA). Fragmenty BglII-XbaI genomowego DNA ligowano z BglII-XbaI wektora pSL301. Zligowanymi produktami transformowano szczep DH5a E. coli [f80 lacZ DM15 koniecA1 recA1 hsdR17 (rK- mK+) supE44 thi-11- gyrA96 relA1 D(lacZYA-argF)U169] (Gibco BRL, Gaithersburg, MD) według metody opisanej przez Simanis (Hanahan, D. DNA cloning, 1985, D.M. Glover (wyd), str. 109-135). Zrekombinowane plazmidy pSL301 plazmids (rpSL301) zawierające gen BVH-3 lub BVH-28 oczyszczano stosując zestaw QIAgen (Chatsworth, CA) i Inserty DNA potwierdzono przeprowadzając analizę sekwencji nukleotydów (zestaw do sekwencjonowania Taq Dye Deoxy Terminator Cycle Sequencing, ABI, Foster City, CA). Zrekombinowane rpSL301 (rpSL301) trawiono enzymami restrykcyjnymi Bglll (AGATCT) i XhoI (CTCGAG). Fragmenty DNA BglII-XhoI oczyszczano stosują c zestaw do ekstrakcji z ż elu
QIAquick z firmy QIAgen (Chatsworth, CA). Wektor ekspresyjny pET-32c(+) (Novagen, Madison, WI) zawierający sekwencję tioredoksyno-HisTag trawiono BamHI (GGATCC) i XhoI i ekstrahowano z żelu stosując zestaw do ekstrakcji z żelu QIAquick z firmy QIAgen (Chatsworth, CA). Fragmenty BglII-XhoI DNA ligowano z BamHI-XhoI wektora pET-32c(+) aby utworzyć sekwencję kodującą dla białka fuzyjnego tioredoksyno-His^Tag-fiyH-3 lub tioredoksyno-His^Tag-BVH-28. Zligowanymi produktami transformowano szczep DH5a E. coli [f80 lacZ DM15 koniecA1 reckA1 hsdR17 (rK-mK+) supE44 thi-11 gyrA96 relA1 D(lacZYA-argF)U169] (Gibco BRL, Gaithersburg, MD) według metody opisanej przez Simanis (Hanahan, D. DNA Klonowanie, 1985, D.M. Glover (ed), str. 109-135). Zrekombinowane plazmidy pET-32c(+) oczyszczano stosując zestaw QIAgen (Chatsworth, CA) i sekwencje nukleotydowe w miejscach łączenia tioredoksyno-HisTag i insertu DNA sprawdzano przez sekwencjonowanie DNA (zestaw do sekwencjonowania Taq Dye Deoxy Terminator Cycle Sequencing, ABI, Foster City, CA).
P r z y k ł a d 2
Niniejszy przykład przedstawia klonowanie genów kodujących białka S. pneumoniae w plazmidzie CMV pCMV-GH.
Region DNA kodujący białka S. pneumoniae wprowadzono do genu kodującego ludzki hormon wzrostu (hGH) w fazie downstream, przy czym gen był pod kontrolą transkrypcyjną promotora cytomegalowirusa (CMV) w wektorze plazmidowym pCMV-GH (Tang i wsp., Nature, 1992, 356:152). Promotor (CMV) jest nie funkcjonalnym plazmidem w komórkach E. coli, ale aktyny po podaniu plazmidu do komórek eukariotycznych. Wektor również obejmuje gen oporności na ampicylinę.
Region kodujący genu BVH-3 (Sekwencja nr 1) i BVH-28 (Sekwencja nr 5) otrzymano z rpSL301 (patrz przykład 1) stosując enzymy restrykcyjne Bglll (AGATCT) i Xbal (TCTAGA). Produkty trawienia oczyszczano z żelu agarozowego stosując zestaw do ekstrakcji z żelu QlAquick z firmy QIAgen (Chatsworth, CA). Wektor pCMV-GH (Laboratory of Dr. Stephen A. Johnston, Department of Biochemistry, The University of Texas, Dallas, Texas) zawierający gen kodujący ludzki hormonu wzrostu aby utworzyć białka fuzyjne trawiono Bglll i Xbal i oczyszczano z żelu agarozowego stosując zestaw do ekstrakcji z żelu QIAquick z firmy QIAgen (Chatsworth, CA). Fragmenty BglII-XbaI DNA ligowano z BglII-XbaI wektora pCMV-GH, aby utworzyć białko fuzyjne hGH-BVH-3 lub hGH-BVH-28 pod kontrolą promotora CMV. Zligowanymi produktami transformowano komórki szczepu E. coli DH5a[f80 lacZ DM15 koniecA1 recA1 hsdR17 (rK-mK+) supE44 thi-11- gyrA96 relA1 D(lacZYA-argF)U169] (Gibco BRL, Gaithersburg, MD) według metody opisanej przez Simanis (Hanahan, D. DNA Klonowanie, 1985, D.M. Glover (ed), str. 109-135). Zrekombinowane plazmidy pCMV oczyszczano stosując zestaw QIAgen (QIAgen, Chatsworth, CA).
Region kodujący genu BVH-11 (Sekwencja nr 3) amplifikowano metodą PCR (DNA Thermal Cycler GeneAmp PCR system 2400 Perkin Elmer, San Jose, CA) z genomowego DNA z grupy surowiczej 6 szczepu S. pneumoniae SP64 stosując oligonukleotydy, które zawierały końcówki nici odpowiednie do dodania miejsc restrykcyjnych Bglll (AGATCT) i Hindlll (AAGCTT). Produkt PCR oczyszczano
PL 206 576 B1 z żelu agarozowego stosują c zestaw do ekstrakcji z żelu QIAquick z firmy QIAgen (Chatsworth, CA), trawiono enzymami restrykcyjnymi (Pharmacia Canada Inc, Baie d'Urfe, Kanada), ekstrahowano fenolem:chloroformem i wytrącano etanolem. Wektor pCMV-GH (Laboratorium Dr. Stephena A. Johnstona, Departament Biochemii, The University of Texas, Dallas, Texas) trawiono Bg1ll i Hindlll i oczyszczano z żelu agarozowego stosując zestaw do ekstrakcji z żelu QIAquick z firmy QIAgen (Chatsworth, CA). Fragment Bg1ll-HindIII DNA ligowano z Bg1ll-HindlIl wektora pCMV-GH, aby utworzyć białko fuzyjne hGH-BVH-11 pod kontrolą promotora CMV. Zligowanymi produktami transformowano komórki szczepu E. coli DH5a[f80 lacZ DM15 koniecA1 recA1 hsdR17 (rK-mK+) supE44 thi-11- gyrA96 relA1 D(lacZYA-arg F)U169] (Gibco BRL, Gaithersburg, MD) według metody opisanej przez Simanis (Hanahan, D. DNA Klonowanie, 1985, D.M. Glover (ed), str. 109-135). Zrekombinowany plazmid pCMV oczyszczano stosując zestaw QIAgen (Chatsworth, CA) i sekwencję nukleotydową wstawki DNA was sprawdzano przez sekwencjonowanie DNA.
P r z y k ł a d 3
Niniejszy przykład przedstawia zastosowanie DNA do wywołania odpowiedzi immunologicznej na antygeny S. pneumoniae.
Grupy 8 samic myszy BALB/c (Charles River, St-Constant, Quebec, Kanada) immunizowano przez domięśniowy zastrzyk 50 μl trzy razy w dwu lub trzytygodniowych odstępach 100 μg zrekombinowanego pCMV-GH kodującego gen BVH-3, BVH-11 lub BVH-28 w obecności 50 μg czynnika stymulującego kolonię granulocytów-makrofagów (GM-CSF)- prowadzącego ekspresję plazmidu pCMV-GH-GM-CSF (Laboratory of Dr. Stephen A. Johnston, Department of Biochemistry, The University of Texas, Dallas, Texas). Jako kontrolę, grupie myszy wstrzykiwano 100 μg pCMV-GH w obecności 50 μg pCMV-GH-GM-CSF. Próbki krwi zbierano z oczodołu przed każdą immunizacją i siedem dni po trzecim zastrzyku i odpowiedzi przeciwciał w surowicy wyznaczono testem ELISA stosując białko fuzyjne tioredoksyno-HisTag-S. pneumoniae jako antygen pokrywający. Immunizacja DNA zrekombinowanym plazmidem pCMV-GH kodującym białko S. pneumoniae BVH-3, BVH-11 lub BVH-28 indukowała przeciwciało reagujące przeciwko odpowiedniemu zrekombinowanemu białku. Miana wzajemnych przeciwciał, zdefiniowane jako najwyższe rozcieńczenie surowicy przy którym wartość absorbancji wynosi 0,1 ponad wartości tła, wynosiło powyżej 4x103.
P r z y k ł a d 4
Niniejszy przykład przedstawia otrzymywanie i oczyszczanie zrekombinowanych białek S. pneumoniae.
Zrekombinowanymi plazmidami pET zawierającymi gen BVH-3, BVH-11 lub BVH-28 odpowiadającymi odpowiednio sekwencjom: Sekwencja nr 1, Sekwencja nr 3 lub Sekwencja nr 5 transformowano przez elektroporację (Gene Pulser II apparatus, BIO-RAD Labs, Mississauga, Canada) komórki szczepu E. coli AD494 (DE3) (Dara-leu7691 DlacX74 DphoA Pvull phoR DmalF3 F'[lac+(lacIq)pro] trxB::Kan) (Novagen, Madison, WI). W tym szczepie E. coli, promotor T7 kontrolujący ekspresję białka fuzyjnego jest specyficznie rozpoznawany przez polimerazę T7 RNA (obecną w profagu 1DE3), której gen jest pod kontrolą promotora lac, który jest indukowany przez izopropylo-e-d-tio-galaktopyranozyd (IPTG). Transformanty AD494(DE3)/rpET hodowano w temp. 37°C z wytrząsaniem przy 250 rpm w pożywce bulionowej LB (pepton 10 g/L, ekstrakt z drożdży 5 g/L, NaCl 10 g/L) zawierającej 100 μg ampicyliny (Sigma-Aldrich Canada Ltd., Oakville, Kanada) na ml do momentu, gdy A600 osiągnęło wartość 0,6. W celu zaindukowania produkcji białka fuzyjnego tioredoksyno-Hisrfag-BVH-3, tioredoksyno-Hisrfag-BVH-11 lub tioredoksyno-HisTag-BVH-28, komórki inkubowano przez 2 dodatkowe godziny w obecności IPTG o stężeniu końcowym 1 mM. Zaindukowane komórki z hodowli 100 ml osadzano przez wirowanie i zamrażano w temp. -70°C.
Oczyszczanie białek fuzyjnych z rozpuszczalnej frakcji cytoplazmatycznej indukowanego IPTG AD494(DE3)/rpET prowadzono stosując chromatografię powinowactwa opartą na właściwości sekwencji HisTag (6 kolejnych reszt histydynowych) aby związać kationy dwuwartościowe (Ni2+) unieruchomione na żywicy chelatującej metale HisBind. Po krótce, osadzone komórki otrzymane z hodowli 100 mL indukowane IPTG ponownie zawieszono w buforze fosforanowym (PBS):500 mM NaCl pH 7,1, sonikowano i wirowano przy 20,000 X g przez 20 min aby usunąć rozpadnięte szczątki. Supernatant odfiltrowano (błona o rozmiarze oczek 0,22 μm) i naniesiono na kolumnę HiTrap® 1 mL chelatującą, wcześniej upakowaną gotową do użycia (Pharmacia Biotech, Baie d'Urfe, Kanada). Białko fuzyjne tioredoksyno-HisTag-S. pneumoniae wymywano roztworem: 1 M imidazol-500 mM NaClPBS pH 7,1. Usunięcie soli i imidazolu z próbki prowadzono przez dializę w PBS w temp. 4°C. Ilości
PL 206 576 B1 białka fuzyjnego otrzymanego z frakcji rozpuszczalnej E. coli oszacowano stosując MicroBCA (Pierce, Rockford, Illinois).
P r z y k ł a d 5
Niniejszy przykład przedstawia ochronę myszy przeciwko śmiertelnemu zakażeniu paciorkowcami przez immunizację.
Grupy 8 samic myszy BALB/c (Charles River) immunizowano podskórnie trzy razy z trzytygodniowymi przerwami stosując 25 μg oczyszczone przez powinowactwo tioredoksyno-HisTag-BVH-3 białko fuzyjne w obecności 15 μg adiuwanta QuilA (Cedarlane Laboratories Ltd, Hornby, Kanada) lub, jako kontrolę, tylko z samym adiuwantem QuilA w PBS. Próbki krwi zbierano z zatoki oczodołowej dnia 1, 22 i 43 przed każdą immunizacją i siedem dni (dnia 50) po trzecim zastrzyku. Tydzień później myszy prowokowano stosując około 106 CFU typu 3 Szczepu S. pneumoniae WU2. Próbki inokulum S. pneumoniae do prowokacji umieszczono na czekoladowych szalkach agarowych do określania CFU i do sprawdzania dawki do prowokacji. Przypadki śmiertelne zliczano przez 14 dni i 14 dnia po prowokacji, myszy, które przeżyły uśmiercano i próbki krwi badano pod kątem obecności S. pneumoniae. Dane określające przeżywalność przedstawiono w tabeli 1.
Próbki surowicy krwi przed prowokacją analizowano pod kątem obecności przeciwciał reagujących z S. pneumoniae standardowymi testami immunologicznymi. Analizy Elisa i immunoblot wykazały, że immunizacja zrekombinowanym białkiem S. pneumoniae otrzymany w komórkach E. coli wywoływane przeciwciała reagujące zarówno ze zrekombinowanym jak i natywnym białkiem paciorkowców.
T a b e l a 1. Ochrona uzyskana w wyniku zastosowania zrekombinowanego białka BVH-3
| Immunogen | Ilość myszy żywych: ilość myszy martwych 14 po teście prowokacji | Średni dzień śmierci |
| BVH-3 | 8 : 0 | >14 |
| żaden | 0 : 8 | 1 |
Wszystkie myszy immunizowane zrekombinowanym białkiem BVH-3 przeżyły zakażenie podczas gdy żadna z kontrolnych myszy którym podano sam adiuwant przeżyło. Stwierdzono znaczącą różnicę przeżywalności pomiędzy tymi dwoma grupami myszy (P<0.0001, logarytmiczna analiza rangowa w analizie nieparametrycznej krzywych przeżycia; P=0.0002, Test dokładności Fishera). Wszystkie posiewy krwi pobrane od myszy, które przeżyły były negatywne dnia 14 po prowokacji.
P r z y k ł a d 6
Niniejszy przykład opisuje klonowanie genów BVH-3 i BVH-11 z różnych szczepów S. pneumoniae i konserwacje molekularną tych genów.
Analiza molekularna chromosomowego DNA z różnych izolatów S. pneumoniae sondami DNA obejmującymi różne regiony BVH-3 lub BVH-11 ujawniła obecność jednej kopii genu BVH-3 i dwóch kopii genu BVH-11. Dwie kopie genu BVH-11 nie są identyczne i geny zostały dowolnie oznaczone jako BVH-11 (Sekwencja nr 12; ORF zlokalizowana od nukleotydu 45 do 2567) i BVH-11-2 (Sekwencja nr 13; ORF zlokalizowana od nukleotydu 114 do 2630).
Pierwsze aminokwasy BVH-3 i BVH-11 regionu kodującego mają charakterystykę sekwencji liderowych również znane jako peptydy sygnałowe. Miejsce cięcia peptydazy sygnału zdolności L-X-X-C lipobiałkowego miejsc modyfikacji/obróbki było obecne w tych sekwencjach. Dojrzałe białka BVH-3, BVH-11 i BVH-11-2 z S. pneumoniae SP64 mają odpowiednio 1019, 821 i 819 aminokwasów. Regiony genów S. pneumoniae kodujące dojrzałe BVH-3, zakończone BVH-3M, (nukleotydy 1837 - 4896; Sekw.nr. NO: 11), BVH-11M (nukleotydy 102-2567; Sekw. nr. NO: 12) i BVH-11-2M (nukleotydy 171-2630; Sekw.nr. NO: 13), amplifikowano metodą PCR (DNA Thermal Cycler GeneAmp PCR system 2400 Perkin Elmer, San Jose, CA) z genomowego DNA 6 lub 7 szczepu S. pneumoniae. Kliniczne izolaty z grup surowiczych 6 S. pneumoniae SP64 i grup surowiczych 9 SP63 zostały dostarczone przez laboratorium - laboratoire de la sante publique du Quebec, Sainte-Anne-de-Bellevue; serotype 4 szczep JNR.7/87 został dostarczony przez Andrew Camilli, Tufts University School of Medicine, Boston; Rx1 szczep, nieotorbiona pochodna typu 2 szczepu D39 i typu 3 szczepów A66 i WU2 zostały dostarczone przez Davida E. Brilesa z University of Alabama, Birmingham i izolat kliniczny typu 3 P4241 został dostarczony przez centrum badawcze - centrę de recherche en infectiologie du centre hospitalier de l'universite Laval, Sainte-Foy. Zestawy starterów oligonukleotydowych OCRR479-OCRR480; HAMJ160-OCRR488 i HAMJ160-HAMJ186, które zawierały końcówki nici odpowiednie do dodania
PL 206 576 B1 miejsc restrykcyjnych zastosowano do amplifikacji genu odpowiednio, BVH-3, BVH-11 i BVH-11-2, z wyją tkiem genu BVH-11 ze szczepu SP64, który amplifikowano stosują c zestaw starterów zawierający HAMJ487 i OCRR488. Sekwencje starterów zostały wymienione poniżej (Tabela 2). Produkty
PCR oczyszczano z żelu agarozowego stosując zestaw do ekstrakcji z żelu QIAquick z firmy QIAgen (Chatsworth, CA) i trawiono Bg1II-XbaI lub Bglll-Hindlll (Pharmacia Canada Inc, Baie d'Urfe, Canada). Produkty po trawieniu oczyszczano stosując zestaw do oczyszczania QIAquick PCR z firmy QIAgen (Chatsworth, CA). Produkty PCR ligowano z Bg1II-XbaI lub Bg1ll-Hindlll wektora pSL301. Zligowanymi produktami transformowano komórki szczepu E. coli DH5n [φ80 lacZ ΔM15 koniecA1 recA1 hsdR17 (rK-mK+) st/pE44 thi-1K gyrA96 relA1 Δ(lacZYA-argF)U169] (Gibco BRL, Gaithersburg, MD) według metody opisanej przez Simanis (Hanahan, D. DNA Klonowanie, 1985, D.M. Glover (ed), str. 109-135). Zrekombinowane plazmidy pSL301 (rpSL301) zawierające BVH-3, BVH-11 lub BVH11-2 oczyszczano stosując zestaw QIAgen (Chatsworth, CA) i inserty DNA sekwencjonowano (zestaw do sekwencjonowania Taq Dye Deoxy Terminator Cycle Sequencing, ABI, Foster City, CA). Fig. 11 i 12 przedstawiają sekwencję zgodności ustaloną na podstawie wyznaczonych sekwencji aminokwasowych, odpowiednio BVH-3, i BVH-11. Porównanie sekwencji białkowych BVH-3 ujawniło 99 do 100% identyczności sekwencji dla wszystkich szczepów z wyjątkiem BVH-3 z grupy surowiczej 9 szczepu SP63 (Sekw.nr. NO: 15 i Sekw.nr. NO: 16) który utracił ciąg 177 aminokwasów odpowiadającym resztom 244 do 420 w sekwencji białkowej BVH-3 S. pneumoniae SP64. Analiza sekwencji dodatkowej grupy surowiczej 9 szczepu ujawniło cząsteczkę BVH-3 mającą taką samą delecję w 3 z 4 szczepów, co sugeruje, że 3 szczepy należą do klonu grupy surowiczej 9 S. pneumoniae.
Porównując 13 BVH-11 sekwencji nukleotydowych otrzymano z 7 szczepów S. pneumoniae, ujawniło że sekwencje nukleotydowe są bardzo podobne. Analiza komputerowa (MacVector, Clustal W 1.4) z wykorzystaniem wielokrotnego przypisania przewidywanych sekwencji białkowych BVH-11 ujawniła, że te sekwencje są w 75% identyczne i 82% homologiczne na długości 834 aminokwasów. Przypisywanie przez parowanie ujawniło 80 do 100% identyczności (fig. 13). Sekwencje wykazały ogromne podobieństwo w całościowej organizacji. Różnorodność pierwszorzędowych sekwencji tych białek jest prawie ograniczone do ostatnich 125 aminokwasów w części C-końcowej białek. Region ten tworzy domenę. Bliższe badanie tej domeny dwie grupy sekwencje, pierwsze 9 sekwencji z fig. 13 należą do jednej grupy podczas gdy ostatnie 4 sekwencje należą do innej grupy. Wartość 39% identyczności otrzymano jeśli zostało porównano sekwencji domen 13 białek (MacVector, Clustal W 1.4). Wartość identyczności zwiększa się do powyżej 92% jeśli porównywane są sekwencje należące do tej samej grupy.
P r z y k ł a d 7
Niniejszy przykład przedstawia homologii części genów BVH-3 i BVH-11.
Analiza molekularna sondami DNA pochodzącymi z genów BVH-3 i BVH-11 wykazała, że BVH-3 i BVH-11 są spokrewnione. W badaniach hybrydyzacji dot blot, sonda DNA zawierająca bądź BVH-3 bądź BVH-11, sekwencja genowa hybrydyzowała z oboma genami, BVH-3 i BVH-11, co wskazuje że geny BVH-3 i BVH-11 mają sekwencje homologiczne. Porównanie sekwencje ujawniło, że otwarte ramki odczytu ORF i białka były odpowiednio, w 43 i 33% identyczne. Dokładniejsze badanie ujawniło że region odpowiadający aminokwasom od 1 do 225 w genie BVH-3 i 1 do 228 w genie BVH-11 wykazywał odpowiednio 73 i 75% identyczności na poziomie DNA i białka. Przeciwnie, regiony 3' odpowiadające aminokwasom od 226 do 1039 z BVH-3 i aminokwasom 229-840 z BVH-11 wykazywały jedynie odpowiednio 34 i 22% identyczności na poziomie DNA i białka. Zatem końce 5' genów BVH-3 i BVH-11 wydają się zawierać wysoce konserwowane sekwencje podczas gdy pozostałe części genów bardzo się różnią. Wyniki te sugerują, że BVH-3 i BVH-11 mogą mieć podobne funkcje w których pośredniczą sekwencje obecne w regionie konserwowanym, podczas gdy specyficzne funkcje BVH-3i BVH-11 mogą być wynikiem sekwencji w regionie zróżnicowanym.
P r z y k ł a d 8
Niniejszy przykład opisuje klonowanie obciętych genów BVH-3, BVH-11 i BVH-11-2 w wyniku reakcji łańcuchowej polimerazy (PCR) i ekspresja obciętych cząsteczek BVH-3 i BVH-11.
Fragmenty genowe amplifikowano metodą PCR stosując pary oligonukleotydów zaprojektowane do prowadzenia amplifikacji fragmentów obejmujących gen BVH-3 (Sekwencja nr 1 i Sekwencja nr 11), BVH-11 (Sekwencja nr 3 i Sekwencja nr 12) lub BVH-11-2 (Sekwencja nr 13) ze szczepu SP64 S. pneumoniae. Każdy ze starterów ma miejsce cięcia endonukleazy na końcu 5', co umożliwia bezpośrednie wklonowanie w ramce amplifikowanego produktu do trawionego wektora plazmidowego (Tabele 2 i 3). Produkty otrzymane w wyniku amplifikacji PCR trawiono endonukleazami restrykcyjnymi
PL 206 576 B1 i ligowano z bądź linearyzowanym plazmidem pSL301 (patrz przykład 1), pCMV-GH (patrz przykład 2) lub pET (Novagen, Madison, WI) wektorem ekspresyjnym trawionym podobnie lub trawionym enzymami, które produkują kompatybilne lepkie końce. Zrekombinowane plazmidy pSL301 i zrekombinowane pCMV-GH trawiono enzymami restrykcyjnymi w celu klonowania w ramce do wektora ekspresyjnego pET. Klony wstępnie stabilizowano w komórkach E. coli DH5D przed wprowadzeniem do E. coli BL21 (DDE3) lub AD494 (DDE3) w celu otrzymania ekspresji obciętych cząsteczek BVH-3 lub BVH11. Każdy z otrzymanych konstruktów plazmidowych potwierdzono przeprowadzając analizę sekwencji nukleotydów. Ekspresję zrekombinowanych białek prowadzono jako fuzję N-końców z tioredoksyną i His-tag lub jako fuzję C-końców z His-tag. Zrekombinowane białka ulegające ekspresji oczyszczano z frakcji supernatantu otrzymanych w wyniku wirowania sonikowanych indukowanych IPTG hodowli E. coli stosując żywicę chelatującą metale His-Bind (QIAgen, Chatsworth, CA). Wytworzone produkty genowe zostały wymienione w tabeli 3. Produkty genowe odpowiadające sekwencjom: region N-końcowy włącznie z sekwencją sygnałową oznaczono jako Lipidowane-białka lub lipobiałka (L-białka). Produkty genowe odpowiadające sekwencjom: region N-końcowy bez sekwencji sygnałowej są określane jako białka bez sekwencji sygnałowej (w/o ss).
T a b e l a 2. Lista starterów oligonukleotydów do PCR
| Starter | Sekw. nr. | Sekwencja 5' - 3' | Pozycja nukleotydu | Miejsca restrykcyjne |
| 1 | 2 | 3 | 4 | 5 |
| OCRR 479 | 17 | cagtagatctgtgcctatgcactaaac | Sekw. nr 1 :61-78 | Bg1ll |
| OCRR 480 | 18 | gatctctagactactgctattccttacgctatg | Sekw. nr 11 :4909-4887 | Xbal |
| OCRR 497 | 19 | atcactcgagcattacctg g ataatcctgt | Sekw. nr 1 :1525-1506 | XhoI |
| OCRR 498 | 20 | ctgctaagcttatgaaagatttagat | Sekw. nr 1 :1534-1548 | Hindlll |
| OCRR 499 | 21 | gatactcgagctgctattccttac | Sekw. nr 11 :4906-4893 | XhoI |
| HAM.I 172 | 22 | gaatctcgagttaagctgctgctaattc | Sekw. nr 1 : 675-661 | XhoI |
| HAMJ 247 | 23 | gacgctcgagcgctatgaaatcagataaattc | Sekw. nr 1 :3117-3096 | XhoI |
| HAMJ 248 | 24 | gacgctcgagggcattacctggataatcctgttcatg | Sekw. nr 1 :1527-1501 | XhoI |
| HAMJ 249 | 25 | cagtagatctcttcatcatttattgaaaagagg | Sekw. nr 11: 1749-1771 | Bg1ll |
| HAMJ 278 | 26 | ttatttcttccatatggacttgacagaagagcaaattaag | Sekw. nr 1 :1414-1437 | Ndel |
| HAMJ 279 | 27 | cgccaagcttcgctatgaaatcagataaattc | Sekw. nr 1 :3117-3096 | Hindlll |
| HAMJ 280 | 28 | cgccaagcttttccacaatataagtcgattgatt | Sekw. nr 1 :2400-2377 | Hindlll |
| HAMJ 281 | 29 | ttatttcttccatatggaagtacctatcttggaaaaagaa | Sekw. nr 1 :2398-2421 | Ndel |
| HAMJ 300 | 30 | ttatttcttccatatggtgcctatgcactaaaccagc | Sekw. nr 1 :62-82 | Ndel |
| HAMJ 313 | 31 | ataagaatgcggccgcttccacaatataagtcgattgatt | Sekw. nr 1 :2400-2377 | Notl |
| OCRR 487 | 32 | cagtagatctgtgcttatgaactaggtttgc | Sekw. nr 3 :58-79 | Bg1ll |
| OCRR 488 | 33 | gatcaagcttgctgctacctttacttactctc | Sekw. nr 12 :2577-2556 | Hindlll |
| HAMJ 171 | 34 | ctgagatatccgttatcgttcaaacc | Sekw. nr 3 :1060-1075 | EcoRV |
| HAMJ 251 | 35 | ctgcaagcttttaaaggggaataatacg | Sekw. nr 3 :1059-1045 | Hindlll |
| HAMJ 264 | 36 | cagtagatctgcagaagccttcctatctg | Sekw. nr 3 :682-700 | Bg1ll |
| HAMJ 282 | 37 | tcgccaagcttcgttatcgttcaaaccattggg | Sekw. nr 3 :1060-1081 | Hindlll |
| HAMJ 283 | 38 | ataagaatgcggccgccttactctcctttaataaagccaa tagtt | Sekw. nr 3 :2520-2492 | Ndel |
| HAMJ 284 | 39 | catgccatgg acattgatagtctcttgaaacagc | Sekw. nr 3 :856-880 | Ncol |
PL 206 576 B1 cd. tabeli 2
| 1 | 2 | 3 | 4 | 5 |
| HAMJ 285 | 40 | cgccaagcttcttactctcctttaataaagccaatag | Sekw. nr 3 :2520-2494 | Hindlll |
| HAMJ 286 | 41 | cgacaagcttaacatggtcgctagcgttacc | Sekw. nr 3 :2139-2119 | Hindlll |
| HAMJ 287 | 42 | cataccatgggcctttatgaggcacctaag | Sekw. nr 3 :2014-2034 | Ncol |
| HAMJ 288 | 43 | cgacaagcttaagtaaatcttcagcctctctcag | Sekw. nr 3 :2376-2353 | Hindlll |
| HAMJ 289 | 44 | gataccatggctagcgaccatgttcaaagaa | Sekw. nr 3 :2125-2146 | Ncol |
| HAMJ 290 | 45 | cgccaagcttatcatccactaacttgactttatcac | Sekw. nr 3 :1533-1508 | Hindlll |
| HAMJ 291 | 46 | cataccatgg atattcttgccttcttagctccg | Sekw. nr 3 :1531-1554 | Ncol |
| HAMJ 301 | 47 | catgccatggtgcttatgaactaggtttgc | Sekw. nr 3 :59-79 | Ncol |
| HAMJ 302 | 48 | cgccaagctttagcgttaccaaaaccattatc | Sekw. nr 3 :2128-2107 | Hindlll |
| HAMJ 160 | 49 | gtattagatctgttcctatgaacttggtcgtcacca | Sekw. nr 13 :172-196 | Bg1ll |
| HAMJ 186 | 50 | cgcctctagactactgtataggagccgg | Sekw. nr 13 :2460-2443 | Xbal |
| HAMJ 292 | 51 | catgccatggaaaacatttcaagccttttacgtg | Sekw. nr 11 :754-778 | Ncol |
| HAMJ 293 | 52 | cgacaagcttctgtataggagccggttgactttc | Sekw. nr 11 :2457-2434 | Hindlll |
| HAMJ 294 | 53 | catgccatggttcgtaaaaataaggcagaccaag | Sekw. nr 11 :2038-2062 | Ncol |
| HAMJ 297 | 54 | catgccatggaagcctattggaatgggaag | Sekw. nr 11 :622-642 | Ncol |
T a b e l a 3. Listy obciętych produktów genowych BVH-3 i BVH-11 wytworzonych z S. pneumoniae SP64
| Zestawy starterów do PCR | Określenie białek | Oznaczenie (kodowane aminokwasy) | Sekw. Nr. | Wektor do klonowania |
| 1 | 2 | 3 | 4 | 5 |
| OCRR479-OCRR480 | BVH-3M | BVH-3 w/o ss (21-1039) | 55 | pSL301 |
| OCRR479-OCRR497 | BVH-3AD | BVH-3 N' koniec w/o ss (21-509) | 56 | pSL301 |
| HAMJ248-HAMJ249 | L-BVH-3AD | BVH-3 N' koniec (1-509) | 57 | pET-21(+) |
| OCRR498-OCRR499 | BVH-3B | BVH-3 C' koniec (512-1039) | 10 | pSL301 |
| OCRR479-HAMJ172 | BVH-3C | BVH-3 N' koniec w/o ss (21-225) | 59 | pET-32c(+) |
| OCRR487-OCRR488 | BVH-11M | BVH-11 w/o ss (20-840) | 60 | pCMV-GH |
| HAMJ251-OCRR487 | BVH-11A | BVH-11 N' koniec w/o ss (20-353) | 61 | pET-32c(+) |
| HAMJ171-OCRR488 | BVH-11B | BVH-11 C' koniec (354-840) | 62 | pET-32a(+) |
| HAMJ264-OCRR488 | BVH-11C | BVH-11 C' koniec (228-840) | 63 | pET-32a(+) |
| HAMJ278-HAMJ279 | NEW1 | BVH-3 C' koniec (472-1039) | 64 | pET-21b(+) |
| HAMJ278-HAMJ280 | NEW2 | BVH-3 C' koniec (472-800) | 65 | pET-21b(+) |
| HAMJ281-HAMJ279 | NEW3 | BVH-3 C' koniec (800-1039) | 66 | pET-21b(+) |
| HAMJ284-HAMJ285 | NEW4 | BVH-11 C' koniec (286-840) | 67 | pET-21d(+) |
| HAMJ284-HAMJ286 | NEW5 | BVH-11 wewnętrzny (286-713) | 68 | pET-21d(+) |
| HAMJ287-HAMJ288 | NEW6 | BVH-11 wewnętrzny (672-792) | 69 | pET-21d(+) |
| HAMJ285-HAMJ289 | NEW7 | BVH-11 wewnętrzny (709-840) | 70 | pET-21d(+) |
| HAMJ284-HAMJ290 | NEW8 | BVH-11 wewnętrzny (286-511) | 71 | pET-21d(+) |
| HAMJ286-HAMJ291 | NEW9 | BVH-11 wewnętrzny (511-713) | 72 | pET-21d(+) |
PL 206 576 B1 cd. tabeli 3
| 1 | 2 | 3 | 4 | 5 |
| HAMJ160-HAMJ186 | BVH-11-2M | BVH-11-2 w/o ss (20-838) | 73 | pSL301 |
| HAMJ292-HAMJ293 | NEW10 | BVH-11-2 C' koniec (271-838) | 74 | pET-21d(+) |
| HAMJ293-HAMJ294 | NEW11 | BVH-11-2 C' koniec (699-838) | 75 | pET-21 d(+) |
| HAMJ282-HAMJ283 | BVH-11B | BVH-11 C' koniec (354-840) | 62 | pET-21 b(+) |
| HAMJ286-HAMJ297 | NEW14 | BVH-11-2 wewnętrzny (227-699) | 77 | pET-21 d(+) |
| HAMJ300-HAMJ313 | NEW15 | BVH-3 N' koniec w/o ss (21-800) | 78 | pET-21b(+) |
| HAMJ301-HAMJ302 | NEW16 | BVH-11 N' koniec w/o ss (20-709) | 79 | pET-21 d(+) |
P r z y k ł a d 9
Niniejszy przykład opisuje izolowanie monoklonalnych przeciwciał (Mabs) i zastosowanie Mabs do charakteryzowania epitopów białkowych BVH-3, BVH-11 i BVH-11-2.
Samice myszy BALB/c (Charles River) immunizowano podskórnie produktami genowymi BVH-3,
BVH-11 lub BVH-11-2 ze szczepu SP64 S. pneumoniae w obecności 15 μg adjuwanta QuilA (Cedarlane Laboratories Ltd, Hornby, Kanada). Jeden zbiór myszy (doświadczenie fuzyjne 1) immunizowano dnia 1 i 14 przy pomocy 25 μg oczyszczonego przez powinowactwo białka fuzyjnego tioredoksyno-HisTag-BVH-3M. Druga grupa myszy (doświadczenie fuzyjne 2) immunizowano trzy razy z trzytygodniowymi przerwami przy pomocy 25 μg oczyszczonego przez powinowactwo tioredoksyno-HisTag-BVH-3M. Trzecia grupa myszy (doświadczenie fuzyjne 3) immunizowano dnia 1 i dnia 15 przy pomocy 25 μg oczyszczonego przez powinowactwo białka fuzyjnego tioredoksyno-His^Tag-BVH-11-2M. Czwarta grupy myszy (doświadczenie fuzyjne 4) immunizowano dnia 1 przy pomocy 25 μg oczyszczonego przez powinowactwo białka fuzyjnego tioredoksyno-HisBVH-11B i zwiększano przez iniekcję dożylną dnia 16 i dnia 37 zrekombinowanego BVH-11B w PBS. Trzy do czterech dni przed fuzją, myszom podawano przez iniekcję dożylną 25 μg odpowiedniego antygeny zawieszone jedynie w PBS. Hybridomy otrzymywano w wyniku fuzji komórek śledziony z niewydzielnicznymi komórkami SP2/0 jak wcześniej opisano w pracy J. Hamel i wsp. [J. Med. Microbiol., 23, pp163-170 (1987)]. Supernatanty kultur hybridom początkowo przeszukiwano stosując test immunologiczny wiązania enzymu według procedury opisanej przez Hamel i wsp. (Supra) stosując szalki powlekane preparatem oczyszczonych zrekombinowanych białek lub zawiesinami komórek S. pneumoniae zabitych ciepłem. Pozytywne hybridomy wybrano na podstawie reagowania w teście ELISA z różnymi antygenami, a następnie zostały sklonowane przez ograniczone rozcieńczenia, zawieszone i zamrożone.
Hybridomy badano testem ELISA lub testem immunoblottingu Westerna przeciwko produktom genowym BVH-3 i BVH-11 w celu scharakteryzowania epitopów rozpoznawanych przez Mabs. BVH-3 i BVH-11 mają wspólne epitopy z 6-ma Mabs (H3-1-F9, H3-1-D4, H3-1-H12, H11-1-E7, H11-1-H10 i H11-1.1-G11) wykazując reaktywność z oboma białkami (Tabela 4). Cząsteczki BVH-11 i BVH-11-2 z S. pneumoniae SP64 mają wspólne epitopy nie obecne na BVH-3 z Mabs (3A1, 13C11, 10H10, 1D8, 10G9, 10A2, 3E8, 10D7, 2H7 i 6H7) reagujące ze zrekombinowanymi białkami zarówno BVH-11 jak i BVH-11-2, (Tabela 5).
T a b e l a 4. Reaktywność BVH-3-immunoreaktywnych Mabs z zespołem produktów genowych BVH-3 i BVH-11
| MAbs | Immunoreakcyjność z | ||||||
| BVH-3M 21-1039 | BVH-3A 21-509 | BVH-3B 512-1039 | BVH-3C 21-225 | NEW2 472-800 | NEW3 800-1039 | BVH-11M 20-840 | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| H3-1-F9 | + | + | - | + | - | - | + |
| H3-1-D4 | + | + | - | + | - | - | + |
| H3-1-H12 | + | + | - | + | - | - | + |
| H3-2-G2 | + | + | - | - | - | - | - |
| H3-3-A1 | + | + | - | - | - | - | - |
PL 206 576 B1 cd. tabeli 4
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| H3-4-D3 | + | - | + | - | - | + | - |
| H11-1-E7 | + | + | - | + | - | - | + |
| H11-1-H10 | + | + | - | + | - | - | + |
| H11-1.1-G11 | + | + | - | + | + | - | + |
T a b e l a 5. Reaktywność Mabs skierowanych przeciwko białku BVH-11-2 ze szczepu S. pneumoniae SP64 z zespołem produktów genowych BVH-11
| Mabsa | Immunoreakcyjność z | |||||||
| Produkty BVH-11 | Produkty BVH-11-2 | |||||||
| BVH-11M 20-840 | NEW8 286-511 | NEW9 511-713 | BVH-11B 354-840 | BVH-11-2 20-838 | NEW10 271-838 | NEW11 699-838 | NEW14 227-699 | |
| 3A1 | + | + | - | + | + | + | - | + |
| 13C11 | + | + | + | + | + | + | - | + |
| 10H10 | + | + | + | + | + | + | - | + |
| 1D8 | + | + | - | + | + | + | - | + |
| 10G9 | + | - | - | + | + | + | - | + |
| 10A2 | + | - | - | + | + | + | - | + |
| 3E8 | + | - | - | + | + | + | - | + |
| 10D7 | + | - | - | + | + | + | - | + |
| 2H7 | + | - | - | - | + | - | - | - |
| 6H7 | + | - | - | - | + | - | - | - |
| 3A4 | - | - | - | - | + | + | + | - |
| 14H6 | - | - | - | - | + | + | + | - |
| 7G2 | - | - | - | - | + | + | - | + |
| 13H10 | - | - | - | - | + | - | - | + |
| 7E8 | - | - | - | - | + | - | - | - |
| 7H6 | - | - | - | - | + | - | - | - |
a Mabs wymienione w tej tabeli nie reagował y ze zrekombinowaną cząsteczką BVH-3
Wyniki otrzymane na podstawie badań immunoreaktywności Mabs (Tabela 4 i Tabela 5) są w zgodzie z sekwencjami białkowymi pochodzącymi od odpowiednich sekwencji genowych. W rzeczywistości Mabs reagujące krzyżowo z cząsteczkami BVH-3 i BVH-11 rozpoznającymi białko BVH-3C odpowiadające sekwencjom: region konserwowany oraz specyficzny Mabs BVH-11 i BVH-11-2 reagowały z epitopami zlokalizowanymi na częściach zmiennych tych cząsteczek. BVH-3 i BVH-11, i BVH-11 i BVH-11-2 mogą być rozpoznawane ze względu na ich reagowanie z Mabs.
P r z y k ł a d 10
Niniejszy przykład przedstawia równoczesną ekspresją produktów genowych BVH-3 i BVH-11 u S. pneumoniae.
Standardową technikę blotu Westerna stosowano do badania czy geny BVH-3 i BVH-11 ulegały ekspresji w S. pneumoniae. Szczepy S. pneumoniae SP64 i SP63 hodowano przez noc w temp. 37°C w 5% CO2 na czekoladowych szalkach agarowych, bakterie zawieszono w PBS i zabito ciepłem w temp. 56°C przez 20 min. Do otrzymywania antygenów, zawiesiny S. pneumoniae poddano działaniu buforu próbki zawierającego SDS i 2-merkaptoetanol przez 5 min w temp. 100°C. białkowe antygeny pneumokokowe rozdzielono stosując elektroforezę SDS-PAGE według metody opisanej przez Laemmli [Nature, 227, str. 680-685 (1970)]. Po SDS-PAGE, białka przenoszono elektroforetycznie z żelu na papier nitrocelulozowy sposobem według Towbina [Proc. Natl. Acad. Sci. USA, 76, str.
PL 206 576 B1
4350-4354 (1979)] i sondowano z mysią surowicą odpornościową lub monoklonalnymi przeciwciałami. Detekcja antygenów reagujących z przeciwciałami prowadzono przez niebezpośredni test enzmymatyczno-immunologiczny stosując koniugowane przeciwko mysie immunoglobuliny i substrat barwiący. Jeśli surowicę odpornościową skierowaną przeciwko zrekombinowanemu BVH-3 badano przeciwko antygenom S. pneumoniae SP64, to wykryto dwa reaktywne prążki mające rzeczywiste masy cząsteczkowe 127 kDa i 99 kDa. Prążki mające takie same rzeczywiste masy cząsteczkowe również wykryto gdy stosowano Mabs H3-1-F9, H3-1-D4, H3-1-H12, H11-1-E7, H11-1-H10 i H11-1.1-G11 indywidualnie jako sondy immunologiczne. Przeciwnie, stosując Mabs specyficzny względem cząsteczki BVH-3 wykryto jedynie prążek 127 kDa a Mabs specyficzny względem BVH-11 wykryto jedynie prążek 99 kDa, potwierdzając w ten sposób identyczność prążków 127 i 99 kDa jako odpowiednio, BVH-3 i BVH-11. Badania te dostarczają dowodów, że białka BVH-3 i BVH-11 są jednocześnie obecne u S. pneumoniae. Ponadto, wyniki są zgodne z naszymi poprzednimi obserwacjami, że BVH-3 i BVH-11 mają epitopy, które są wspólne dla białek i epitopów, które są wyłączne dla któregoś z tych białek.
W S. pneumoniae SP64, dojrzałe BVH-3, BVH-11 i BVH-11-2 są białkami o 1019, 821 i 819 aminokwasach o przewidywanych masach cząsteczkowych odpowiednio 112,5 kDa, 92,4 kDa, i 91,7 kDa. Pomimo, że jest pewna rozbieżność pomiędzy masami cząsteczkowymi przewidzianymi na podstawie sekwencji a masami cząsteczkowymi wyznaczonymi na SDS-PAGE, BVH-3 mogą być rozpoznawane z BVH-11 dzięki jego wyższym masom cząsteczkowym. Ponadto, cząsteczki BVH-3 ze szczepu S. pneumoniae SP63 mają rzeczywiste masy cząsteczkowe 112 kDa w SDS-PAGE w porównaniu do 127 kDa dla BVH-3 ze szczepu SP64. Dane te są zgodne z usunięciem ciągu 177 reszt aminokwasowych w BVH-3 szczepu S. pneumoniae SP63.
P r z y k ł a d 11
Niniejszy przykład opisuje ochronę uzyskaną w przypadku doświadczalnej infekcji myszy szczepionych zrekombinowanymi produktami genowymi BVH-3 lub BVH-11.
Grupy 7 lub 8 samic myszy BALB/c (Charles River) immunizowano podskórnie trzy razy z trzytygodniowymi przerwami stosując oczyszczone przez powinowactwo białko fuzyjne tioredoksyno-HisTag-BVH-3M, oczyszczone przez powinowactwo białko fuzyjne tioredoksyno-HisTag-BVH-77M lub, jako kontrolę, tylko z samym adiuwantem QuilA w PBS. Dwanaście do 14 dni po trzeciej immunizacji, myszy prowokowano dożylnie S. pneumoniae szczep WU2 lub donosowo szczepem P4241. Próbki inokulum S. pneumoniae do prowokacji umieszczono na czekoladowych szalkach agarowych do określania CFU i do sprawdzania dawki do prowokacji. Dawki do prowokacji wynosiły około 106 CFU. Przypadki śmiertelne zliczano przez 14 dni i dnia 14 po prowokacji, myszy, które przeżyły uśmiercano i próbki krwi badano pod kątem obecności organizmów S. pneumoniae. Dane określające przeżywalność przedstawiono w tabelach 6 i 7.
T a b e l a 6. Ochrona w której tworzeniu biorą udział zrekombinowane BVH-3M i BVH-11M białka w przypadku doświadczalnej infekcji wirulentymi S. pneumoniae WU2
| Doświadczenie | Immunogen | żywe : | martwea | Średni dzień przeżycia |
| 1 | BVH-3M | 8 | : 0 | >14 |
| żaden | 0 | : 8 | 1 | |
| 2 | BVH-11M | 8 | : 0 | >14 |
| żaden | 0 | : 8 | 1 |
a Ilość myszy ż ywych : ilość myszy martwe dnia 14 po prowokacji.
T a b e l a 7. Ochrona w której tworzeniu biorą udział zrekombinowane BVH-3M i BVH-11M białka w przypadku doświadczalnej infekcji wirulentymi S. pneumoniae P4241
| Doświadczenie | Immunogen | żywe : | martwea | Średni dzień przeżycia |
| 1 | BVH-3M | 6 | : 1 | >14 |
| żaden | 1 | : 7 | 4.5 | |
| 2 | BVH-3M | 8 | : 0 | >14 |
| BVH-11M | 8 | : 0 | >14 | |
| żaden | 0 | : 8 | 4 |
a Ilość myszy ż ywe : ilość myszy martwe dnia 14 po prowokacji.
PL 206 576 B1
Wszystkie myszy immunizowane zrekombinowanym białkiem BVH-3M lub BVH-11M przeżyły zakażenie WU2, podczas gdy żadna z kontrolnych myszy którym podano sam adiuwant nie przeżyła. Wszystkie z wyjątkiem jednej myszy immunizowanej zrekombinowanym białkiem BVH-3M lub BVH-11M przeżyły zakażenie P4241 podczas gdy tylko jedna mysz kontrolna, z myszy którym podano sam adiuwant przeżyła. Wszystkie posiewy krwi pobrane od myszy, które przeżyły były negatywne dnia 14 po prowokacji. Wyniki te jasno wskazują, że oba, BVH-3M i BVH-11M, wywołują ochronne anty-paciorkowcom odpowiedzi immunologiczne u myszy. Fakt, że te białka są wysoce konserwowane w przypadku izolatów S. pneumoniae podkreśla skuteczność BVH-3 i BVH-11 jako uniwersalnych kandydatów do przygotowywania szczepionek. W rzeczywistości, białka BVH-3 i BVH-11 z grupy surowiczej 6 S. pneumoniae szczepu SP64 powodują ochronę przeciwko zakażeniu paciorkowcami w przypadku szczepów o różnych serotypach otoczkowych.
Idealnie, szczepionka, która może zabezpieczać przeciwko chorobom spowodowanym przez paciorkowce, może chronić przeciwko zapaleniu opon, zapaleniu ucha środkowego, bakteriemii lub, zapaleniu płuc. BVH-3 i BVH-11 miały działanie ochronne przeciwko letalnym ogólnoustrojowym i płucnym modelom infekcji, co sugeruje, że u ludzi, szczepionki oparte na białkach BVH-3- i BVH-11 mogą zmniejszać częstość występowania choroby w szerokim spektrum chorób powodowanych przez zasadniczo wszystkie S. pneumoniae niezależnie od serotypu otoczkowego.
Dane z tabeli 6 i 7 jasno wykazują, że BVH-3 i BVH-11 były obydwa, cząsteczkami z S. pneumoniae wywołującymi ochronę. Jednakże nie było wiadomym, czy w ochronie mogą pośredniczyć specyficzne sekwencje, które nie były obecne w cząsteczkach BVH-3 i BVH-11. Grupy samic myszy BALB/c (Charles River) immunizowano podskórnie trzy razy z trzytygodniowymi przerwami stosując oczyszczane przez powinowactwo białko fuzyjne tioredoksyno-Hisrfag-BVH-3AD, -BVH-3B lub -BVH-3C w obecności 15 μg adiuwanta QuilA (Cedarlane Laboratories Ltd, Hornby, Kanada). Myszy kontrolne immunizowano tylko samym adiuwantem QuilA w PBS lub oczyszczanym przez powinowactwo białkiem fuzyjnym tioredoksyno-Hisrfag lub tioredoksyno-HisTag (His-Tio) w obecności QuilA.
Do określania zdolności ochronnych zestawu obciętych białek, zakończonych NEW4, NEW5, NEW6, NEW7, NEW8, NEW9, NEW10, NEW11, NEW14 i BVH-11B, grupy samic myszy BALB/c (Charles River) immunizowano podskórnie dwa razy z trzytygodniowymi przerwami 25 μg bądź oczyszczonym przez powinowactwo HisTag-białkiem fuzyjnym w obecności 15 μg adiuwanta QuilA. Dziesięć do 14 dni po ostatniej immunizacji, myszy prowokowano wirulentymi S. pneumoniae. Nasze wyniki wskazują, że, BVH-3B, obcięta cząsteczka BVH-3 zawierająca 512-1039 aminokwasów, wywołuje ochronę przeciwko wirulentnych względem myszy szczepów WU2 i P4241. Podobnie, cząsteczki BVH-11B, NEW4 i NEW5, trzy obcięte cząsteczki BVH-11 zawierające 354-840 aminokwasów, 286-840 aminokwasów i 286-713 aminokwasów, odpowiednio, wywoływały ochronę przeciwko doświadczalnym dożylnym prowokacjom WU2 i donosowym prowokacjom P4241. Ponadto, szczepienie NEW10 i NEW14, zawierającym 272-838 aminokwasów i 227-699 aminokwasów z cząsteczki BVH-11-2 również prowadziło do uzyskania ochrony przeciwko śmierci spowodowanej przez szczepy paciorkowców. Wyniki te wskazują, że region zawierający 428 aminokwasów rozciągający się w sekwencjach białkowych odpowiednio, od aminokwasów 286-713 i aminokwasów 272-699 w S. pneumoniae SP64 BVH-11 i BVH-11-2 zawiera epitopy ochronne. Region ten jest wysoce konserwowany przy ogólnej 91% identyczności i 94% homologii pomiędzy trzynastoma sekwencjami białkowymi BVH-11.
T a b e l a 8. Ocena ochrony wywoł ywanej przez szczepienie myszy produktami genowymi BVH-3 i BVH-11
| Prowokacja WU2 | Prowokacja P4241 | ||||
| Średni dzień | Średni dzień | ||||
| Doświadczenie | Immunogen | żywe : martwea | przeżycia | żywe : martwea | przeżycia |
| 1 | 2 | 3 | 4 | 5 | 6 |
| 1b | Żaden | 0 : 8 | 1.5 | 1 : 7 | 4.5 |
| NEW4 | 8 : 0 | >14 | 8 : 0 | >14 | |
| NEW5 | 8 : 0 | >14 | 8 : 0 | >14 | |
| NEW7 | 0 : 8 | 2 | 0 : 8 | 5 | |
| BVH-11M | 8 : 0 | >14 | 8 : 0 | >14 |
PL 206 576 B1 cd. tabeli 8
| 1 | 2 | 3 | 4 | 5 | 6 |
| 2b | Żaden | 0 : 8 | 1 | 0 : 8 | 4 |
| NEW5 | 8 : 0 | >14 | 8 : 0 | >14 | |
| NEW8 | 0 : 8 | 1.5 | 0 : 8 | 5.5 | |
| NEW9 | 3 : 5 | 3.5 | 2 : 6 | 7 | |
| BVH-11M | 8 : 0 | >14 | 8 : 0 | >14 | |
| 3b | Żaden | 0 : 8 | 1 | 0 : 8 | 4 |
| NEW6 | 0 : 8 | 1 | 4 : 4 | 10.5c | |
| NEW10 | 8 : 0 | >14 | 8 : 0 | >14 | |
| NEW11 | 0 : 8 | 1.5 | 1 : 7 | 6 | |
| BVH-11M | 8 : 0 | >14 | 8 : 0 | >14 | |
| 4b | Żaden | 0 : 8 | 2 | 0 : 8 | 4 |
| BVH-11B | 7 : 1 | >14 | 8 : 0 | >14 | |
| NEW14 | 8 : 0 | >14 | 8 : 0 | >14 | |
| 5 | His-Tio | 0 : 8 | 2 | ||
| BVH-3AD | 1 : 7 | 2.5 | |||
| BVH-3B | 5 : 3 | >14 | |||
| 6 | His-Tio | 0 : 8 | 1 | ||
| BVH-3C | 0 : 8 | 1 |
a Ilość myszy ż ywe : ilość myszy martwe dnia 14 po prowokacji.
b dawka prowokacji WU2 105 CFU.
c u myszy, które żyły dłużej niż 14 dni, oznaczano czas przeżycia 14 dni w celu określenia wartości średnich.
P r z y k ł a d 12
Niniejszy przykład przedstawia klonowanie i ekspresję chimerycznego genu kodującego chimeryczny polipeptyd odpowiadający sekwencjom: region końca karboksylowego BVH-3 w połączeniu na końcu C' z regionem końca karboksylowego BVH-11 i dodatkową ochronę obserwowano po szczepieniu chimerycznymi polipeptydem.
Jasne jest z badań przedstawionych powyżej, że BVH-3 i BVH-11 są serologicznie różniącymi się cząsteczkami jednocześnie obecnymi w S. pneumoniae. Wyniki badań immunologicznych myszy wskazują, że oba białka są dobrymi kandydatami do przygotowania szczepionki. Białka te mogą być skuteczne w zapewnianiu ochrony przeciwko wszelkim paciorkowcom, bez względu na serotyp. Pomimo, że dwa białka mają takie same epitopy i sekwencje, mają one różne charakterystyki i mogą służyć różnym funkcjom biologicznym. Zatem, immunizacja przeciwko dwóm białkom może dostarczyć wyższy poziom ochrony niż uzyskiwany przez każde z białek oddzielnie. W celu sprawdzenia tej tezy, kilka dróg może być badanych, BVH-3 i BVH-11 pełnej długości lub obcięte, podawane w połączeniu z lub w sprzężeniu. W niniejszym opisie opisujemy inżynierię genetyczną genu fuzyjnego i białka BVH-3-BVH-11, zakończonego NEW12 (odpowiednio Sekwencja nr 76 i Sekwencja nr 58) i możliwość zastosowania białka NEW12 jako szczepionki.
Fragmenty genowe BVH-3 i BVH-11 odpowiadające sekwencjom: koniec 3' genów amplifikowano metodą PCR stosując pary oligonukleotydów zaprojektowane do prowadzenia amplifikacji fragmentów obejmujących nukleotydy 1414 do 3117 (Sekwencja nr 1) i nukleotydy 1060 do 2520 (Sekwencja nr 3) ze szczepu S. pneumoniae SP64 genów odpowiednio BVH-3 i BVH-11. Stosowane startery, HAMJ278 i HAMJ279; HAMJ282 i HAMJ283 miały miejsca cięcia endonukleaz na końcu 5', co umożliwia bezpośrednie klonowanie w ramce amplifikowanego produktu do trawionego wektora plazmidowego pET21b(+) (Tabela 2). Produkty amplifikacji PCR trawiono endonukleazami restrykcyjnymi i ligowano ze linearyzowanym plazmidem pET21b(+), trawionym podobnie. Otrzymane konstrukty plazmidowe potwierdzono przeprowadzając analizę sekwencji nukleotydów. Zrekombinowane
PL 206 576 B1 plazmidy pET21b(+) zawierające produkt PCR Ndel-Hindlll BVH-3 linearyzowano trawiąc enzymami restrykcyjnymi Hindlll i Notl w celu klonowania w ramce fragmentu Hindlll-Notl DNA otrzymanego ze zrekombinowanego pET21(+) wektora zawierającego fragment genu BVH-11. Klony na wstępnie stabilizowano w E. coli DH5n przed wprowadzeniem do E. coli BL21(dDE3) w celu uzyskania ekspresji chimerycznej cząsteczki białka paciorkowców. Zrekombinowany chimeryczny polipeptyd, zakończony NEW12, ulegał ekspresji jako połączenie C-końcowe z His-tag. Otrzymane w wyniku ekspresji zrekombinowane białko NEW12 oczyszczano z frakcji supernatantu otrzymanej w wyniku wirowania sonikowanej indukowanej IPTG hodowli E. coli stosując żywicę chelatującą metal His-Bind (QIAgen, Chatsworth, CA).
Według tej samej procedury opisanej powyżej, możliwe jest skonstruowanie innych chimerycznych polipeptydów, w wyniku jednoczesnej ekspresji New 1 i New 4, New 1 i New 5, New 1 i New 10, lub New 1 i New 14. Konstrukt może zawierać New 1 upstream lub downstream względem New 4, New 5, New 10, BVH-11B lub New 14. W wyniku jednoczesnej ekspresji więcej niż dwóch fragmentów dowolnego z genów BVH-3, BVH-11 lub BVH-11-2, jest również możliwe skonstruowanie innych chimerycznych polipeptydów.
Grupy 8 samic myszy BALB/c (Charles River) immunizowano podskórnie dwa razy z trzytygodniowymi przerwami 25 μg dowolnym oczyszczonym przez powinowactwo fuzją HisTag z białkiem NEW1, BVH-11B lub NEW12 w obecności 15 μg adiuwanta QuilA dziesięć do 14 dni po ostatniej immunizacji, myszy prowokowano wirulentym S. pneumoniae. Jak wykazano poprzednio, cząsteczki NEW1 i BVH-11B zawierające odpowiednio, aminokwasy 472 do 1039 z białka BVH-3 i aminokwasy 354-840 z białka BVH-11, odpowiadają częściom białka zdolnego do wywołania ochronnej odpowiedzi immunologicznej. W celu określania czy chimeryczny polipeptyd może specyficznie zwiększać ochronę porównano z ochroną obserwowaną dla poszczególnych części, dawki do prowokacji dostosowano w sposób, taki, aby nie spodziewać się ochrony w przypadku cząsteczek NEW1 i BVH-11B. Co ciekawe, chimeryczne białko NEW12, wywołuje odpowiedź przeciwko mysim wirulentmym szczepom WU2 i P4241. Siedem z 8 myszy immunizowanych NEW12 było nadal żywe 10 dni po prowokacji podczas gdy 28 z 32 myszy immunizowanych NEW1, BVH-11B, BVH-3M lub samym adiuwantem było martwych pięć dni po prowokacji. Zatem, szczepienie myszy NEW12 zapewniało najwyższy stopień ochrony przeciwko prowokacji WU2. Wyniki te wskazują, że immunizacja chimerycznym polipeptydem i możliwe połączenia produktów genowych BVH-3 i BVH-11 mogą dostarczyć dodatkowej ochrony do tej jaką otrzymano w wyniku podawania samych antygenów BVH-3 lub BVH-11.
T a b e l a 9. Ocena ochrony wywoływanej przez szczepienie myszy chimeryczną cząsteczką NEW12
| Prowokacja WU2 | Prowokacja P4241 | |||
| Immunogen | żywe : martwea | Średni dzień przeżycia | żywe : martwea | Średni dzień przeżycia |
| Żaden | 0 : 8 | 1 | 0 : 8 | 5 |
| NEW1 | 2 : 6 | 2 | 1 : 7 | 8 |
| BVH-11B | 1 : 7 | 3.5 | 8 : 0 | >14 |
| NEW12 | 6 : 2 | >14 | 7 : 1 | >14 |
| BVH-3M | 1 : 7 | 3 | 8 : 1 | >14 |
P r z y k ł a d 13
Niniejszy przykład przedstawia identyfikację dodatkowych pokrewnych sekwencji BVH-3 i BVH-11 u gatunków Streptococcus innych niż S. pneumoniae.
Wykazano uprzednio, że BVH-3, BVH-11 i BVH-11-2 stanowią rodzinę pokrewnych białek mających wspólne sekwencje. Przeprowadzono badania homologii z sekwencją nukleotydową z regionu konserwowanego tych genów i porównano z sekwencjami z GenBank i EMBL stosując technikę FASTA. Najbardziej znaczącą homologię obserwowano z genem kodującym 2.469-kb obliczoną masą 92-kDa białka (Sekwencja nr 81) o nieznanej funkcji u S. agalactiae zwanych również paciorkowce grupy B lub GBS. Gen oznaczono jako BVH-71. Białko wykazujące 99.2% identyczności i 99.5% podobieństwa z GBS było również zidentyfikowano w S. pyogenes zwanym również paciorkowcem grupy A lub GAS (Sekwencja nr 83). Region 5' sekwencji BVH-71 (Sekwencja nr 80 i Sekwencja nr 82), obejmujący
PL 206 576 B1 nukleotydy 1 do 717, wykazano 58 i 60% identyczności z regionami konserwowanymi genów odpowiednio BVH-3 (nukleotydy 1 do 675) i BVH-11 (nukleotydy 1 do 684). Pierwsze 239 aminokwasy sekwencji GBS i GAS BVH-71 otwarte ramki odczytu, które uległy translacji są w 51 i 54% identyczne z pierwszymi 225 i 228 aminokwasami odpowiednio BVH-3 i BVH-11. Oprócz podobieństw strukturalnych, białka pneumokokowe BVH-3, BVH-11 i BVH-71 również mają epitopy antygenowe. Prążek 97-kDa ujawniony w analizie blotu Westerna całych komórek GAS lub GBS, stosując Mab H11-1.1-G11 reagujące z regionami konserwowanymi BVH-3 i BVH-11. Podobnie, zrekombinowane białka BVH-71 GAS i GBS wykryto analizą immunoblotu Westerna.
Wyniki te wskazują, że białka BVH-71, BVH-3 i BVH-11 mogą mieć podobne funkcje. Nasze wyniki również sugerują, że białka BVH-71 mogą być stosowane jako białkowe składniki szczepionek skierowane przeciwko paciorkowcom. Białka BVH-71 mogą być stosowane jako białkowe składniki szczepionek w szczepionkach anti-GAS lub anti-GBS.
PL 206 576 B1
Wykaz sekwencj i <110> BIOCHEM PHARMA INC. hamel, Josee BRODEUR, Bernard R.
PINEAU, Isabelle MARTIN, Denis RIOUX, element <120> Nowe antygeny paciorkowców .
<130> 12806-11PCT <150> US 60/113,800 <151> 1998-12-23 <160> 102 <170> FastSEQ for Windows Version 3.0 <210> 1 <211> 3120 <212> DNA <213> S. pneumoniae <220>
| atg | <400> aaa ttt | 1 agt | aaa | aaa | tat | ata | gca | gct | gga | tea | gct | gtt | atc | gta | 48 | |
| tcc | ttg | agt | eta | tgt | gee | tat | gca | eta | aac | cag | cat | cgt | teg | cag | gaa | 96 |
| aat | aag | gac | aat | aat | cgt | gtc | tct | tat | gtg | gat | ggc | age | cag | tea | agt | 144 |
| cag | aaa | agt | gaa | aac | ttg | aca | cca | gac | cag | gtt | age | cag | aaa | gaa | gga | 192 |
| att | cag | gct | gag | caa | att | gta | atc | aaa | att | aca | gat | cag | ggc | tat | gta | 240 |
| acg | tea | cac | ggt | gac | cac | tat | cat | tac | tat | aat | ggg | aaa | gtt | cct | tat | 288 |
| gat | gee | ctc | ttt | agt | gaa | gaa | ctc | ttg | atg | aag | gat | cca | aac | tat | caa | 336 |
| ctt | aaa | gac | gct | gat | att | gtc | aat | gaa | gtc | aag | ggt | ggt | tat | atc | atc | 384 |
| aag | gtc | gat | gga | aaa | tat | tat | gtc | tac | ctg | aaa | gat | gca | gct | cat | gct | 432 |
| gat | aat | gtt | ega | act | aaa | gat | gaa | atc | aat | cgt | caa | aaa | caa | gaa | cat | 480 |
| gtc | aaa | gat | aat | gag | aag | gtt | aac | tct | aat | gtt | gct | gta | gca | agg | tct | 528 |
| cag | gga | ega | tat | acg | aca | aat | gat | ggt | tat | gtc | ttt | aat | cca | gct | gat | 576 |
| att | atc | gaa | gat | acg | ggt | aat | gct | tat | atc | gtt | cct | cat | gga | ggt | cac | 624 |
| tat | cac | tac | att | ccc | aaa | age | gat | tta | tct | gct | agt | gaa | tta | gca | gca | 672 |
| gct | aaa | gca | cat | ctg | gct | gga | aaa | aat | atg | caa | ccg | agt | cag | tta | age | 720 |
| tat | tct | tea | aca | gct | agt | gac | aat | aac | acg | caa | tct | gta | gca | aaa | gga | 768 |
| tea | act | age | aag | cca | gca | aat | aaa | tct | gaa | aat | ctc | cag | agt | ctt | ttg | 816 |
| aag | gaa | ctc | tat | gat | tea | cct | age | gee | caa | cgt | tac | agt | gaa | tea | gat | 864 |
| ggc | ctg | gtc | ttt | gac | cct | gct | aag | att | atc | agt | cgt | aca | cca | aat | gga | 912 |
| gtt | gcg | att | ccg | cat | ggc | gac | cat | tac | cac | ttt | att | cct | tac | age | aag | 960 |
| ctt | tct | gct | tta | gaa | gaa | aag | att | gee | aga | atg | gtg | cct | atc | agt | gga | 1008 |
| act | ggt | tct | aca | gtt | tct | aca | aat | gca | aaa | cct | aat | gaa | gta | gtg | tct | 1056 |
| agt | eta | ggc | agt | ctt | tea | age | aat | cct | tct | tct | tta | acg | aca | agt | aag | 1104 |
| gag | ctc | tct | tea | gca | tct | gat | ggt | tat | att | ttt | aat | cca | aaa | gat | atc | 1152 |
| gtt | gaa | gaa | acg | gct | aca | gct | tat | att | gta | aga | cat | ggt | gat | cat | ttc | 1200 |
| cat | tac | att | cca | aaa | tea | aat | caa | att | ggg | caa | ccg | act | ctt | cca | aac | 1248 |
| aat | agt | eta | gca | aca | cct | tct | cca | tct | ctt | cca | atc | aat | cca | gga | act | 1296 |
| tea | cat | gag | aaa | cat | gaa | gaa | gat | gga | tac | gga | ttt | gat | gct | aat | cgt | 1344 |
| att | atc | gct | gaa | gat | gaa | tea | ggt | ttt | gtc | atg | agt | cac | gga | gac | cac | 1392 |
PL 206 576 B1
| aat | cat | tat | ttc | ttc | aag | aag | gac | ttg | aca | gaa | gag | caa | att | aag | gct | 1440 |
| gcg | caa | aaa | cat | tta | gag | gaa | gtt | aaa | act | agt | cat | aat | gga | tta | gat | 1488 |
| tct | ttg | tca | tct | cat | gaa | cag | gat | tat | cca | ggt | aat | gee | aaa | gaa | atg | 1536 |
| aaa | gat | tta | gat | aaa | aaa | atc | gaa | gaa | aaa | att | gct | ggc | att | atg | aaa | 1584 |
| caa | tat | ggt | gtc | aaa | cgt | gaa | agt | att | gtc | gtg | aat | aaa | gaa | aaa | aat | 1632 |
| gcg | att | att | tat | ccg | cat | gga | gat | cac | cat | cat | gca | gat | ccg | att | gat | 1680 |
| gaa | cat | aaa | ccg | gtt | gga | att | ggt | cat | tct | cac | agt | aac | tat | gaa | ctg | 1728 |
| ttt | aaa | ccc | gaa | gaa | gga | gtt | gct | aaa | aaa | gaa | ggg | aat | aaa | gtt | tat | 1776 |
| act | gga | gaa | gaa | tta | acg | aat | gtt | gtt | aat | ttg | tta | aaa | aat | agt | acg | 1824 |
| ttt | aat | aat | caa | aac | ttt | act | eta | gee | aat | ggt | caa | aaa | ege | gtt | tct | 1872 |
| ttt | agt | ttt | ccg | cct | gaa | ttg | gag | aaa | aaa | tta | ggt | atc | aat | atg | eta | 1920 |
| gta | aaa | tta | ata | aca | cca | gat | gga | aaa | gta | ttg | gag | aaa | gta | tct | ggt | 1968 |
| aaa | gta | ttt | gga | gaa | gga | gta | ggg | aat | att | gca | aac | ttt | gaa | tta | gat | 2016 |
| caa | cct | tat | tta | cca | gga | caa | aca | ttt | aag | tat | act | atc | gct | tca | aaa | 2064 |
| gat | tat | cca | gaa | gta | agt | tat | gat | ggt | aca | ttt | aca | gtt | cca | acc | tct | 2112 |
| tta | gct | tac | aaa | atg | gee | agt | caa | acg | att | ttc | tat | cct | ttc | cat | gca | 2160 |
| ggg | gat | act | tat | tta | aga | gtg | aac | cct | caa | ttt | gca | gtg | cct | aaa | gga | 2208 |
| act | gat | gct | tta | gtc | aga | gtg | ttt | gat | gaa | ttt | cat | gga | aat | gct | tat | 2256 |
| tta | gaa | aat | aac | tat | aaa | gtt | ggt | gaa | atc | aaa | tta | ccg | att | ccg | aaa | 2304 |
| tta | aac | caa | gga | aca | acc | aga | acg | gee | gga | aat | aaa | att | cct | gta | acc | 2352 |
| ttc | atg | gca | aat | gct | tat | ttg | gac | aat | caa | teg | act | tat | att | gtg | gaa | 2400 |
| gta | cct | atc | ttg | gaa | aaa | gaa | aat | caa | act | gat | aaa | cca | agt | att | eta | 2448 |
| cca | caa | ttt | aaa | agg | aat | aaa | gca | caa | gaa | aac | tca | aaa | ctt | gat | gaa | 2496 |
| aag | gta | gaa | gaa | cca | aag | act | agt | gag | aag | gta | gaa | aaa | gaa | aaa | ctt | 2544 |
| tct | gaa | act | ggg | aat | agt | act | agt | aat | tca | acg | tta | gaa | gaa | gtt | cct | 2592 |
| aca | gtg | gat | cct | gta | caa | gaa | aaa | gta | gca | aaa | ttt | gct | gaa | agt | tat | 2640 |
| ggg | atg | aag | eta | gaa | aat | gtc | ttg | ttt | aat | atg | gac | gga | aca | att | gaa | 2688 |
| tta | tat | tta | cca | tca | gga | gaa | gtc | att | aaa | aag | aat | atg | gca | gat | ttt | 2736 |
| aca | gga | gaa | gca | cct | caa | gga | aat | ggt | gaa | aat | aaa | cca | tct | gaa | aat | 2784 |
| gga | aaa | gta | tct | act | gga | aca | gtt | gag | aac | caa | cca | aca | gaa | aat | aaa | 2832 |
| cca | gca | gat | tct | tta | cca | gag | gca | cca | aac | gaa | aaa | cct | gta | aaa | cca | 2880 |
| gaa | aac | tca | acg | gat | aat | gga | atg | ttg | aat | cca | gaa | ggg | aat | gtg | ggg | 2928 |
| agt | gac | cct | atg | tta | gat | cca | gca | tta | gag | gaa | gct | cca | gca | gta | gat | 2976 |
| cct | gta | caa | gaa | aaa | tta | gaa | aaa | ttt | aca | gct | agt | tac | gga | tta | ggc | 3024 |
| tta | gat | agt | gtt | ata | ttc | aat | atg | gat | gga | acg | att | gaa | tta | aga | ttg | 3072 |
| cca | agt | gga | gaa | gtg | ata | aaa | aag | aat | tta | tct | gat | ttc | ata | gcg | 3117 | |
| taa | 3120 | |||||||||||||||
| <210> | 2 | |||||||||||||||
| <211> | 1039 | |||||||||||||||
| <212> | PRT | |||||||||||||||
| <213> | S. pneumoniae | |||||||||||||||
| <400> | 2 | |||||||||||||||
| Met | Lys | Phe | Ser | Lys | Lys | Tyr | Ile | Ala | Ala | Gly | Ser | Ala | Val | Ile | Val | |
| 1 | 5 | 10 | 15 | |||||||||||||
| Ser | Leu | Ser | Leu | Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu | |
| 20 | 25 | 30 | ||||||||||||||
| Asn | Lys | Asp | Asn | Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | |
| 35 | 40 | 45 | ||||||||||||||
| Gin | Lys | Ser | Glu | Asn | Leu | Thr | Pro | Asp | Gin | val | Ser | Gin | Lys | Glu | Gly | |
| 50 | 55 | 60 | ||||||||||||||
| Ile | Gin | Ala | Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | |
| 65 | 70 | 75 | 80 | |||||||||||||
| Thr | Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | |
| 85 | 90 | 95 | ||||||||||||||
| Asp | Ala | Leu | Phe | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin |
PL 206 576 B1
| 100 | 105 | 110 | |||||||||||||
| Leu | Lys | Asp | Ala | Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile |
| 115 | 120 | 125 | |||||||||||||
| Lys | Val | Asp | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala |
| 130 | 135 | 140 | |||||||||||||
| Asp | Asn | Val | Arg | Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His |
| 145 | 150 | 155 | 160 | ||||||||||||
| Val | Lys | Asp | Asn | Glu | Lys | val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser |
| 165 | 170 | 175 | |||||||||||||
| Gin | Gly | Arg | Tyr | Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp |
| 180 | 185 | 190 | |||||||||||||
| Ile | ile | Glu | Asp | Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His |
| 195 | 200 | 205 | |||||||||||||
| Tyr | His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala |
| 210 | 215 | 220 | |||||||||||||
| Ala | Lys | Ala | His | Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Tyr | Ser | Ser | Thr | Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly |
| 245 | 250 | 255 | |||||||||||||
| Ser | Thr | Ser | Lys | Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu |
| 260 | 265 | 270 | |||||||||||||
| Lys | Glu | Leu | Tyr | Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp |
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Val | Phe | Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly |
| 290 | 295 | 300 | |||||||||||||
| Val | Ala | Ile | Pro | His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Ser | Ala | Leu | Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly |
| 325 | 330 | 335 | |||||||||||||
| Thr | Gly | Ser | Thr | Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ser | Leu | Gly | Ser | Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Leu | Ser | Ser | Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile |
| 370 | 375 | 380 | |||||||||||||
| Val | Glu | Glu | Thr | Ala | Thr | Ala | Tyr | ile | Val | Arg | His | Gly | Asp | His | Phe |
| 385 | 390 | 395 | 400 | ||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn |
| 405 | 410 | 415 | |||||||||||||
| Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr |
| 420 | 425 | 43 0 | |||||||||||||
| Ser | His | Glu | Lys | His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg |
| 435 | 440 | 445 | |||||||||||||
| Ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His |
| 450 | 455 | 460 | |||||||||||||
| Asn | His | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Gin | Lys | His | Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met |
| 500 | 505 | 510 | |||||||||||||
| Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys |
| 515 | 520 | 525 | |||||||||||||
| Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | ile | Val | Val | Asn | Lys | Glu | Lys | Asn |
| 530 | 535 | 540 | |||||||||||||
| Ala | Ile | Ile | Tyr | Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp |
| 545 | 550 | 555 | 560 |
PL 206 576 B1
| Glu | His | Lys | Pro | Val 565 | Gly | Ile Gly His | Ser 570 | His | Ser Asn | Tyr | Glu 575 | Leu |
| Phe | Lys | Pro | Glu | Glu | Gly | Val Ala Lys | Lys | Glu | Gly Asn | Lys | Val | Tyr |
| 580 | 585 | 590 | ||||||||||
| Thr | Gly | Glu | Glu | Leu | Thr | Asn Val Val | Asn | Leu | Leu Lys | Asn | Ser | Thr |
| 595 | 600 | 605 | ||||||||||
| Phe | Asn | Asn | Gin | Asn | Phe | Thr Leu Ala | Asn | Gly | Gin Lys | Arg | Val | Ser |
| 610 | 615 | 620 | ||||||||||
| Phe | Ser | Phe | Pro | Pro | Glu | Leu Glu Lys | Lys | Leu | Gly Ile | Asn | Met | Leu |
| 625 | 630 | 635 | 640 | |||||||||
| Val | Lys | Leu | Ile | Thr | Pro | Asp Gly Lys | Val | Leu | Glu Lys | Val | Ser | Gly |
| 645 | 650 | 655 | ||||||||||
| Lys | Val | Phe | Gly | Glu | Gly | Val Gly Asn | Ile | Ala | Asn Phe | Glu | Leu | Asp |
| 660 | 665 | 670 | ||||||||||
| Gin | Pro | Tyr | Leu | Pro | Gly | Gin Thr Phe | Lys | Tyr | Thr Ile | Ala | Ser | Lys |
| 675 | 680 | 685 | ||||||||||
| Asp | Tyr | Pro | Glu | Val | Ser | Tyr Asp Gly | Thr | Phe | Thr Val | Pro | Thr | Ser |
| 690 | 695 | 700 | ||||||||||
| Leu | Ala | Tyr | Lys | Met | Ala | Ser Gin Thr | Ile | Phe | Tyr Pro | Phe | His | Ala |
| 705 | 710 | 715 | 720 | |||||||||
| Gly | Asp | Thr | Tyr | Leu | Arg | Val Asn Pro | Gin | Phe | Ala Val | Pro | Lys | Gly |
| 725 | 730 | 735 | ||||||||||
| Thr | Asp | Ala | Leu | Val | Arg | Val Phe Asp | Glu | Phe | His Gly | Asn | Ala | Tyr |
| 740 | 745 | 750 | ||||||||||
| Leu | Glu | Asn | Asn | Tyr | Lys | Val Gly Glu | Ile | Lys | Leu Pro | Ile | Pro | Lys |
| 755 | 760 | 765 | ||||||||||
| Leu | Asn | Gin | Gly | Thr | Thr | Arg Thr Ala | Gly | Asn | Lys Ile | Pro | val | Thr |
| 770 | 775 | 780 | ||||||||||
| Phe | Met | Ala | Asn | Ala | Tyr | Leu Asp Asn | Gin | Ser | Thr Tyr | Ile | val | Glu |
| 785 | 790 | 795 | 800 | |||||||||
| Val | Pro | Ile | Leu | Glu | Lys | Glu Asn Gin | Thr | Asp | Lys Pro | Ser | Ile | Leu |
| 805 | 810 | 815 | ||||||||||
| Pro | Gin | Phe | Lys | Arg | Asn | Lys Ala Gin | Glu | Asn | Ser Lys | Leu | Asp | Glu |
| 820 | 825 | 830 | ||||||||||
| Lys | Val | Glu | Glu | Pro | Lys | Thr Ser Glu | Lys | Val | Glu Lys | Glu | Lys | Leu |
| 835 | 840 | 845 | ||||||||||
| Ser | Glu | Thr | Gly | Asn | Ser | Thr Ser Asn | Ser | Thr | Leu Glu | Glu | Val | Pro |
| 850 | 855 | 860 | ||||||||||
| Thr | Val | Asp | Pro | Val | Gin | Glu Lys Val | Ala | Lys | Phe Ala | Glu | Ser | Tyr |
| 865 | 870 | 875 | 880 | |||||||||
| Gly | Met | Lys | Leu | Glu | Asn | Val Leu Phe | Asn | Met | Asp Gly | Thr | Ile | Glu |
| 885 | 890 | 895 | ||||||||||
| Leu | Tyr | Leu | Pro | Ser | Gly | Glu Val Ile | Lys | Lys | Asn Met | Ala | Asp | Phe |
| 900 | 905 | 910 | ||||||||||
| Thr | Gly | Glu | Ala | Pro | Gin | Gly Asn Gly | Glu | Asn | Lys Pro | Ser | Glu | Asn |
| 915 | 920 | 925 | ||||||||||
| Gly | Lys | Val | Ser | Thr | Gly | Thr Val Glu | Asn | Gin | Pro Thr | Glu | Asn | Lys |
| 930 | 935 | 940 | ||||||||||
| Pro | Ala | Asp | Ser | Leu | Pro | Glu Ala Pro | Asn | Glu | Lys Pro | Val | Lys | Pro |
| 945 | 950 | 955 | 960 | |||||||||
| Glu | Asn | Ser | Thr | Asp | Asn | Gly Met Leu | Asn | Pro | Glu Gly | Asn | Val | Gly |
| 965 | 970 | 975 | ||||||||||
| Ser | Asp | Pro | Met | Leu | Asp | Pro Ala Leu | Glu | Glu | Ala Pro | Ala | Val | Asp |
| 980 | 985 | 990 | ||||||||||
| Pro | Val | Gin | Glu | Lys | Leu | Glu Lys Phe | Thr | Ala | Ser Tyr | Gly | Leu | Gly |
| 995 | 1000 | 1005 | ||||||||||
| Leu | Asp | Ser | Val | Ile | Phe | Asn Met Asp | Gly | Thr | Ile Glu | Leu | Arg | Leu |
PL 206 576 B1
| 1010 | 1015 | 1020 | Ile | Ala | ||||||||||||
| Pro Ser 1025 | Gly | Glu | Val | Ile Lys 1030 | Lys Asn Leu | Ser Asp 1035 | Phe | |||||||||
| <210> | 3 | |||||||||||||||
| <211> | 2523 | |||||||||||||||
| <212> | DNA | |||||||||||||||
| <213> | S. pneumoniae | |||||||||||||||
| <220> <221> | CDS | |||||||||||||||
| <222> | (1) | . . . (2520) | ||||||||||||||
| <223> | Region kodujący | genu BVH-11 | ||||||||||||||
| <400> | 3 | |||||||||||||||
| atg | aaa | atc | aat | aaa | aaa | tat | eta | gct | ggg | tca | gta | gct | aca | ctt | gtt | 48 |
| Met | Lys | Ile | Asn | Lys | Lys | Tyr | Leu | Ala | Gly | Ser | Val | Ala | Thr | Leu | Val | |
| 1 | 5 | 10 | 15 | |||||||||||||
| tta | agt | gtc | tgt | gct | tat | gaa | eta | ggt | ttg | cat | caa | gct | caa | act | gta | 96 |
| Leu | Ser | Val | Cys | Ala | Tyr | Glu | Leu | Gly | Leu | His | Gin | Ala | Gin | Thr | Val | |
| 20 | 25 | 30 | ||||||||||||||
| aaa | gaa | aat | aat | cgt | gtt | tcc | tat | ata | gat | gga | aaa | caa | gcg | acg | caa | 144 |
| Lys | Glu | Asn | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Lys | Gin | Ala | Thr | Gin | |
| 35 | 40 | 45 | ||||||||||||||
| aaa | acg | gag | aat | ttg | act | cct | gat | gag | gtt | age | aag | cgt | gaa | gga | atc | 192 |
| Lys | Thr | Glu | Asn | Leu | Thr | Pro | Asp | Glu | val | Ser | Lys | Arg | Glu | Gly | Ile | |
| 50 | 55 | 60 | ||||||||||||||
| aac | gcc | gaa | caa | atc | gtc | atc | aag | att | acg | gat | caa | ggt | tat | gtg | acc | 240 |
| Asn | Ala | Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | |
| 65 | 70 | 75 | 80 | |||||||||||||
| tct | cat | gga | gac | cat | tat | cat | tac | tat | aat | ggc | aag | gtc | cct | tat | gat | 288 |
| Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | |
| 85 | 90 | 95 | ||||||||||||||
| gcc | atc | atc | agt | gaa | gag | ctc | ctc | atg | aaa | gat | ceg | aat | tat | cag | ttg | 336 |
| Ala | Ile | Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | |
| 100 | 105 | 110 | ||||||||||||||
| aag | gat | tca | gac | att | gtc | aat | gaa | atc | aag | ggt | ggt | tat | gtc | att | aag | 384 |
| Lys | Asp | Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | |
| 115 | 120 | 125 | ||||||||||||||
| gta | aac | ggt | aaa | tac | tat | gtt | tac | ctt | aag | gat | gca | gct | cat | gcg | gat | 432 |
| Val | Asn | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | |
| 130 | 135 | 140 | ||||||||||||||
| aat | gtc | cgt | aca | aaa | gaa | gaa | atc | aat | cgg | caa | aaa | caa | gaa | cat | agt | 480 |
| Asn | Val | Arg | Thr | Lys | Glu | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Ser | |
| 145 | 150 | 155 | 160 | |||||||||||||
| cag | cat | cgt | gaa | gga | ggg | act | tca | gca | aac | gat | ggt | gcg | gta | gcc | ttt | 528 |
| Gin | His | Arg | Glu | Gly | Gly | Thr | Ser | Ala | Asn | Asp | Gly | Ala | Val | Ala | Phe |
PL 206 576 B1
| 165 | 170 | 175 | ||||||||||||||
| gca | cgt | tca | cag | gga | cgc | tac | acc | aca | gat | gat | ggt | tat | atc | ttc | aat | 576 |
| Ala | Arg | Ser | Gin 180 | Gly | Arg | Tyr | Thr | Thr 185 | Asp | Asp | Gly | Tyr | Ile 190 | Phe | Asn | |
| gca | tct | gat | atc | atc | gaa | gat | acg | ggc | gat | gcc | tat | atc | gtt | cct | cat | 624 |
| Ala | Ser | Asp 195 | Ile | Ile | Glu | Asp | Thr 200 | Gly | Asp | Ala | Tyr | Ile 205 | Val | Pro | His | |
| gga | gat | cat | tac | cat | tac | att | cct | aag | aat | gag | tta | tca | gct | agc | gag | 672 |
| Gly | Asp 210 | His | Tyr | His | Tyr | Ile 215 | Pro | Lys | Asn | Glu | Leu 220 | Ser | Ala | Ser | Glu | |
| ttg | gct | gct | gca | gaa | gcc | ttc | eta | tct | ggt | cgg | gaa | aat | ctg | tca | aat | 720 |
| Leu 225 | Ala | Ala | Ala | Glu | Ala 230 | Phe | Leu | Ser | Gly | Arg 235 | Glu | Asn | Leu | Ser | Asn 240 | |
| tta | aga | acc | tat | cgc | ega | caa | aat | agc | gat | aac | act | cca | aga | aca | aac | 768 |
| Leu | Arg | Thr | Tyr | Arg 245 | Arg | Gin | Asn | Ser | Asp 250 | Asn | Thr | Pro | Arg | Thr 255 | Asn | |
| tgg | gta | cct | tct | gta | agc | aat | cca | gga | act | aca | aat | act | aac | aca | agc | 816 |
| Trp | Val | Pro | Ser 260 | Val | Ser | Asn | Pro | Gly 265 | Thr | Thr | Asn | Thr | Asn 270 | Thr | Ser | |
| aac | aac | agc | aac | act | aac | agt | caa | gca | agt | caa | agt | aat | gac | att | gat | 864 |
| Asn | Asn | Ser 275 | Asn | Thr | Asn | Ser | Gin 280 | Ala | Ser | Gin | Ser | Asn 285 | Asp | Ile | Asp | |
| agt | ctc | ttg | aaa | cag | ctc | tac | aaa | ctg | cct | ttg | agt | caa | cgc | cat | gta | 912 |
| Ser | Leu 290 | Leu | Lys | Gin | Leu | Tyr 295 | Lys | Leu | Pro | Leu | Ser 300 | Gin | Arg | His | Val | |
| gaa | tct | gat | ggc | ctt | att | ttc | gac | cca | gcg | caa | atc | aca | agt | ega | acc | 960 |
| Glu 305 | Ser | Asp | Gly | Leu | Ile 310 | Phe | Asp | Pro | Ala | Gin 315 | Ile | Thr | Ser | Arg | Thr 320 | |
| gcc | aga | ggt | gta | gct | gtc | cct | cat | ggt | aac | cat | tac | cac | ttt | atc | cct | 1008 |
| Ala | Arg | Gly | Val | Ala 325 | Val | Pro | His | Gly | Asn 330 | His | Tyr | His | Phe | Ile 335 | Pro | |
| tat | gaa | caa | atg | tct | gaa | ttg | gaa | aaa | ega | att | gct | cgt | att | att | ccc | 1056 |
| Tyr | Glu | Gin | Met 340 | Ser | Glu | Leu | Glu | Lys 345 | Arg | Ile | Ala | Arg | Ile 350 | Ile | Pro | |
| ctt | cgt | tat | cgt | tca | aac | cat | tgg | gta | cca | gat | tca | aga | cca | gaa | gaa | 1104 |
| Leu | Arg | Tyr 355 | Arg | Ser | Asn | His | Trp 360 | Val | Pro | Asp | Ser | Arg 365 | Pro | Glu | Glu | |
| cca | agt | cca | caa | ccg | act | cca | gaa | cct | agt | cca | agt | ccg | caa | cct | gca | 1152 |
| Pro | Ser 370 | Pro | Gin | Pro | Thr | Pro 375 | Glu | Pro | Ser | Pro | Ser 380 | Pro | Gin | Pro | Ala | |
| cca | aat | cct | caa | cca | gct | cca | agc | aat | cca | att | gat | gag | aaa | ttg | gtc | 1200 |
| Pro 385 | Asn | Pro | Gin | Pro | Ala 390 | Pro | Ser | Asn | Pro | Ile 395 | Asp | Glu | Lys | Leu | Val 400 |
PL 206 576 B1
| aaa Lys | gaa Glu | get Ala | gtt Val | ega aaa | gta ggc | gat Asp | ggt Gly 410 | tat Tyr | gtc Val | ttt Phe | gag Glu | gag Glu 415 | aat Asn | 1248 | ||
| Arg 405 | Lys | Val | Gly | |||||||||||||
| gga | gtt | tet | cgt | tat | atc | cca | gee | aag | aat | ctt | tea | gca | gaa | aca | gca | 1296 |
| Gly | Val | Ser | Arg 420 | Tyr | Ile | Pro | Ala | Lys 425 | Asn | Leu | Ser | Ala | Glu 430 | Thr | Ala | |
| gca | ggc | att | gat | age | aaa | ctg | gee | aag | cag | gaa | agt | tta | tet | cat | aag | 1344 |
| Ala | Gly | Ile 435 | Asp | Ser | Lys | Leu | Ala 440 | Lys | Gin | Glu | Ser | Leu 445 | Ser | His | Lys | |
| eta | gga | get | aag | aaa | act | gac | etc | cca | tet | agt | gat | ega | gaa | ttt | tac | 1392 |
| Leu | Gly 450 | Ala | Lys | Lys | Thr | Asp 455 | Leu | Pro | Ser | Ser | Asp 460 | Arg | Glu | Phe | Tyr | |
| aat | aag | get | tat | gac | tta | eta | gca | aga | att | cac | caa | gat | tta | ctt | gat | 1440 |
| Asn 465 | Lys | Ala | Tyr | Asp | Leu 470 | Leu | Ala | Arg | Ile | His 475 | Gin | Asp | Leu | Leu | Asp 480 | |
| aat | aaa | ggt | ega | caa | gtt | gat | ttt | gag | get | ttg | gat | aac | ctg | ttg | gaa | 1488 |
| Asn | Lys | Gly | Arg | Gin 485 | Val | Asp | Phe | Glu | Ala 490 | Leu | Asp | Asn | Leu | Leu 495 | Glu | |
| ega | etc | aag | gat | gtc | tea | agt | gat | aaa | gtc | aag | tta | gtg | gat | gat | att | 1536 |
| Arg | Leu | Lys | Asp 500 | Val | Ser | Ser | Asp | Lys 505 | Val | Lys | Leu | Val | Asp 510 | Asp | Ile | |
| ctt | gee | ttc | tta | get | ccg | att | cgt | cat | cca | gaa | cgt | tta | gga | aaa | cca | 1584 |
| Leu | Ala | Phe 515 | Leu | Ala | Pro | Ile | Arg 520 | His | Pro | Glu | Arg | Leu 525 | Gly | Lys | Pro | |
| aat | gcg | caa | att | acc | tac | act | gat | gat | gag | att | caa | gta | gee | aag | ttg | 1632 |
| Asn | Ala 530 | Gin | Ile | Thr | Tyr | Thr 535 | Asp | Asp | Glu | Ile | Gin 540 | Val | Ala | Lys | Leu | |
| gca | ggc | aag | tac | aca | aca | gaa | gac | ggt | tat | atc | ttt | gat | cct | cgt | gat | 1680 |
| Ala 545 | Gly | Lys | Tyr | Thr | Thr 550 | Glu | Asp | Gly | Tyr | Ile 555 | Phe | Asp | Pro | Arg | Asp 560 | |
| ata | acc | agt | gat | gag | ggg | gat | gee | tat | gta | act | cca | cat | atg | acc | cat | 1728 |
| Ile | Thr | Ser | Asp | Glu 565 | Gly | Asp | Ala | Tyr | Val 570 | Thr | Pro | His | Met | Thr 575 | His | |
| age | cac | tgg | att | aaa | aaa | gat | agt | ttg | tet | gaa | get | gag | aga | gcg | gca | 1776 |
| Ser | His | Trp | Ile 580 | Lys | Lys | Asp | Ser | Leu 585 | Ser | Glu | Ala | Glu | Arg 590 | Ala | Ala | |
| gee | cag | get | tat | get | aaa | gag | aaa | ggt | ttg | acc | cct | cct | teg | aca | gac | 1824 |
| Ala | Gin | Ala 595 | Tyr | Ala | Lys | Glu | Lys 600 | Gly | Leu | Thr | Pro | Pro 605 | Ser | Thr | Asp | |
| cat | cag | gat | tea | gga | aat | act | gag | gca | aaa | gga | gca | gaa | get | atc | tac | 1872 |
| His | Gin 610 | Asp | Ser | Gly | Asn | Thr 615 | Glu | Ala | Lys | Gly | Ala 620 | Glu | Ala | Ile | Tyr |
PL 206 576 B1
| aac Asn 625 | cgc Arg | gtg Val | aaa Lys | gca Ala | gct Ala 630 | aag Lys | aag Lys | gtg Val | cca Pro | ctt Leu 635 | gat Asp | cgt Arg | atg Met | cct Pro | tac Tyr 640 | 1920 |
| aat | ctt | caa | tat | act | gta | gaa | gtc | aaa | aac | ggt | agt | tta | atc | ata | cct | 1968 |
| Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | |
| 645 | 650 | 655 | ||||||||||||||
| cat | tat | gac | cat | tac | cat | aac | atc | aaa | ttt | gag | tgg | ttt | gac | gaa | ggc | 2016 |
| His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | |
| 660 | 665 | 670 | ||||||||||||||
| ctt | tat | gag | gca | cct | aag | ggg | tat | act | ctt | gag | gat | ctt | ttg | gcg | act | 2064 |
| Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | |
| 675 | 680 | 685 | ||||||||||||||
| gtc | aag | tac | tat | gtc | gaa | cat | cca | aac | gaa | cgt | ccg | cat | tca | gat | aat | 2112 |
| Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | |
| 690 | 695 | 700 | ||||||||||||||
| ggt | ttt | ggt | aac | gct | agc | gac | cat | gtt | caa | aga | aac | aaa | aat | ggt | caa | 2160 |
| Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | |
| 705 | 710 | 715 | 720 | |||||||||||||
| gct | gat | acc | aat | caa | acg | gaa | aaa | cca | agc | gag | gag | aaa | cct | cag | aca | 2208 |
| Ala | Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr | |
| 725 | 730 | 735 | ||||||||||||||
| gaa | aaa | cct | gag | gaa | gaa | acc | cct | ega | gaa | gag | aaa | cca | caa | agc | gag | 2256 |
| Glu | Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | |
| 740 | 745 | 750 | ||||||||||||||
| aaa | cca | gag | tct | cca | aaa | cca | aca | gag | gaa | cca | gaa | gaa | gaa | tca | cca | 2304 |
| Lys | Pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | |
| 755 | 760 | 765 | ||||||||||||||
| gag | gaa | tca | gaa | gaa | cct | cag | gtc | gag | act | gaa | aag | gtt | gaa | gaa | aaa | 2352 |
| Glu | Glu | Ser | Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys | |
| 770 | 775 | 780 | ||||||||||||||
| ctg | aga | gag | gct | gaa | gat | tta | ctt | gga | aaa | atc | cag | gat | cca | att | atc | 2400 |
| Leu | Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | Ile | Ile | |
| 785 | 790 | 795 | 800 | |||||||||||||
| aag | tcc | aat | gcc | aaa | gag | act | ctc | aca | gga | tta | aaa | aat | aat | tta | eta | 2448 |
| Lys | Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | |
| 805 | 810 | 815 | ||||||||||||||
| ttt | ggc | acc | cag | gac | aac | aat | act | att | atg | gca | gaa | gct | gaa | aaa | eta | 2496 |
| Phe | Gly | Thr | Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu | |
| 820 | 825 | 830 | ||||||||||||||
| ttg | gct | tta | tta | aag | gag | agt | aag | taa | 2523 | |||||||
| Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys | |||||||||
| 835 | 840 |
PL 206 576 B1 <210> 4 <211> 840 <212> PRT <213> S. pneumoniae <400> 4
| Met | Lys | Ile | Asn | Lys | Lys | Tyr | Leu | Ala | Gly | Ser | Val | Ala | Thr | Leu | Val |
| 1 | 5 | 10 | 15 | ||||||||||||
| Leu | Ser | Val | Cys | Ala | Tyr | Glu | Leu | Gly | Leu | His | Gin | Ala | Gin | Thr | Val |
| 20 | 25 | 30 | |||||||||||||
| Lys | Glu | Asn | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Lys | Gin | Ala | Thr | Gin |
| 35 | 40 | 45 | |||||||||||||
| Lys | Thr | Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile |
| 50 | 55 | 60 | |||||||||||||
| Asn | Ala | Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ala | ile | Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu |
| 100 | 105 | 110 | |||||||||||||
| Lys | Asp | Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys |
| 115 | 120 | 125 | |||||||||||||
| Val | Asn | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp |
| 130 | 135 | 140 | |||||||||||||
| Asn | Val | Arg | Thr | Lys | Glu | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Ser |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gin | His | Arg | Glu | Gly | Gly | Thr | Ser | Ala | Asn | Asp | Gly | Ala | Val | Ala | Phe |
| 165 | 170 | 175 | |||||||||||||
| Ala | Arg | Ser | Gin | Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn |
| 180 | 185 | 190 | |||||||||||||
| Ala | Ser | Asp | Ile | ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His |
| 195 | 200 | 205 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu |
| 210 | 215 | 220 | |||||||||||||
| Leu | Ala | Ala | Ala | Glu | Ala | Phe | Leu | Ser | Gly | Arg | Glu | Asn | Leu | Ser | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Arg | Thr | Tyr | Arg | Arg | Gin | Asn | Ser | Asp | Asn | Thr | Pro | Arg | Thr | Asn |
| 245 | 250 | 255 | |||||||||||||
| Trp | Val | Pro | Ser | Val | Ser | Asn | Pro | Gly | Thr | Thr | Asn | Thr | Asn | Thr | Ser |
| 260 | 265 | 270 | |||||||||||||
| Asn | Asn | Ser | Asn | Thr | Asn | Ser | Gin | Ala | Ser | Gin | Ser | Asn | Asp | Ile | Asp |
| 275 | 280 | 285 | |||||||||||||
| Ser | Leu | Leu | Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser | Gin | Arg | His | Val |
| 290 | 295 | 300 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 325 | 330 | 335 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 340 | 345 | 350 | |||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu |
| 355 | 360 | 365 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala |
| 370 | 375 | 380 | |||||||||||||
| Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val |
| 385 | 390 | 395 | 400 | ||||||||||||
| Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn |
PL 206 576 B1
| 405 | 410 | 415 | |||||||||||||
| Gly | Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala |
| 420 | 425 | 430 | |||||||||||||
| Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys |
| 435 | 440 | 445 | |||||||||||||
| Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr |
| 450 | 455 | 460 | |||||||||||||
| Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp |
| 465 | 470 | 475 | 480 | ||||||||||||
| Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu |
| 485 | 490 | 495 |
| Arg | Leu | Lys Asp Val 500 | Ser | Ser | Asp | Lys Val 505 | Lys Leu Val Asp 510 | Asp | Ile | ||||||
| Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro |
| 515 | 520 | 525 | |||||||||||||
| Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu |
| 530 | 535 | 540 | |||||||||||||
| Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His |
| 565 | 570 | 575 | |||||||||||||
| Ser | His | Trp | Ile | Lys | Lys | ASp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala |
| 580 | 585 | 590 | |||||||||||||
| Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp |
| 595 | 600 | 605 | |||||||||||||
| His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr |
| 610 | 615 | 620 | |||||||||||||
| Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr |
| 625 | 630 | 635 | 640 | ||||||||||||
| Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro |
| 645 | 650 | 655 | |||||||||||||
| His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly |
| 660 | 665 | 670 | |||||||||||||
| Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr |
| 675 | 680 | 685 | |||||||||||||
| Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn |
| 690 | 695 | 700 | |||||||||||||
| Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin |
| 705 | 710 | 715 | 720 | ||||||||||||
| Ala | Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr |
| 725 | 730 | 735 | |||||||||||||
| Glu | Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu |
| 740 | 745 | 750 | |||||||||||||
| Lys | Pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro |
| 755 | 760 | 765 | |||||||||||||
| Glu | Glu | Ser | Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys |
| 770 | 775 | 780 | |||||||||||||
| Leu | Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | Ile | Ile |
| 785 | 790 | 795 | 800 | ||||||||||||
| Lys | Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu |
| 805 | 810 | 815 | |||||||||||||
| Phe | Gly | Thr | Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu |
| 820 | 825 | 830 | |||||||||||||
| Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys | ||||||||
| 835 | 840 |
<210> 5
PL 206 576 B1 <211> 1581 <212> DNA
| <213> | S. pneumoniae | |||||||||||||||
| <220> | ||||||||||||||||
| <221> | CDS | |||||||||||||||
| <222> | (1) | ...(1578) | ||||||||||||||
| <400> | 5 | |||||||||||||||
| atg | gag | aat | ata | gac | atg | ttt | aaa | tca | aat | cat | gag | ega | aga | atg | cgt | 48 |
| Met | Glu | Asn | Ile | Asp | Met | Phe | Lys | Ser | Asn | His | Glu | Arg | Arg | Met | Arg | |
| 1 | 5 | 10 | 15 | |||||||||||||
| tat | tcc | att | cgt | aaa | ttt | agt | gta | gga | gta | gct | age | gta | gct | gtt | gee | 96 |
| Tyr | Ser | Ile | Arg | Lys | Phe | Ser | Val | Gly | Val | Ala | Ser | Val | Ala | Val | Ala | |
| 20 | 25 | 30 | ||||||||||||||
| agt | ctt | ttt | atg | gga | agt | gtt | gta | cat | gcg | aca | gag | aaa | gag | gga | agt | 144 |
| Ser | Leu | Phe | Met | Gly | Ser | val | Val | His | Ala | Thr | Glu | Lys | Glu | Gly | Ser | |
| 35 | 40 | 45 | ||||||||||||||
| acc | caa | gca | gee | act | tct | ttt | aat | agg | gga | aat | gga | agt | cag | gca | gaa | 192 |
| Thr | Gin | Ala | Ala | Thr | Ser | Phe | Asn | Arg | Gly | Asn | Gly | Ser | Gin | Ala | Glu | |
| 50 | 55 | 60 | ||||||||||||||
| caa | cgt | gga | gaa | ctc | gat | tta | gaa | ega | gat | aag | gca | atg | aaa | gcg | gtc | 240 |
| Gin | Arg | Gly | Glu | Leu | Asp | Leu | Glu | Arg | Asp | Lys | Ala | Met | Lys | Ala | Val | |
| 65 | 70 | 75 | 80 | |||||||||||||
| agt | gaa | tat | gta | gga | aaa | atg | gtg | aga | gat | gee | tat | gta | aaa | tca | gat | 288 |
| Ser | Glu | Tyr | Val | Gly | Lys | Met | Val | Arg | Asp | Ala | Tyr | Val | Lys | Ser | Asp | |
| 85 | 90 | 95 | ||||||||||||||
| aga | aaa | ega | cat | aaa | aat | act | gta | gct | eta | gtt | aac | cag | ttg | gga | aac | 336 |
| Arg | Lys | Arg | His | Lys | Asn | Thr | Val | Ala | Leu | Val | Asn | Gin | Leu | Gly | Asn | |
| 100 | 105 | 110 | ||||||||||||||
| att | aag | aac | agg | tat | ttg | aat | gaa | ata | gtt | cat | tca | acc | tca | aaa | age | 384 |
| Ile | Lys | Asn | Arg | Tyr | Leu | Asn | Glu | Ile | Val | His | Ser | Thr | Ser | Lys | Ser | |
| 115 | 120 | 125 | ||||||||||||||
| caa | eta | cag | gaa | ctg | atg | atg | aag | agt | caa | tca | gaa | gta | gat | gaa | gct | 432 |
| Gin | Leu | Gin | Glu | Leu | Met | Met | Lys | Ser | Gin | Ser | Glu | Val | Asp | Glu | Ala | |
| 130 | 135 | 140 | ||||||||||||||
| gtg | tct | aaa | ttt | gaa | aag | gac | tca | ttt | tct | teg | tca | agt | tca | gga | tcc | 480 |
| Val | Ser | Lys | Phe | Glu | Lys | Asp | Ser | Phe | Ser | Ser | Ser | Ser | Ser | Gly | Ser | |
| 145 | 150 | 155 | 160 | |||||||||||||
| tcc | act | aaa | cca | gaa | act | ccg | cag | ccg | gaa | aat | cca | gag | cat | caa | aaa | 528 |
| Ser | Thr | Lys | Pro | Glu | Thr | Pro | Gin | Pro | Glu | Asn | Pro | Glu | His | Gin | Lys | |
| 165 | 170 | 175 | ||||||||||||||
| cca | aca | act | cca | tct | ccg | gat | acc | aaa | cca | age | cct | caa | cca | gaa | ggc | 576 |
| Pro | Thr | Thr | Pro | Ser | Pro | Asp | Thr | Lys | Pro | Ser | Pro | Gin | Pro | Glu | Gly | |
| 180 | 185 | 190 |
PL 206 576 B1 aag aaa cca agc gta cca gac att aat cag gaa aaa gaa aaa gct aag 624
Lys Lys Pro Ser Val Pro Asp Ile Asn Gin Glu Lys Glu Lys Ala Lys
195 200 205 ctt gct gta gta acc tac atg agc aag att tta gat gat ata caa aaa 672
Leu Ala Val Val Thr Tyr Met Ser Lys Ile Leu Asp Asp Ile Gin Lys
210 215 220 cat cat ctg cag aaa gaa aaa cat cgt cag att gtt gct ctt att aag 720
His His Leu Gin Lys Glu Lys His Arg Gin Ile Val Ala Leu Ile Lys
225 230 235 240 gag ctt gat gag ctt aaa aag caa gct ctt tct gaa att gat aat gta 768
Glu Leu Asp Glu Leu Lys Lys Gin Ala Leu Ser Glu Ile Asp Asn Val
245 250 255 aat acc aaa gta gaa att gaa aat aca gtc cac aag ata ttt gca gac 816
Asn Thr Lys Val Glu Ile Glu Asn Thr Val His Lys Ile Phe Ala Asp
260 265 270 atg gat gca gtt gtg act aaa ttc aaa aaa ggc tta act cag gac aca 864
Met Asp Ala Val Val Thr Lys Phe Lys Lys Gly Leu Thr Gin Asp Thr
275 280 285 cca aaa gaa cca ggt aac aaa aaa cca tct gct cca aaa cca ggt atg 912
Pro Lys Glu Pro Gly Asn Lys Lys Pro Ser Ala Pro Lys Pro Gly Met
290 295 300 caa cca agt cct caa cca gag gtt aaa ccg cag ctg gaa aaa cca aaa 960
Gin Pro Ser Pro Gin Pro Glu Val Lys Pro Gin Leu Glu Lys Pro Lys
305 310 315 320 cca gag gtt aaa ccg caa cca gaa aaa cca aaa cca gag gtt aaa ccg 1008
Pro Glu Val Lys Pro Gin Pro Glu Lys Pro Lys Pro Glu Val Lys Pro
325 330 335 cag ccg gaa aaa cca aaa cca gag gtt aaa ccg cag ccg gaa aaa cca 1056
Gin Pro Glu Lys Pro Lys Pro Glu Val Lys Pro Gin Pro Glu Lys Pro
340 345 350 aaa cca gag gtt aaa ccg cag ccg gaa aaa cca aaa cca gag gtt aaa 1104
Lys Pro Glu Val Lys Pro Gin Pro Glu Lys Pro Lys Pro Glu Val Lys
355 360 365 ccg cag ccg gaa aaa cca aaa cca gag gtt aaa ccg cag ccg gaa aaa 1152
Pro Gin Pro Glu Lys Pro Lys Pro Glu Val Lys Pro Gin Pro Glu Lys
370 375 380 cca aaa cca gag gtt aaa ccg cag ccg gaa aaa cca aaa cca gag gtt 1200
Pro Lys Pro Glu Val Lys Pro Gin Pro Glu Lys Pro Lys Pro Glu Val
385 390 395 400 aaa ccg cag ccg gaa aaa cca aaa cca gag gtt aaa ccg cag ccg gaa 1248
Lys Pro Gin Pro Glu Lys Pro Lys Pro Glu Val Lys Pro Gin Pro Glu
405 410 415 aaa cca aaa cca gag gtt aaa ccg cag ccg gaa aaa cca aaa cca gag 1296
PL 206 576 B1
| Lys | Pro | Lys | Pro 420 | Glu | Val | Lys | Pro | Gin 425 | Pro | Glu | Lys | Pro | Lys 430 | Pro | Glu | |
| gtt | aa a | ccg | caa | cca | gaa | aaa | cca | aaa | cca | gag | gtt | aaa | ccg | caa | cca | 1344 |
| Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | |
| 435 | 440 | 445 | ||||||||||||||
| gaa | aa a | cca | aaa | cca | gat | aat | agc | a ag | cca | caa | gca | gat | gat | aag | aag | 1392 |
| Glu | Lys | Pro | Lys | Pro | Asp | Asn | Ser | Lys | Pro | Gin | Ala | Asp | Asp | Lys | Lys | |
| 450 | 455 | 460 | ||||||||||||||
| cca | tca | act | aca | aat | aat | tta | agc | a ag | gac | aag | caa | cct | tct | aac | caa | 1440 |
| Pro | Ser | Thr | Thr | Asn | Asn | Leu | Ser | Lys | Asp | Lys | Gin | Pro | Ser | Asn | Gin | |
| 465 | 470 | 475 | 480 | |||||||||||||
| gct | tca | aca | aac | gaa | aaa | gca | aca | aat | aaa | ccg | aag | aag | tca | ttg | cca | 1488 |
| Ala | Ser | Thr | Asn | Glu | Lys | Ala | Thr | Asn | Lys | Pro | Lys | Lys | Ser | Leu | Pro | |
| 485 | 490 | 495 | ||||||||||||||
| tca | act | gga | tct | att | tca | aat | eta | gca | ctt | gaa | att | gca | ggt | ctt | ctt | 1536 |
| Ser | Thr | Gly | Ser | Ile | Ser | Asn | Leu | Ala | Leu | Glu | Ile | Ala | Gly | Leu | Leu | |
| 500 | 505 | 510 | ||||||||||||||
| acc | ttg | gcg | ggg | gca | acc | att | ctt | gct | aag | aaa | aga | atg | aaa | 1578 | ||
| Thr | Leu | Ala | Gly | Ala | Thr | Ile | Leu | Ala | Lys | Lys | Arg | Met | Lys | |||
| 515 | 520 | 525 | ||||||||||||||
| tag | 1581 | |||||||||||||||
| <210> | 6 | |||||||||||||||
| <211> | 526 | |||||||||||||||
| <212> | PRT | |||||||||||||||
| <213> | S. pneumoniae | |||||||||||||||
| <400> | 6 | |||||||||||||||
| Met | Glu | Asn | Ile | Asp | Met | Phe | Lys | Ser | Asn | His | Glu | Arg | Arg | Met | Arg | |
| 1 | 5 | 10 | 15 | |||||||||||||
| Tyr | Ser | Ile | Arg | Lys | Phe | Ser | Val | Gly | Val | Ala | Ser | Val | Ala | val | Ala | |
| 20 | 25 | 30 | ||||||||||||||
| Ser | Leu | Phe | Met | Gly | Ser | Val | val | His | Ala | Thr | Glu | Lys | Glu | Gly | Ser | |
| 35 | 40 | 45 | ||||||||||||||
| Thr | Gin | Ala | Ala | Thr | Ser | Phe | Asn | Arg | Gly | Asn | Gly | Ser | Gin | Ala | Glu | |
| 50 | 55 | 60 | ||||||||||||||
| Gin | Arg | Gly | Glu | Leu | Asp | Leu | Glu | Arg | Asp | Lys | Ala | Met | Lys | Ala | Val | |
| 65 | 70 | 75 | 80 | |||||||||||||
| Ser | Glu | Tyr | Val | Gly | Lys | Met | Val | Arg | Asp | Ala | Tyr | Val | Lys | Ser | Asp | |
| 85 | 90 | 95 | ||||||||||||||
| Arg | Lys | Arg | His | Lys | Asn | Thr | Val | Ala | Leu | Val | Asn | Gin | Leu | Gly | Asn | |
| 100 | 105 | 110 | ||||||||||||||
| Ile | Lys | Asn | Arg | Tyr | Leu | Asn | Glu | Ile | Val | His | Ser | Thr | Ser | Lys | Ser | |
| 115 | 120 | 125 | ||||||||||||||
| Gin | Leu | Gin | Glu | Leu | Met | Met | Lys | Ser | Gin | Ser | Glu | Val | Asp | Glu | Ala | |
| 130 | 135 | 140 | ||||||||||||||
| Val | Ser | Lys | Phe | Glu | Lys | Asp | Ser | Phe | Ser | Ser | Ser | Ser | Ser | Gly | Ser | |
| 145 | 150 | 155 | 160 | |||||||||||||
| Ser | Thr | Lys | Pro | Glu | Thr | Pro | Gin | Pro | Glu | Asn | Pro | Glu | His | Gin | Lys | |
| 165 | 170 | 175 |
PL 206 576 B1
| Pro | Thr | Thr | Pro 180 | Ser Pro Asp Thr | Lys 185 | Pro | Ser | Pro | Gin | Pro 190 | Glu | Gly | |||
| Lys | Lys | Pro | Ser | Val | Pro | Asp | Ile | Asn | Gin | Glu | Lys | Glu | Lys | Ala | Lys |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Val | Val | Thr | Tyr | Met | Ser | Lys | Ile | Leu | Asp | Asp | Ile | Gin | Lys |
| 210 | 215 | 220 | |||||||||||||
| His | His | Leu | Gin | Lys | Glu | Lys | His | Arg | Gin | Ile | Val | Ala | Leu | Ile | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Glu | Leu | Asp | Glu | Leu | Lys | Lys | Gin | Ala | Leu | Ser | Glu | Ile | Asp | Asn | Val |
| 245 | 250 | 255 | |||||||||||||
| Asn | Thr | Lys | Val | Glu | Ile | Glu | Asn | Thr | Val | His | Lys | Ile | Phe | Ala | Asp |
| 260 | 265 | 270 | |||||||||||||
| Met | Asp | Ala | Val | Val | Thr | Lys | Phe | Lys | Lys | Gly | Leu | Thr | Gin | Asp | Thr |
| 275 | 280 | 285 | |||||||||||||
| Pro | Lys | Glu | Pro | Gly | Asn | Lys | Lys | Pro | Ser | Ala | Pro | Lys | Pro | Gly | Met |
| 290 | 295 | 300 | |||||||||||||
| Gin | Pro | Ser | Pro | Gin | Pro | Glu | Val | Lys | Pro | Gin | Leu | Glu | Lys | Pro | Lys |
| 305 | 310 | 315 | 320 | ||||||||||||
| Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro |
| 325 | 330 | 335 | |||||||||||||
| Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro |
| 340 | 345 | 350 | |||||||||||||
| Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys |
| 370 | 375 | 380 | |||||||||||||
| Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val |
| 385 | 390 | 395 | 400 | ||||||||||||
| Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu |
| 405 | 410 | 415 | |||||||||||||
| Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu |
| 420 | 425 | 430 | |||||||||||||
| Val | Lys | Pro | Gin | Pro | Glu | Lys | Pro | Lys | Pro | Glu | Val | Lys | Pro | Gin | Pro |
| 435 | 440 | 445 | |||||||||||||
| Glu | Lys | Pro | Lys | Pro | Asp | Asn | Ser | Lys | Pro | Gin | Ala | Asp | Asp | Lys | Lys |
| 450 | 455 | 460 | |||||||||||||
| Pro | Ser | Thr | Thr | Asn | Asn | Leu | Ser | Lys | Asp | Lys | Gin | Pro | Ser | Asn | Gin |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Ser | Thr | Asn | Glu | Lys | Ala | Thr | Asn | Lys | Pro | Lys | Lys | Ser | Leu | Pro |
| 485 | 490 | 495 | |||||||||||||
| Ser | Thr | Gly | Ser | Ile | Ser | Asn | Leu | Ala | Leu | Glu | Ile | Ala | Gly | Leu | Leu |
| 500 | 505 | 510 | |||||||||||||
| Thr | Leu | Ala | Gly | Ala | Thr | Ile | Leu | Ala | Lys | Lys | Arg | Met | Lys |
515 520 525 <210> 7 <211> 1455 <212> DNA <213> S. pneumoniae <220>
<221> CDS
| <222> | (1) . | ...(1452) | ||||||||||||
| <400> | 7 | |||||||||||||
| atg | aaa ttt | agt | aaa aaa | tat | ata | gca | get | gga | tea | get | gtt | atc | gta | 48 |
| Met | Lys Phe | Ser | Lys Lys | Tyr | Ile | Ala | Ala | Gly | Ser | Ala | Val | Ile | Val |
PL 206 576 B1
| 1 | 5 | 10 | 15 | ||||||||||||
| tcc | ttg | agt | eta | tgt | gcc | tat | gca | eta | aac | cag | cat | cgt | teg | cag | gaa |
| Ser | Leu | Ser | Leu 20 | Cys | Ala | Tyr | Ala | Leu 25 | Asn | Gin | His | Arg | Ser 30 | Gin | Glu |
| aat | aag | gac | aat | aat | cgt | gtc | tct | tat | gtg | gat | ggc | agc | cag | tca | agt |
| Asn | Lys | Asp 35 | Asn | Asn | Arg | Val | Ser 40 | Tyr | Val | Asp | Gly | Ser 45 | Gin | Ser | Ser |
| cag | aaa | agt | gaa | aac | ttg | aca | cca | gac | cag | gtt | agc | cag | aaa | gaa | gga |
| Gin | Lys 50 | Ser | Glu | Asn | Leu | Thr 55 | Pro | Asp | Gin | Val | Ser 60 | Gin | Lys | Glu | Gly |
| att | cag | gct | gag | caa | att | gta | atc | aaa | att | aca | gat | cag | ggc | tat | gta |
| Ile 65 | Gin | Ala | Glu | Gin | Ile 70 | Val | Ile | Lys | Ile | Thr 75 | Asp | Gin | Gly | Tyr | Val 80 |
| acg | tca | cac | ggt | gac | cac | tat | cat | tac | tat | aat | ggg | aaa | gtt | cct | tat |
| Thr | Ser | His | Gly | Asp 85 | His | Tyr | His | Tyr | Tyr 90 | Asn | Gly | Lys | Val | Pro 95 | Tyr |
| gat | gcc | ctc | ttt | agt | gaa | gaa | ctc | ttg | atg | aag | gat | cca | aac | tat | caa |
| Asp | Ala | Leu | Phe 100 | Ser | Glu | Glu | Leu | Leu 105 | Met | Lys | Asp | Pro | Asn 110 | Tyr | Gin |
| ctt | aaa | gac | gct | gat | att | gtc | aat | gaa | gtc | aag | ggt | ggt | tat | atc | atc |
| Leu | Lys | Asp 115 | Ala | Asp | Ile | val | Asn 120 | Glu | Val | Lys | Gly | Gly 125 | Tyr | Ile | Ile |
| aag | gtc | gat | gga | aaa | tat | tat | gtc | tac | ctg | aaa | gat | gca | gct | cat | gct |
| Lys | Val 130 | Asp | Gly | Lys | Tyr | Tyr 135 | Val | Tyr | Leu | Lys | Asp 140 | Ala | Ala | His | Ala |
| gat | aat | gtt | ega | act | aaa | gat | gaa | atc | aat | cgt | caa | aaa | caa | gaa | cat |
| Asp 145 | Asn | Val | Arg | Thr | Lys 150 | Asp | Glu | Ile | Asn | Arg 155 | Gin | Lys | Gin | Glu | His 160 |
| gtc | aaa | gat | aat | gag | aag | gtt | aac | tct | aat | gtt | gct | gta | gca | agg | tct |
| Val | Lys | Asp | Asn | Glu 165 | Lys | val | Asn | Ser | Asn 170 | Val | Ala | Val | Ala | Arg 175 | Ser |
| cag | gga | ega | tat | acg | aca | aat | gat | ggt | tat | gtc | ttt | aat | cca | gct | gat |
| Gin | Gly | Arg | Tyr 180 | Thr | Thr | Asn | Asp | Gly 185 | Tyr | Val | Phe | Asn | Pro 190 | Ala | Asp |
| att | atc | gaa | gat | acg | ggt | aat | gct | tat | atc | gtt | cct | cat | gga | ggt | cac |
| Ile | Ile | Glu 195 | Asp | Thr | Gly | Asn | Ala 200 | Tyr | Ile | Val | Pro | His 205 | Gly | Gly | His |
| tat | cac | tac | att | ccc | aaa | agc | gat | tta | tct | gct | agt | gaa | tta | gca | gca |
| Tyr | His 210 | Tyr | Ile | Pro | Lys | Ser 215 | Asp | Leu | Ser | Ala | Ser 220 | Glu | Leu | Ala | Ala |
| gct | aaa | gca | cat | ctg | gct | gga | aaa | aat | atg | caa | ccg | agt | cag | tta | agc |
| Ala 225 | Lys | Ala | His | Leu | Ala 230 | Gly | Lys | Asn | Met | Gin 235 | Pro | Ser | Gin | Leu | Ser 240 |
144
192
240
288
336
384
432
480
528
576
624
672
720
PL 206 576 B1
| tat Tyr | tct Ser | tca Ser | aca Thr | gct Ala 245 | agt Ser | gac Asp | aat Asn | aac Asn | acg caa | tct Ser | gta Val | gca Ala | aaa Lys 255 | gga Gly | 768 | |
| Thr 250 | Gin | |||||||||||||||
| tca | act | agc | aag | cca | gca | aat | aaa | tct | gaa | aat | ctc | cag | agt | ctt | ttg | 816 |
| Ser | Thr | Ser | Lys 260 | Pro | Ala | Asn | Lys | Ser 265 | Glu | Asn | Leu | Gin | Ser 270 | Leu | Leu | |
| aag | gaa | ctc | tat | gat | tca | cct | agc | gcc | caa | cgt | tac | agt | gaa | tca | gat | 864 |
| Lys | Glu | Leu 275 | Tyr | Asp | Ser | Pro | Ser 280 | Ala | Gin | Arg | Tyr | Ser 285 | Glu | Ser | Asp | |
| ggc | ctg | gtc | ttt | gac | cct | gct | aag | att | atc | agt | cgt | aca | cca | aat | gga | 912 |
| Gly | Leu 290 | Val | Phe | Asp | Pro | Ala 295 | Lys | Ile | Ile | Ser | Arg 300 | Thr | Pro | Asn | Gly | |
| gtt | gcg | att | ccg | cat | ggc | gac | cat | tac | cac | ttt | att | cct | tac | agc | aag | 960 |
| Val 305 | Ala | Ile | Pro | His | Gly 310 | Asp | His | Tyr | His | Phe 315 | Ile | Pro | Tyr | Ser | Lys 320 | |
| ctt | tct | gct | tta | gaa | gaa | aag | att | gcc | aga | atg | gtg | cct | atc | agt | gga | 1008 |
| Leu | Ser | Ala | Leu | Glu 325 | Glu | Lys | Ile | Ala | Arg 330 | Met | Val | Pro | Ile | Ser 335 | Gly | |
| act | ggt | tct | aca | gtt | tct | aca | aat | gca | aaa | cct | aat | gaa | gta | gtg | tct | 1056 |
| Thr | Gly | Ser | Thr 340 | val | Ser | Thr | Asn | Ala 345 | Lys | Pro | Asn | Glu | Val 350 | Val | Ser | |
| agt | gta | ggc | agt | ctt | tca | agc | aat | cct | tct | tct | tta | acg | aca | agt | aag | 1104 |
| Ser | Leu | Gly 355 | Ser | Leu | Ser | Ser | Asn 360 | Pro | Ser | Ser | Leu | Thr 365 | Thr | Ser | Lys | |
| gag | ctc | tct | tca | gca | tct | gat | ggt | tat | att | ttt | aat | cca | aaa | gat | atc | 1152 |
| Glu | Leu 370 | Ser | Ser | Ala | Ser | Asp 375 | Gly | Tyr | Ile | Phe | Asn 380 | Pro | Lys | Asp | Ile | |
| gtt | gaa | gaa | acg | gct | aca | gct | tat | att | gta | aga | cat | ggt | gat | cat | ttc | 1200 |
| Val 385 | Glu | Glu | Thr | Ala | Thr 390 | Ala | Tyr | Ile | Val | Arg 395 | His | Gly | Asp | His | Phe 400 | |
| cat | tac | att | cca | aaa | tca | aat | caa | att | ggg | caa | ccg | act | ctt | cca | aac | 1248 |
| His | Tyr | Ile | Pro | Lys 405 | Ser | Asn | Gin | Ile | Gly 410 | Gin | Pro | Thr | Leu | Pro 415 | Asn | |
| aat | agt | eta | gca | aca | cct | tct | cca | tct | ctt | cca | atc | aat | cca | gga | act | 1296 |
| Asn | Ser | Leu | Ala 420 | Thr | Pro | Ser | Pro | Ser 425 | Leu | Pro | Ile | Asn | Pro 430 | Gly | Thr | |
| tca | cat | gag | aaa | cat | gaa | gaa | gat | gga | tac | gga | ttt | gat | gct | aat | cgt | 1344 |
| Ser | His | Glu 435 | Lys | His | Glu | Glu | Asp 440 | Gly | Tyr | Gly | Phe | Asp 445 | Ala | Asn | Arg | |
| att | atc | gct | gaa | gat | gaa | tca | ggt | ttt | gtc | atg | agt | cac | gga | gac | cac | 1392 |
| Ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His |
450 455 460
PL 206 576 B1
| aat Asn 465 | cat His | tat Tyr | ttc Phe | ttc Phe | aag Lys 470 | aag Lys | gac Asp | ttg Leu | aca Thr | gaa gag caa Glu Glu Gin 475 | att Ile | aag gtg | 1440 | |||
| Lys | Val 480 | |||||||||||||||
| cgc | aaa | aac | att | tag | 1455 | |||||||||||
| Arg | Lys | Asn | Ile |
<210> 8 <211> 484 <212> PRT <213> S. pneumoniae <400> 8
| Met 1 | Lys | Phe | Ser | Lys 5 | Lys | Tyr | Ile | Ala | Ala Gly Ser Ala Val 10 | Ile Val 15 | |||||
| Ser | Leu | Ser | Leu | Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Lys | Asp | Asn | Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser |
| 35 | 40 | 45 | |||||||||||||
| Gin | Lys | Ser | Glu | Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly |
| 50 | 55 | 60 | |||||||||||||
| Ile | Gin | Ala | Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val |
| 65 | 70 | 75 | 80 | ||||||||||||
| Thr | Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ala | Leu | Phe | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin |
| 100 | 105 | 110 | |||||||||||||
| Leu | Lys | Asp | Ala | Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile |
| 115 | 120 | 125 | |||||||||||||
| Lys | Val | Asp | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala |
| 130 | 135 | 140 | |||||||||||||
| Asp | Asn | Val | Arg | Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His |
| 145 | 150 | 155 | 160 | ||||||||||||
| Val | Lys | Asp | Asn | Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser |
| 165 | 170 | 175 | |||||||||||||
| Gin | dy | Arg | Tyr | Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp |
| 180 | 185 | 190 | |||||||||||||
| Ile | Ile | Glu | Asp | Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His |
| 195 | 200 | 205 | |||||||||||||
| Tyr | His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala |
| 210 | 215 | 220 | |||||||||||||
| Ala | Lys | Ala | His | Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Tyr | Ser | Ser | Thr | Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly |
| 245 | 250 | 255 | |||||||||||||
| Ser | Thr | Ser | Lys | Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu |
| 260 | 265 | 270 | |||||||||||||
| Lys | Glu | Leu | Tyr | Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp |
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Val | Phe | Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly |
| 290 | 295 | 300 | |||||||||||||
| Val | Ala | Ile | Pro | His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Ser | Ala | Leu | Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly |
| 325 | 330 | 335 |
PL 206 576 B1
| Thr | Gly | Ser Thr 340 | val | Ser Thr Asn | Ala Lys 345 | Pro | Asn | Glu | Val 350 | Val | Ser | ||||
| Ser | Leu | Gly | Ser | Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Leu | Ser | Ser | Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile |
| 370 | 375 | 380 | |||||||||||||
| Val | Glu | Glu | Thr | Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe |
| 385 | 390 | 395 | 400 | ||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn |
| 405 | 410 | 415 | |||||||||||||
| Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr |
| 420 | 425 | 430 | |||||||||||||
| Ser | His | Glu | Lys | His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg |
| 435 | 440 | 445 | |||||||||||||
| Ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His |
| 450 | 455 | 460 | |||||||||||||
| Asn | His | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Val |
| 465 | 470 | 475 | 480 | ||||||||||||
| Arg | Lys | Asn | Ile |
| <210> 9 <211> 1587 <212> DNA <213> S pneumoniae | ||||||||||||||
| <220> <221> | CDS | |||||||||||||
| <222> | (1) | .,.(1584) | ||||||||||||
| <400> | 9 | |||||||||||||
| atg | aaa gat | tta | gat | aaa | aaa | atc | gaa | gaa | aaa | att | gct | ggc | att | atg |
| Met | Lys Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met |
| 1 | 5 | 10 | 15 | |||||||||||
| aaa | caa tat | ggt | gtc | aaa | cgt | gaa | agt | att | gtc | gtg | aat | aaa | gaa | aaa |
| Lys | Gin Tyr | Gly | val | Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys |
| 20 | 25 | 30 | ||||||||||||
| aat | gcg att | att | tat | ccg | cat | gga | gat | cac | cat | cat | gca | gat | ccg | att |
| Asn | Ala Ile | Ile | Tyr | Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | ile |
| 35 | 40 | 45 | ||||||||||||
| gat | gaa cat | aaa | ccg | gtt | gga | att | ggt | cat | tct | cac | agt | aac | tat | gaa |
| Asp | Glu His | Lys | Pro | Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu |
| 50 | 55 | 60 | ||||||||||||
| ctg | ttt aaa | ccc | gaa | gaa | gga | gtt | gct | aaa | aaa | gaa | ggg | aat | aaa | gtt |
| Leu | Phe Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val |
| 65 | 70 | 75 | 80 | |||||||||||
| tat | act gga | gaa | gaa | tta | acg | aat | gtt | gtt | aat | ttg | tta | aaa | aat | agt |
| Tyr | Thr Gly | Glu | Glu | Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser |
| 85 | 90 | 95 | ||||||||||||
| acg | ttt aat | aat | caa | aac | ttt | act | eta | gee | aat | ggt | caa | aaa | ege | gtt |
| Thr | Phe Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val |
PL 206 576 B1
| 100 | 105 | 110 | ||||||||||||||
| tct | ttt | agt | ttt | ccg | cct | gaa | ttg | gag | aaa | aaa | tta | ggt | atc | aat | atg | 384 |
| Ser | Phe | Ser 115 | Phe | Pro | Pro | Glu | Leu 120 | Glu | Lys | Lys | Leu | Gly 125 | Ile | Asn | Met | |
| eta | gta | aaa | tta | ata | aca | cca | gat | gga | aaa | gta | ttg | gag | aaa | gta | tct | 432 |
| Leu | Val 130 | Lys | Leu | Ile | Thr | Pro 135 | Asp | Gly | Lys | Val | Leu 140 | Glu | Lys | Val | Ser | |
| ggt | aaa | gta | ttt | gga | gaa | gga | gta | ggg | aat | att | gca | aac | ttt | gaa | tta | 480 |
| Gly 145 | Lys | Val | Phe | Gly | Glu 150 | Gly | Val | Gly | Asn | Ile 155 | Ala | Asn | Phe | Glu | Leu 160 | |
| gat | caa | cct | tat | tta | cca | gga | caa | aca | ttt | aag | tat | act | atc | gct | tca | 528 |
| Asp | Gin | Pro | Tyr | Leu 165 | Pro | Gly | Gin | Thr | Phe 170 | Lys | Tyr | Thr | Ile | Ala 175 | Ser | |
| aaa | gat | tat | cca | gaa | gta | agt | tat | gat | ggt | aca | ttt | aca | gtt | cca | acc | 576 |
| Lys | Asp | Tyr | Pro 180 | Glu | Val | Ser | Tyr | ASp 185 | Gly | Thr | Phe | Thr | Val 190 | Pro | Thr | |
| tct | tta | gct | tac | aaa | atg | gcc | agt | caa | acg | att | ttc | tat | cct | ttc | cat | 624 |
| Ser | Leu | Ala 195 | Tyr | Lys | Met | Ala | Ser 200 | Gin | Thr | Ile | Phe | Tyr 205 | Pro | Phe | His | |
| gca | ggg | gat | act | tat | tta | aga | gtg | aac | cct | caa | ttt | gca | gtg | cct | aaa | 672 |
| Ala | Gly 210 | Asp | Thr | Tyr | Leu | Arg 215 | Val | Asn | Pro | Gin | Phe 220 | Ala | Val | Pro | Lys | |
| gga | act | gat | gct | tta | gtc | aga | gtg | ttt | gat | gaa | ttt | cat | gga | aat | gct | 720 |
| Gly 225 | Thr | Asp | Ala | Leu | Val 230 | Arg | Val | Phe | Asp | Glu 235 | Phe | His | Gly | Asn | Ala 240 | |
| tat | tta | gaa | aat | aac | tat | aaa | gtt | ggt | gaa | atc | aaa | tta | ccg | att | ccg | 768 |
| Tyr | Leu | Glu | Asn | Asn 245 | Tyr | Lys | Val | Gly | Glu 250 | Ile | Lys | Leu | Pro | Ile 255 | Pro | |
| aaa | tta | aac | caa | gga | aca | acc | aga | acg | gcc | gga | aat | aaa | att | cct | gta | 816 |
| Lys | Leu | Asn | Gin 260 | Gly | Thr | Thr | Arg | Thr 265 | Ala | Gly | Asn | Lys | Ile 270 | Pro | Val | |
| acc | ttc | atg | gca | aat | gct | tat | ttg | gac | aat | caa | teg | act | tat | att | gtg | 864 |
| Thr | Phe | Met 275 | Ala | Asn | Ala | Tyr | Leu 280 | Asp | Asn | Gin | Ser | Thr 285 | Tyr | Ile | Val | |
| gaa | gta | cct | atc | ttg | gaa | aaa | gaa | aat | caa | act | gat | aaa | cca | agt | att | 912 |
| Glu | Val 290 | Pro | Ile | Leu | Glu | Lys 295 | Glu | Asn | Gin | Thr | Asp 300 | Lys | Pro | Ser | Ile | |
| eta | cca | caa | ttt | aaa | agg | aat | aaa | gca | caa | gaa | aac | tca | aaa | ctt | gat | 960 |
| Leu 305 | Pro | Gin | Phe | Lys | Arg 310 | Asn | Lys | Ala | Gin | Glu 315 | Asn | Ser | Lys | Leu | Asp 320 | |
| gaa | aag | gta | gaa | gaa | cca | aag | act | agt | gag | aag | gta | gaa | aaa | gaa | aaa | 1008 |
| Glu | Lys | Val | Glu | Glu 325 | Pro | Lys | Thr | Ser | Glu 330 | Lys | Val | Glu | Lys | Glu 335 | Lys |
PL 206 576 B1
| ctt Leu | tct Ser | gaa Glu | act Thr 340 | ggg Gly | aat Asn | agt Ser | act Thr | agt Ser 345 | aat Asn | tca Ser | acg Thr | tta Leu | gaa Glu 350 | gaa Glu | gtt Val | 1056 |
| cct | aca | gtg | gat | cct | gta | caa | gaa | aaa | gta | gca | aaa | ttt | gct | gaa | agt | 1104 |
| Pro | Thr | Val | Asp | Pro | Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | |
| 355 | 360 | 365 | ||||||||||||||
| tat | ggg | atg | aag | eta | gaa | aat | gtc | ttg | ttt | aat | atg | gac | gga | aca | att | 1152 |
| Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | |
| 370 | 375 | 380 | ||||||||||||||
| gaa | tta | tat | tta | cca | tca | gga | gaa | gtc | att | aaa | aag | aat | atg | gca | gat | 1200 |
| Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | |
| 385 | 390 | 395 | 400 | |||||||||||||
| ttt | aca | gga | gaa | gca | cct | caa | gga | aat | ggt | gaa | aat | aaa | cca | tct | gaa | 1248 |
| Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | |
| 405 | 410 | 415 | ||||||||||||||
| aat | gga | aaa | gta | tct | act | gga | aca | gtt | gag | aac | caa | cca | aca | gaa | aat | 1296 |
| Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | |
| 420 | 425 | 430 | ||||||||||||||
| aaa | cca | gca | gat | tct | tta | cca | gag | gca | cca | aac | gaa | aaa | cct | gta | aaa | 1344 |
| Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | |
| 435 | 440 | 445 | ||||||||||||||
| cca | gaa | aac | tca | acg | gat | aat | gga | atg | ttg | aat | cca | gaa | ggg | aat | gtg | 1392 |
| Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | |
| 450 | 455 | 460 | ||||||||||||||
| ggg | agt | gac | cct | atg | tta | gat | cca | gca | tta | gag | gaa | gct | cca | gca | gta | 1440 |
| Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | |
| 465 | 470 | 475 | 480 | |||||||||||||
| gat | cct | gta | caa | gaa | aaa | tta | gaa | aaa | ttt | aca | gct | agt | tac | gga | tta | 1488 |
| Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | |
| 485 | 490 | 495 | ||||||||||||||
| ggc | tta | gat | agt | gtt | ata | ttc | aat | atg | gat | gga | acg | att | gaa | tta | aga | 1536 |
| Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | |
| 500 | 505 | 510 | ||||||||||||||
| ttg | cca | agt | gga | gaa | gtg | ata | aaa | aag | aat | tta | tct | gat | ttc | ata | gcg | 1584 |
| Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |
| 515 | 520 | 525 | ||||||||||||||
| taa | 1587 | |||||||||||||||
| <210> | 10 | |||||||||||||||
| <211> | 528 | |||||||||||||||
| <212> | PRT | |||||||||||||||
| <213> | S pneumoniae | |||||||||||||||
| <400> | 10 |
PL 206 576 B1
| Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met |
| 1 | 5 | 10 | 15 | ||||||||||||
| Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | Ile | Val | val | Asn | Lys | Glu | Lys |
| 20 | 25 | 30 | |||||||||||||
| Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile |
| 35 | 40 | 45 | |||||||||||||
| Asp | Glu | His | Lys | Pro | Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu |
| 50 | 55 | 60 | |||||||||||||
| Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val |
| 65 | 70 | 75 | 80 | ||||||||||||
| Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser |
| 85 | 90 | 95 | |||||||||||||
| Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val |
| 100 | 105 | 110 | |||||||||||||
| Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met |
| 115 | 120 | 125 | |||||||||||||
| Leu | Val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser |
| 130 | 135 | 140 | |||||||||||||
| Gly | Lys | Val | Phe | Gly | Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser |
| 165 | 170 | 175 | |||||||||||||
| Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr |
| 180 | 185 | 190 | |||||||||||||
| Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His |
| 195 | 200 | 205 | |||||||||||||
| Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys |
| 210 | 215 | 220 | |||||||||||||
| Gly | Thr | Asp | Ala | Leu | Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala |
| 225 | 230 | 235 | 240 | ||||||||||||
| Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro |
| 245 | 250 | 255 | |||||||||||||
| Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val |
| 260 | 265 | 270 | |||||||||||||
| Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val |
| 275 | 280 | 285 | |||||||||||||
| Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile |
| 290 | 295 | 300 | |||||||||||||
| Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp |
| 305 | 310 | 315 | 320 | ||||||||||||
| Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val |
| 340 | 345 | 350 | |||||||||||||
| Pro | Thr | Val | Asp | Pro | Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser |
| 355 | 360 | 365 | |||||||||||||
| Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile |
| 370 | 375 | 380 | |||||||||||||
| Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu |
| 405 | 410 | 415 | |||||||||||||
| Asn | Gly | Lys | val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys |
| 435 | 440 | 445 | |||||||||||||
| Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val |
PL 206 576 B1
| 450 | 455 | 460 | |||||||||||||
| Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val |
| 465 | 470 | 475 | 480 | ||||||||||||
| Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu |
| 485 | 490 | 495 | |||||||||||||
| Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg |
| 500 | 505 | 510 | |||||||||||||
| Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
| 515 | 520 | 525 |
<210> 11 <211> 5048 <212> DNA <213> S. pneumoniae <400> 11 aattccttgt cgggtaagtt ccgacccgca cgaaaggcgt aatgatttgg gcactgtctc aacgagagac tcggtgaaat tttagtacct gtgaagatgc aggttacccg cgacaggacg gaaagacccc atggagcttt actgcagttt gatattgagt gtctgtacca catgtacagg ataggtagga gtctaagaga tcgggacgcc agtttcgaag gagacgctgt tgggatacta cccttgtgtt atggccactc taacccagat aggtgatccc tatcggagac agtgtctgac gggcagtttg actggggcgg tcgcctccta aaaggtaacg gaggcgccca aaggttccct cagaatggtt ggaaatcatt cgcagagtgt aaaggtataa gggagcttga ctgcgagagc tacaactcga gcagggacga aagtcgggct tagtgatccg gtggttccgt atggaagggc catcgctcaa cggataaaag ctaccctggg gataacaggc ttatctcccc caagagttca catcgacggg gaggtttggc acctcgatgt cggctcgtcg catcctgggg ctgtagtcgg tcccaagggt tgggctgttc gcccattaaa gcggcacgcg agctgggttc agaacgtcgt gagacagttc ggtccctatc cgtcgcgggc gtaggaaatt tgagaggatc tgctcctagt acgagaggac cagagtggac ttaccgctgg tgtaccagtt gtcttgccaa aggcatcgct gggtagctat gtagggaagg gataaacgct gaaagcatct aagtgtgaaa cccacctcaa gatgagattt cccatgatta tatatcagta agagccctga gagatgatca ggtagatagg ttagaagtgg aagtgtggcg acacatgtag cggactaata ctaatagctc gaggacttat ccaaagtaac tgagaatatg aaagcgaacg gttttcttaa attgaataga tattcaattt tgagtaggta ttactcagag ttaagtgacg atagcctagg agatacacct gtacccatgc cgaacacaga agttaagccc tagaacgccg gaagtagttg ggggttgccc cctgtgagat agggaagtcg cttagctcta gggagtttag ctcagctggg agagcatctg ccttacaagc agagggtcag cggttcgatc ccgttaactc ccaaaggtcc cgtagtgtag cggttatcac gtcgccctgt cacggcgaag atcgcgggtt cgattcccgt cgggaccgtt taaggtaacg caagttattt tagactcgtt agctcagttg gtagagcaat tgacttttaa tcaatgggtc actggttcga gcccagtacg ggtcatatat gcgggtttgg cggaattcta atctctttga aatcatcttc tctcactttc caaaactcta ttacctctta ttataccaca tttcaatctt caacttccca gtaatataag cacctctggc gaaagaagtt tcaatgtcct aaagtaataa gtgaatccaa ttcaggaact ccaagaacaa aagaaacatc tggtgtcaca agtattggat ggcacagagt cacgtggtag tctgacccta gcagaaattt taaatagtaa actatttact ggttaattaa atggttaaat aaccggttta gaaaactatt taataaagta aaagaagttg agaaaaaact tcatcattta ttgaaatgag ggatttatga aatttagtaa aaaatatata gcagctggat cagctgttat cgtatccttg agtctatgtg cctatgcact aaaccagcat cgttcgcagg aaaataagga caataatcgt gtctcttatg tggatggcag ccagtcaagt cagaaaagtg aaaacttgac accagaccag gttagccaga aagaaggaat tcaggctgag caaattgtaa tcaaaattac agatcagggc tatgtaacgt cacacggtga ccactatcat tactataatg ggaaagttcc ttatgatgcc ctctttagtg aagaactctt gatgaaggat ccaaactatc aacttaaaga cgctgatatt gtcaatgaag tcaagggtgg ttatatcatc aaggtcgatg gaaaatatta tgtctacctg aaagatgcag ctcatgctga taatgttcga actaaagatg aaatcaatcg tcaaaaacaa gaacatgtca aagataatga gaaggttaac tctaatgttg ctgtagcaag gtctcaggga cgatatacga caaatgatgg ttatgtcttt aatccagctg atattatcga agatacgggt aatgcttata tcgttcctca tggaggtcac tatcactaca ttcccaaaag cgatttatct gctagtgaat tagcagcagc taaagcacat
120
180
240
300
360
420
480
540
600
660
720
780
840
900
960
1020
1080
1140
1200
1260
1320
1380
1440
1500
1560
1620
1680
1740
1800
1860
1920
1980
2040
2100
2160
2220
2280
2340
2400
2460
PL 206 576 B1 ctggctggaa aaaatatgca accgagtcag ttaagctatt cttcaacagc tagtgacaat 2520 aacacgcaat ctgtagcaaa aggatcaact agcaagccag caaataaatc tgaaaatctc 2580 cagagtcttt tgaaggaact ctatgattca cctagcgccc aacgttacag tgaatcagat 2640 ggcctggtct ttgaccctgc taagattatc agtcgtacac caaatggagt tgcgattccg 2700 catggcgacc attaccactt tattccttac agcaagcttt ctgctttaga agaaaagatt 2760 gccagaatgg tgcctatcag tggaactggt tctacagttt ctacaaatgc aaaacctaat 2820 gaagtagtgt ctagtctagg cagtctttca agcaatcctt cttctttaac gacaagtaag 2880 gagctctctt cagcatctga tggttatatt tttaatccaa aagatatcgt tgaagaaacg 2940 gctacagctt atattgtaag acatggtgat catttccatt acattccaaa atcaaatcaa 3000 attgggcaac cgactcttcc aaacaatagt ctagcaacac cttctccatc tcttccaatc 3060 aatccaggaa cttcacatga gaaacatgaa gaagatggat acggatttga tgctaatcgt 3120 attatcgctg aagatgaatc aggttttgtc atgagtcacg gagaccacaa tcattatttc 3180 ttcaagaagg acttgacaga agagcaaatt aaggctgcgc aaaaacattt agaggaagtt 3240 aaaactagtc ataatggatt agattctttg tcatctcatg aacaggatta tccaggtaat 3300 gccaaagaaa tgaaagattt agataaaaaa atcgaagaaa aaattgctgg cattatgaaa 3360 caatatggtg tcaaacgtga aagtattgtc gtgaataaag aaaaaaatgc gattatttat 3420 ccgcatggag atcaccatca tgcagatccg attgatgaac ataaaccggt tggaattggt 3480 cattctcaca gtaactatga actgtttaaa cccgaagaag gagttgctaa aaaagaaggg 3540 aataaagttt atactggaga agaattaacg aatgttgtta atttgttaaa aaatagtacg 3600 tttaataatc aaaactttac tctagccaat ggtcaaaaac gcgtttcttt tagttttccg 3660 cctgaattgg agaaaaaatt aggtatcaat atgctagtaa aattaataac accagatgga 3720 aaagtattgg agaaagtatc tggtaaagta tttggagaag gagtagggaa tattgcaaac 3780 tttgaattag atcaacctta tttaccagga caaacattta agtatactat cgcttcaaaa 3840 gattatccag aagtaagtta tgatggtaca tttacagttc caacctcttt agcttacaaa 3900 atggccagtc aaacgatttt ctatcctttc catgcagggg atacttattt aagagtgaac 3960 cctcaatttg cagtgcctaa aggaactgat gctttagtca gagtgtttga tgaatttcat 4020 ggaaatgctt atttagaaaa taactataaa gttggtgaaa tcaaattacc gattccgaaa 4080 ttaaaccaag gaacaaccag aacggccgga aataaaattc ctgtaacctt catggcaaat 4140 gcttatttgg acaatcaatc gacttatatt gtggaagtac ctatcttgga aaaagaaaat 4200 caaactgata aaccaagtat tctaccacaa tttaaaagga ataaagcaca agaaaactca 4260 aaacttgatg aaaaggtaga agaaccaaag actagtgaga aggtagaaaa agaaaaactt 4320 tctgaaactg ggaatagtac tagtaattca acgttagaag aagttcctac agtggatcct 4380 gtacaagaaa aagtagcaaa atttgctgaa agttatggga tgaagctaga aaatgtcttg 4440 tttaatatgg acggaacaat tgaattatat ttaccatcag gagaagtcat taaaaagaat 4500 atggcagatt ttacaggaga agcacctcaa ggaaatggtg aaaataaacc atctgaaaat 4560 ggaaaagtat ctactggaac agttgagaac caaccaacag aaaataaacc agcagattct 4620 ttaccagagg caccaaacga aaaacctgta aaaccagaaa actcaacgga taatggaatg 4680 ttgaatccag aagggaatgt ggggagtgac cctatgttag atccagcatt agaggaagct 4740 ccagcagtag atcctgtaca agaaaaatta gaaaaattta cagctagtta cggattaggc 4800 ttagatagtg ttatattcaa tatggatgga acgattgaat taagattgcc aagtggagaa 4860 gtgataaaaa agaatttatc tgatttcata gcgtaaggaa tagcagtaga aaaagtctga 4920 atcaaaaatg aagttctctc aaaagttaga aataaaactc tgactttggg agaatttcat 4980 tttattatta atatataaaa tttcttgaca tacaacttaa aaagaggtgg aatatttact 5040 agttaatt 5048 <210> 12 <211> 2647 <212> DNA <213> Ξ. pneumoniae cagagatctt aatatctagc tgcatcaagc cgacgcaaaa agtgaatcaa tgggtcagta tcaaactgta aacggagaat atatacttaa gctacacttg aaagaaaata ttgactcctg gaaaagagga ttttaagtgt atcgtgtttc atgaggttag aagaatgaaa ctgtgcttat ctatatagat caagcgtgaa atcaataaaa gaactaggtt ggaaaacaag ggaatcaacg
120
180
240
PL 206 576 B1 ccgaacaaat cgtcatcaag attacggatc aaggttatgt gacctctcat ggagaccatt 300 atcattacta taatggcaag gtcccttatg atgccatcat cagtgaagag ctcctcatga 360 aagatccgaa ttatcagttg aaggattcag acattgtcaa tgaaatcaag ggtggttatg 420 tcattaaggt aaacggtaaa tactatgttt accttaagga tgcagctcat gcggataatg 480 tccgtacaaa agaagaaatc aatcggcaaa aacaagaaca tagtcagcat cgtgaaggag 540 ggacttcagc aaacgatggt gcggtagcct ttgcacgttc acagggacgc tacaccacag 600 atgatggtta tatcttcaat gcatctgata tcatcgaaga tacgggcgat gcctatatcg 660 ttcctcatgg agatcattac cattacattc ctaagaatga gttatcagct agcgagttgg 720 ctgctgcaga agccttccta tctggtcggg aaaatctgtc aaatttaaga acctatcgcc 780 gacaaaatag cgataacact ccaagaacaa actgggtacc ttctgtaagc aatccaggaa 840 ctacaaatac taacacaagc aacaacagca acactaacag tcaagcaagt caaagtaatg 900 acattgatag tctcttgaaa cagctctaca aactgccttt gagtcaacgc catgtagaat 960 ctgatggcct tattttcgac ccagcgcaaa tcacaagtcg aaccgccaga ggtgtagctg 1020 tccctcatgg taaccattac cactttatcc cttatgaaca aatgtctgaa ttggaaaaac 1080 gaattgctcg tattattccc cttcgttatc gttcaaacca ttgggtacca gattcaagac 1140 cagaagaacc aagtccacaa ccgactccag aacctagtcc aagtccgcaa cctgcaccaa 1200 atcctcaacc agctccaagc aatccaattg atgagaaatt ggtcaaagaa gctgttcgaa 1260 aagtaggcga tggttatgtc tttgaggaga atggagtttc tcgttatatc ccagccaaga 1320 atctttcagc agaaacagca gcaggcattg atagcaaact ggccaagcag gaaagtttat 1380 ctcataagct aggagctaag aaaactgacc tcccatctag tgatcgagaa ttttacaata 1440 aggcttatga cttactagca agaattcacc aagatttact tgataataaa ggtcgacaag 1500 ttgattttga ggctttggat aacctgttgg aacgactcaa ggatgtctca agtgataaag 1560 tcaagttagt ggatgatatt cttgccttct tagctccgat tcgtcatcca gaacgtttag 1620 gaaaaccaaa tgcgcaaatt acctacactg atgatgagat tcaagtagcc aagttggcag 1680 gcaagtacac aacagaagac ggttatatct ttgatcctcg tgatataacc agtgatgagg 1740 gggatgccta tgtaactcca catatgaccc atagccactg gattaaaaaa gatagtttgt 1800 ctgaagctga gagagcggca gcccaggctt atgctaaaga gaaaggtttg acccctcctt 1860 cgacagacca tcaggattca ggaaatactg aggcaaaagg agcagaagct atctacaacc 1920 gcgtgaaagc agctaagaag gtgccacttg atcgtatgcc ttacaatctt caatatactg 1980 tagaagtcaa aaacggtagt ttaatcatac ctcattatga ccattaccat aacatcaaat 2040 ttgagtggtt tgacgaaggc ctttatgagg cacctaaggg gtatactctt gaggatcttt 2100 tggcgactgt caagtactat gtcgaacatc caaacgaacg tccgcattca gataatggtt 2160 ttggtaacgc tagcgaccat gttcaaagaa acaaaaatgg tcaagctgat accaatcaaa 2220 cggaaaaacc aagcgaggag aaacctcaga cagaaaaacc tgaggaagaa acccctcgag 2280 aagagaaacc acaaagcgag aaaccagagt ctccaaaacc aacagaggaa ccagaagaag 2340 aatcaccaga ggaatcagaa gaacctcagg tcgagactga aaaggttgaa gaaaaactga 2400 gagaggctga agatttactt ggaaaaatcc aggatccaat tatcaagtcc aatgccaaag 2460 agactctcac aggattaaaa aataatttac tatttggcac ccaggacaac aatactatta 2520 tggcagaagc tgaaaaacta ttggctttat taaaggagag taagtaaagg tagcagcatt 2580 ttctaactcc taaaaacagg ataggagaac gggaaaacga aaaatgagag cagaatgtga 2640 gttctag 2647 <210> 13 <211> 2639 <212> DNA <213> S. pneumoniae <220>
<221> CDS <222> (114) ... (2627) <400> 13 gggtcttaaa actctgaatc ctttagaggc agacccacaa aatgacaaga cctatttaga 60 aaatctggaa gaaaatatga gtgttctagc agaagaatta aagtgaggaa aga atg 116
Met
PL 206 576 B1
| aaa Lys | atc Ile | aat Asn | aaa Lys 5 | aaa Lys | tat Tyr | eta gca | ggt Gly 10 | tca Ser | gtg val | gca Ala | gtc Val | ctt Leu 15 | gcc Ala | eta Leu | 164 | |
| Leu | Ala | |||||||||||||||
| agt | gtt | tgt | tcc | tat | gaa | ctt | ggt | cgt | cac | caa | gct | ggt | cag | gtt | aag | 212 |
| Ser | Val | Cys 20 | Ser | Tyr | Glu | Leu | Gly 25 | Arg | His | Gin | Ala | Gly 30 | Gin | Val | Lys | |
| aaa | gag | tct | aat | ega | gtt | tct | tat | ata | gat | ggt | gat | cag | gct | ggt | caa | 260 |
| Lys | Glu 35 | Ser | Asn | Arg | Val | Ser 40 | Tyr | Ile | Asp | Gly | Asp 45 | Gin | Ala | Gly | Gin | |
| aag | gca | gaa | aat | ttg | aca | cca | gat | gaa | gtc | agt | aag | aga | gag | ggg | atc | 308 |
| Lys 50 | Ala | Glu | Asn | Leu | Thr 55 | Pro | Asp | Glu | Val | Ser 60 | Lys | Arg | Glu | Gly | Ile 65 | |
| aac | gcc | gaa | caa | att | gtt | atc | aag | att | acg | gat | caa | ggt | tat | gtg | acc | 356 |
| Asn | Ala | Glu | Gin | Ile 70 | Val | Ile | Lys | Ile | Thr 75 | Asp | Gin | Gly | Tyr | Val 80 | Thr | |
| tct | cat | gga | gac | cat | tat | cat | tac | tat | aat | ggc | aag | gtt | cct | tat | gat | 404 |
| Ser | His | Gly | Asp 85 | His | Tyr | His | Tyr | Tyr 90 | Asn | Gly | Lys | Val | Pro 95 | Tyr | Asp | |
| gcc | atc | atc | agt | gaa | gaa | ctt | ctc | atg | aaa | gat | ccg | aat | tat | cag | ttg | 452 |
| Ala | Ile | Ile 100 | Ser | Glu | Glu | Leu | Leu 105 | Met | Lys | Asp | Pro | Asn 110 | Tyr | Gin | Leu | |
| aag | gat | tca | gac | att | gtc | aat | gaa | atc | aag | ggt | ggc | tat | gtg | att | aag | 500 |
| Lys | Asp 115 | Ser | Asp | Ile | Val | Asn 120 | Glu | Ile | Lys | Gly | Gly 125 | Tyr | Val | Ile | Lys | |
| gta | gac | gga | aaa | tac | tat | gtt | tac | ctt | aaa | gat | gcg | gcc | cat | gcg | gac | 548 |
| Val 130 | Asp | Gly | Lys | Tyr | Tyr 135 | Val | Tyr | Leu | Lys | Asp 140 | Ala | Ala | His | Ala | Asp 145 | |
| aat | att | cgg | aca | aaa | gaa | gag | att | aaa | cgt | cag | aag | cag | gaa | cac | agt | 596 |
| Asn | Ile | Arg | Thr | Lys 150 | Glu | Glu | Ile | Lys | Arg 155 | Gin | Lys | Gin | Glu | His 160 | Ser | |
| cat | aat | cat | aac | tca | aga | gca | gat | aat | gct | gtt | gct | gca | gcc | aga | gcc | 644 |
| His | Asn | His | Asn 165 | Ser | Arg | Ala | Asp | Asn 170 | Ala | Val | Ala | Ala | Ala 175 | Arg | Ala | |
| caa | gga | cgt | tat | aca | acg | gat | gat | ggg | tat | atc | ttc | aat | gca | tct | gat | 692 |
| Gin | Gly | Arg 180 | Tyr | Thr | Thr | Asp | Asp 185 | Gly | Tyr | Ile | Phe | Asn 190 | Ala | Ser | Asp | |
| atc | att | gag | gac | acg | ggt | gat | gct | tat | atc | gtt | cct | cac | ggc | gac | cat | 740 |
| Ile | Ile 195 | Glu | Asp | Thr | Gly | Asp 200 | Ala | Tyr | Ile | Val | Pro 205 | His | Gly | Asp | His | |
| tac | cat | tac | att | cct | aag | aat | gag | tta | tca | gct | age | gag | tta | gct | gct | 788 |
| Tyr 210 | His | Tyr | Ile | Pro | Lys 215 | Asn | Glu | Leu | Ser | Ala 220 | Ser | Glu | Leu | Ala | Ala 225 | |
| gca | gaa | gcc | tat | tgg | aat | ggg | aag | cag | gga | tct | cgt | cct | tct | tca | agt | 836 |
PL 206 576 B1
| Ala | Glu | Ala | Tyr | Trp 230 | Asn | Gly | Lys | Gin | Gly 235 | Ser | Arg | Pro | Ser | Ser 240 | Ser | |
| tct | agt | tat | aat | gca | aat | cca | gtt | caa | cca | aga | ttg | tca | gag | aac | cac | 884 |
| Ser | Ser | Tyr | Asn 245 | Ala | Asn | Pro | Val | Gin 250 | Pro | Arg | Leu | Ser | Glu 255 | Asn | His | |
| aat | ctg | act | gtc | act | cca | act | tat | cat | caa | aat | caa | ggg | gaa | aac | att | 932 |
| Asn | Leu | Thr 260 | Val | Thr | Pro | Thr | Tyr 265 | His | Gin | Asn | Gin | Gly 270 | Glu | Asn | Ile | |
| tca | agc | ctt | tta | cgt | gaa | ttg | tat | gct | aaa | ccc | tta | tca | gaa | cgc | cat | 980 |
| Ser | Ser 275 | Leu | Leu | Arg | Glu | Leu 280 | Tyr | Ala | Lys | Pro | Leu 285 | Ser | Glu | Arg | His | |
| gta | gaa | tct | gat | ggc | ctt | att | ttc | gac | cca | gcg | caa | atc | aca | agt | ega | 1028 |
| Val 290 | Glu | Ser | Asp | Gly | Leu 295 | Ile | Phe | Asp | Pro | Ala 300 | Gin | Ile | Thr | Ser | Arg 305 | |
| acc | gcc | aga | ggt | gta | gct | gtc | cct | cat | ggt | aac | cat | tac | cac | ttt | atc | 1076 |
| Thr | Ala | Arg | Gly | Val 310 | Ala | Val | Pro | His | Gly 315 | Asn | His | Tyr | His | Phe 320 | Ile | |
| cct | tat | gaa | caa | atg | tct | gaa | ttg | gaa | aaa | ega | att | gct | cgt | att | att | 1124 |
| Pro | Tyr | Glu | Gin 325 | Met | Ser | Glu | Leu | Glu 330 | Lys | Arg | Ile | Ala | Arg 335 | Ile | Ile | |
| ccc | ctt | cgt | tat | cgt | tca | aac | cat | tgg | gta | cca | gat | tca | aga | cca | gaa | 1172 |
| Pro | Leu | Arg 340 | Tyr | Arg | Ser | Asn | His 345 | Trp | Val | Pro | Asp | Ser 350 | Arg | Pro | Glu | |
| caa | cca | agt | cca | caa | teg | act | ccg | gaa | cct | agt | cca | agt | ctg | caa | cct | 1220 |
| Gin | Pro 355 | Ser | Pro | Gin | Ser | Thr 360 | Pro | Glu | Pro | Ser | Pro 365 | Ser | Leu | Gin | Pro | |
| gca | cca | aat | cct | caa | cca | gct | cca | agc | aat | cca | att | gat | gag | aaa | ttg | 1268 |
| Ala 370 | Pro | Asn | Pro | Gin | Pro 375 | Ala | Pro | Ser | Asn | Pro 380 | Ile | Asp | Glu | Lys | Leu 385 | |
| gtc | aaa | gaa | gct | gtt | ega | aaa | gta | ggc | gat | ggt | tat | gtc | ttt | gag | gag | 1316 |
| Val | Lys | Glu | Ala | Val 390 | Arg | Lys | Val | Gly | Asp 395 | Gly | Tyr | Val | Phe | Glu 400 | Glu | |
| aat | gga | gtt | tct | cgt | tat | atc | cca | gcc | aag | gat | ctt | tca | gca | gaa | aca | 1364 |
| Asn | Gly | Val | Ser 405 | Arg | Tyr | Ile | Pro | Ala 410 | Lys | Asp | Leu | Ser | Ala 415 | Glu | Thr | |
| gca | gca | ggc | att | gat | agc | aaa | ctg | gcc | aag | cag | gaa | agt | tta | tct | cat | 1412 |
| Ala | Ala | Gly 420 | Ile | Asp | Ser | Lys | Leu 425 | Ala | Lys | Gin | Glu | Ser 430 | Leu | Ser | His | |
| aag | eta | gga | gct | aag | aaa | act | gac | ctc | cca | tct | agt | gat | ega | gaa | ttt | 1460 |
| Lys | Leu 435 | Gly | Ala | Lys | Lys | Thr 440 | Asp | Leu | Pro | Ser | Ser 445 | Asp | Arg | Glu | Phe | |
| tac | aat | aag | gct | tat | gac | tta | eta | gca | aga | att | cac | caa | gat | tta | ctt | 1508 |
| Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu |
PL 206 576 B1
| 450 | 455 | 460 | 465 | |||||||||||||
| gat | aat | aaa | ggt | ega | caa | gtt | gat | ttt | gag | gtt | ttg | gat | aac | ctg | ttg | 1556 |
| Asp | Asn | Lys | Gly | Arg 470 | Gin | val | Asp | Phe | Glu 475 | Val | Leu | Asp | Asn | Leu 480 | Leu | |
| gaa | ega | ctc | aag | gat | gtc | tca | agt | gat | aaa | gtc | aag | tta | gtg | gat | gat | 1604 |
| Glu | Arg | Leu | Lys 485 | Asp | Val | Ser | Ser | Asp 490 | Lys | Val | Lys | Leu | vai 495 | Asp | Asp | |
| att | ctt | gcc | ttc | tta | gct | ccg | att | cgt | cat | cca | gaa | cgt | tta | gga | aaa | 1652 |
| Ile | Leu | Ala 500 | Phe | Leu | Ala | Pro | Ile 505 | Arg | His | Pro | Glu | Arg 510 | Leu | Gly | Lys | |
| cca | aat | gcg | caa | att | acc | tac | act | gat | gat | gag | att | caa | gta | gcc | aag | 1700 |
| Pro | Asn 515 | Ala | Gin | Ile | Thr | Tyr 520 | Thr | Asp | Asp | Glu | Ile 525 | Gin | Val | Ala | Lys | |
| ttg | gca | ggc | aag | tac | aca | aca | gaa | gac | ggt | tat | atc | ttt | gat | cct | cgt | 1748 |
| Leu 530 | Ala | Gly | Lys | Tyr | Thr 535 | Thr | Glu | Asp | Gly | Tyr 540 | Ile | Phe | Asp | Pro | Arg 545 | |
| gat | ata | acc | agt | gat | gag | ggg | gat | gcc | tat | gta | act | cca | cat | atg | acc | 1796 |
| Asp | Ile | Thr | Ser | Asp 550 | Glu | Gly | Asp | Ala | Tyr 555 | Val | Thr | Pro | His | Met 560 | Thr | |
| cat | agc | cac | tgg | att | aaa | aaa | gat | agt | ttg | tct | gaa | gct | gag | aga | gcg | 1844 |
| His | Ser | His | Trp 565 | Ile | Lys | Lys | Asp | Ser 570 | Leu | Ser | Glu | Ala | Glu 575 | Arg | Ala | |
| gca | gcc | cag | gct | tat | gct | aaa | gag | aaa | ggt | ttg | acc | cct | cct | teg | aca | 1892 |
| Ala | Ala | Gin 580 | Ala | Tyr | Ala | Lys | Glu 585 | Lys | Gly | Leu | Thr | Pro 590 | Pro | Ser | Thr | |
| gac | cac | cag | gat | tca | gga | aat | act | gag | gca | aaa | gga | gca | gaa | gct | atc | 1940 |
| Asp | His 595 | Gin | Asp | Ser | Gly | Asn 600 | Thr | Glu | Ala | Lys | Gly 605 | Ala | Glu | Ala | Ile | |
| tac | aac | cgc | gtg | aaa | gca | gct | aag | aag | gtg | cca | ctt | gat | cgt | atg | cct | 1988 |
| Tyr 610 | Asn | Arg | Val | Lys | Ala 615 | Ala | Lys | Lys | Val | Pro 620 | Leu | Asp | Arg | Met | Pro 625 | |
| tac | aat | ctt | caa | tat | act | gta | gaa | gtc | aaa | aac | ggt | agt | tta | atc | ata | 2036 |
| Tyr | Asn | Leu | Gin | Tyr 630 | Thr | Val | Glu | Val | Lys 635 | Asn | Gly | Ser | Leu | Ile 640 | Ile | |
| cct | cat | tat | gac | cat | tac | cat | aac | atc | aaa | ttt | gag | tgg | ttt | gac | gaa | 2084 |
| Pro | His | Tyr | Asp 645 | His | Tyr | His | Asn | Ile 650 | Lys | Phe | Glu | Trp | Phe 655 | Asp | Glu | |
| ggc | ctt | tat | gag | gca | cct | aag | ggg | tat | agt | ctt | gag | gat | ctt | ttg | gcg | 2132 |
| Gly | Leu | Tyr 660 | Glu | Ala | Pro | Lys | Gly 665 | Tyr | Ser | Leu | Glu | Asp 670 | Leu | Leu | Ala | |
| act | gtc | aag | tac | tat | gtc | gaa | cat | cca | aac | gaa | cgt | ccg | cat | tca | gat | 2180 |
| Thr | Val 675 | Lys | Tyr | Tyr | Val | Glu 680 | His | Pro | Asn | Glu | Arg 685 | Pro | His | Ser | Asp |
PL 206 576 B1
| aat Asn 690 | ggt Gly | ttt Phe | ggt Gly | aac Asn | gct Ala 695 | agt Ser | gac Asp | cat His | gtt Val | cgt aaa Arg Lys 700 | aat Asn | aag gca | gac Asp 705 | 2228 | |
| Lys | Ala | ||||||||||||||
| caa | gat | agt | aaa | cct | gat | gaa | gat | aag | gaa | cat gat | gaa | gta | agt | gag | 2276 |
| Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His Asp | Glu | Val | Ser | Glu | |
| 710 | 715 | 720 | |||||||||||||
| cca | act | cac | cct | gaa | tct | gat | gaa | aaa | gag | aat cac | gct | ggt | tta | aat | 2324 |
| Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn His | Ala | Gly | Leu | Asn | |
| 725 | 730 | 735 | |||||||||||||
| cct | tea | gca | gat | aat | ctt | tat | aaa | cca | age | act gat | acg | gaa | gag | aca | 2372 |
| Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr Asp | Thr | Glu | Glu | Thr | |
| 740 | 745 | 750 | |||||||||||||
| gag | gaa | gaa | gct | gaa | gat | acc | aca | gat | gag | gct gaa | att | cct | caa | gta | 2420 |
| Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala Glu | Ile | Pro | Gin | Val | |
| 755 | 760 | 765 | |||||||||||||
| gag | aat | tct | gtt | att | aac | gct | aag | ata | gca | gat gcg | gag | gee | ttg | eta | 2468 |
| Glu | Asn | Ser | val | Ile | Asn | Ala | Lys | Ile | Ala | Asp Ala | Glu | Ala | Leu | Leu | |
| 770 | 775 | 780 | 785 | ||||||||||||
| gaa | aaa | gta | aca | gat | cct | agt | att | aga | caa | aat gct | atg | gag | aca | ttg | 2516 |
| Glu | Lys | Val | Thr | Asp | Pro | Ser | Ile | Arg | Gin | Asn Ala | Met | Glu | Thr | Leu | |
| 790 | 795 | 800 | |||||||||||||
| act | ggt | eta | aaa | agt | agt | ctt | ctt | ctc | gga | acg aaa | gat | aat | aac | act | 2564 |
| Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr Lys | Asp | Asn | Asn | Thr | |
| 805 | 810 | 815 | |||||||||||||
| att | tea | gca | gaa | gta | gat | agt | ctc | ttg | gct | ttg tta | aaa | gaa | agt | caa | 2612 |
| Ile | Ser | Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu Leu | Lys | Glu | Ser | Gin | |
| 820 | 825 | 830 | |||||||||||||
| ccg | gct | cct | ata | cag | tagtaaaatg aa | 2639 | |||||||||
| Pro | Ala | Pro | Ile | Gin | |||||||||||
| 835 |
| <210> <211> <212> <213> | 14 838 PRT S. pneumoniae | |||||||||||||
| <400> | 14 | |||||||||||||
| Met | Lys Ile | Asn | Lys | Lys | Tyr | Leu | Ala | Gly | Ser | Val | Ala | Val | Leu | Ala |
| 1 | 5 | 10 | 15 | |||||||||||
| Leu | Ser Val | Cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Gly | Gin | Val |
| 20 | 25 | 30 | ||||||||||||
| Lys | Lys Glu | Ser | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly |
| 35 | 40 | 45 | ||||||||||||
| Gin | Lys Ala | Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly |
| 50 | 55 | 60 | ||||||||||||
| Ile | Asn Ala | Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val |
PL 206 576 B1
| 65 | 70 | 75 | 80 | ||||||||||||
| Thr | Ser | His | Gly | Asp 85 | His | Tyr | His | Tyr | Tyr 90 | Asn | Gly | Lys | Val | Pro 95 | Tyr |
| Asp | Ala | Ile | Ile 100 | Ser | Glu | Glu | Leu | Leu 105 | Met | Lys | Asp | Pro | Asn 110 | Tyr | Gin |
| Leu | Lys | Asp 115 | Ser | Asp | Ile | Val | Asn 120 | Glu | ile | Lys | Gly | Gly 125 | Tyr | Val | Ile |
| Lys | Val 130 | Asp | Gly | Lys | Tyr | Tyr 135 | Val | Tyr | Leu | Lys | Asp 140 | Ala | Ala | His | Ala |
| Asp 145 | Asn | Ile | Arg | Thr | Lys 150 | Glu | Glu | Ile | Lys | Arg 155 | Gin | Lys | Gin | Glu | His 160 |
| Ser | His | Asn | His | Asn 165 | Ser | Arg | Ala | Asp | Asn 170 | Ala | Val | Ala | Ala | Ala 175 | Arg |
| Ala | Gin | Gly | Arg 180 | Tyr | Thr | Thr | Asp | Asp 185 | Gly | Tyr | Ile | Phe | Asn 190 | Ala | Ser |
| Asp | Ile | Ile 195 | Glu | Asp | Thr | Gly | Asp 200 | Ala | Tyr | Ile | Val | Pro 205 | His | Gly | Asp |
| His | Tyr 210 | His | Tyr | Ile | Pro | Lys 215 | Asn | Glu | Leu | Ser | Ala 220 | Ser | Glu | Leu | Ala |
| Ala 225 | Ala | Glu | Ala | Tyr | Trp 230 | Asn | Gly | Lys | Gin | Gly 235 | Ser | Arg | Pro | Ser | Ser 240 |
| Ser | Ser | Ser | Tyr | Asn 245 | Ala | Asn | Pro | Val | Gin 250 | Pro | Arg | Leu | Ser | Glu 255 | Asn |
| His | Asn | Leu | Thr 260 | Val | Thr | Pro | Thr | Tyr 265 | His | Gin | Asn | Gin | Gly 270 | Glu | Asn |
| Ile | Ser | Ser 275 | Leu | Leu | Arg | Glu | Leu 280 | Tyr | Ala | Lys | Pro | Leu 285 | Ser | Glu | Arg |
| His | Val 290 | Glu | Ser | Asp | Gly | Leu 295 | Ile | Phe | Asp | Pro | Ala 300 | Gin | Ile | Thr | Ser |
| Arg 305 | Thr | Ala | Arg | Gly | Val 310 | Ala | Val | Pro | His | Gly 315 | Asn | His | Tyr | His | Phe 320 |
| Ile | Pro | Tyr | Glu | Gin 325 | Met | Ser | Glu | Leu | Glu 330 | Lys | Arg | Ile | Ala | Arg 335 | Ile |
| Ile | Pro | Leu | Arg 340 | Tyr | Arg | Ser | Asn | His 345 | Trp | Val | Pro | Asp | Ser 350 | Arg | Pro |
| Glu | Gin | Pro 355 | Ser | Pro | Gin | Ser | Thr 360 | Pro | Glu | Pro | Ser | Pro 365 | Ser | Leu | Gin |
| Pro | Ala 370 | Pro | Asn | Pro | Gin | Pro 375 | Ala | Pro | Ser | Asn | Pro 380 | Ile | Asp | Glu | Lys |
| Leu 385 | Val | Lys | Glu | Ala | Val 390 | Arg | Lys | Val | Gly | Asp 395 | Gly | Tyr | Val | Phe | Glu 400 |
| Glu | Asn | Gly | Val | Ser 405 | Arg | Tyr | Ile | Pro | Ala 410 | Lys | Asp | Leu | Ser | Ala 415 | Glu |
| Thr | Ala | Ala | Gly 420 | Ile | Asp | Ser | Lys | Leu 425 | Ala | Lys | Gin | Glu | Ser 430 | Leu | Ser |
| His | Lys | Leu 435 | Gly | Ala | Lys | Lys | Thr 440 | Asp | Leu | Pro | Ser | Ser 445 | Asp | Arg | Glu |
| Phe | Tyr 450 | Asn | Lys | Ala | Tyr | Asp 455 | Leu | Leu | Ala | Arg | Ile 460 | His | Gin | Asp | Leu |
| Leu 465 | Asp | Asn | Lys | Gly | Arg 470 | Gin | Val | Asp | Phe | Glu 475 | Val | Leu | Asp | Asn | Leu 480 |
| Leu | Glu | Arg | Leu | Lys 485 | Asp | Val | Ser | Ser | Asp 490 | Lys | Val | Lys | Leu | Val 495 | Asp |
| Asp | Ile | Leu | Ala 500 | Phe | Leu | Ala | Pro | Ile 505 | Arg | His | Pro | Glu | Arg 510 | Leu | Gly |
| Lys | Pro | Asn 515 | Ala | Gin | Ile | Thr | Tyr 520 | Thr | Asp | Asp | Glu | Ile 525 | Gin | Val | Ala |
PL 206 576 B1
| Lys Leu Ala Gly | Lys Tyr Thr Thr Glu Asp Gly Tyr | Ile | Phe | Asp | Pro | ||||||||||
| 530 | 535 | 540 | |||||||||||||
| Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met |
| 545 | 550 | 555 | 560 | ||||||||||||
| Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg |
| 565 | 570 | 575 | |||||||||||||
| Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser |
| 580 | 585 | 590 | |||||||||||||
| Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala |
| 595 | 600 | 605 | |||||||||||||
| Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met |
| 610 | 615 | 620 | |||||||||||||
| Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile |
| 625 | 630 | 635 | 640 | ||||||||||||
| Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp |
| 645 | 650 | 655 | |||||||||||||
| Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu |
| 660 | 665 | 670 | |||||||||||||
| Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser |
| 675 | 680 | 685 | |||||||||||||
| Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala |
| 690 | 695 | 700 | |||||||||||||
| Asp | Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | Ser |
| 705 | 710 | 715 | 720 | ||||||||||||
| Glu | Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu |
| 725 | 730 | 735 | |||||||||||||
| Asn | Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu |
| 740 | 745 | 750 | |||||||||||||
| Thr | Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin |
| 755 | 760 | 765 | |||||||||||||
| Val | Glu | Asn | Ser | Val | Ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu |
| 770 | 775 | 780 | |||||||||||||
| Leu | Glu | Lys | Val | Thr | Asp | Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr |
| 785 | 790 | 795 | 800 | ||||||||||||
| Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn |
| 805 | 810 | 815 | |||||||||||||
| Thr | Ile | Ser | Ala | Glu | Val | ASp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser |
| 820 | 825 | 830 | |||||||||||||
| Gin | Pro | Ala | Pro | Ile | Gin |
835 <210> 15 <211> 2528 <212> DNA <213> S. pneumoniae <220>
| <221> CDS | |||||||||||||
| <222> | (1) | ...(2520) | |||||||||||
| <400> | 15 | ||||||||||||
| tgt | gcc tat | gca | eta aac | cag | cat | cgt | tog | cag | gaa | aat | aag | gac | aat |
| Cys | Ala Tyr | Ala | Leu Asn | Gin | His | Arg | Ser | Gin | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | ||||||||||
| aat | cgt gtc | tct | tat gtg | gat | ggc | age | cag | tca | agt | cag | aaa | agt | gaa |
| Asn | Arg Val | Ser | Tyr val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
PL 206 576 B1
| 20 | 25 | 30 | ||||||||||||||
| aac | ttg | aca | cca | gac | cag | gtt | agc | cag | aaa | gaa | gga | att | cag | gct | gag | 144 |
| Asn | Leu | Thr 35 | Pro | Asp | Gin | Val | Ser 40 | Gin | Lys | Glu | Gly | Ile 45 | Gin | Ala | Glu | |
| caa | att | gta | atc | aaa | att | aca | gat | cag | ggc | tat | gta | acg | tca | cac | ggt | 192 |
| Gin | Ile 50 | Val | Ile | Lys | Ile | Thr 55 | Asp | Gin | Gly | Tyr | Val 60 | Thr | Ser | His | Gly | |
| gat | cac | tat | cat | tac | tat | aat | ggg | aaa | gtt | cct | tat | gat | gcc | ctc | ttt | 240 |
| Asp 65 | His | Tyr | His | Tyr | Tyr 70 | Asn | Gly | Lys | Val | Pro 75 | Tyr | Asp | Ala | Leu | Phe 80 | |
| agt | gaa | gaa | ctc | ttg | atg | aag | gat | cca | aac | tat | caa | ctt | aaa | gac | gct | 288 |
| Ser | Glu | Glu | Leu | Leu 85 | Met | Lys | Asp | Pro | Asn 90 | Tyr | Gin | Leu | Lys | Asp 95 | Ala | |
| gat | att | gtc | aat | gaa | gtc | aag | ggt | ggt | tat | atc | atc | aag | gtc | gat | gga | 336 |
| Asp | Ile | Val | Asn 100 | Glu | Val | Lys | Gly | Gly 105 | Tyr | Ile | Ile | Lys | Val 110 | Asp | Gly | |
| aaa | tat | tat | gtc | tac | ctg | aaa | gat | gca | gct | cat | gct | gat | aat | gtt | ega | 384 |
| Lys | Tyr | Tyr 115 | Val | Tyr | Leu | Lys | Asp 120 | Ala | Ala | His | Ala | Asp 125 | Asn | Val | Arg | |
| act | aaa | gat | gaa | atc | aat | cgt | caa | aaa | caa | gaa | cat | gtc | aaa | gat | aat | 432 |
| Thr | Lys 130 | Asp | Glu | Ile | Asn | Arg 135 | Gin | Lys | Gin | Glu | His 140 | Val | Lys | Asp | Asn | |
| gag | aag | gtt | aac | tct | aat | gtt | gct | gta | gca | agg | tct | cag | gga | ega | tat | 480 |
| Glu 145 | Lys | Val | Asn | Ser | Asn 150 | Val | Ala | Val | Ala | Arg 155 | Ser | Gin | Gly | Arg | Tyr 160 | |
| acg | aca | aat | gat | ggt | tat | gtc | ttt | aat | cca | gct | gat | att | atc | gaa | gat | 528 |
| Thr | Thr | Asn | Asp | Gly 165 | Tyr | Val | Phe | Asn | Pro 170 | Ala | Asp | Ile | Ile | Glu 175 | Asp | |
| acg | ggt | aat | gct | tat | atc | gtt | cct | cat | gga | ggt | cac | tat | cac | tac | att | 576 |
| Thr | Gly | Asn | Ala 180 | Tyr | Ile | Val | Pro | His 185 | Gly | Gly | His | Tyr | His 190 | Tyr | Ile | |
| ccc | aaa | agc | gat | tta | tct | gct | agt | gaa | tta | gca | gca | gct | aaa | gca | cat | 624 |
| Pro | Lys | Ser 195 | Asp | Leu | Ser | Ala | Ser 200 | Glu | Leu | Ala | Ala | Ala 205 | Lys | Ala | His | |
| ctg | gct | gga | aaa | aat | atg | caa | ccg | agt | cag | tta | agc | tat | tct | tca | aca | 672 |
| Leu | Ala 210 | Gly | Lys | Asn | Met | Gin 215 | Pro | Ser | Gin | Leu | Ser 220 | Tyr | Ser | Ser | Thr | |
| cct | tct | cca | tct | ctt | cca | atc | aat | cca | gga | act | tca | cat | gag | aaa | cat | 720 |
| Pro 225 | Ser | Pro | Ser | Leu | Pro 230 | Ile | Asn | Pro | Gly | Thr 235 | Ser | His | Glu | Lys | His 240 | |
| gaa | gaa | gat | gga | tac | gga | ttt | gat | gct | aat | cgt | att | atc | gct | gaa | gat | 768 |
| Glu | Glu | Asp | Gly | Tyr 245 | Gly | Phe | Asp | Ala | Asn 250 | Arg | Ile | Ile | Ala | Glu 255 | Asp |
PL 206 576 B1
| gaa Glu | tca Ser | ggt Gly | ttt Phe 260 | gtc Val | atg Met | agt Ser | cac His | gga Gly 265 | gac Asp | cac His | aat Asn | cat His | tat Tyr 270 | ttc Phe | ttc Phe | 816 |
| aag | aag | gac | ttg | aca | gaa | gag | caa | att | aag | gct | gcg | caa | aaa | cat | tta | 864 |
| Lys | Lys | Asp 275 | Leu | Thr | Glu | Glu | Gin 280 | Ile | Lys | Ala | Ala | Gin 285 | Lys | His | Leu | |
| gag | gaa | gtt | aaa | act | agt | cat | aat | gga | tta | gat | tct | ttg | tca | tct | cat | 912 |
| Glu | Glu 290 | Val | Lys | Thr | Ser | His 295 | Asn | Gly | Leu | Asp | Ser 300 | Leu | Ser | Ser | His | |
| gaa | cag | gat | tat | cca | agt | aat | gcc | aaa | gaa | atg | aaa | gat | tta | gat | aaa | 960 |
| Glu 305 | Gin | Asp | Tyr | Pro | Ser 310 | Asn | Ala | Lys | Glu | Met 315 | Lys | Asp | Leu | Asp | Lys 320 | |
| aaa | atc | gaa | gaa | aaa | att | gct | ggc | att | atg | aaa | caa | tat | ggt | gtc | aaa | 1008 |
| Lys | Ile | Glu | Glu | Lys 325 | Ile | Ala | Gly | Ile | Met 330 | Lys | Gin | Tyr | Gly | Val 335 | Lys | |
| cgt | gaa | agt | att | gtc | gtg | aat | aaa | gaa | aaa | aat | gcg | att | att | tat | ccg | 1056 |
| Arg | Glu | Ser | Ile 340 | Val | Val | Asn | Lys | Glu 345 | Lys | Asn | Ala | Ile | Ile 350 | Tyr | Pro | |
| cat | gga | gat | cac | cat | cat | gca | gat | ccg | att | gat | gaa | cat | aaa | ccg | gtt | 1104 |
| His | Gly | Asp 355 | His | His | His | Ala | Asp 360 | Pro | Ile | Asp | Glu | His 365 | Lys | Pro | Val | |
| gga | att | ggt | cat | tct | cac | agt | aac | tat | gaa | ctg | ttt | aaa | ccc | gaa | gaa | 1152 |
| Gly | Ile 370 | Gly | His | Ser | His | Ser 375 | Asn | Tyr | Glu | Leu | Phe 380 | Lys | Pro | Glu | Glu | |
| gga | gtt | gct | aaa | aaa | gaa | ggg | aat | aaa | gtt | tat | act | gga | gaa | gaa | tta | 1200 |
| Gly 385 | Val | Ala | Lys | Lys | Glu 390 | Gly | Asn | Lys | Val | Tyr 395 | Thr | Gly | Glu | Glu | Leu 400 | |
| acg | aat | gtt | gtt | aat | ttg | tta | aaa | aat | agt | acg | ttt | aat | aat | caa | aac | 1248 |
| Thr | Asn | Val | Val | Asn 405 | Leu | Leu | Lys | Asn | Ser 410 | Thr | Phe | Asn | Asn | Gin 415 | Asn | |
| ttt | act | eta | gcc | aat | ggt | caa | aaa | cgc | gtt | tct | ttt | agt | ttt | ccg | cct | 1296 |
| Phe | Thr | Leu | Ala 420 | Asn | Gly | Gin | Lys | Arg 42 5 | Val | Ser | Phe | Ser | Phe 430 | Pro | Pro | |
| gaa | ttg | gag | aaa | aaa | tta | ggt | atc | aat | atg | eta | gta | aaa | tta | ata | aca | 1344 |
| Glu | Leu | Glu 435 | Lys | Lys | Leu | Gly | Ile 440 | Asn | Met | Leu | Val | Lys 445 | Leu | Ile | Thr | |
| cca | gat | gga | aaa | gta | ttg | gag | aaa | gta | tct | ggt | aaa | gta | ttt | gga | gaa | 1392 |
| Pro | Asp 450 | Gly | Lys | Val | Leu | Glu 455 | Lys | Val | Ser | Gly | Lys 460 | Val | Phe | Gly | Glu | |
| gga | gta | ggg | aat | att | gca | aac | ttt | gaa | tta | gat | caa | cct | tat | tta | cca | 1440 |
| Gly 465 | Val | Gly | Asn | Ile | Ala 470 | Asn | Phe | Glu | Leu | Asp 475 | Gin | Pro | Tyr | Leu | Pro 480 |
PL 206 576 B1
| gga caa aca | ttt Phe | aag Lys 485 | tat Tyr | act Thr | atc Ile | get Ala | tea aaa gat Ser Lys Asp 490 | tat Tyr | cca Pro | gaa Glu 495 | gta Val | 1488 | ||
| Gly | Gin | Thr | ||||||||||||
| agt | tat | gat | ggt | aca | ttt | aca | gtt | cca | acc tet tta | get | tac | aaa | atg | 1536 |
| Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr Ser Leu | Ala | Tyr | Lys | Met | |
| 500 | 505 | 510 | ||||||||||||
| gcc | agt | caa | acg | att | ttc | tat | cct | ttc | cat gca ggg | gat | act | tat | tta | 1584 |
| Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His Ala Gly | Asp | Thr | Tyr | Leu | |
| 515 | 520 | 525 | ||||||||||||
| aga | gtg | aac | cct | caa | ttt | gca | gtg | cct | aaa gga act | gat | get | tta | gtc | 1632 |
| Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys Gly Thr | Asp | Ala | Leu | Val | |
| 530 | 535 | 540 | ||||||||||||
| aga | gtg | ttt | gat | gaa | ttt | cat | gga | aat | get tat tta | gaa | aat | aac | tat | 1680 |
| Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala Tyr Leu | Glu | Asn | Asn | Tyr | |
| 545 | 550 | 555 | 560 | |||||||||||
| aaa | gtt | ggt | gaa | atc | aaa | tta | ccg | att | ccg aaa tta | aac | caa | gga | aca | 1728 |
| Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro Lys Leu | Asn | Gin | Gly | Thr | |
| 565 | 570 | 575 | ||||||||||||
| acc | aga | acg | gcc | gga | aat | aaa | att | cct | gta acc ttc | atg | gca | aat | get | 1776 |
| Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val Thr Phe | Met | Ala | Asn | Ala | |
| 580 | 585 | 590 | ||||||||||||
| tat | ttg | gac | aat | caa | teg | act | tat | att | gtg gaa gta | cct | atc | ttg | gaa | 1824 |
| Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val Glu Val | Pro | Ile | Leu | Glu | |
| 595 | 600 | 605 | ||||||||||||
| aaa | gaa | aat | caa | act | gat | aaa | cca | agt | att eta cca | caa | ttt | aaa | agg | 1872 |
| Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile Leu Pro | Gin | Phe | Lys | Arg | |
| 610 | 615 | 620 | ||||||||||||
| aat | aaa | gca | caa | gaa | aac | tea | aaa | ctt | gat gaa aag | gta | gaa | gaa | cca | 1920 |
| Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp Glu Lys | Val | Glu | Glu | Pro | |
| 625 | 630 | 635 | 640 | |||||||||||
| aag | act | agt | gag | aag | gta | gaa | aaa | gaa | aaa ctt tet | gaa | act | ggg | aat | 1968 |
| Lys | Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys Leu Ser | Glu | Thr | Gly | Asn | |
| 645 | 650 | 655 | ||||||||||||
| agt | act | agt | aat | tea | acg | tta | gaa | gaa | gtt cct aca | gtg | gat | cct | gta | 2016 |
| Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val Pro Thr | Val | Asp | Pro | Val | |
| 660 | 665 | 670 | ||||||||||||
| caa | gaa | aaa | gta | gca | aaa | ttt | get | gaa | agt tat ggg | atg | aag | eta | gaa | 2064 |
| Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser Tyr Gly | Met | Lys | Leu | Glu | |
| 675 | 680 | 685 | ||||||||||||
| aat | gtc | ttg | ttt | aat | atg | gac | gga | aca | att gaa tta | tat | tta | cca | teg | 2112 |
| Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile Glu Leu | Tyr | Leu | Pro | Ser | |
| 690 | 695 | 700 | ||||||||||||
| gga | gaa | gtc | att | aaa | aag | aat | atg | gca | gat ttt aca | gga | gaa | gca | cct | 2160 |
PL 206 576 B1
| Gly 705 | Glu | Val | Ile | Lys | Lys 710 | Asn | Met | Ala Asp | Phe 715 | Thr Gly | Glu | Ala | Pro 720 | |||
| caa | gga | aat | ggt | gaa | aat | aaa | cca | tct | gaa | aat | gga | aaa | gta | tct | act | 2208 |
| Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | |
| 725 | 730 | 735 | ||||||||||||||
| gga | aca | gtt | gag | aac | caa | cca | aca | gaa | aat | aaa | cca | gca | gat | tct | tta | 2256 |
| Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | |
| 740 | 745 | 750 | ||||||||||||||
| cca | gag | gca | cca | aac | gaa | aaa | cct | gta | aaa | cca | gaa | aac | tea | acg | gat | 2304 |
| Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | |
| 755 | 760 | 765 | ||||||||||||||
| aat | gga | atg | ttg | aat | cca | gaa | ggg | aat | gtg | ggg | agt | gac | cct | atg | tta | 2352 |
| Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | |
| 770 | 775 | 780 | ||||||||||||||
| gat | tea | gca | tta | gag | gaa | gct | cca | gca | gta | gat | cct | gta | caa | gaa | aaa | 2400 |
| Asp | Ser | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys | |
| 785 | 790 | 795 | 800 | |||||||||||||
| tta | gaa | aaa | ttt | aca | gct | agt | tac | gga | tta | ggc | tta | gat | agt | gtt | ata | 2448 |
| Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | |
| 805 | 810 | 815 | ||||||||||||||
| ttc | aat | atg | gat | gga | acg | att | gaa | tta | aga | ttg | cca | agt | gga | gaa | gtg | 2496 |
| Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | |
| 820 | 825 | 830 | ||||||||||||||
| ata | aaa | aag | aat | tta | ttg | atc | tea | tagcgtaa | 2528 | |||||||
| Ile | Lys | Lys | Asn | Leu | Leu | Ile | Ser | |||||||||
| 835 | 840 |
| <210> 16 <211> 840 <212> PRT <213> S. i | □neumoniae | ||||||||||||||
| <400> | 16 | ||||||||||||||
| Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
PL 206 576 B1
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His |
| 225 | 230 | 235 | 240 | ||||||||||||
| Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp |
| 245 | 250 | 255 | |||||||||||||
| Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe | Phe |
| 260 | 265 | 270 | |||||||||||||
| Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu |
| 275 | 280 | 285 | |||||||||||||
| Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His |
| 290 | 295 | 300 | |||||||||||||
| Glu | Gin | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys |
| 305 | 310 | 315 | 320 | ||||||||||||
| Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys |
| 325 | 330 | 335 | |||||||||||||
| Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro |
| 340 | 345 | 350 | |||||||||||||
| His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val |
| 355 | 360 | 365 | |||||||||||||
| Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu |
| 370 | 375 | 380 | |||||||||||||
| Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn |
| 405 | 410 | 415 | |||||||||||||
| Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro |
| 420 | 425 | 430 | |||||||||||||
| Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr |
| 435 | 440 | 445 | |||||||||||||
| Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu |
| 450 | 455 | 460 | |||||||||||||
| Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro |
| 465 | 470 | 475 | 430 | ||||||||||||
| Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val |
| 485 | 490 | 495 | |||||||||||||
| Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met |
| 500 | 505 | 510 | |||||||||||||
| Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu |
| 515 | 520 | 525 | |||||||||||||
| Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val |
| 530 | 535 | 540 | |||||||||||||
| Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr |
| 565 | 570 | 575 |
PL 206 576 B1
| Thr Arg Thr Ala 580 | Gly Asn | Lys | Ile | Pro 585 | Val | Thr Phe Met Ala 590 | Asn | Ala | |||||||
| Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu | Glu |
| 595 | 600 | 605 | |||||||||||||
| Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg |
| 610 | 615 | 620 | |||||||||||||
| Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro |
| 625 | 630 | 635 | 640 | ||||||||||||
| Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn |
| 645 | 650 | 655 | |||||||||||||
| Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro | val |
| 660 | 665 | 670 | |||||||||||||
| Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu |
| 675 | 680 | 685 | |||||||||||||
| Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser |
| 690 | 695 | 700 | |||||||||||||
| Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro |
| 705 | 710 | 715 | 720 | ||||||||||||
| Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr |
| 725 | 730 | 735 | |||||||||||||
| Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu |
| 740 | 745 | 750 | |||||||||||||
| Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp |
| 755 | 760 | 765 | |||||||||||||
| Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu |
| 770 | 775 | 780 | |||||||||||||
| Asp | Ser | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile |
| 805 | 810 | 815 | |||||||||||||
| Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val |
| 820 | 825 | 830 | |||||||||||||
| Ile | Lys | Lys | Asn | Leu | Leu | Ile | Ser | ||||||||
| 835 | 840 |
<210> 17 <211> 27 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 17 cagtagatct gtgcctatgc actaaac 27 <210> 18 <211> 33 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 18 gatctctaga ctactgctat tccttacgct atg 33
PL 206 576 B1 <210> 19 <211> 30 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 19 atcactcgag cattacctgg ataatcctgt <210> 20 <211> 26 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 20 ctgctaagct tatgaaagat ttagat <210> 21 <211> 24 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 21 gatactcgag ctgctattcc ttac <210> 22 <211> 28 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 22 gaatctcgag ttaagctgct gctaattc <210> 23 <211> 32 <212 > DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 23 gacgctcgag cgctatgaaa tcagataaat tc <210> 24 <211> 37
PL 206 576 B1 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 24 gacgctcgag ggcattacct ggataatcct gttcatg 37 <210> 25 <211> 33 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 25 cagtagatct cttcatcatt tattgaaaag agg 33 <210> 26 <211> 40 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 26 ttatttcttc catatggact tgacagaaga gcaaattaag 40 <210> 27 <211> 32 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 27 cgccaagctt cgctatgaaa tcagataaat tc 32 <210> 28 <211> 34 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 28 cgccaagctt ttccacaata taagtcgatt gatt 34 <210> 29 <211> 40 <212> DNA <213> Sewkencja sztucznie otrzymana
PL 206 576 B1 <220>
<223> Starter oligonukleotydowy do PCR <400> 29 ttatttcttc catatggaag tacctatctt ggaaaaagaa 40 <210> 30 <211> 37 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 30 ttatttcttc catatggtgc ctatgcacta aaccagc 37 <210> 31 <211> 40 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 31 ataagaatgc ggccgcttcc acaatataag tcgattgatt 40 <210> 32 <211> 31 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 32 cagtagatct gtgcttatga actaggtttg c 31 <210> 33 <211> 32 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 33 gatcaagctt gctgctacct ttacttactc tc 32 <210> 34 <211> 26 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
PL 206 576 B1 <22 3> Starter oligonukleotydowy do PCR <400> 34 ctgagatatc cgttatcgtt caaacc 26 <210> 35 <211> 28 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 35 ctgcaagctt ttaaagggga ataatacg 28 <210> 36 <211> 29 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 36 cagtagatct gcagaagcct tcctatctg 29 <210> 37 <211> 33 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 37 tcgccaagct tcgttatcgt tcaaaccatt ggg 33 <210> 38 <211> 45 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 38 ataagaatgc ggccgcctta ctctccttta ataaagccaa tagtt 45 <210> 39 <211> 34 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR
PL 206 576 B1 <400> 39 catgccatgg acattgatag tctcttgaaa cagc <210> 40 <211> 37 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 40 cgccaagctt cttactctcc tttaataaag ccaatag 37 <210> 41 <211> 31 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 41 cgacaagctt aacatggtcg ctagcgttac c 31 <210> 42 <211> 30 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 42 cataccatgg gcctttatga ggcacctaag <210> 43 <211> 34 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 43 cgacaagctt aagtaaatct tcagcctctc tcag 34 <210> 44 <211> 31 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 44 gataccatgg ctagcgacca tgttcaaaga a
PL 206 576 B1 <210> 45 <211> 36 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 45 cgccaagctt atcatccact aacttgactt tatcac 36 <210> 46 <211> 33 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 46 cataccatgg atattcttgc cttcttagct ccg 33 <210> 47 <211> 30 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 47 catgccatgg tgcttatgaa ctaggtttgc 30 <210> 48 <211> 32 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 48 cgccaagctt tagcgttacc aaaaccatta tc 32 <210> 49 <211> 36 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 49 gtattagatc tgttcctatg aacttggtcg tcacca 36 <210> 50
PL 206 576 B1 <211> 28 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 50 cgcctctaga ctactgtata ggagccgg 28 <210> 51 <211> 34 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 51 catgccatgg aaaacatttc aagcctttta cgtg 34 <210> 52 <211> 34 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 52 cgacaagctt ctgtatagga gccggttgac tttc 34 <210> 53 <211> 34 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 53 catgccatgg ttcgtaaaaa taaggcagac caag 34 <210> 54 <211> 30 <212> DNA <213> Sewkencja sztucznie otrzymana <220>
<223> Starter oligonukleotydowy do PCR <400> 54 catgccatgg aagcctattg gaatgggaag 30 <210> 55 <211> 1019 <212> PRT
PL 206 576 B1 <213> S. pneumoniae <400> 55
| Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu |
| 420 | 425 | 430 |
PL 206 576 B1
| Asp Glu Ser | Gly | Phe | Val | Met | Ser His Gly Asp His Asn His | Tyr | Phe | ||||||||
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | ASp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 775 | 780 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 825 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
PL 206 576 B1
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
| 930 | 935 | 940 | |||||||||||||
| Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met |
| 945 | 950 | 955 | 960 | ||||||||||||
| Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu |
| 965 | 970 | 975 | |||||||||||||
| Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val |
| 980 | 985 | 990 | |||||||||||||
| Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu |
| 995 | 1000 | 1005 | |||||||||||||
| Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | ile | Ala | |||||
| 1010 | 1015 | ||||||||||||||
| <210> | 56 | ||||||||||||||
| <211> | 489 | ||||||||||||||
| <212> | PRT | ||||||||||||||
| <213> | S. pneumoniae | ||||||||||||||
| <400> | 56 | ||||||||||||||
| Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Giy | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
PL 206 576 B1
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | ile | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | |||||||
| 485 | |||||||||||||||
| <210> | 57 | ||||||||||||||
| <211> | 509 | ||||||||||||||
| <212> | PRT | ||||||||||||||
| <213> | S. pneumoniae | ||||||||||||||
| <400> | 57 | ||||||||||||||
| Met | Lys | Phe | Ser | Lys | Lys | Tyr | Ile | Ala | Ala | Gly | Ser | Ala | Val | Ile | Val |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ser | Leu | Ser | Leu | Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Lys | Asp | Asn | Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser |
| 35 | 40 | 45 | |||||||||||||
| Gin | Lys | Ser | Glu | Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly |
| 50 | 55 | 60 | |||||||||||||
| Ile | Gin | Ala | Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val |
| 65 | 70 | 75 | 80 | ||||||||||||
| Thr | Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ala | Leu | Phe | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin |
| 100 | 105 | 110 | |||||||||||||
| Leu | Lys | Asp | Ala | Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile |
| 115 | 120 | 125 | |||||||||||||
| Lys | Val | Asp | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala |
| 130 | 135 | 140 | |||||||||||||
| Asp | Asn | Val | Arg | Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His |
| 145 | 150 | 155 | 160 | ||||||||||||
| Val | Lys | ASp | Asn | Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser |
PL 206 576 B1
| 165 | 170 | 175 | |||||||||||||
| Gin | Gly | Arg | Tyr | Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp |
| 180 | 185 | 190 | |||||||||||||
| Ile | Ile | Glu | Asp | Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His |
| 195 | 200 | 205 | |||||||||||||
| Tyr | His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala |
| 210 | 215 | 220 | |||||||||||||
| Ala | Lys | Ala | His | Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Tyr | Ser | Ser | Thr | Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly |
| 245 | 250 | 255 | |||||||||||||
| Ser | Thr | Ser | Lys | Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu |
| 260 | 265 | 270 | |||||||||||||
| Lys | Glu | Leu | Tyr | Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp |
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Val | Phe | Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly |
| 290 | 295 | 300 | |||||||||||||
| Val | Ala | Ile | Pro | His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Ser | Ala | Leu | Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly |
| 325 | 330 | 335 | |||||||||||||
| Thr | Gly | Ser | Thr | Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ser | Leu | Gly | Ser | Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Leu | Ser | Ser | Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile |
| 370 | 375 | 380 | |||||||||||||
| val | Glu | Glu | Thr | Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe |
| 385 | 390 | 395 | 400 | ||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn |
| 405 | 410 | 415 | |||||||||||||
| Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr |
| 420 | 425 | 430 | |||||||||||||
| Ser | His | Glu | Lys | His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg |
| 435 | 440 | 445 | |||||||||||||
| Ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His |
| 450 | 455 | 460 | |||||||||||||
| Asn | His | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Gin | Lys | His | Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | |||
| 500 | 505 |
<210> 58 <211> 1057 <212> PRT <213> S. pneumoniae <400> 58
| Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin |
| 20 | 25 | 30 | |||||||||||||
| Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile |
| 35 | 40 | 45 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu |
PL 206 576 B1
55 60
| Ser | Ile Val Val Asn Lys | Glu Lys Asn Ala | Ile | ile | Tyr | Pro | His | Gly | |||||||
| 65 | 70 | 75 | 80 | ||||||||||||
| Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly | Ile |
| 85 | 90 | 95 | |||||||||||||
| Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val |
| 100 | 105 | 110 | |||||||||||||
| Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn |
| 115 | 120 | 125 | |||||||||||||
| Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr |
| 130 | 135 | 140 | |||||||||||||
| Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro | Asp |
| 165 | 170 | 175 | |||||||||||||
| Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly | Val |
| 180 | 185 | 190 | |||||||||||||
| Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin |
| 195 | 200 | 205 | |||||||||||||
| Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr |
| 210 | 215 | 220 | |||||||||||||
| ASp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val |
| 245 | 250 | 255 | |||||||||||||
| Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg | Val |
| 260 | 265 | 270 | |||||||||||||
| Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val |
| 275 | 280 | 285 | |||||||||||||
| Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg |
| 290 | 295 | 300 | |||||||||||||
| Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu |
| 325 | 330 | 335 | |||||||||||||
| Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys |
| 340 | 345 | 350 | |||||||||||||
| Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr |
| 370 | 375 | 380 | |||||||||||||
| Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | val | ASp | Pro | Val | Gin | Glu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val |
| 405 | 410 | 415 | |||||||||||||
| Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu |
| 420 | 425 | 430 | |||||||||||||
| Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly |
| 435 | 440 | 445 | |||||||||||||
| Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr |
| 450 | 455 | 460 | |||||||||||||
| Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly |
| 485 | 490 | 495 | |||||||||||||
| Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro |
| 500 | 505 | 510 |
PL 206 576 B1
| Ala Leu Glu Glu Ala | Pro | Ala Val Asp 520 | Pro | Val | Gin Glu Lys 525 | Leu | Glu | ||||||||
| 515 | |||||||||||||||
| Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn |
| 530 | 535 | 540 | |||||||||||||
| Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys |
| 545 | 550 | 555 | 560 | ||||||||||||
| Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | Lys | Leu | Arg | Tyr | Arg | Ser | Asn | His |
| 565 | 570 | 575 | |||||||||||||
| Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro | Ser | Pro | Gin | Pro | Thr | Pro |
| 580 | 585 | 590 | |||||||||||||
| Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro |
| 595 | 600 | 605 | |||||||||||||
| Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val | Arg | Lys | Val |
| 610 | 615 | 620 | |||||||||||||
| Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro |
| 625 | 630 | 635 | 640 | ||||||||||||
| Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu |
| 645 | 650 | 655 | |||||||||||||
| Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp |
| 660 | 665 | 670 | |||||||||||||
| Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu |
| 675 | 680 | 685 | |||||||||||||
| Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp |
| 690 | 695 | 700 | |||||||||||||
| Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser |
| 705 | 710 | 715 | 720 | ||||||||||||
| Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile |
| 725 | 730 | 735 | |||||||||||||
| Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr |
| 740 | 745 | 750 | |||||||||||||
| Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu |
| 755 | 760 | 765 | |||||||||||||
| Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp |
| 770 | 775 | 780 | |||||||||||||
| Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp |
| 785 | 790 | 795 | 800 | ||||||||||||
| Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu |
| 805 | 810 | 815 | |||||||||||||
| Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr |
| 820 | 825 | 830 | |||||||||||||
| Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys |
| 835 | 840 | 845 | |||||||||||||
| Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu |
| 850 | 855 | 860 | |||||||||||||
| Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly |
| 885 | 890 | 895 | |||||||||||||
| Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His |
| 900 | 905 | 910 | |||||||||||||
| Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp |
| 915 | 920 | 925 | |||||||||||||
| His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | Ala | Asp | Thr | Asn | Gin | Thr | Glu |
| 930 | 935 | 940 | |||||||||||||
| Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr | Glu | Lys | Pro | Glu | Glu | Glu | Thr |
| 945 | 950 | 955 | 960 | ||||||||||||
| Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys | Pro | Glu | Ser | Pro | Lys | Pro |
PL 206 576 B1
| 965 | 970 | 975 | |
| Thr Glu | Glu Pro Glu Glu | Glu Ser Pro Glu Glu Ser | Glu Glu Pro Gin |
| 980 | 985 | 990 | |
| Val Glu | Thr Glu Lys Val | Glu Glu Lys Leu Arg Glu | Ala Glu Asp Leu |
| 995 | 1000 | 1005 | |
| Leu Gly | Lys Ile Gin Asp | Pro Ile Ile Lys Ser Asn | Ala Lys Glu Thr |
| 1010 | 1015 1020 | ||
| Leu Thr | Gly Leu Lys Asn | Asn Leu Leu Phe Gly Thr | Gin Asp Asn Asn |
| 1025 | 1030 1035 | 1040 | |
| Thr Ile | Met Ala Glu Ala | Glu Lys Leu Leu Ala Leu | Leu Lys Glu Ser |
| 1045 | 1050 | 1055 |
Lys <210> 59 <211> 205 <212> PRT <213> S. pneumoniae <400> 59
| Cys Ala Tyr Ala Leu Asn Gin His Arg Ser Gin Glu Asn Lys Asp Asn | |||
| 1 | 5 | 10 | 15 |
| Asn Arg Val Ser | Tyr Val | Asp Gly Ser Gin | Ser Ser Gin Lys Ser Glu |
| 20 | 25 | 30 | |
| Asn Leu Thr Pro | Asp Gin | Val Ser Gin Lys | Glu Gly Ile Gin Ala Glu |
| 35 | 40 | 45 | |
| Gin Ile Val Ile | Lys Ile | Thr Asp Gin Gly | Tyr Val Thr Ser His Gly |
| 50 | 55 | 60 | |
| Asp His Tyr His | Tyr Tyr | Asn Gly Lys Val | Pro Tyr Asp Ala Leu Phe |
| 65 | 70 | 75 80 | |
| Ser Glu Glu Leu | Leu Met | Lys Asp Pro Asn | Tyr Gin Leu Lys Asp Ala |
| 85 | 90 | 95 | |
| Asp Ile Val Asn | Glu Val | Lys Gly Gly Tyr | Ile Ile Lys Val Asp Gly |
| 100 | 105 | 110 | |
| Lys Tyr Tyr Val | Tyr Leu | Lys Asp Ala Ala | His Ala Asp Asn Val Arg |
| 115 | 120 | 125 | |
| Thr Lys Asp Glu | Ile Asn | Arg Gin Lys Gin | Glu His Val Lys Asp Asn |
| 130 | 135 | 140 | |
| Glu Lys Val Asn | Ser Asn | Val Ala Val Ala | Arg Ser Gin Gly Arg Tyr |
| 145 | 150 | 155 160 | |
| Thr Thr Asn Asp | Gly Tyr | Val Phe Asn Pro | Ala Asp Ile Ile Glu Asp |
| 165 | 170 | 175 | |
| Thr Gly Asn Ala | Tyr Ile | Val Pro His Gly | Gly His Tyr His Tyr Ile |
| 180 | 185 | 190 | |
| Pro Lys Ser Asp | Leu Ser | Ala Ser Glu Leu | Ala Ala Ala |
| 195 | 200 | 205 | |
| <210> 60 | |||
| <211> 821 | |||
| <212> PRT | |||
| <213> S. pneumoniae | |||
| <400> 60 | |||
| Cys Ala Tyr Glu | Leu Gly | Leu His Gin Ala | Gin Thr Val Lys Glu Asn |
| 1 | 5 | 10 | 15 |
| Asn Arg Val Ser | Tyr Ile | Asp Gly Lys Gin | Ala Thr Gin Lys Thr Glu |
| 20 | 25 | 30 |
PL 206 576 B1
| Asn Leu Thr | Pro Asp Glu Val | Ser Lys Arg Glu Gly Ile Asn Ala Glu | |||||||||||||
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ser |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Glu | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Ser | Gin | His | Arg |
| 130 | 135 | 140 | |||||||||||||
| Glu | Gly | Gly | Thr | Ser | Ala | Asn | Asp | Gly | Ala | Val | Ala | Phe | Ala | Arg | Ser |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gin | Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp |
| 165 | 170 | 175 | |||||||||||||
| Ile | Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Ala | Glu | Ala | Phe | Leu | Ser | Gly | Arg | Glu | Asn | Leu | Ser | Asn | Leu | Arg | Thr |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Arg | Arg | Gin | Asn | Ser | Asp | Asn | Thr | Pro | Arg | Thr | Asn | Trp | Val | Pro |
| 225 | 230 | 235 | 240 | ||||||||||||
| Ser | Val | Ser | Asn | Pro | Gly | Thr | Thr | Asn | Thr | Asn | Thr | Ser | Asn | Asn | Ser |
| 245 | 250 | 255 | |||||||||||||
| Asn | Thr | Asn | Ser | Gin | Ala | Ser | Gin | Ser | Asn | Asp | Ile | Asp | Ser | Leu | Leu |
| 260 | 265 | 270 | |||||||||||||
| Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser | Gin | Arg | His | Val | Glu | Ser | Asp |
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala | Arg | Gly |
| 290 | 295 | 300 | |||||||||||||
| Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr | Glu | Gin |
| 305 | 310 | 315 | 320 | ||||||||||||
| Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu | Arg | Tyr |
| 325 | 330 | 335 | |||||||||||||
| Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro | Ser | Pro |
| 340 | 345 | 350 | |||||||||||||
| Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro |
| 355 | 360 | 365 | |||||||||||||
| Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala |
| 370 | 375 | 380 | |||||||||||||
| Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | val | Phe | Glu | Glu | Asn | Gly | Val | Ser |
| 385 | 390 | 395 | 400 | ||||||||||||
| Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile |
| 405 | 410 | 415 | |||||||||||||
| Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Ala |
| 420 | 425 | 430 | |||||||||||||
| Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala |
| 435 | 440 | 445 | |||||||||||||
| Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly |
| 450 | 455 | 460 | |||||||||||||
| Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys |
| 465 | 470 | 475 | 480 | ||||||||||||
| Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe |
PL 206 576 B1
| 485 | 490 | 495 | |
| Leu | Ala Pro Ile Arg 500 | His Pro Glu Arg Leu Gly Lys 505 | Pro Asn Ala Gin 510 |
| Ile | Thr Tyr Thr Asp 515 | Asp Glu Ile Gin Val Ala Lys 520 | Leu Ala Gly Lys 525 |
| Tyr | Thr Thr Glu Asp 530 | Gly Tyr Ile Phe Asp Pro Arg 535 540 | Asp Ile Thr Ser |
| Asp 545 | Glu Gly Asp Ala | Tyr Val Thr Pro His Met Thr 550 555 | His Ser His Trp 560 |
| Ile | Lys Lys Asp Ser 565 | Leu Ser Glu Ala Glu Arg Ala 570 | Ala Ala Gin Ala 575 |
| Tyr | Ala Lys Glu Lys 580 | Gly Leu Thr Pro Pro Ser Thr 585 | Asp His Gin Asp 590 |
| Ser | Gly Asn Thr Glu 595 | Ala Lys Gly Ala Glu Ala Ile 600 | Tyr Asn Arg Val 605 |
| Lys | Ala Ala Lys Lys 610 | Val Pro Leu Asp Arg Met Pro 615 620 | Tyr Asn Leu Gin |
| Tyr 625 | Thr Val Glu Val | Lys Asn Gly Ser Leu Ile Ile 630 635 | Pro His Tyr Asp 640 |
| His | Tyr His Asn Ile 645 | Lys Phe Glu Trp Phe Asp Glu 650 | Gly Leu Tyr Glu 655 |
| Ala | Pro Lys Gly Tyr 660 | Thr Leu Glu Asp Leu Leu Ala 665 | Thr Val Lys Tyr 670 |
| Tyr | Val Glu His Pro 675 | Asn Glu Arg Pro His Ser Asp 680 | Asn Gly Phe Gly 685 |
| Asn | Ala Ser Asp His 690 | Val Gin Arg Asn Lys Asn Gly 695 700 | Gin Ala Asp Thr |
| Asn 705 | Gin Thr Glu Lys | Pro Ser Glu Glu Lys Pro Gin 710 715 | Thr Glu Lys Pro 720 |
| Glu | Glu Glu Thr Pro 725 | Arg Glu Glu Lys Pro Gin Ser 730 | Glu Lys Pro Glu 735 |
| Ser | Pro Lys Pro Thr 740 | Glu Glu Pro Glu Glu Glu Ser 745 | Pro Glu Glu Ser 750 |
| Glu | Glu Pro Gin Val 755 | Glu Thr Glu Lys Val Glu Glu 760 | Lys Leu Arg Glu 765 |
| Ala | Glu Asp Leu Leu 770 | Gly Lys Ile Gin Asp Pro Ile 775 780 | Ile Lys Ser Asn |
| Ala 785 | Lys Glu Thr Leu | Thr Gly Leu Lys Asn Asn Leu 790 795 | Leu Phe Gly Thr 800 |
| Gin Leu | Asp Asn Asn Thr Ile Met Ala Glu Ala Glu Lys 805 810 Lys Glu Ser Lys 820 <210> 61 <211> 334 <212> PRT <213> S. pneumoniae <400> 61 | Leu Leu Ala Leu 815 | |
| Cys 1 | Ala Tyr Glu Leu 5 | Gly Leu His Gin Ala Gin Thr 10 | Val Lys Glu Asn 15 |
| Asn | Arg Val Ser Tyr 20 | Ile Asp Gly Lys Gin Ala Thr 25 | Gin Lys Thr Glu 30 |
| Asn | Leu Thr Pro Asp 35 | Glu Val Ser Lys Arg Glu Gly 40 | Ile Asn Ala Glu 45 |
| Gin | Ile Val Ile Lys | Ile Thr Asp Gin Gly Tyr Val | Thr Ser His Gly |
PL 206 576 B1
55 60
| Asp | His Tyr His Tyr Tyr Asn Gly Lys | Val | Pro Tyr | Asp | Ala | Ile | Ile |
| 65 | 70 | 75 | 80 | ||||
| Ser | Glu Glu Leu Leu Met Lys Asp Pro | Asn | Tyr Gin | Leu | Lys | Asp | Ser |
| 85 | 90 | 95 | |||||
| Asp | Ile Val Asn Glu Ile Lys Gly Gly | Tyr | Val Ile | Lys | Val | Asn | Gly |
| 100 105 | 110 | ||||||
| Lys | Tyr Tyr Val Tyr Leu Lys Asp Ala | Ala | His Ala | Asp | Asn | Val | Arg |
| 115 120 | 125 | ||||||
| Thr | Lys Glu Glu Ile Asn Arg Gin Lys | Gin | Glu His | Ser | Gin | His | Arg |
| 130 135 | 140 | ||||||
| Glu | Gly Gly Thr Ser Ala Asn Asp Gly | Ala | Val Ala | Phe | Ala | Arg | Ser |
| 145 | 150 | 155 | 160 | ||||
| Gin | Gly Arg Tyr Thr Thr Asp Asp Gly | Tyr | Ile Phe | Asn | Ala | Ser | Asp |
| 165 | 170 | 175 | |||||
| ile | Ile Glu Asp Thr Gly Asp Ala Tyr | Ile | Val Pro | His | Gly | Asp | His |
| 180 185 | 190 | ||||||
| Tyr | His Tyr Ile Pro Lys Asn Glu Leu | Ser | Ala Ser | Glu | Leu | Ala | Ala |
| 195 200 | 205 | ||||||
| Ala | Glu Ala Phe Leu Ser Gly Arg Glu | Asn | Leu Ser | Asn | Leu | Arg | Thr |
| 210 215 | 220 | ||||||
| Tyr | Arg Arg Gin Asn Ser Asp Asn Thr | Pro | Arg Thr | Asn | Trp | Val | Pro |
| 225 | 230 | 235 | 240 | ||||
| Ser | Val Ser Asn Pro Gly Thr Thr Asn | Thr | Asn Thr | Ser | Asn | Asn | Ser |
| 245 | 250 | 255 | |||||
| Asn | Thr Asn Ser Gin Ala Ser Gin Ser | Asn | Asp Ile | Asp | Ser | Leu | Leu |
| 260 265 | 270 | ||||||
| Lys | Gin Leu Tyr Lys Leu Pro Leu Ser | Gin | Arg His | Val | Glu | Ser | Asp |
| 275 280 | 285 | ||||||
| Gly | Leu Ile Phe Asp Pro Ala Gin Ile | Thr | Ser Arg | Thr | Ala | Arg | Gly |
| 290 295 | 300 | ||||||
| Val | Ala Val Pro His Gly Asn His Tyr | His | Phe Ile | Pro | Tyr | Glu | Gin |
| 305 | 310 | 315 | 320 | ||||
| Met | Ser Glu Leu Glu Lys Arg Ile Ala | Arg | Ile Ile | Pro | Leu | ||
| 325 | 330 | ||||||
| <210> 62 | |||||||
| <211> 487 | |||||||
| <212> PRT | |||||||
| <213> Ξ. pneumoniae | |||||||
| <400> 62 | |||||||
| Arg | Tyr Arg Ser Asn His Trp Val Pro | Asp | Ser Arg | Pro | Glu | Glu | Pro |
| 1 | 5 | 10 | 15 | ||||
| Ser | Pro Gin Pro Thr Pro Glu Pro Ser | Pro | Ser Pro | Gin | Pro | Ala | Pro |
| 20 25 | 30 | ||||||
| Asn | Pro Gin Pro Ala Pro Ser Asn Pro | Ile | Asp Glu | Lys | Leu | Val | Lys |
| 35 40 | 45 | ||||||
| Glu | Ala Val Arg Lys Val Gly Asp Gly | Tyr | Val Phe | Glu | Glu | Asn | Gly |
| 50 55 | 60 | ||||||
| Val | Ser Arg Tyr Ile Pro Ala Lys Asn | Leu | Ser Ala | Glu | Thr | Ala | Ala |
| 65 | 70 | 75 | 80 | ||||
| Gly | Ile Asp Ser Lys Leu Ala Lys Gin | Glu | Ser Leu | Ser | His | Lys | Leu |
| 85 | 90 | 95 | |||||
| Gly | Ala Lys Lys Thr Asp Leu Pro Ser | Ser | Asp Arg | Glu | Phe | Tyr | Asn |
| 100 105 | 110 | ||||||
| Lys | Ala Tyr Asp Leu Leu Ala Arg Ile | His | Gin Asp | Leu | Leu | Asp | Asn |
PL 206 576 B1
| 115 | 120 | 125 |
| Lys Gly Arg Gin Val | Asp Phe Glu Ala | Leu Asp Asn Leu Leu Glu Arg |
| 130 | 135 | 140 |
| Leu Lys Asp Val Ser | Ser Asp Lys Val | Lys Leu Val Asp Asp Ile Leu |
| 145 | 150 | 155 160 |
| Ala Phe Leu Ala Pro | Ile Arg His Pro | Glu Arg Leu Gly Lys Pro Asn |
| 165 | 170 175 | |
| Ala Gin Ile Thr Tyr | Thr Asp Asp Glu | Ile Gin Val Ala Lys Leu Ala |
| 180 | 185 | 190 |
| Gly Lys Tyr Thr Thr | Glu Asp Gly Tyr | Ile Phe Asp Pro Arg Asp Ile |
| 195 | 200 | 205 |
| Thr Ser Asp Glu Gly | Asp Ala Tyr Val | Thr Pro His Met Thr His Ser |
| 210 | 215 | 220 |
| His Trp Ile Lys Lys | Asp Ser Leu Ser | Glu Ala Glu Arg Ala Ala Ala |
| 225 | 230 | 235 240 |
| Gin Ala Tyr Ala Lys | Glu Lys Gly Leu | Thr Pro Pro Ser Thr Asp His |
| 245 | 250 255 | |
| Gin Asp Ser Gly Asn | Thr Glu Ala Lys | Gly Ala Glu Ala Ile Tyr Asn |
| 260 | 265 | 270 |
| Arg Val Lys Ala Ala | Lys Lys Val Pro | Leu Asp Arg Met Pro Tyr Asn |
| 275 | 280 | 285 |
| Leu Gin Tyr Thr Val | Glu Val Lys Asn | Gly Ser Leu Ile Ile Pro His |
| 290 | 295 | 300 |
| Tyr Asp His Tyr His | Asn Ile Lys Phe | Glu Trp Phe Asp Glu Gly Leu |
| 305 | 310 | 315 320 |
| Tyr Glu Ala Pro Lys | Gly Tyr Thr Leu | Glu Asp Leu Leu Ala Thr Val |
| 325 | 330 335 | |
| Lys Tyr Tyr Val Glu | His Pro Asn Glu | Arg Pro His Ser Asp Asn Gly |
| 340 | 345 | 350 |
| Phe Gly Asn Ala Ser | Asp His Val Gin | Arg Asn Lys Asn Gly Gin Ala |
| 355 | 360 | 365 |
| Asp Thr Asn Gin Thr | Glu Lys Pro Ser | Glu Glu Lys Pro Gin Thr Glu |
| 370 | 375 | 380 |
| Lys Pro Glu Glu Glu | Thr Pro Arg Glu | Glu Lys Pro Gin Ser Glu Lys |
| 385 | 390 | 395 400 |
| Pro Glu Ser Pro Lys | Pro Thr Glu Glu | Pro Glu Glu Glu Ser Pro Glu |
| 405 | 410 415 | |
| Glu Ser Glu Glu Pro | Gin Val Glu Thr | Glu Lys Val Glu Glu Lys Leu |
| 420 | 425 | 430 |
| Arg Glu Ala Glu Asp | Leu Leu Gly Lys | Ile Gin Asp Pro Ile Ile Lys |
| 435 | 440 | 445 |
| Ser Asn Ala Lys Glu | Thr Leu Thr Gly | Leu Lys Asn Asn Leu Leu Phe |
| 450 | 455 | 460 |
| Gly Thr Gin Asp Asn | Asn Thr Ile Met | Ala Glu Ala Glu Lys Leu Leu |
| 465 | 470 | 475 480 |
| Ala Leu Leu Lys Glu | Ser Lys | |
| 485 | ||
| <210> 63 | ||
| <211> 613 | ||
| <212> PRT | ||
| <213> S. pneumoniae | ||
| <400> 63 | ||
| Ala Glu Ala Phe Leu | Ser Gly Arg Glu | Asn Leu Ser Asn Leu Arg Thr |
| 1 5 | 10 15 | |
| Tyr Arg Arg Gin Asn | Ser Asp Asn Thr | Pro Arg Thr Asn Trp Val Pro |
PL 206 576 B1
25 30
| Ser | Val | Ser 35 | Asn | Pro Gly | Thr | Thr Asn Thr Asn Thr Ser Asn Asn | Ser | ||||||||
| 40 | 45 | ||||||||||||||
| Asn | Thr | Asn | Ser | Gin | Ala | Ser | Gin | Ser | Asn | Asp | Ile | Asp | Ser | Leu | Leu |
| 50 | 55 | 60 | |||||||||||||
| Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser | Gin | Arg | His | Val | Glu | Ser | Asp |
| 65 | 70 | 75 | 80 | ||||||||||||
| Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala | Arg | Gly |
| 85 | 90 | 95 | |||||||||||||
| Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr | Glu | Gin |
| 100 | 105 | 110 | |||||||||||||
| Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu | Arg | Tyr |
| 115 | 120 | 125 | |||||||||||||
| Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro | Ser | Pro |
| 130 | 135 | 140 | |||||||||||||
| Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala |
| 165 | 170 | 175 | |||||||||||||
| Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser |
| 180 | 185 | 190 | |||||||||||||
| Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile |
| 195 | 200 | 205 | |||||||||||||
| Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Ala |
| 210 | 215 | 220 | |||||||||||||
| Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala |
| 225 | 230 | 235 | 240 | ||||||||||||
| Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly |
| 245 | 250 | 255 | |||||||||||||
| Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys |
| 260 | 265 | 270 | |||||||||||||
| Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe |
| 275 | 280 | 285 | |||||||||||||
| Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ala | Gin |
| 290 | 295 | 300 | |||||||||||||
| Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys |
| 305 | 310 | 315 | 320 | ||||||||||||
| Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser |
| 325 | 330 | 335 | |||||||||||||
| Asp | Glu | Gly | ASp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp |
| 340 | 345 | 350 | |||||||||||||
| Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala |
| 355 | 360 | 365 | |||||||||||||
| Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp |
| 370 | 375 | 380 | |||||||||||||
| Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val |
| 385 | 390 | 395 | 400 | ||||||||||||
| Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin |
| 405 | 410 | 415 | |||||||||||||
| Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp |
| 420 | 425 | 430 | |||||||||||||
| His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu |
| 435 | 440 | 445 | |||||||||||||
| Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr |
| 450 | 455 | 460 | |||||||||||||
| Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly |
| 465 | 470 | 475 | 480 |
PL 206 576 B1
| Asn Ala | Ser | Asp His 485 | Val | Gin | Arg Asn Lys Asn Gly Gin Ala Asp Thr | ||||||||||
| 490 | 495 | ||||||||||||||
| Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr | Glu | Lys | Pro |
| 500 | 505 | 510 | |||||||||||||
| Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys | Pro | Glu |
| 515 | 520 | 525 | |||||||||||||
| Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu | Glu | Ser |
| 530 | 535 | 540 | |||||||||||||
| Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys | Leu | Arg | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | Ile | Ile | Lys | Ser | Asn |
| 565 | 570 | 575 | |||||||||||||
| Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe | Gly | Thr |
| 580 | 585 | 590 | |||||||||||||
| Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu | Leu | Ala | Leu |
| 595 | 600 | 605 | |||||||||||||
| Leu | Lys | Glu | Ser | Lys | |||||||||||
| 610 | |||||||||||||||
| <210> | 64 | ||||||||||||||
| <211> | 568 | ||||||||||||||
| <212> | PRT | ||||||||||||||
| <213> | S. pneumoniae | ||||||||||||||
| <400> | 64 | ||||||||||||||
| Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin |
| 20 | 25 | 30 | |||||||||||||
| Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile |
| 35 | 40 | 45 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu |
| 50 | 55 | 60 | |||||||||||||
| Ser | ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly |
| 65 | 70 | 75 | 80 | ||||||||||||
| Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly | Ile |
| 85 | 90 | 95 | |||||||||||||
| Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val |
| 100 | 105 | 110 | |||||||||||||
| Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn |
| 115 | 120 | 125 | |||||||||||||
| Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr |
| 130 | 135 | 140 | |||||||||||||
| Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro | Asp |
| 165 | 170 | 175 | |||||||||||||
| Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly | Val |
| 180 | 185 | 190 | |||||||||||||
| Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | ASp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin |
| 195 | 200 | 205 | |||||||||||||
| Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr |
| 210 | 215 | 220 | |||||||||||||
| Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val |
| 245 | 250 | 255 |
PL 206 576 B1
| Asn | Pro Gin | Phe 260 | Ala | Val | Pro | Lys | Gly Thr Asp Ala Leu Val | Arg | Val | ||||||
| 265 | 270 | ||||||||||||||
| Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val |
| 275 | 280 | 285 | |||||||||||||
| Gly | Glu | Ile | Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg |
| 290 | 295 | 300 | |||||||||||||
| Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu |
| 325 | 330 | 335 | |||||||||||||
| Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys |
| 340 | 345 | 350 | |||||||||||||
| Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr |
| 370 | 375 | 380 | |||||||||||||
| Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro | Val | Gin | Glu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val |
| 405 | 410 | 415 | |||||||||||||
| Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu |
| 420 | 425 | 430 | |||||||||||||
| val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly |
| 435 | 440 | 445 | |||||||||||||
| Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr |
| 450 | 455 | 460 | |||||||||||||
| Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly |
| 485 | 490 | 495 | |||||||||||||
| Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro |
| 500 | 505 | 510 | |||||||||||||
| Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu |
| 515 | 520 | 525 | |||||||||||||
| Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn |
| 530 | 535 | 540 | |||||||||||||
| Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys |
| 545 | 550 | 555 | 560 | ||||||||||||
| Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | ||||||||
| 565 |
<210> 65 <211> 329 <212> PRT <213> S. pneumoniae <400> 65
| Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin |
| 20 | 25 | 30 | |||||||||||||
| Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile |
| 35 | 40 | 45 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu |
| 50 | 55 | 60 | |||||||||||||
| Ser | ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly |
| 65 | 70 | 75 | 80 |
PL 206 576 B1
| Asp His | His | His | Ala 85 | ASp | Pro | Ile Asp Glu His Lys 90 | Pro | Val | Gly 95 | Ile | |||||
| Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val |
| 100 | 105 | 110 | |||||||||||||
| Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn |
| 115 | 120 | 125 | |||||||||||||
| Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr |
| 130 | 135 | 140 | |||||||||||||
| Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro | Asp |
| 165 | 170 | 175 | |||||||||||||
| Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly | Val |
| 180 | 185 | 190 | |||||||||||||
| Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin |
| 195 | 200 | 205 | |||||||||||||
| Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr |
| 210 | 215 | 220 | |||||||||||||
| Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val |
| 245 | 250 | 255 | |||||||||||||
| Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg | Val |
| 260 | 265 | 270 | |||||||||||||
| Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val |
| 275 | 280 | 285 | |||||||||||||
| Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg |
| 290 | 295 | 300 | |||||||||||||
| Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | |||||||
| 325 |
<210> 66 <211> 240 <212> PRT <213> S. pneumoniae <400> 66
| Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile |
| 1 | 5 | 10 | 15 | ||||||||||||
| Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp |
| 20 | 25 | 30 | |||||||||||||
| Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys |
| 35 | 40 | 45 | |||||||||||||
| Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val |
| 50 | 55 | 60 | |||||||||||||
| Pro | Thr | Val | Asp | Pro | Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser |
| 65 | 70 | 75 | 80 | ||||||||||||
| Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile |
| 85 | 90 | 95 | |||||||||||||
| Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp |
| 100 | 105 | 110 | |||||||||||||
| Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu |
| 115 | 120 | 125 | |||||||||||||
| Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn |
| 130 | 135 | 140 |
PL 206 576 B1
| Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys |
| 145 | 150 | 155 | 160 | ||||||||||||
| Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val |
| 165 | 170 | 175 | |||||||||||||
| Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val |
| 180 | 185 | 190 | |||||||||||||
| Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu |
| 195 | 200 | 205 | |||||||||||||
| Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg |
| 210 | 215 | 220 | |||||||||||||
| Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
| 225 | 230 | 235 | 240 |
<210> 67 <211> 555 <212> PRT <213> S. pneumoniae <400> 67
| Asp 1 | Ile | Asp Ser | Leu Leu Lys Gin Leu Tyr | Lys | Leu | Pro | Leu | Ser 15 | Gin | ||||||
| 5 | 10 | ||||||||||||||
| Arg | His | Val | Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr |
| 20 | 25 | 30 | |||||||||||||
| Ser | Arg | Thr | Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His |
| 35 | 40 | 45 | |||||||||||||
| Phe | Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg |
| 50 | 55 | 60 | |||||||||||||
| Ile | Ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg |
| 65 | 70 | 75 | 80 | ||||||||||||
| Pro | Glu | Glu | Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro |
| 85 | 90 | 95 | |||||||||||||
| Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu |
| 100 | 105 | 110 | |||||||||||||
| Lys | Leu | Val | Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe |
| 115 | 120 | 125 | |||||||||||||
| Glu | Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala |
| 130 | 135 | 140 | |||||||||||||
| Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg |
| 165 | 170 | 175 | |||||||||||||
| Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp |
| 180 | 185 | 190 | |||||||||||||
| Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn |
| 195 | 200 | 205 | |||||||||||||
| Leu | Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val |
| 210 | 215 | 220 | |||||||||||||
| Asp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val |
| 245 | 250 | 255 | |||||||||||||
| Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp |
| 260 | 265 | 270 | |||||||||||||
| Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His |
| 275 | 280 | 285 | |||||||||||||
| Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu |
| 290 | 295 | 300 |
PL 206 576 B1
| Arg 305 | Ala | Ala | Ala | Gin | Ala 310 | Tyr |
| Ser | Thr | Asp | His | Gin 325 | Asp | Ser |
| Ala | Ile | Tyr | Asn 340 | Arg | Val | Lys |
| Met | Pro | Tyr 355 | Asn | Leu | Gin | Tyr |
| Ile | Ile 370 | Pro | His | Tyr | Asp | His 375 |
| Asp 385 | Glu | Gly | Leu | Tyr | Glu 390 | Ala |
| Leu | Ala | Thr | Val | Lys 405 | Tyr | Tyr |
| Ser | Asp | Asn | Gly 420 | Phe | Gly | Asn |
| Asn | Gly | Gin 435 | Ala | Asp | Thr | Asn |
| Pro | Gin 450 | Thr | Glu | Lys | Pro | Glu 455 |
| Gin 465 | Ser | Glu | Lys | Pro | Glu 470 | Ser |
| Glu | Ser | Pro | Glu | Glu 485 | Ser | Glu |
| Glu | Glu | Lys | Leu 500 | Arg | Glu | Ala |
| Pro | Ile | Ile 515 | Lys | Ser | Asn | Ala |
| Asn | Leu 530 | Leu | Phe | Gly | Thr | Gin 535 |
| Glu | Lys | Leu | Leu | Ala | Leu | Leu |
| Ala | Lys | Glu | Lys 315 | Gly | Leu | Thr | Pro |
| Gly | Asn | Thr 330 | Glu | Ala | Lys | Gly | Ala 335 |
| Ala | Ala 345 | Lys | Lys | Val | Pro | Leu 350 | Asp |
| Thr 360 | Val | Glu | Val | Lys | Asn 365 | Gly | Ser |
| Tyr | His | Asn | Ile | Lys 380 | Phe | Glu | Trp |
| Pro | Lys | Gly | Tyr 395 | Thr | Leu | Glu | Asp |
| Val | Glu | His 410 | Pro | Asn | Glu | Arg | Pro 415 |
| Ala | Ser 425 | Asp | His | Val | Gin | Arg 430 | Asn |
| Gin 440 | Thr | Glu | Lys | Pro | Ser 445 | Glu | Glu |
| Glu | Glu | Thr | Pro | Arg 460 | Glu | Glu | Lys |
| Pro | Lys | Pro | Thr 475 | Glu | Glu | Pro | Glu |
| Glu | Pro | Gin 490 | Val | Glu | Thr | Glu | Lys 495 |
| Glu | Asp 505 | Leu | Leu | Gly | Lys | Ile 510 | Gin |
| Lys 520 | Glu | Thr | Leu | Thr | Gly 525 | Leu | Lys |
| Asp Lys | Asn Glu | Asn Ser | Thr Lys 555 | Ile 540 | Met | Ala | Glu |
Pro
320
Glu
Arg
Leu
Phe
Leu
400
His
Lys
Lys
Pro
Glu
480
Val
Asp
Asn
Ala
545 550 <210> 68 <211> 428 <212> PRT <213> S. pneumoniae
| <400> | 68 | |||||
| Asp 1 | Ile | Asp | Ser | Leu 5 | Leu | Lys |
| Arg | His | Val | Glu 20 | Ser | Asp | Gly |
| Ser | Arg | Thr 35 | Ala | Arg | Gly | Val |
| Phe | Ile 50 | Pro | Tyr | Glu | Gin | Met 55 |
| Ile 65 | Ile | Pro | Leu | Arg | Tyr 70 | Arg |
| Pro | Glu | Glu | Pro | Ser 85 | Pro | Gin |
| Gin | Pro | Ala | Pro 100 | Asn | Pro | Gin |
| Lys | Leu | Val 115 | Lys | Glu | Ala | Val |
| Glu | Glu 130 | Asn | Gly | Val | Ser | Arg 135 |
| Gin Leu Tyr | Lys | Leu | Pro | Leu | Ser 15 | ||
| 10 | |||||||
| Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile |
| 25 | 30 | ||||||
| Ala | Val | Pro | His | Gly | Asn | His | Tyr |
45
Ser Glu Leu Glu Lys Arg Ile Ala 60
| Ser | Asn | His | Trp 75 | Val | Pro | Asp | Ser |
| Pro | Thr | Pro 90 | Glu | Pro | Ser | Pro | Ser 95 |
| Pro | Ala 105 | Pro | Ser | Asn | Pro | Ile 110 | Asp |
| Arg 120 | Lys | Val | Gly | Asp | Gly 125 | Tyr | Val |
| Tyr | Ile | Pro | Ala | Lys 140 | Asn | Leu | Ser |
Gin
Thr
His
Arg
Arg
Pro
Glu
Phe
Ala
PL 206 576 B1
| Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu |
| 145 | 150 | 155 | 160 | ||||||||||||
| Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg |
| 165 | 170 | 175 | |||||||||||||
| Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp |
| 180 | 185 | 190 | |||||||||||||
| Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn |
| 195 | 200 | 205 | |||||||||||||
| Leu | Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val |
| 210 | 215 | 220 | |||||||||||||
| Asp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val |
| 245 | 250 | 255 | |||||||||||||
| Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp |
| 260 | 265 | 270 | |||||||||||||
| Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His |
| 275 | 280 | 285 | |||||||||||||
| Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu |
| 290 | 295 | 300 | |||||||||||||
| Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu |
| 325 | 330 | 335 | |||||||||||||
| Ala | Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg |
| 340 | 345 | 350 | |||||||||||||
| Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu |
| 355 | 360 | 365 | |||||||||||||
| Ile | Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe |
| 370 | 375 | 380 | |||||||||||||
| Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Leu | Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His |
| 405 | 410 | 415 | |||||||||||||
| Ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val |
420 425 <210> 69 <211> 121 <212> PRT <213> S. pneumoniae <400> 69
| Gly Leu Tyr 1 | Glu Ala 5 | Pro | Lys | Gly | Tyr Thr Leu Glu Asp Leu Leu Ala | ||||||||||
| 10 | 15 | ||||||||||||||
| Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp |
| 20 | 25 | 30 | |||||||||||||
| Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ala | Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin |
| 50 | 55 | 60 | |||||||||||||
| Thr | Glu | Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser |
| 65 | 70 | 75 | 80 | ||||||||||||
| Glu | Lys | Pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser |
| 85 | 90 | 95 | |||||||||||||
| Pro | Glu | Glu | Ser | Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu |
| 100 | 105 | 110 |
PL 206 576 B1
Lys Leu Arg Glu Ala Glu Asp Leu Leu 115 120 <210> 70 <211> 132 <212> PRT <213> S. pneumoniae <400> 70
| Ala Ser | Asp | His Val | Gin Arg Asn Lys Asn Gly Gin Ala Asp Thr Asn | ||||||||||||
| 1 | 5 | 10 | 15 | ||||||||||||
| Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr | Glu | Lys | Pro | Glu |
| 20 | 25 | 30 | |||||||||||||
| Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys | Pro | Glu | Ser |
| 35 | 40 | 45 | |||||||||||||
| Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu | Glu | Ser | Glu |
| 50 | 55 | 60 | |||||||||||||
| Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys | Leu | Arg | Glu | Ala |
| 65 | 70 | 75 | 80 | ||||||||||||
| Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | Ile | Ile | Lys | Ser | Asn | Ala |
| 85 | 90 | 95 | |||||||||||||
| Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe | Gly | Thr | Gin |
| 100 | 105 | 110 | |||||||||||||
| Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu | Leu | Ala | Leu | Leu |
| 115 | 120 | 125 | |||||||||||||
| Lys | Glu | Ser | Lys | ||||||||||||
| 130 |
<210> 71 <211> 226 <212> PRT <213> S. pneumoniae <400> 71
| Asp 1 | Ile | Asp | Ser | Leu 5 | Leu | Lys | Gin | Leu | Tyr 10 | Lys | Leu | Pro | Leu | Ser 15 | Gin |
| Arg | His | Val | Glu 20 | Ser | Asp | Gly | Leu | Ile 25 | Phe | Asp | Pro | Ala | Gin 30 | Ile | Thr |
| Ser | Arg | Thr 35 | Ala | Arg | Gly | Val | Ala 40 | Val | Pro | His | Gly | Asn 45 | His | Tyr | His |
| Phe | Ile 50 | Pro | Tyr | Glu | Gin | Met 55 | Ser | Glu | Leu | Glu | Lys 60 | Arg | Ile | Ala | Arg |
| Ile 65 | Ile | Pro | Leu | Arg | Tyr 70 | Arg | Ser | Asn | His | Trp 75 | Val | Pro | Asp | Ser | Arg 80 |
| Pro | Glu | Glu | Pro | Ser 85 | Pro | Gin | Pro | Thr | Pro 90 | Glu | Pro | Ser | Pro | Ser 95 | Pro |
| Gin | Pro | Ala | Pro 100 | Asn | Pro | Gin | Pro | Ala 105 | Pro | Ser | Asn | Pro | Ile 110 | Asp | Glu |
| Lys | Leu | Val 115 | Lys | Glu | Ala | Val | Arg 120 | Lys | Val | Gly | Asp | Gly 125 | Tyr | Val | Phe |
| Glu | Glu 130 | Asn | Gly | Val | Ser | Arg 135 | Tyr | Ile | Pro | Ala | Lys 140 | Asn | Leu | Ser | Ala |
| Glu 145 | Thr | Ala | Ala | Gly | Ile 150 | Asp | Ser | Lys | Leu | Ala 155 | Lys | Gin | Glu | Ser | Leu 160 |
| Ser | His | Lys | Leu | Gly 165 | Ala | Lys | Lys | Thr | Asp 170 | Leu | Pro | Ser | Ser | Asp 175 | Arg |
| Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp |
PL 206 576 B1
| 180 | 185 | 190 | |
| Leu | Leu Asp Asn Lys Gly Arg Gin 195 200 | Val Asp Phe Glu Ala 205 | Leu Asp Asn |
| Leu Asp 225 | Leu Glu Arg Leu Lys Asp Val 210 215 Asp <210> 72 <211> 203 <212> PRT <213> S. pneumoniae <400> 72 | Ser Ser Asp Lys Val 220 | Lys Leu Val |
| Asp 1 | Ile Leu Ala Phe Leu Ala Pro 5 | Ile Arg His Pro Glu 10 | Arg Leu Gly 15 |
| Lys | Pro Asn Ala Gin Ile Thr Tyr 20 | Thr Asp Asp Glu Ile 25 | Gin Val Ala 30 |
| Lys | Leu Ala Gly Lys Tyr Thr Thr 35 40 | Glu Asp Gly Tyr Ile 45 | Phe Asp Pro |
| Arg | Asp Ile Thr Ser Asp Glu Gly 50 55 | Asp Ala Tyr Val Thr 60 | Pro His Met |
| Thr 65 | His Ser His Trp Ile Lys Lys 70 | Asp Ser Leu Ser Glu 75 | Ala Glu Arg 80 |
| Ala | Ala Ala Gin Ala Tyr Ala Lys 85 | Glu Lys Gly Leu Thr 90 | Pro Pro Ser 95 |
| Thr | Asp His Gin Asp Ser Gly Asn 100 | Thr Glu Ala Lys Gly 105 | Ala Glu Ala 110 |
| Ile | Tyr Asn Arg Val Lys Ala Ala 115 120 | Lys Lys Val Pro Leu 125 | Asp Arg Met |
| Pro | Tyr Asn Leu Gin Tyr Thr Val 130 135 | Glu Val Lys Asn Gly 140 | Ser Leu Ile |
| Ile 145 | Pro His Tyr Asp His Tyr His 150 | Asn Ile Lys Phe Glu 155 | Trp Phe Asp 160 |
| Glu | Gly Leu Tyr Glu Ala Pro Lys 165 | Gly Tyr Thr Leu Glu 170 | Asp Leu Leu 175 |
| Ala Asp | Thr Val Lys Tyr Tyr Val Glu 180 Asn Gly Phe Gly Asn Ala Ser 195 200 <210> 73 <211> 819 <212> PRT <213> S. pneumoniae <400> 73 | His Pro Asn Glu Arg 185 Asp His Val | Pro His Ser 190 |
| Cys 1 | Ser Tyr Glu Leu Gly Arg His 5 | Gin Ala Gly Gin Val 10 | Lys Lys Glu 15 |
| Ser | Asn Arg Val Ser Tyr Ile Asp 20 | Gly Asp Gin Ala Gly 25 | Gin Lys Ala 30 |
| Glu | Asn Leu Thr Pro Asp Glu Val 35 40 | Ser Lys Arg Glu Gly 45 | Ile Asn Ala |
| Glu | Gin Ile Val Ile Lys Ile Thr 50 55 | Asp Gin Gly Tyr Val 60 | Thr Ser His |
| Gly 65 | Asp His Tyr His Tyr Tyr Asn 70 | Gly Lys Val Pro Tyr 75 | Asp Ala Ile 80 |
PL 206 576 B1
| Ile | Ser | Glu Glu | Leu Leu Met Lys Asp Pro Asn Tyr Gin Leu Lys Asp | ||||||||||||
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asp |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | Val | Ala | Ala | Ala | Arg | Ala | Gin | Gly |
| 145 | 150 | 155 | 160 | ||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile | Ile |
| 165 | 170 | 175 | |||||||||||||
| Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His | Tyr | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Glu |
| 195 | 200 | 205 | |||||||||||||
| Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Asn | Ala | Asn | Pro | Val | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser | Ser |
| 245 | 250 | 255 | |||||||||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala |
| 275 | 280 | 285 | |||||||||||||
| Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin | Pro |
| 325 | 330 | 335 | |||||||||||||
| Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Leu | Gin | Pro | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly |
| 370 | 375 | 380 | |||||||||||||
| Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu |
| 405 | 410 | 415 | |||||||||||||
| Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn |
| 435 | 440 | 445 | |||||||||||||
| Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 450 | 455 | 460 | |||||||||||||
| Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 485 | 490 | 495 | |||||||||||||
| Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
| 500 | 505 | 510 | |||||||||||||
| Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile |
| 515 | 520 | 525 | |||||||||||||
| Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | val | Thr | Pro | His | Met | Thr | His | Ser |
PL 206 576 B1
530 535 540
| His | Trp | ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 565 | 570 | 575 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn |
| 580 | 585 | 590 | |||||||||||||
| Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn |
| 595 | 600 | 605 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
| 625 | 630 | 635 | 640 | ||||||||||||
| Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val |
| 645 | 650 | 655 | |||||||||||||
| Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly |
| 660 | 665 | 670 | |||||||||||||
| Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp |
| 675 | 680 | 685 | |||||||||||||
| Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | Ser | Glu | Pro | Thr |
| 690 | 695 | 700 | |||||||||||||
| His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser |
| 705 | 710 | 715 | 720 | ||||||||||||
| Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu |
| 725 | 730 | 735 | |||||||||||||
| Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu | Asn |
| 740 | 745 | 750 | |||||||||||||
| Ser | Val | Ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys |
| 755 | 760 | 765 | |||||||||||||
| Val | Thr | Asp | Pro | Ser | ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly |
| 770 | 775 | 780 | |||||||||||||
| Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser |
| 785 | 790 | 795 | 800 | ||||||||||||
| Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala |
| 805 | 810 | 815 | |||||||||||||
| Pro | Ile | Gin |
| <210> | 74 | |||||||||||||
| <211> | 568 | |||||||||||||
| <212> | PRT | |||||||||||||
| <213> | S. pneumoniae | |||||||||||||
| <400> | 74 | |||||||||||||
| Glu | Asn Ile | Ser | Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser |
| 1 | 5 | 10 | 15 | |||||||||||
| Glu | Arg His | Val | Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile |
| 20 | 25 | 30 | ||||||||||||
| Thr | Ser Arg | Thr | Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr |
| 35 | 40 | 45 | ||||||||||||
| His | Phe Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala |
| 50 | 55 | 60 | ||||||||||||
| Arg | Ile Ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser |
| 65 | 70 | 75 | 80 | |||||||||||
| Arg | Pro Glu | Gin | Pro | Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser |
| 85 | 90 | 95 | ||||||||||||
| Leu | Gin Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp |
PL 206 576 B1
| 100 | 105 | 110 | |||||||||||||
| Glu | Lys | Leu | Val | Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val |
| 115 | 120 | 125 | |||||||||||||
| Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser |
| 130 | 135 | 140 | |||||||||||||
| Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser |
| 145 | 150 | 155 | 160 | ||||||||||||
| Leu | Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp |
| 165 | 170 | 175 | |||||||||||||
| Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin |
| 180 | 185 | 190 | |||||||||||||
| Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu | Asp |
| 195 | 200 | 205 | |||||||||||||
| Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu |
| 210 | 215 | 220 | |||||||||||||
| Val | Asp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin |
| 245 | 250 | 255 | |||||||||||||
| Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala |
| 290 | 295 | 300 | |||||||||||||
| Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala |
| 325 | 330 | 335 | |||||||||||||
| Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp |
| 340 | 345 | 350 | |||||||||||||
| Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser |
| 355 | 360 | 365 | |||||||||||||
| Leu | Ile | Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp |
| 370 | 375 | 380 | |||||||||||||
| Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro |
| 405 | 410 | 415 | |||||||||||||
| His | Ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu |
| 435 | 440 | 445 | |||||||||||||
| Val | Ser | Glu | Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala |
| 450 | 455 | 460 | |||||||||||||
| Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr |
| 465 | 470 | 475 | 480 | ||||||||||||
| Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile |
| 485 | 490 | 495 | |||||||||||||
| Pro | Gin | Val | Glu | Asn | Ser | Val | Ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu |
| 500 | 505 | 510 | |||||||||||||
| Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp | Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met |
| 515 | 520 | 525 | |||||||||||||
| Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp |
| 530 | 535 | 540 | |||||||||||||
| Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys |
| 545 | 550 | 555 | 560 |
PL 206 576 B1
Glu Ser Gin Pro Ala Pro Ile Gin 565 <210> 75 <211> 140 <212> PRT <213> S. pneumoniae <400> 75
| Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys |
| 1 | 5 | 10 | 15 | ||||||||||||
| Glu | His | Asp | Glu | Val | Ser | Glu | Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro |
| 35 | 40 | 45 | |||||||||||||
| Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp |
| 50 | 55 | 60 | |||||||||||||
| Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu | Asn | Ser | Val | Ile | Asn | Ala | Lys | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp | Pro | Ser | Ile | Arg |
| 85 | 90 | 95 | |||||||||||||
| Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu |
| 100 | 105 | 110 | |||||||||||||
| Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val | Asp | Ser | Leu | Leu |
| 115 | 120 | 125 | |||||||||||||
| Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin | ||||
| 130 | 135 | 140 |
<210> 76 <211> 3171 <212> DNA <213> S. pneumoniae <400:
gacttgacag cataatggat atgaaagatt gtcaaacgtg gatcaccatc agtaactatg tatactggag caaaacttta gagaaaaaat gagaaagtat gatcaacctt gaagtaagtt caaacgattt gcagtgccta tatttagaaa ggaacaacca gacaatcaat aaaccaagta gaaaaggtag gggaatagta aaagtagcaa gacggaacaa tttacaggag aagagcaaat tagattcttt tagataaaaa aaagtattgt atgcagatcc aactgtttaa aagaattaac ctctagccaa taggtatcaa ctggtaaagt atttaccagg atgatggtac tctatccttt aaggaactga ataactataa gaacggccgg cgacttatat ttctaccaca aagaaccaaa ctagtaattc aatttgctga ttgaattata aagcacctca taaggctgcg gtcatctcat aatcgaagaa cgtgaataaa gattgatgaa acccgaagaa gaatgttgtt tggtcaaaaa tatgctagta atttggagaa acaaacattt atttacagtt ccatgcaggg tgctttagtc agttggtgaa aaataaaatt tgtggaagta atttaaaagg gactagtgag aacgttagaa aagttatggg tttaccatca aggaaatggt caaaaacatt gaacaggatt aaaattgctg gaaaaaaatg cataaaccgg ggagttgcta aatttgttaa cgcgtttctt aaattaataa ggagtaggga aagtatacta ccaacctctt gatacttatt agagtgtttg atcaaattac cctgtaacct cctatcttgg aataaagcac aaggtagaaa gaagttccta atgaagctag ggagaagtca gaaaataaac tagaggaagt atccaggtaa gcattatgaa cgattattta ttggaattgg aaaaagaagg aaaatagtac ttagttttcc caccagatgg atattgcaaa tcgcttcaaa tagcttacaa taagagtgaa atgaatttca cgattccgaa tcatggcaaa aaaaagaaaa aagaaaactc aagaaaaact cagtggatcc aaaatgtctt ttaaaaagaa catctgaaaa taaaactagt tgccaaagaa aoaatatggt tccgcatgga tcattctcac gaataaagtt gtttaataat gcctgaattg aaaagtattg ctttgaatta agattatcca aatggccagt ccctcaattt tggaaatgct attaaaccaa tgcttatttg tcaaactgat aaaacttgat ttctgaaact tgtacaagaa gtttaatatg tatggcagat tggaaaagta
120
180
240
300
360
420
480
540
600
660
720
780
840
900
960
1020
1080
1140
1200
1260
1320
1380
PL 206 576 B1 tctactggaa cagttgagaa ccaaccaaca gaaaataaac cagcagattc tttaccagag 1440 gcaccaaacg aaaaacctgt aaaaccagaa aactcaacgg ataatggaat gttgaatcca 1500 gaagggaatg tggggagtga ccctatgtta gatccagcat tagaggaagc tccagcagta 1560 gatcctgtac aagaaaaatt agaaaaattt acagctagtt acggattagg cttagatagt 1620 gttatattca atatggatgg aacgattgaa ttaagattgc caagtggaga agtgataaaa 1680 aagaatttat ctgatttcat agcgaagctt cgttatcgtt caaaccattg ggtaccagat 1740 tcaagaccag aagaaccaag tccacaaccg actccagaac ctagtccaag tccgcaacct 1800 gcaccaaatc ctcaaccagc tccaagcaat ccaattgatg agaaattggt caaagaagct 1860 gttcgaaaag taggcgatgg ttatgtcttt gaggagaatg gagtttctcg ttatatccca 1920 gccaagaatc tttcagcaga aacagcagca ggcattgata gcaaactggc caagcaggaa 1980 agtttatctc ataagctagg agctaagaaa actgacctcc catctagtga tcgagaattt 2040 tacaataagg cttatgactt actagcaaga attcaccaag atttacttga taataaaggt 2100 cgacaagttg attttgaggc tttggataac ctgttggaac gactcaagga tgtctcaagt 2160 gataaagtca agttagtgga tgatattctt gccttcttag ctccgattcg tcatccagaa 2220 cgtttaggaa aaccaaatgc gcaaattacc tacactgatg atgagattca agtagccaag 2280 ttggcaggca agtacacaac agaagacggt tatatctttg atcctcgtga tataaccagt 2340 gatgaggggg atgcctatgt aactccacat atgacccata gccactggat taaaaaagat 2400 agtttgtctg aagctgagag agcggcagcc caggcttatg ctaaagagaa aggtttgacc 2460 cctccttcga cagaccatca ggattcagga aatactgagg caaaaggagc agaagctatc 2520 tacaaccgcg tgaaagcagc taagaaggtg ccacttgatc gtatgcctta caatcttcaa 2580 tatactgtag aagtcaaaaa cggtagttta atcatacctc attatgacca ttaccataac 2640 atcaaatttg agtggtttga cgaaggcctt tatgaggcac ctaaggggta tactcttgag 2700 gatcttttgg cgactgtcaa gtactatgtc gaacatccaa acgaacgtcc gcattcagat 2760 aatggttttg gtaacgctag cgaccatgtt caaagaaaca aaaatggtca agctgatacc 2820 aatcaaacgg aaaaaccaag cgaggagaaa cctcagacag aaaaacctga ggaagaaacc 2880 cctcgagaag agaaaccaca aagcgagaaa ccagagtctc caaaaccaac agaggaacca 2940 gaagaagaat caccagagga atcagaagaa cctcaggtcg agactgaaaa ggttgaagaa 3000 aaactgagag aggctgaaga tttacttgga aaaatccagg atccaattat caagtccaat 3060 gccaaagaga ctctcacagg attaaaaaat aatttactat ttggcaccca ggacaacaat 3120 actattatgg cagaagctga aaaactattg gctttattaa aggagagtaa g 3171 <210> 77 <211> 473 <212> PRT <213> S. pneumoniae <400> 77
| Glu 1 | Ala Tyr | Trp Asn Gly Lys Gin Gly Ser Arg | Pro | Ser | Ser | Ser 15 | Ser | ||||||||
| 5 | 10 | ||||||||||||||
| Ser | Tyr | Asn | Ala | Asn | Pro | Val | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 20 | 25 | 30 | |||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 35 | 40 | 45 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 50 | 55 | 60 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 85 | 90 | 95 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 100 | 105 | 110 | |||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 115 | 120 | 125 | |||||||||||||
| Pro | Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Leu | Gin | Pro | Ala |
| 130 | 135 | 140 | |||||||||||||
| Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val |
| 145 | 150 | 155 | 160 |
PL 206 576 B1
| Lys Glu Ala Val Arg Lys Val Gly Asp Gly | Tyr | Val | Phe | Glu | Glu 175 | Asn | ||
| 165 | 170 | |||||||
| Gly Val Ser | Arg Tyr | Ile Pro Ala Lys Asp | Leu | Ser | Ala | Glu | Thr | Ala |
| 180 | 185 | 190 | ||||||
| Ala Gly Ile | Asp Ser | Lys Leu Ala Lys Gin | Glu | Ser | Leu | Ser | His | Lys |
| 195 | 200 | 205 | ||||||
| Leu Gly Ala | Lys Lys | Thr Asp Leu Pro Ser | Ser | Asp | Arg | Glu | Phe | Tyr |
| 210 | 215 | 220 | ||||||
| Asn Lys Ala | Tyr Asp | Leu Leu Ala Arg Ile | His | Gin | Asp | Leu | Leu | Asp |
| 225 | 230 | 235 | 240 | |||||
| Asn Lys Gly | Arg Gin | Val Asp Phe Glu Val | Leu | Asp | Asn | Leu | Leu | Glu |
| 245 | 250 | 255 | ||||||
| Arg Leu Lys | Asp Val | Ser Ser Asp Lys Val | Lys | Leu | Val | Asp | Asp | Ile |
| 260 | 265 | 270 | ||||||
| Leu Ala Phe | Leu Ala | Pro Ile Arg His Pro | Glu | Arg | Leu | Gly | Lys | Pro |
| 275 | 280 | 285 | ||||||
| Asn Ala Gin | Ile Thr | Tyr Thr Asp Asp Glu | Ile | Gin | Val | Ala | Lys | Leu |
| 290 | 295 | 300 | ||||||
| Ala Gly Lys | Tyr Thr | Thr Glu Asp Gly Tyr | Ile | Phe | Asp | Pro | Arg | Asp |
| 305 | 310 | 315 | 320 | |||||
| Ile Thr Ser | Asp Glu | Gly Asp Ala Tyr Val | Thr | Pro | His | Met | Thr | His |
| 325 | 330 | 335 | ||||||
| Ser His Trp | Ile Lys | Lys Asp Ser Leu Ser | Glu | Ala | Glu | Arg | Ala | Ala |
| 340 | 345 | 350 | ||||||
| Ala Gin Ala | Tyr Ala | Lys Glu Lys Gly Leu | Thr | Pro | Pro | Ser | Thr | Asp |
| 355 | 360 | 365 | ||||||
| His Gin Asp | Ser Gly | Asn Thr Glu Ala Lys | Gly | Ala | Glu | Ala | Ile | Tyr |
| 370 | 375 | 380 | ||||||
| Asn Arg val | Lys Ala | Ala Lys Lys Val Pro | Leu | Asp | Arg | Met | Pro | Tyr |
| 385 | 390 | 395 | 400 | |||||
| Asn Leu Gin | Tyr Thr | Val Glu Val Lys Asn | Gly | Ser | Leu | Ile | Ile | Pro |
| 405 | 410 | 415 | ||||||
| His Tyr Asp | His Tyr | His Asn Ile Lys Phe | Glu | Trp | Phe | Asp | Glu | Gly |
| 420 | 425 | 430 | ||||||
| Leu Tyr Glu | Ala Pro | Lys Gly Tyr Ser Leu | Glu | Asp | Leu | Leu | Ala | Thr |
| 435 | 440 | 445 | ||||||
| Val Lys Tyr | Tyr Val | Glu His Pro Asn Glu | Arg | Pro | His | Ser | Asp | Asn |
| 450 | 455 | 460 | ||||||
| Gly Phe Gly | Asn Ala | Ser Asp His Val | ||||||
| 465 | 470 | |||||||
| <210> | 78 | |||||||
| <211> | 780 | |||||||
| <212> | PRT | |||||||
| <213> | S. pneumoniae | |||||||
| <400> | 78 | |||||||
| Cys Ala Tyr | Ala Leu | Asn Gin His Arg Ser | Gin | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | |||||
| Asn Arg Val | Ser Tyr | Val Asp Gly Ser Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | ||||||
| Asn Leu Thr | Pro Asp | Gin Val Ser Gin Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | ||||||
| Gin Ile Val | Ile Lys | Ile Thr Asp Gin Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | ||||||
| Asp His Tyr | His Tyr | Tyr Asn Gly Lys Val | Pro | Tyr | Asp | Ala | Leu | Phe |
70 75 80
PL 206 576 B1
| Ser | Glu | Glu | Leu | Leu 85 | Met | Lys | Asp | Pro | Asn 90 | Tyr | Gin | Leu | Lys | Asp 95 | Ala |
| Asp | Ile | Val | Asn 100 | Glu | Val | Lys | Gly | Gly 105 | Tyr | Ile | Ile | Lys | Val 110 | Asp | Gly |
| Lys | Tyr | Tyr 115 | Val | Tyr | Leu | Lys | Asp 120 | Ala | Ala | His | Ala | Asp 125 | Asn | Val | Arg |
| Thr | Lys 130 | Asp | Glu | Ile | Asn | Arg 135 | Gin | Lys | Gin | Glu | His 140 | Val | Lys | Asp | Asn |
| Glu 145 | Lys | Val | Asn | Ser | Asn 150 | Val | Ala | Val | Ala | Arg 155 | Ser | Gin | Gly | Arg | Tyr 160 |
| Thr | Thr | Asn | Asp | Gly 165 | Tyr | Val | Phe | Asn | Pro 170 | Ala | Asp | Ile | Ile | Glu 175 | Asp |
| Thr | Gly | Asn | Ala 180 | Tyr | Ile | Val | Pro | His 185 | Gly | Gly | His | Tyr | His 190 | Tyr | Ile |
| Pro | Lys | Ser 195 | Asp | Leu | Ser | Ala | Ser 200 | Glu | Leu | Ala | Ala | Ala 205 | Lys | Ala | His |
| Leu | Ala 210 | Gly | Lys | Asn | Met | Gin 215 | Pro | Ser | Gin | Leu | Ser 220 | Tyr | Ser | Ser | Thr |
| Ala 225 | Ser | Asp | Asn | Asn | Thr 230 | Gin | Ser | Val | Ala | Lys 235 | Gly | Ser | Thr | Ser | Lys 240 |
| Pro | Ala | Asn | Lys | Ser 245 | Glu | Asn | Leu | Gin | Ser 250 | Leu | Leu | Lys | Glu | Leu 255 | Tyr |
| Asp | Ser | Pro | Ser 260 | Ala | Gin | Arg | Tyr | Ser 265 | Glu | Ser | Asp | Gly | Leu 270 | Val | Phe |
| Asp | Pro | Ala 275 | Lys | Ile | Ile | Ser | Arg 280 | Thr | Pro | Asn | Gly | Val 285 | Ala | Ile | Pro |
| His | Gly 290 | Asp | His | Tyr | His | Phe 295 | Ile | Pro | Tyr | Ser | Lys 300 | Leu | Ser | Ala | Leu |
| Glu 305 | Glu | Lys | Ile | Ala | Arg 310 | Met | Val | Pro | Ile | Ser 315 | Gly | Thr | Gly | Ser | Thr 320 |
| Val | Ser | Thr | Asn | Ala 325 | Lys | Pro | Asn | Glu | Val 330 | Val | Ser | Ser | Leu | Gly 335 | Ser |
| Leu | Ser | Ser | Asn 340 | Pro | Ser | Ser | Leu | Thr 345 | Thr | Ser | Lys | Glu | Leu 350 | Ser | Ser |
| Ala | Ser | Asp 355 | Gly | Tyr | Ile | Phe | Asn 360 | Pro | Lys | Asp | Ile | Val 365 | Glu | Glu | Thr |
| Ala | Thr 370 | Ala | Tyr | Ile | Val | Arg 375 | His | Gly | Asp | His | Phe 380 | His | Tyr | Ile | Pro |
| Lys 385 | Ser | Asn | Gin | Ile | Gly 390 | Gin | Pro | Thr | Leu | Pro 395 | Asn | Asn | Ser | Leu | Ala 400 |
| Thr | Pro | Ser | Pro | Ser 405 | Leu | Pro | Ile | Asn | Pro 410 | Gly | Thr | Ser | His | Glu 415 | Lys |
| His | Glu | Glu | Asp 420 | Gly | Tyr | Gly | Phe | Asp 425 | Ala | Asn | Arg | Ile | Ile 430 | Ala | Glu |
| Asp | Glu | Ser 435 | Gly | Phe | Val | Met | Ser 440 | His | Gly | Asp | His | Asn 445 | His | Tyr | Phe |
| Phe | Lys 450 | Lys | Asp | Leu | Thr | Glu 455 | Glu | Gin | Ile | Lys | Ala 460 | Ala | Gin | Lys | His |
| Leu 465 | Glu | Glu | Val | Lys | Thr 470 | Ser | His | Asn | Gly | Leu 475 | Asp | Ser | Leu | Ser | Ser 480 |
| His | Glu | Gin | Asp | Tyr 485 | Pro | Gly | Asn | Ala | Lys 490 | Glu | Met | Lys | Asp | Leu 495 | Asp |
| Lys | Lys | Ile | Glu 500 | Glu | Lys | Ile | Ala | Gly 505 | Ile | Met | Lys | Gin | Tyr 510 | Gly | Val |
| Lys | Arg | Glu 515 | Ser | Ile | val | Val | Asn 520 | Lys | Glu | Lys | Asn | Ala 525 | Ile | Ile | Tyr |
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
PL 206 576 B1
530 535 540
| Val Gly Ile | Gly | His | Ser His | Ser | Asn | Tyr Glu Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | |||||||
| Glu Gly Val | Ala | Lys | Lys Glu | Gly | Asn | Lys Val Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | ||||||||
| Leu Thr Asn | Val | Val | Asn Leu | Leu | Lys | Asn Ser Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | ||||||||
| Asn Phe Thr | Leu | Ala | Asn Gly | Gin | Lys | Arg Val Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | ||||||||
| Pro Glu Leu | Glu | Lys | Lys Leu | Gly | Ile | Asn Met Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | ||||||||
| Thr Pro Asp | Gly | Lys | Val Leu | Glu | Lys | Val Ser Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | |||||||
| Glu Gly Val | Gly | Asn | Ile Ala | Asn | Phe | Glu Leu Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | ||||||||
| Pro Gly Gin | Thr | Phe | Lys Tyr | Thr | Ile | Ala Ser Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | ||||||||
| Val Ser Tyr | Asp | Gly | Thr Phe | Thr | Val | Pro Thr Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | ||||||||
| Met Ala Ser | Gin | Thr | Ile Phe | Tyr | Pro | Phe His Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | ||||||||
| Leu Arg Val | Asn | Pro | Gin Phe | Ala | Val | Pro Lys Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | |||||||
| Val Arg Val | Phe | Asp | Glu Phe | His | Gly | Asn Ala Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | ||||||||
| Tyr Lys Val | Gly | Glu | Ile Lys | Leu | Pro | Ile Pro Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | ||||||||
| Thr Thr Arg | Thr | Ala | Gly Asn | Lys | Ile | Pro Val Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | ||||||||
| Ala Tyr Leu | Asp | Asn | Gin Ser | Thr | Tyr | Ile Val Glu | ||||
| 770 | 775 | 780 | ||||||||
| <210> | 79 | |||||||||
| <211> | 690 | |||||||||
| <212> | PRT | |||||||||
| <213> | S. pneumoniae | |||||||||
| <400> | 79 | |||||||||
| Cys Ala Tyr | Glu | Leu | Gly Leu | His | Gin | Ala Gin Thr | Val | Lys | Glu | Asn |
| 1 | 5 | 10 | 15 | |||||||
| Asn Arg Val | Ser | Tyr | Ile Asp | Gly | Lys | Gin Ala Thr | Gin | Lys | Thr | Glu |
| 20 | 25 | 30 | ||||||||
| Asn Leu Thr | Pro | Asp | Glu Val | Ser | Lys | Arg Glu Gly | Ile | Asn | Ala | Glu |
| 35 | 40 | 45 | ||||||||
| Gin Ile Val | Ile | Lys | Ile Thr | Asp | Gin | Gly Tyr Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | ||||||||
| Asp His Tyr | His | Tyr | Tyr Asn | Gly | Lys | Val Pro Tyr | Asp | Ala | Ile | Ile |
| 65 | 70 | 75 | 80 | |||||||
| Ser Glu Glu | Leu | Leu | Met Lys | Asp | Pro | Asn Tyr Gin | Leu | Lys | Asp | Ser |
| 85 | 90 | 95 | ||||||||
| Asp Ile Val | Asn | Glu | Ile Lys | Gly | Gly | Tyr Val Ile | Lys | Val | Asn | Gly |
| 100 | 105 | 110 | ||||||||
| Lys Tyr Tyr | Val | Tyr | Leu Lys | Asp | Ala | Ala His Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | ||||||||
| Thr Lys Glu | Glu | Ile | Asn Arg | Gin | Lys | Gin Glu His | Ser | Gin | His | Arg |
| 130 | 135 | 140 | ||||||||
| Glu Gly Gly | Thr | Ser | Ala Asn | Asp | Gly | Ala Val Ala | Phe | Ala | Arg | Ser |
PL 206 576 B1
| 145 | 150 | 155 | 160 | ||||||||||||
| Gin | Gly | Arg | Tyr | Thr 165 | Thr | Asp | Asp | Gly | Tyr 170 | Ile | Phe | Asn | Ala | Ser 175 | Asp |
| Ile | Ile | Glu | Asp 180 | Thr | Gly | Asp | Ala | Tyr 185 | Ile | Val | Pro | His | Gly 190 | Asp | His |
| Tyr | His | Tyr 195 | Ile | Pro | Lys | Asn | Glu 200 | Leu | Ser | Ala | Ser | Glu 205 | Leu | Ala | Ala |
| Ala | Glu 210 | Ala | Phe | Leu | Ser | Gly 215 | Arg | Glu | Asn | Leu | Ser 220 | Asn | Leu | Arg | Thr |
| Tyr 225 | Arg | Arg | Gin | Asn | Ser 230 | Asp | Asn | Thr | Pro | Arg 235 | Thr | Asn | Trp | Val | Pro 240 |
| Ser | Val | Ser | Asn | Pro 245 | Gly | Thr | Thr | Asn | Thr 250 | Asn | Thr | Ser | Asn | Asn 255 | Ser |
| Asn | Thr | Asn | Ser 260 | Gin | Ala | Ser | Gin | Ser 265 | Asn | Asp | Ile | Asp | Ser 270 | Leu | Leu |
| Lys | Gin | Leu 275 | Tyr | Lys | Leu | Pro | Leu 280 | Ser | Gin | Arg | His | Val 285 | Glu | Ser | Asp |
| Gly | Leu 290 | Ile | Phe | Asp | Pro | Ala 295 | Gin | Ile | Thr | Ser | Arg 300 | Thr | Ala | Arg | Gly |
| Val 305 | Ala | Val | Pro | His | Gly 310 | Asn | His | Tyr | His | Phe 315 | Ile | Pro | Tyr | Glu | Gin 320 |
| Met | Ser | Glu | Leu | Glu 325 | Lys | Arg | Ile | Ala | Arg 330 | Ile | Ile | Pro | Leu | Arg 335 | Tyr |
| Arg | Ser | Asn | His 340 | Trp | Val | Pro | Asp | Ser 345 | Arg | Pro | Glu | Glu | Pro 350 | Ser | Pro |
| Gin | Pro | Thr 355 | Pro | Glu | Pro | Ser | Pro 360 | Ser | Pro | Gin | Pro | Ala 365 | Pro | Asn | Pro |
| Gin | Pro 370 | Ala | Pro | Ser | Asn | Pro 375 | ile | Asp | Glu | Lys | Leu 380 | Val | Lys | Glu | Ala |
| Val 385 | Arg | Lys | Val | Gly | Asp 390 | Gly | Tyr | Val | Phe | Glu 395 | Glu | Asn | Gly | Val | Ser 400 |
| Arg | Tyr | Ile | Pro | Ala 405 | Lys | Asn | Leu | Ser | Ala 410 | Glu | Thr | Ala | Ala | Gly 415 | Ile |
| Asp | Ser | Lys | Leu 420 | Ala | Lys | Gin | Glu | Ser 425 | Leu | Ser | His | Lys | Leu 430 | Gly | Ala |
| Lys | Lys | Thr 435 | Asp | Leu | Pro | Ser | Ser 440 | Asp | Arg | Glu | Phe | Tyr 445 | Asn | Lys | Ala |
| Tyr | Asp 450 | Leu | Leu | Ala | Arg | Ile 455 | His | Gin | Asp | Leu | Leu 460 | Asp | Asn | Lys | Gly |
| Arg 465 | Gin | Val | Asp | Phe | Glu 470 | Ala | Leu | Asp | Asn | Leu 475 | Leu | Glu | Arg | Leu | Lys 480 |
| Asp | Val | Ser | Ser | Asp 485 | Lys | Val | Lys | Leu | Val 490 | Asp | Asp | Ile | Leu | Ala 495 | Phe |
| Leu | Ala | Pro | Ile 500 | Arg | His | Pro | Glu | Arg 505 | Leu | Gly | Lys | Pro | Asn 510 | Ala | Gin |
| Ile | Thr | Tyr 515 | Thr | Asp | Asp | Glu | Ile 520 | Gin | Val | Ala | Lys | Leu 525 | Ala | Gly | Lys |
| Tyr | Thr 53 0 | Thr | Glu | Asp | Gly | Tyr 535 | Ile | Phe | Asp | Pro | Arg 540 | Asp | Ile | Thr | Ser |
| Asp 545 | Glu | Gly | Asp | Ala | Tyr 550 | Val | Thr | Pro | His | Met 555 | Thr | His | Ser | His | Trp 560 |
| Ile | Lys | Lys | Asp | Ser 565 | Leu | Ser | Glu | Ala | Glu 570 | Arg | Ala | Ala | Ala | Gin 575 | Ala |
| Tyr | Ala | Lys | Glu 580 | Lys | Gly | Leu | Thr | Pro 585 | Pro | Ser | Thr | Asp | His 590 | Gin | Asp |
| Ser | Gly | Asn 595 | Thr | Glu | Ala | Lys | Gly 600 | Ala | Glu | Ala | Ile | Tyr 605 | Asn | Arg | Val |
PL 206 576 B1
| Lys | Ala 610 | Ala | Lys | Lys | Val | Pro 615 | Leu | Asp | Arg | Met | Pro 620 | Tyr | Asn | Leu | Gin |
| Tyr 625 | Thr | Val | Glu | Val | Lys 630 | Asn | Gly | Ser | Leu | Ile 635 | Ile | Pro | His | Tyr | Asp 640 |
| His | Tyr | His | Asn | Ile 645 | Lys | Phe | Glu | Trp | Phe 650 | Asp | Glu | Gly | Leu | Tyr 655 | Glu |
| Ala | Pro | Lys | Gly 660 | Tyr | Thr | Leu | Glu | Asp 665 | Leu | Leu | Ala | Thr | Val 670 | Lys | Tyr |
| Tyr Asn | Val Ala 690 | Glu 675 | His | Pro | Asn | Glu | Arg 680 | Pro | His | Ser | Asp | Asn 685 | Gly | Phe | Gly |
<210> 80 <211> 2469 <212> DNA <213> S. pneumoniae <400> 80 gtgaagaaaa catatggtta tatcggctca gttgctgcca ttttactagc tactcatatt 60 ggaagttacc aacttggtaa gcatcatatg ggtctagcaa caaaggacaa tcagattgcc 120 tatattgatg acagcaaagg taaggcaaaa gcccctaaaa caaacaaaac gatggatcaa 180 atcagtgctg aagaaggcat ctctgctgaa cagatcgtag tcaaaattac tgaccaaggc 240 tatgtgacct cacacggtga ccattatcat ttttacaatg ggaaagttcc ttatgatgcg 300 attattagtg aagagttgtt gatgacggat cctaattacc gttttaaaca atcagacgtt 360 atcaatgaaa tcttagacgg ttacgttatt aaagtcaatg gcaactatta tgtttacctc 420 aagccaggta gtaagcgcaa aaacattcga accaaacaac aaattgctga gcaagtagcc 480 aaaggaacta aagaagctaa agaaaaaggt ttagctcaag tggcccatct cagtaaagaa 540 gaagttgcgg cagtcaatga agcaaaaaga caaggacgct atactacaga cgatggctat 600 atttttagtc cgacagatat cattgatgat ttaggagatg cttatttagt acctcatggt 660 aatcactatc attatattcc taaaaaggat ttgtctccaa gtgagctagc tgctgcacaa 720 gcctactgga gtcaaaaaca aggtcgaggt gctagaccgt ctgafctaccg cccgacacca 780 gccccaggtc gtaggaaagc cccaattcct gatgtgacgc ctaaccctgg acaaggtcat 840 cagccagata acggtggcta tcatccagcg cctcctaggc caaatgatgc gtcacaaaac 900 aaacaccaaa gagatgagtt taaaggaaaa acctttaagg aacttttaga tcaactacac 960 cgtcttgatt tgaaataccg tcatgtggaa gaagatgggt tgatttttga accgactcaa 1020 gtgatcaaat caaacgcttt tgggtatgtg gtgcctcatg gagatcatta tcatattatc 1080 ccaagaagtc agttatcacc tcttgaaatg gaattagcag atcgatactt agctggccaa 1140 actgaggaca atgactcagg ttcagagcac tcaaaaccat cagataaaga agtgacacat 1200 acctttcttg gtcatcgcat caaagcttac ggaaaaggct tagatggtaa accatatgat 1260 acgagtgatg cttatgtttt tagtaaagaa tccattcatt cagtggataa atcaggagtt 1320 acagctaaac acggagatca tttccactat ataggatttg gagaacttga acaatatgag 1380 ttggatgagg tcgctaactg ggtgaaagca aaaggtcaag ctgatgagct tgctgctgct 1440 ttggatcagg aacaaggcaa agaaaaacca ctctttgaca ctaaaaaagt gagtcgcaaa 1500 gtaacaaaag atggtaaagt gggctatatg atgccaaaag atggtaagga ctatttctat 1560 gctcgtgatc aacttgattt gactcagatt gcctttgccg aacaagaact aatgcttaaa 1620 gataagaagc attaccgtta tgacattgtt gacacaggta ttgagccacg acttgctgta 1680 gatgtgtcaa gtctgccgat gcatgctggt aatgctactt acgatactgg aagttcgttt 1740 gttatcccac atattgatca tatccatgtc gttccgtatt catggttgac gcgcgatcag 1800 attgcaacag tcaagtatgt gatgcaacac cccgaagttc gtccggatgt atggtctaag 1860 ccagggcatg aagagtcagg ttcggtcatt ccaaatgtta cgcctcttga taaacgtgct 1920 ggtatgccaa actggcaaat tatccattct gctgaagaag ttcaaaaagc cctagcagaa 1980 ggtcgttttg caacaccaga cggctatatt ttcgatccac gagatgtttt ggccaaagaa 2040 acttttgtat ggaaagatgg ctcctttagc atcccaagag cagatggcag ttcattgaga 2100 accattaata aatctgatct atcccaagct gagtggcaac aagctcaaga gttattggca 2160 aagaaaaata ctggtgatgc tactgatacg gataaaccca aagaaaagca acaggcagat 2220 aagagcaatg aaaaccaaca gccaagtgaa gccagtaaag aagaaaaaga atcagatgac 2280
PL 206 576 B1 tttatagaca gtttaccaga ctatggtcta gatagagcaa ccctagaaga tcatatcaat caattagcac aaaaagctaa tatcgatcct aagtatctca ttttccaacc agaaggtgtc caattttata ataaaaatgg tgaattggta acttatgata tcaagacact tcaacaaata aacccttaa <210> 81 <211> 823 <212> PRT <213> S. pneumoniae
2340
2400
2460
2469 <400> 81
| Val 1 | Lys | Lys | Thr Tyr 5 | Gly Tyr | Ile | Gly | Ser Val 10 | Ala | Ala | Ile | Leu 15 | Leu | |||
| Ala | Thr | His | Ile | Gly | Ser | Tyr | Gin | Leu | Gly | Lys | His | His | Met | Gly | Leu |
| 20 | 25 | 30 | |||||||||||||
| Ala | Thr | Lys | Asp | Asn | Gin | Ile | Ala | Tyr | Ile | Asp | Asp | Ser | Lys | Gly | Lys |
| 35 | 40 | 45 | |||||||||||||
| Ala | Lys | Ala | Pro | Lys | Thr | Asn | Lys | Thr | Met | Asp | Gin | Ile | Ser | Ala | Glu |
| 50 | 55 | 60 | |||||||||||||
| Glu | Gly | Ile | Ser | Ala | Glu | Gin | Ile | Val | Val | Lys | Ile | Thr | Asp | Gin | Gly |
| 65 | 70 | 75 | 80 | ||||||||||||
| Tyr | Val | Thr | Ser | His | Gly | Asp | His | Tyr | His | Phe | Tyr | Asn | Gly | Lys | Val |
| 85 | 90 | 95 | |||||||||||||
| Pro | Tyr | Asp | Ala | Ile | Ile | Ser | Glu | Glu | Leu | Leu | Met | Thr | Asp | Pro | Asn |
| 100 | 105 | 110 | |||||||||||||
| Tyr | Arg | Phe | Lys | Gin | Ser | Asp | Val | Ile | Asn | Glu | Ile | Leu | Asp | Gly | Tyr |
| 115 | 120 | 125 | |||||||||||||
| Val | Ile | Lys | Val | Asn | Gly | Asn | Tyr | Tyr | Val | Tyr | Leu | Lys | Pro | Gly | Ser |
| 130 | 135 | 140 | |||||||||||||
| Lys | Arg | Lys | Asn | Ile | Arg | Thr | Lys | Gin | Gin | Ile | Ala | Glu | Gin | Val | Ala |
| 145 | 150 | 155 | 160 | ||||||||||||
| Lys | Gly | Thr | Lys | Glu | Ala | Lys | Glu | Lys | Gly | Leu | Ala | Gin | val | Ala | His |
| 165 | 170 | 175 | |||||||||||||
| Leu | Ser | Lys | Glu | Glu | Val | Ala | Ala | Val | Asn | Glu | Ala | Lys | Arg | Gin | Gly |
| 180 | 185 | 190 | |||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | dy | Tyr | Ile | Phe | Ser | Pro | Thr | ASp | Ile | Ile |
| 195 | 200 | 205 | |||||||||||||
| Asp | Asp | Leu | Gly | Asp | Ala | Tyr | Leu | Val | Pro | His | Gly | Asn | His | Tyr | His |
| 210 | 215 | 220 | |||||||||||||
| Tyr | Ile | Pro | Lys | Lys | Asp | Leu | Ser | Pro | Ser | Glu | Leu | Ala | Ala | Ala | Gin |
| 225 | 230 | 235 | 240 | ||||||||||||
| Ala | Tyr | Trp | Ser | Gin | Lys | Gin | Gly | Arg | Gly | Ala | Arg | Pro | Ser | Asp | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Arg | Pro | Thr | Pro | Ala | Pro | Gly | Arg | Arg | Lys | Ala | Pro | ile | Pro | Asp | Val |
| 260 | 265 | 270 | |||||||||||||
| Thr | Pro | Asn | Pro | Gly | Gin | Gly | His | Gin | Pro | Asp | Asn | Gly | Gly | Tyr | His |
| 275 | 280 | 285 | |||||||||||||
| Pro | Ala | Pro | Pro | Arg | Pro | Asn | Asp | Ala | Ser | Gin | Asn | Lys | His | Gin | Arg |
| 290 | 295 | 300 | |||||||||||||
| Asp | Glu | Phe | Lys | Gly | Lys | Thr | Phe | Lys | Glu | Leu | Leu | Asp | Gin | Leu | His |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Leu | Asp | Leu | Lys | Tyr | Arg | His | Val | Glu | Glu | Asp | Gly | Leu | Ile | Phe |
| 325 | 330 | 335 | |||||||||||||
| Glu | Pro | Thr | Gin | Val | Ile | Lys | Ser | Asn | Ala | Phe | Gly | Tyr | Val | Val | Pro |
| 340 | 345 | 350 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Ile | Ile | Pro | Arg | Ser | Gin | Leu | Ser | Pro | Leu |
| 355 | 360 | 365 |
PL 206 576 B1
| Glu | Met 370 | Glu | Leu | Ala | Asp Arg Tyr 375 | Leu Ala Gly Gin Thr Glu Asp 380 | Asn | ||||||||
| Asp | Ser | Gly | Ser | Glu | His | Ser | Lys | Pro | Ser | Asp | Lys | Glu | Val | Thr | His |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Phe | Leu | Gly | His | Arg | Ile | Lys | Ala | Tyr | Gly | Lys | Gly | Leu | Asp | Gly |
| 405 | 410 | 415 | |||||||||||||
| Lys | Pro | Tyr | Asp | Thr | Ser | Asp | Ala | Tyr | Val | Phe | Ser | Lys | Glu | Ser | Ile |
| 420 | 425 | 430 | |||||||||||||
| His | Ser | Val | Asp | Lys | Ser | Gly | Val | Thr | Ala | Lys | His | Gly | Asp | His | Phe |
| 435 | 440 | 445 | |||||||||||||
| His | Tyr | Ile | Gly | Phe | Gly | Glu | Leu | Glu | Gin | Tyr | Glu | Leu | Asp | Glu | Val |
| 450 | 455 | 460 | |||||||||||||
| Ala | Asn | Trp | Val | Lys | Ala | Lys | Gly | Gin | Ala | Asp | Glu | Leu | Ala | Ala | Ala |
| 465 | 470 | 475 | 480 | ||||||||||||
| Leu | Asp | Gin | Glu | Gin | Gly | Lys | Glu | Lys | Pro | Leu | Phe | Asp | Thr | Lys | Lys |
| 485 | 490 | 495 | |||||||||||||
| Val | Ser | Arg | Lys | Val | Thr | Lys | Asp | Gly | Lys | Val | Gly | Tyr | Met | Met | Pro |
| 500 | 505 | 510 | |||||||||||||
| Lys | Asp | Gly | Lys | Asp | Tyr | Phe | Tyr | Ala | Arg | Asp | Gin | Leu | Asp | Leu | Thr |
| 515 | 520 | 525 | |||||||||||||
| Gin | Ile | Ala | Phe | Ala | Glu | Gin | Glu | Leu | Met | Leu | Lys | ASp | Lys | Lys | His |
| 530 | 535 | 540 | |||||||||||||
| Tyr | Arg | Tyr | Asp | Ile | Val | Asp | Thr | Gly | Ile | Glu | Pro | Arg | Leu | Ala | Val |
| 545 | 550 | 555 | 560 | ||||||||||||
| Asp | Val | Ser | Ser | Leu | Pro | Met | His | Ala | Gly | Asn | Ala | Thr | Tyr | Asp | Thr |
| 565 | 570 | 575 | |||||||||||||
| Gly | Ser | Ser | Phe | Val | Ile | Pro | His | Ile | Asp | His | Ile | His | Val | Val | Pro |
| 580 | 585 | 590 | |||||||||||||
| Tyr | Ser | Trp | Leu | Thr | Arg | Asp | Gin | Ile | Ala | Thr | Val | Lys | Tyr | Val | Met |
| 595 | 600 | 605 | |||||||||||||
| Gin | His | Pro | Glu | Val | Arg | Pro | Asp | Val | Trp | Ser | Lys | Pro | Gly | His | Glu |
| 610 | 615 | 620 | |||||||||||||
| Glu | Ser | Gly | Ser | Val | Ile | Pro | Asn | Val | Thr | Pro | Leu | Asp | Lys | Arg | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Gly | Met | Pro | Asn | Trp | Gin | Ile | Ile | His | Ser | Ala | Glu | Glu | Val | Gin | Lys |
| 645 | 650 | 655 | |||||||||||||
| Ala | Leu | Ala | Glu | Gly | Arg | Phe | Ala | Thr | Pro | Asp | Gly | Tyr | Ile | Phe | Asp |
| 660 | 665 | 670 | |||||||||||||
| Pro | Arg | Asp | Val | Leu | Ala | Lys | Glu | Thr | Phe | Val | Trp | Lys | Asp | Gly | Ser |
| 675 | 680 | 685 | |||||||||||||
| Phe | Ser | Ile | Pro | Arg | Ala | Asp | Gly | Ser | Ser | Leu | Arg | Thr | Ile | Asn | Lys |
| 690 | 695 | 700 | |||||||||||||
| Ser | Asp | Leu | Ser | Gin | Ala | Glu | Trp | Gin | Gin | Ala | Gin | Glu | Leu | Leu | Ala |
| 705 | 710 | 715 | 720 | ||||||||||||
| Lys | Lys | Asn | Thr | Gly | Asp | Ala | Thr | Asp | Thr | Asp | Lys | Pro | Lys | Glu | Lys |
| 725 | 730 | 735 | |||||||||||||
| Gin | Gin | Ala | Asp | Lys | Ser | Asn | Glu | Asn | Gin | Gin | Pro | Ser | Glu | Ala | Ser |
| 740 | 745 | 750 | |||||||||||||
| Lys | Glu | Glu | Lys | Glu | Ser | Asp | Asp | Phe | Ile | Asp | Ser | Leu | Pro | Asp | Tyr |
| 755 | 760 | 765 | |||||||||||||
| Gly | Leu | Asp | Arg | Ala | Thr | Leu | Glu | Asp | His | Ile | Asn | Gin | Leu | Ala | Gin |
| 770 | 775 | 780 | |||||||||||||
| Lys | Ala | Asn | Ile | Asp | Pro | Lys | Tyr | Leu | Ile | Phe | Gin | Pro | Glu | Gly | Val |
| 785 | 790 | 795 | 800 | ||||||||||||
| Gin | Phe | Tyr | Asn | Lys | Asn | Gly | Glu | Leu | Val | Thr | Tyr | Asp | Ile | Lys | Thr |
| 805 | 810 | 815 | |||||||||||||
| Leu | Gin | Gin | Ile | Asn | Pro | Pro |
PL 206 576 B1
820 <210> 82 <211> 2472 <212> DNA <213> S. pneumoniae <400> 82 gtgaagaaaa catatggtta tatcggctca gttgctgcca ttttactagc tactcatatt ggaagttacc aacttggtaa gcatcatatg ggtctagcaa caaaggacaa tcagattgcc tatattgatg atagcaaagg taaggcaaaa gcccctaaaa caaacaaaac gatggatcaa atcagtgctg aagaaggcat ctctgctgaa cagatcgtag tcaaaattac tgaccaaggt tatgtgacct cacacggtga ccattatcat ttttacaatg ggaaagttcc ttatgatgcg attattagtg aagagttgtt gatgacggat cctaattacc attttaaaca atcagacgtt atcaatgaaa tcttagacgg ttacgttatt aaagtcaatg gcaactatta tgtttacctc aagccaggta gtaagcgcaa aaacattcga accaaacaac aaattgctga gcaagtagcc aaaggaacta aagaagctaa agaaaaaggt ttagctcaag tggcccatct cagtaaagaa gaagttgcgg cagtcaatga agcaaaaaga caaggacgct atactacaga cgatggctat atttttagtc cgacagatat cattgatgat ttaggagacg cttatttagt acctcatggt aatcactatc attatattcc taaaaaagat ttgtctccaa gtgagctagc tgctgcacaa gcttactgga gtcaaaaaca aggtcgaggt gctagaccgt ctgattaccg cccgacacca gccccaggtc gtaggaaagc tccaattcct gatgtgacgc ctaaccctgg acaaggtcat cagccagata acggtggcta tcatccagcg cctcctaggc caaatgatgc gtcacaaaac aaacaccaaa gagatgagtt taaaggaaaa acctttaagg aacttttaga tcaactacac cgtcttgatt tgaaataccg tcatgtggaa gaagatgggt tgatttttga accgactcaa gtgatcaaat caaacgcttt tgggtatgtg gtgcctcatg gagatcatta tcatattatc ccaagaagtc agttatcacc tcttgaaatg gaattagcag atcgatactt agccggtcaa actgaggaca atgattcagg ttcagatcac tcaaaaccat cagataaaga agtgacacat acctttcttg gtcatcgcat caaagcttac ggaaaaggct tagatggtaa accatatgat acgagtgatg cttatgtttt tagtaaagaa tccattcatt cagtggataa atcaggagtt acagctaaac acggagatca tttccactat ataggatttg gagaacttga acaatatgag ttggatgagg tcgctaactg ggtgaaagca aaaggtcaag ctgatgagct tgctgctgct ttggatcagg aacaaggcaa agaaaaacca ctctttgaca ctaaaaaagt gagtcgcaaa gtaacaaaag atggtaaagt gggctatatt atgccaaaag atggcaagga ctatttctat gctcgtgatc aacttgattt gactcagatt gcctttgccg aacaagaact aatgcttaaa gataagaacc attaccgtta tgacattgtt gacacaggta ttgagccacg acttgctgta gatgtgtcaa gtctgccgat gcatgctggt aatgctactt acgatactgg aagttcgttt gttatccctc atattgatca tatccatgtc gttccgtatt catggttgac gcgcgatcag attgcaacaa tcaagtatgt gatgcaacac cccgaagttc gtccagatgt atggtctaag ccagggcatg aagagtcagg ttcggtcatt ccaaatgtta cgcctcttga taaacgtgct ggtatgccaa attggcaaat catccattct gctgaagaag ttcaaaaagc cctagcagaa ggtcgttttg caacaccaga cggctatatt ttcgatccac gagatgtttt ggccaaagaa acttttgtat ggaaagatgg ctcctttagc atcccaagag cagatggcag ttcattgaga accattaata aatctgatct atcccaagct gagtggcaac aagctcaaga gttattggca aagaaaaacg ctggtgatgc tactgatacg gataaaccca aagaaaagca acaggcagat aagagcaatg aaaaccaaca gccaagtgaa gccagtaaag aagaagaaaa agaatcagat gactttatag acagtttacc agactatggt ctagatagag caaccctaga agatcatatc aatcaattag cacaaaaagc taatatcgat cctaagtatc tcattttcca accagaaggt gtccaatttt ataataaaaa tggtgaatta gtaacttatg atatcaagac gcttcaacaa ataaaccctt aa <210> 83 <211> 824 <212> PRT <213> S. pneumoniae <400> 83
120
180
240
300
360
420
480
540
600
660
720
780
840
900
960
1020
1080
1140
1200
1260
1320
1380
1440
1500
1560
1620
1680
1740
1800
1860
1920
1980
2040
2100
2160
2220
2280
2340
2400
2460
2472
PL 206 576 B1
| Val | Lys | Lys | Thr | Tyr | Gly | Tyr | Ile | Gly | Ser | Val | Ala | Ala | Ile | Leu | Leu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ala | Thr | His | Ile | Gly | Ser | Tyr | Gin | Leu | Gly | Lys | His | His | Met | Gly | Leu |
| 20 | 25 | 30 | |||||||||||||
| Ala | Thr | Lys | Asp | Asn | Gin | Ile | Ala | Tyr | Ile | Asp | Asp | Ser | Lys | Gly | Lys |
| 35 | 40 | 45 | |||||||||||||
| Ala | Lys | Ala | Pro | Lys | Thr | Asn | Lys | Thr | Met | Asp | Gin | Ile | Ser | Ala | Glu |
| 50 | 55 | 60 | |||||||||||||
| Glu | Gly | Ile | Ser | Ala | Glu | Gin | Ile | Val | val | Lys | Ile | Thr | Asp | Gin | Gly |
| 65 | 70 | 75 | 80 | ||||||||||||
| Tyr | Val | Thr | Ser | His | Gly | Asp | His | Tyr | His | Phe | Tyr | Asn | Gly | Lys | Val |
| 85 | 90 | 95 | |||||||||||||
| Pro | Tyr | Asp | Ala | Ile | Ile | Ser | Glu | Glu | Leu | Leu | Met | Thr | Asp | Pro | Asn |
| 100 | 105 | 110 | |||||||||||||
| Tyr | His | Phe | Lys | Gin | Ser | Asp | Val | Ile | Asn | Glu | Ile | Leu | Asp | Gly | Tyr |
| 115 | 120 | 125 | |||||||||||||
| Val | Ile | Lys | Val | Asn | Gly | Asn | Tyr | Tyr | Val | Tyr | Leu | Lys | Pro | Gly | Ser |
| 130 | 135 | 140 | |||||||||||||
| Lys | Arg | Lys | Asn | Ile | Arg | Thr | Lys | Gin | Gin | Ile | Ala | Glu | Gin | Val | Ala |
| 145 | 150 | 155 | 160 | ||||||||||||
| Lys | Gly | Thr | Lys | Glu | Ala | Lys | Glu | Lys | Gly | Leu | Ala | Gin | Val | Ala | His |
| 165 | 170 | 175 | |||||||||||||
| Leu | Ser | Lys | Glu | Glu | Val | Ala | Ala | Val | Asn | Glu | Ala | Lys | Arg | Gin | Gly |
| 180 | 185 | 190 | |||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Ser | Pro | Thr | Asp | Ile | Ile |
| 195 | 200 | 205 | |||||||||||||
| Asp | Asp | Leu | Gly | Asp | Ala | Tyr | Leu | Val | Pro | His | Gly | Asn | His | Tyr | His |
| 210 | 215 | 220 | |||||||||||||
| Tyr | ile | Pro | Lys | Lys | Asp | Leu | Ser | Pro | Ser | Glu | Leu | Ala | Ala | Ala | Gin |
| 225 | 230 | 235 | 240 | ||||||||||||
| Ala | Tyr | Trp | Ser | Gin | Lys | Gin | Gly | Arg | Gly | Ala | Arg | Pro | Ser | Asp | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Arg | Pro | Thr | Pro | Ala | Pro | Gly | Arg | Arg | Lys | Ala | Pro | Ile | Pro | Asp | Val |
| 260 | 265 | 270 | |||||||||||||
| Thr | Pro | Asn | Pro | Gly | Gin | Gly | His | Gin | Pro | Asp | Asn | Gly | Gly | Tyr | His |
| 275 | 280 | 285 | |||||||||||||
| Pro | Ala | Pro | Pro | Arg | Pro | Asn | Asp | Ala | Ser | Gin | Asn | Lys | His | Gin | Arg |
| 290 | 295 | 300 | |||||||||||||
| Asp | Glu | Phe | Lys | Gly | Lys | Thr | Phe | Lys | Glu | Leu | Leu | Asp | Gin | Leu | His |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Leu | Asp | Leu | Lys | Tyr | Arg | His | Val | Glu | Glu | Asp | Gly | Leu | Ile | Phe |
| 325 | 330 | 335 | |||||||||||||
| Glu | Pro | Thr | Gin | Val | Ile | Lys | Ser | Asn | Ala | Phe | Gly | Tyr | Val | Val | Pro |
| 340 | 345 | 350 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Ile | Ile | Pro | Arg | Ser | Gin | Leu | Ser | Pro | Leu |
| 355 | 360 | 365 | |||||||||||||
| Glu | Met | Glu | Leu | Ala | Asp | Arg | Tyr | Leu | Ala | Gly | Gin | Thr | Glu | Asp | Asn |
| 370 | 375 | 380 | |||||||||||||
| Asp | Ser | Gly | Ser | Asp | His | Ser | Lys | Pro | Ser | Asp | Lys | Glu | Val | Thr | His |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Phe | Leu | Gly | His | Arg | Ile | Lys | Ala | Tyr | Gly | Lys | Gly | Leu | Asp | Gly |
| 405 | 410 | 415 | |||||||||||||
| Lys | Pro | Tyr | Asp | Thr | Ser | Asp | Ala | Tyr | Val | Phe | Ser | Lys | Glu | Ser | Ile |
| 420 | 425 | 430 | |||||||||||||
| His | Ser | Val | Asp | Lys | Ser | Gly | Val | Thr | Ala | Lys | His | Gly | Asp | His | Phe |
| 435 | 440 | 445 | |||||||||||||
| His | Tyr | Ile | Gly | Phe | Gly | Glu | Leu | Glu | Gin | Tyr | Glu | Leu | Asp | Glu | Val |
100
PL 206 576 B1
| 450 | 455 | 460 | |||||||||||||
| Ala | Asn | Trp | Val | Lys | Ala | Lys | Gly | Gin | Ala | Asp | Glu | Leu | Ala | Ala | Ala |
| 465 | 470 | 475 | 480 | ||||||||||||
| Leu. | Asp | Gin | Glu | Gin | Gly | Lys | Glu | Lys | Pro | Leu | Phe | Asp | Thr | Lys | Lys |
| 485 | 490 | 495 | |||||||||||||
| Val | Ser | Arg | Lys | Val | Thr | Lys | Asp | Gly | Lys | Val | Gly | Tyr | Ile | Met | Pro |
| 500 | 505 | 510 | |||||||||||||
| Lys | Asp | Gly | Lys | Asp | Tyr | Phe | Tyr | Ala | Arg | Asp | Gin | Leu | ASp | Leu | Thr |
| 515 | 520 | 525 | |||||||||||||
| Gin | Ile | Ala | Phe | Ala | Glu | Gin | Glu | Leu | Met | Leu | Lys | Asp | Lys | Asn | His |
| 530 | 535 | 540 | |||||||||||||
| Tyr | Arg | Tyr | Asp | Ile | Val | Asp | Thr | Gly | Ile | Glu | Pro | Arg | Leu | Ala | Val |
| 545 | 550 | 555 | 560 | ||||||||||||
| Asp | Val | Ser | Ser | Leu | Pro | Met | His | Ala | Gly | Asn | Ala | Thr | Tyr | Asp | Thr |
| 565 | 570 | 575 | |||||||||||||
| Gly | Ser | Ser | Phe | Val | Ile | Pro | His | Ile | Asp | His | Ile | His | Val | Val | Pro |
| 580 | 585 | 590 | |||||||||||||
| Tyr | Ser | Trp | Leu | Thr | Arg | Asp | Gin | Ile | Ala | Thr | Ile | Lys | Tyr | Val | Met |
| 595 | 600 | 605 | |||||||||||||
| Gin | His | Pro | Glu | Val | Arg | Pro | Asp | Val | Trp | Ser | Lys | Pro | Gly | His | Glu |
| 610 | 615 | 620 | |||||||||||||
| Glu | Ser | Gly | Ser | Val | Ile | Pro | Asn | Val | Thr | Pro | Leu | Asp | Lys | Arg | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Gly | Met | Pro | Asn | Trp | Gin | Ile | Ile | His | Ser | Ala | Glu | Glu | Val | Gin | Lys |
| 645 | 650 | 655 | |||||||||||||
| Ala | Leu | Ala | Glu | Gly | Arg | Phe | Ala | Thr | Pro | Asp | Gly | Tyr | Ile | Phe | Asp |
| 660 | 665 | 670 | |||||||||||||
| Pro | Arg | Asp | Val | Leu | Ala | Lys | Glu | Thr | Phe | Val | Trp | Lys | Asp | Gly | Ser |
| 675 | 680 | 685 | |||||||||||||
| Phe | Ser | Ile | Pro | Arg | Ala | Asp | Gly | Ser | Ser | Leu | Arg | Thr | Ile | Asn | Lys |
| 690 | 695 | 700 | |||||||||||||
| Ser | Asp | Leu | Ser | Gin | Ala | Glu | Trp | Gin | Gin | Ala | Gin | Glu | Leu | Leu | Ala |
| 705 | 710 | 715 | 720 | ||||||||||||
| Lys | Lys | Asn | Ala | Gly | Asp | Ala | Thr | Asp | Thr | Asp | Lys | Pro | Lys | Glu | Lys |
| 725 | 730 | 735 | |||||||||||||
| Gin | Gin | Ala | Asp | Lys | Ser | Asn | Glu | Asn | Gin | Gin | Pro | Ser | Glu | Ala | Ser |
| 740 | 745 | 750 | |||||||||||||
| Lys | Glu | Glu | Glu | Lys | Glu | Ser | Asp | Asp | Phe | Ile | Asp | Ser | Leu | Pro | Asp |
| 755 | 760 | 765 | |||||||||||||
| Tyr | Gly | Leu | Asp | Arg | Ala | Thr | Leu | Glu | Asp | His | Ile | Asn | Gin | Leu | Ala |
| 770 | 775 | 780 | |||||||||||||
| Gin | Lys | Ala | Asn | Ile | Asp | Pro | Lys | Tyr | Leu | Ile | Phe | Gin | Pro | Glu | Gly |
| 785 | 790 | 795 | 800 | ||||||||||||
| Val | Gin | Phe | Tyr | Asn | Lys | Asn | Gly | Glu | Leu | Val | Thr | Tyr | Asp | Ile | Lys |
| 805 | 810 | 815 | |||||||||||||
| Thr | Leu | Gin | Gin | Ile | Asn | Pro | Pro | ||||||||
| 820 | |||||||||||||||
| <210> | 84 | ||||||||||||||
| <211> | 1019 | ||||||||||||||
| <212> | PRT | ||||||||||||||
| <213> | S. pneumoniae | ||||||||||||||
| <400> | 84 | ||||||||||||||
| Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
PL 206 576 B1
101
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | ASp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Arg | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 |
102
PL 206 576 B1
| His Glu Gin Asp Tyr | Pro | Ser Asn Ala | Lys Glu Met Lys Asp Leu | Asp | |||||||||||
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 775 | 780 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Phe | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 825 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
PL 206 576 B1
103
| 930 | 935 | 940 | |
| Asp 945 | Asn Gly Met Leu Asn 950 | Pro Glu Gly Asn | Val Gly Ser Asp Pro Met 955 960 |
| Leu | Asp Pro Ala Leu Glu 965 | Glu Ala Pro Ala 970 | Val Asp Pro Val Gin Glu 975 |
| Lys | Leu Glu Lys Phe Thr 980 | Ala Ser Tyr Gly 985 | Leu Gly Leu Asp Ser Val 990 |
| Ile Val | Phe Asn Met Asp Gly Thr Ile Glu Leu 995 1000 Ile Lys Lys Asn Leu Ser Asp Leu Ile 1010 1015 <210> 85 <211> 1019 <212> PRT <213> S. pneumoniae <400> 85 | Arg Leu Pro Ser Gly Glu 1005 Ala | |
| Cys 1 | Ala Tyr Ala Leu Asn 5 | Gin His Arg Ser 10 | Gin Glu Asn Lys Asp Asn 15 |
| Asn | Arg Val Ser Tyr Val 20 | Asp Gly Ser Gin 25 | Ser Ser Gin Lys Ser Glu 30 |
| Asn | Leu Thr Pro Asp Gin 35 | Val Ser Gin Lys 40 | Glu Gly Ile Gin Ala Glu 45 |
| Gin | Ile Val Ile Lys Ile 50 | Thr Asp Gin Gly 55 | Tyr Val Thr Ser His Gly 60 |
| Asp 65 | His Tyr His Tyr Tyr 70 | Asn Gly Lys Val | Pro Tyr Asp Ala Leu Phe 75 80 |
| Ser | Glu Glu Leu Leu Met 85 | Lys Asp Pro Asn 90 | Tyr Gin Leu Lys Asp Ala 95 |
| Asp | Ile Val Asn Glu Val 100 | Lys Gly Gly Tyr 105 | Ile Ile Lys Val Asp Gly 110 |
| Lys | Tyr Tyr Val Tyr Leu 115 | Lys Asp Ala Ala 120 | His Ala Asp Asn Val Arg 125 |
| Thr | Lys Asp Glu Ile Asn 130 | Arg Gin Lys Gin 135 | Glu His Val Lys Asp Asn 140 |
| Glu 145 | Lys Val Asn Ser Asn 150 | Val Ala Val Ala | Arg Ser Gin Gly Arg Tyr 155 160 |
| Thr | Thr Asn Asp Gly Tyr 165 | Val Phe Asn Pro 170 | Ala Asp Ile Ile Glu Asp 175 |
| Thr | Gly Asn Ala Tyr Ile 180 | Val Pro His Gly 185 | Gly His Tyr His Tyr Ile 190 |
| Pro | Lys Ser Asp Leu Ser 195 | Ala Ser Glu Leu 200 | Ala Ala Ala Lys Ala His 205 |
| Leu | Ala Gly Lys Asn Met 210 | Gin Pro Ser Gin 215 | Leu Ser Tyr Ser Ser Thr 220 |
| Ala 225 | Ser Asp Asn Asn Thr 230 | Gin Ser Val Ala | Lys Gly Ser Thr Ser Lys 235 240 |
| Pro | Ala Asn Lys Ser Glu 245 | Asn Leu Gin Ser 250 | Leu Leu Lys Glu Leu Tyr 255 |
| Asp | Ser Pro Ser Ala Gin 260 | Arg Tyr Ser Glu 265 | Ser Asp Gly Leu Val Phe 270 |
| Asp | Pro Ala Lys Ile Ile 275 | Ser Arg Thr Pro 280 | Asn Gly Val Ala Ile Pro 285 |
| His | Gly Asp His Tyr His 290 | Phe Ile Pro Tyr 295 | Ser Lys Leu Ser Ala Leu 300 |
| Glu | Glu Lys Ile Ala Arg | Arg Val Pro Ile | Ser Gly Thr Gly Ser Thr |
104
PL 206 576 B1
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Ile | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Ile | Met | Ser | His | Gly | Asn | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 |
PL 206 576 B1
105
| Ala | Tyr Leu 770 | Asp Asn | Gin Ser Thr 775 | Tyr | Ile | Val Glu Val 780 | Pro | Ile Leu |
| Glu | Lys Glu | Asn Gin | Thr Asp Lys | Pro | Ser | Ile Leu Pro | Gin | Phe Lys |
| 785 | 790 | 795 | 800 | |||||
| Arg | Asn Lys | Ala Gin | Glu Asn Ser | Lys | Leu | Asp Glu Lys | Val | Glu Glu |
| 805 | 810 | 815 | ||||||
| Pro | Lys Thr | Ser Glu | Lys Val Glu | Lys | Glu | Lys Leu Ser | Glu | Thr Gly |
| 820 | 825 | 830 | ||||||
| Asn | Ser Thr | Ser Asn | Ser Thr Leu | Glu | Glu | Val Pro Thr | Val | Asp Pro |
| 835 | 840 | 845 | ||||||
| Val | Gin Glu | Lys Val | Ala Lys Phe | Ala | Glu | Ser Tyr Gly | Met | Lys Leu |
| 850 | 855 | 860 | ||||||
| Glu | Asn Val | Leu Phe | Asn Met Asp | Gly | Thr | Ile Glu Leu | Tyr | Leu Pro |
| 865 | 870 | 875 | 880 | |||||
| Ser | Gly Glu | Val Ile | Lys Lys Asn | Met | Ala | Asp Phe Thr | Gly | Glu Ala |
| 885 | 890 | 895 | ||||||
| Pro | Gin Gly | Asn Gly | Glu Asn Lys | Pro | Ser | Glu Asn Gly | Lys | Val Ser |
| 900 | 905 | 910 | ||||||
| Thr | Gly Thr | Val Glu | Asn Gin Pro | Thr | Glu | Asn Lys Pro | Ala | Asp Ser |
| 915 | 920 | 925 | ||||||
| Leu | Pro Glu | Ala Pro | Asn Glu Lys | Pro | Val | Lys Pro Glu | Asn | Ser Thr |
| 930 | 935 | 940 | ||||||
| Asp | Asn Gly | Met Leu | Asn Pro Glu | Gly | Asn | Val Gly Ser | Asp | Pro Met |
| 945 | 950 | 955 | 960 | |||||
| Leu | Asp Pro | Ala Leu | Glu Glu Ala | Pro | Ala | Val Asp Pro | Val | Gin Glu |
| 965 | 970 | 975 | ||||||
| Lys | Leu Glu | Lys Phe | Thr Ala Ser | Tyr | Gly | Leu Gly Leu | Asp | Ser Val |
| 980 | 985 | 990 | ||||||
| Ile | Phe Asn | Met Asp | Gly Thr Ile | Glu | Leu | Arg Leu Pro | Ser | Gly Glu |
| 995 | 1000 | 1005 | ||||||
| val | Ile Lys | Lys Asn | Leu Ser Asp | Leu | Ile | Ala | ||
| 1010 | 1015 | |||||||
| <210> | 86 | |||||||
| <211> | 1019 | |||||||
| <212> | PRT | |||||||
| <213> | S. pneumoniae | |||||||
| <400> | 86 | |||||||
| Cys | Ala Tyr | Ala Leu | Asn Gin His | Arg | Ser | Gin Glu Asn | Lys | Asp Asn |
| 1 | 5 | 10 | 15 | |||||
| Asn | Arg Val | Ser Tyr | Val Asp Gly | Ser | Gin | Ser Ser Gin | Lys | Ser Glu |
| 20 | 25 | 30 | ||||||
| Asn | Leu Thr | Pro Asp | Gin Val Ser | Gin | Lys | Glu Gly Ile | Gin | Ala Glu |
| 35 | 40 | 45 | ||||||
| Gin | Ile Val | Ile Lys | Ile Thr Asp | Gin | Gly | Tyr Val Thr | Ser | His Gly |
| 50 | 55 | 60 | ||||||
| Asp | His Tyr | His Tyr | Tyr Asn Gly | Lys | Val | Pro Tyr Asp | Ala | Leu Phe |
| 65 | 70 | 75 | 80 | |||||
| Ser | Glu Glu | Leu Leu | Met Lys Asp | Pro | Asn | Tyr Gin Leu | Lys | Asp Ala |
| 85 | 90 | 95 | ||||||
| Asp | Ile Val | Asn Glu | Val Lys Gly | Gly | Tyr | Ile Ile Lys | Val | Asp Gly |
| 100 | 105 | 110 | ||||||
| Lys | Tyr Tyr | Val Tyr | Leu Lys Asp | Ala | Ala | His Ala Asp | Asn | Val Arg |
| 115 | 120 | 125 | ||||||
| Thr | Lys Asp | Glu Ile | Asn Arg Gin | Lys | Gin | Glu His Val | Lys | Asp Asn |
130 135 140
106
PL 206 576 B1
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | ASp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
PL 206 576 B1
107
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 775 | 780 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Leu | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 825 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
| 930 | 935 | 940 | |||||||||||||
| Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met |
| 945 | 950 | 955 | 960 | ||||||||||||
| Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu |
| 965 | 970 | 975 | |||||||||||||
| Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val |
| 980 | 985 | 990 | |||||||||||||
| Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu |
| 995 | 1000 | 1005 | |||||||||||||
| Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Leu | Ile | Ala |
1010 1015 <210> 87 <211> 1019 <212> PRT
108
PL 206 576 B1 <213> S. pneumoniae <400> 87
| Cys | Ala | Tyr | Ala | Leu | Asn | Gin | His | Arg | Ser | Gin | Glu | Asn | Lys | Asp | Asn |
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 | |||||||||||||
| Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly |
| 100 | 105 | 110 | |||||||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | Val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu |
| 420 | 425 | 430 |
PL 206 576 B1
109
| Asp Glu Ser Gly | Phe Val | Met | Ser His Gly Asp His Asn His Tyr | Phe | |||||||||||
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | He |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 775 | 780 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Qiy |
| 820 | 825 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
110
PL 206 576 B1
| 885 | 890 | 895 | |
| Pro Gin | Gly Asn Gly Glu Asn Lys 900 | Pro Ser Glu Asn Gly Lys 905 910 | Val Ser |
| Thr Gly | Thr Val Glu Asn Gin Pro 915 920 | Thr Glu Asn Lys Pro Ala 925 | Asp Ser |
| Leu Pro 930 | Glu Ala Pro Asn Glu Lys 935 | Pro Val Lys Pro Glu Asn 940 | Ser Thr |
| Asp Asn 945 | Gly Met Leu Asn Pro Glu 950 | Gly Asn Val Gly Ser Asp 955 | Pro Met 960 |
| Leu Asp | Pro Ala Leu Glu Glu Ala 965 | Pro Ala Val Asp Pro Val 970 | Gin Glu 975 |
| Lys Leu | Glu Lys Phe Thr Ala Ser 980 | Tyr Gly Leu Gly Leu Asp 985 990 | Ser Val |
| Ile Phe Asn Met Asp Gly Thr Ile Glu Leu Arg Leu Pro Ser 995 1000 1005 Val Ile Lys Lys Asn Leu Ser Asp Phe Ile Ala 1010 1015 <210> 88 <211> 1019 <212> PRT <213> Ξ. pneumoniae <400> 88 | Gly Glu | ||
| Cys Ala 1 | Tyr Ala Leu Asn Gin His 5 | Arg Ser Gin Glu Asn Lys 10 | Asp Asn 15 |
| Asn Arg | Val Ser Tyr Val Asp Gly 20 | Ser Gin Ser Ser Gin Lys 25 30 | Ser Glu |
| Asn Leu | Thr Pro Asp Gin Val Ser 35 40 | Gin Lys Glu Gly Ile Gin 45 | Ala Glu |
| Gin Ile 50 | Val Ile Lys Ile Thr Asp 55 | Gin Gly Tyr Val Thr Ser 60 | His Gly |
| Asp His 65 | Tyr His Tyr Tyr Asn Gly 70 | Lys Val Pro Tyr Asp Ala 75 | Leu Phe 80 |
| Ser Glu | Glu Leu Leu Met Lys Asp 85 | Pro Asn Tyr Gin Leu Lys 90 | Asp Ala 95 |
| Asp Ile | Val Asn Glu Val Lys Gly 100 | Gly Tyr Ile Ile Lys Val 105 110 | Asp Gly |
| Lys Tyr | Tyr Val Tyr Leu Lys Asp 115 120 | Ala Ala His Ala Asp Asn 125 | Val Arg |
| Thr Lys 130 | Asp Glu Ile Asn Arg Gin 135 | Lys Gin Glu His Val Lys 140 | Asp Asn |
| Glu Lys 145 | Val Asn Ser Asn Val Ala 150 | Val Ala Arg Ser Gin Gly 155 | Arg Tyr 160 |
| Thr Thr | Asn Asp Gly Tyr Val Phe 165 | Asn Pro Ala Asp Ile Ile 170 | Glu Asp 175 |
| Thr Gly | Asn Ala Tyr Ile Val Pro 180 | His Arg Gly His Tyr His 185 190 | Tyr Ile |
| Pro Lys | Ser Asp Leu Ser Ala Ser 195 200 | Glu Leu Ala Ala Ala Lys 205 | Ala His |
| Leu Ala 210 | Gly Lys Asn Met Gin Pro 215 | Ser Gin Leu Ser Tyr Ser 220 | Ser Thr |
| Ala Ser 225 | Asp Asn Asn Thr Gin Ser 230 | Val Ala Lys Gly Ser Thr 235 | Ser Lys 240 |
| Pro Ala | Asn Lys Ser Glu Asn Leu 245 | Gin Ser Leu Leu Lys Glu 250 | Leu Tyr 255 |
| Asp Ser | Pro Ser Ala Gin Arg Tyr | Ser Glu Ser Asp Gly Leu | Val Phe |
PL 206 576 B1
111
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | ASp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 |
112
PL 206 576 B1
| Val | Arg | Val | Phe Asp Glu 725 | Phe | His | Gly Asn Ala 730 | Tyr | Leu | Glu | Asn 735 | Asn | ||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 775 | 780 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Phe | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 825 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
| 930 | 935 | 940 | |||||||||||||
| Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met |
| 945 | 950 | 955 | 960 | ||||||||||||
| Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu |
| 965 | 970 | 975 | |||||||||||||
| Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val |
| 980 | 985 | 990 | |||||||||||||
| Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu |
| 995 | 1000 | 1005 | |||||||||||||
| Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Leu | Ile | Ala | |||||
| 1010 | 1015 |
<210> 89 <211> 1019 <212> PRT <213> S. pneumoniae <400> 89
| Cys Ala Tyr Ala Leu Asn Gin His Arg Ser Gin Glu Asn Lys Asp Asn | |||||||||||||||
| 1 | 5 | 10 | 15 | ||||||||||||
| Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
| 20 | 25 | 30 | |||||||||||||
| Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
| 35 | 40 | 45 | |||||||||||||
| Gin | ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
| 50 | 55 | 60 | |||||||||||||
| Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Leu | Phe |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
| 85 | 90 | 95 |
PL 206 576 B1
113
| Asp | Ile Val | Asn Glu Val Lys 100 | Gly | Gly Tyr 105 | Ile | Ile Lys Val Asp Gly 110 | |||||||||
| Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg |
| 115 | 120 | 125 | |||||||||||||
| Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn |
| 130 | 135 | 140 | |||||||||||||
| Glu | Lys | Val | Asn | Ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
| 145 | 150 | 155 | 160 | ||||||||||||
| Thr | Thr | Asn | Asp | Gly | Tyr | val | Phe | Asn | Pro | Ala | Asp | Ile | Ile | Glu | Asp |
| 165 | 170 | 175 | |||||||||||||
| Thr | Gly | Asn | Ala | Tyr | Ile | Val | Pro | His | Arg | Gly | His | Tyr | His | Tyr | Ile |
| 180 | 185 | 190 | |||||||||||||
| Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
| 195 | 200 | 205 | |||||||||||||
| Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
| 210 | 215 | 220 | |||||||||||||
| Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys |
| 225 | 230 | 235 | 240 | ||||||||||||
| Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr |
| 245 | 250 | 255 | |||||||||||||
| Asp | Ser | Pro | Ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe |
| 260 | 265 | 270 | |||||||||||||
| Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro |
| 275 | 280 | 285 | |||||||||||||
| His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu |
| 290 | 295 | 300 | |||||||||||||
| Glu | Glu | Lys | Ile | Ala | Arg | Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr |
| 305 | 310 | 315 | 320 | ||||||||||||
| Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser |
| 325 | 330 | 335 | |||||||||||||
| Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser |
| 340 | 345 | 350 | |||||||||||||
| Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | Ile | Val | Glu | Glu | Thr |
| 355 | 360 | 365 | |||||||||||||
| Ala | Thr | Ala | Tyr | He | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
| 405 | 410 | 415 | |||||||||||||
| His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu |
| 420 | 425 | 430 | |||||||||||||
| Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser |
| 465 | 470 | 475 | 480 | ||||||||||||
| His | Glu | Gin | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp |
| 485 | 490 | 495 | |||||||||||||
| Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val |
| 500 | 505 | 510 | |||||||||||||
| Lys | Arg | Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr |
| 515 | 520 | 525 | |||||||||||||
| Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro |
| 530 | 535 | 540 | |||||||||||||
| Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu |
114
PL 206 576 B1
| 545 | 550 | 555 | 560 | ||||||||||||
| Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu |
| 565 | 570 | 575 | |||||||||||||
| Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin |
| 580 | 585 | 590 | |||||||||||||
| Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro |
| 595 | 600 | 605 | |||||||||||||
| Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile |
| 610 | 615 | 620 | |||||||||||||
| Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu |
| 645 | 650 | 655 | |||||||||||||
| Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu |
| 660 | 665 | 670 | |||||||||||||
| Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys |
| 675 | 680 | 685 | |||||||||||||
| Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn |
| 725 | 730 | 735 | |||||||||||||
| Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly |
| 740 | 745 | 750 | |||||||||||||
| Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu |
| 770 | 775 | 780 | |||||||||||||
| Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Phe | Asp | Glu | Lys | Val | Glu | Glu |
| 805 | 810 | 815 | |||||||||||||
| Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly |
| 820 | 825 | 830 | |||||||||||||
| Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro |
| 835 | 840 | 845 | |||||||||||||
| Val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu |
| 850 | 855 | 860 | |||||||||||||
| Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro |
| 865 | 870 | 875 | 880 | ||||||||||||
| Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala |
| 885 | 890 | 895 | |||||||||||||
| Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser |
| 900 | 905 | 910 | |||||||||||||
| Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser |
| 915 | 920 | 925 | |||||||||||||
| Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr |
| 930 | 935 | 940 | |||||||||||||
| Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met |
| 945 | 950 | 955 | 960 | ||||||||||||
| Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu |
| 965 | 970 | 975 | |||||||||||||
| Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val |
| 980 | 985 | 990 | |||||||||||||
| Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu |
| 995 | 1000 | 1005 |
PL 206 576 B1
115
| Val | Ile Lys 1010 | Lys | Asn Leu Ser Asp Leu 1015 | Ile | Ala |
| <210> <211> <212> <213> <400> | 90 819 PRT S. pneumoniae 90 | ||||
| Cys 1 | Ser Tyr | Glu | Leu Gly Arg His Gin 5 | Ala 10 | Gly Gin Val Lys Lys Glu 15 |
| Ser | Asn Arg | Val 20 | Ser Tyr Ile Asp Gly 25 | Asp | Gin Ala Gly Gin Lys Ala 30 |
| Glu | Asn Leu 35 | Thr | Pro Asp Glu Val Ser 40 | Lys | Arg Glu Gly Ile Asn Ala 45 |
| Glu | Gin Ile 50 | Val | Ile Lys Ile Thr Asp 55 | Gin | Gly Tyr Val Thr Ser His 60 |
| Gly 65 | Asp His | Tyr | His Tyr Tyr Asn Gly 70 | Lys | Val Pro Tyr Asp Ala Ile 75 80 |
| Ile | Ser Glu | Glu | Leu Leu Met Lys Asp 85 | Pro 90 | Asn Tyr Gin Leu Lys Asp 95 |
| Ser | Asp Ile | Val 100 | Asn Glu Ile Lys Gly 105 | Gly | Tyr Val Ile Lys Val Asp 110 |
| Gly | Lys Tyr 115 | Tyr | Val Tyr Leu Lys Asp 120 | Ala | Ala His Ala Asp Asn Ile 125 |
| Arg | Thr Lys 130 | Glu | Glu Ile Lys Arg Gin 135 | Lys | Gin Glu His Ser His Asn 140 |
| His 145 | Asn Ser | Arg | Ala Asp Asn Ala Val 150 | Ala | Ala Ala Arg Ala Gin Gly 155 160 |
| Arg | Tyr Thr | Thr | Asp Asp Gly Tyr Ile 165 | Phe 170 | Asn Ala Ser Asp Ile Ile 175 |
| Glu | Asp Thr | Gly 180 | Asp Ala Tyr Ile Val 185 | Pro | His Gly Asp His Tyr His 190 |
| Tyr | Ile Pro 195 | Lys | Asn Glu Leu Ser Ala 200 | Ser | Glu Leu Ala Ala Ala Glu 205 |
| Ala | Tyr Trp 210 | Asn | Gly Lys Gin Gly Ser 215 | Arg | Pro Ser Ser Ser Ser Ser 220 |
| Tyr 225 | Asn Ala | Asn | Pro Val Gin Pro Arg 230 | Leu | Ser Glu Asn His Asn Leu 235 240 |
| Thr | Val Thr | Pro | Thr Tyr His Gin Asn 245 | Gin 250 | Gly Glu Asn Ile Ser Ser 255 |
| Leu | Leu Arg | Glu 260 | Leu Tyr Ala Lys Pro 265 | Leu | Ser Glu Arg His Val Glu 270 |
| Ser | Asp Gly 275 | Leu | Ile Phe Asp Pro Ala 280 | Gin | Ile Thr Ser Arg Thr Ala 285 |
| Arg | Gly Val 290 | Ala | Val Pro His Gly Asn 295 | His | Tyr His Phe Ile Pro Tyr 300 |
| Glu 305 | Gin Met | Ser | Glu Leu Glu Lys Arg 310 | Ile | Ala Arg Ile Ile Pro Leu 315 320 |
| Arg | Tyr Arg | Ser | Asn His Trp Val Pro 325 | Asp 330 | Ser Arg Pro Glu Gin Pro 335 |
| Ser | Pro Gin | Ser 340 | Thr Pro Glu Pro Ser 345 | Pro | Ser Leu Gin Pro Ala Pro 350 |
| Asn | Pro Gin 355 | Pro | Ala Pro Ser Asn Pro 360 | Ile | Asp Glu Lys Leu Val Lys 365 |
| Glu | Ala Val 370 | Arg | Lys Val Gly Asp Gly 375 | Tyr | Val Phe Glu Glu Asn Gly 380 |
116
PL 206 576 B1
| Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu |
| 405 | 410 | 415 | |||||||||||||
| Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn |
| 435 | 440 | 445 | |||||||||||||
| Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 450 | 455 | 460 | |||||||||||||
| Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 485 | 490 | 495 | |||||||||||||
| Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
| 500 | 505 | 510 | |||||||||||||
| Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile |
| 515 | 520 | 525 | |||||||||||||
| Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser |
| 530 | 535 | 540 | |||||||||||||
| His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 565 | 570 | 575 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn |
| 580 | 585 | 590 | |||||||||||||
| Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn |
| 595 | 600 | 605 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
| 625 | 630 | 635 | 640 | ||||||||||||
| Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val |
| 645 | 650 | 655 | |||||||||||||
| Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly |
| 660 | 665 | 670 | |||||||||||||
| Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp |
| 675 | 680 | 685 | |||||||||||||
| Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | Ser | Glu | Pro | Thr |
| 690 | 695 | 700 | |||||||||||||
| His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser |
| 705 | 710 | 715 | 720 | ||||||||||||
| Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu |
| 725 | 730 | 735 | |||||||||||||
| Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu | Asn |
| 740 | 745 | 750 | |||||||||||||
| Ser | Val | Ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys |
| 755 | 760 | 765 | |||||||||||||
| Val | Thr | Asp | Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly |
| 770 | 775 | 780 | |||||||||||||
| Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser |
| 785 | 790 | 795 | 800 | ||||||||||||
| Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala |
| 805 | 810 | 815 | |||||||||||||
| Pro | Ile | Gin |
PL 206 576 B1
117 <210> 91 <211> 820 <212> PRT <213> S. pneumoniae <400> 91
| Cys 1 | Ser | Tyr | Glu | Leu 5 | Gly Arg His Gin | Ala 10 | Gly Gin Val | Lys | Lys 15 | Glu | |||||
| Ser | Asn | Arg | Val | Ser | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asp |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His | Tyr |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Glu | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | Tyr | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala |
| 340 | 345 | 350 | |||||||||||||
| Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val |
| 355 | 360 | 365 | |||||||||||||
| Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn |
| 370 | 375 | 380 | |||||||||||||
| Gly | Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys |
118
PL 206 576 B1
| 405 | 410 | 415 | |||||||||||||
| Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr |
| 420 | 425 | 430 | |||||||||||||
| Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp |
| 435 | 440 | 445 | |||||||||||||
| Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu |
| 450 | 455 | 460 | |||||||||||||
| Arg | Leu | Lys | Asp | Val | Pro | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile |
| 465 | 470 | 475 | 480 | ||||||||||||
| Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro |
| 485 | 490 | 495 | |||||||||||||
| Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu |
| 500 | 505 | 510 | |||||||||||||
| Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp |
| 515 | 520 | 525 | |||||||||||||
| Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His |
| 530 | 535 | 540 | |||||||||||||
| Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp |
| 565 | 570 | 575 | |||||||||||||
| His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr |
| 580 | 585 | 590 | |||||||||||||
| Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr |
| 595 | 600 | 605 | |||||||||||||
| Asn | Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro |
| 610 | 615 | 620 | |||||||||||||
| His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr |
| 645 | 650 | 655 | |||||||||||||
| Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn |
| 660 | 665 | 670 | |||||||||||||
| Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Val | Asp | Gin |
| 675 | 680 | 685 | |||||||||||||
| Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | Ser | Glu | Pro |
| 690 | 695 | 700 | |||||||||||||
| Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro |
| 705 | 710 | 715 | 720 | ||||||||||||
| Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu |
| 725 | 730 | 735 | |||||||||||||
| Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu |
| 740 | 745 | 750 | |||||||||||||
| Asn | Ser | val | Ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu |
| 755 | 760 | 765 | |||||||||||||
| Lys | Val | Thr | Asp | Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr |
| 770 | 775 | 780 | |||||||||||||
| Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile |
| 785 | 790 | 795 | 800 | ||||||||||||
| Ser | Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro |
| 805 | 810 | 815 |
Ala Pro Ile Gin
820 <210> 92 <211> 816 <212> PRT
PL 206 576 B1
119 <213> S. pneumoniae <400> 92
| Cys 1 | Ser | Tyr | Glu Leu 5 | Gly | Arg | His | Gin Ala Gly 10 | Gin | Asp | Lys | Lys 15 | Glu | |||
| Ser | Asn | Arg | Val | Ala | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asn | His | Phe |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Gin | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin |
| 340 | 345 | 350 | |||||||||||||
| Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val |
| 355 | 360 | 365 | |||||||||||||
| Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 425 | 430 |
120
PL 206 576 B1
| ASP | Leu | Leu 435 | Ala | Arg | Ile | His | Gin 440 | Asp | Leu | Leu | Asp | Asn 445 | Lys | Gly | Arg |
| Gin | Val 450 | Asp | Phe | Glu | Ala | Leu 455 | Asp | Asn | Leu | Leu | Glu 460 | Arg | Leu | Lys | Asp |
| Val 465 | Ser | Ser | Asp | Lys | Val 470 | Lys | Leu | Val | Glu | Asp 475 | Ile | Leu | Ala | Phe | Leu 480 |
| Ala | Pro | Ile | Arg | His 485 | Pro | Glu | Arg | Leu | Gly 490 | Lys | Pro | Asn | Ser | Gin 495 | Ile |
| Thr | Tyr | Thr | Asp 500 | Asp | Glu | Ile | Gin | Val 505 | Ala | Lys | Leu | Ala | Gly 510 | Lys | Tyr |
| Thr | Thr | Glu 515 | Asp | Gly | Tyr | Ile | Phe 520 | Asp | Pro | Arg | Asp | Ile 525 | Thr | Ser | Asp |
| Glu | Gly 530 | Asp | Ala | Tyr | Val | Thr 535 | Pro | His | Met | Thr | His 540 | Ser | His | Trp | Ile |
| Lys 545 | Lys | Asp | Ser | Leu | Ser 550 | Glu | Ala | Glu | Arg | Ala 555 | Ala | Ala | Gin | Ala | Tyr 560 |
| Ala | Lys | Glu | Lys | Gly 565 | Leu | Thr | Pro | Pro | Ser 570 | Thr | Asp | His | Arg | Asp 575 | Ser |
| Gly | Asn | Thr | Glu 580 | Ala | Lys | Gly | Ala | Glu 585 | Ala | Ile | Tyr | Asn | Arg 590 | Val | Lys |
| Ala | Ala | Lys 595 | Lys | Val | Pro | Leu | Asp 600 | Arg | Met | Pro | Tyr | Asn 605 | Leu | Gin | Tyr |
| Thr | Val 610 | Glu | Val | Lys | Asn | Gly 615 | Ser | Leu | Ile | Ile | Pro 620 | His | Tyr | Asp | His |
| Tyr 625 | His | Asn | Ile | Lys | Phe 630 | Glu | Trp | Phe | Asp | Glu 635 | Gly | Leu | Tyr | Glu | Ala 640 |
| Pro | Lys | Gly | Tyr | Thr 645 | Leu | Glu | Asp | Leu | Leu 650 | Ala | Thr | Val | Lys | Tyr 655 | Tyr |
| Val | Glu | His | Pro 660 | Asn | Glu | Arg | Pro | His 665 | Ser | Asp | Asn | Gly | Phe 670 | Gly | Asn |
| Ala | Ser | Asp 675 | His | Val | Arg | Lys | Asn 680 | Lys | Ala | Asp | Gin | Asp 685 | Ser | Lys | Pro |
| Asp | Glu 690 | Asp | Lys | Gly | His | Asp 695 | Glu | Val | Ser | Glu | Pro 700 | Thr | His | Pro | Glu |
| Ser 705 | Asp | Glu | Lys | Glu | Asn 710 | His | Ala | Gly | Leu | Asn 715 | Pro | Ser | Ala | Asp | Asn 720 |
| Leu | Tyr | Lys | Pro | Ser 725 | Thr | Asp | Thr | Glu | Glu 730 | Thr | Glu | Glu | Glu | Ala 735 | Glu |
| Asp | Thr | Thr | Asp 740 | Glu | Ala | Glu | Ile | Pro 745 | Gin | Val | Glu | His | Ser 750 | Val | Ile |
| Asn | Ala | Lys 755 | Ile | Ala | Asp | Ala | Glu 760 | Ala | Leu | Leu | Glu | Lys 765 | Val | Thr | Asp |
| Pro | Ser 770 | Ile | Arg | Gin | Asn | Ala 775 | Met | Glu | Thr | Leu | Thr 780 | Gly | Leu | Lys | Ser |
| Ser 785 | Leu | Leu | Leu | Gly | Thr 790 | Lys | Asp | Asn | Asn | Thr 795 | Ile | Ser | Ala | Glu | Val 800 |
| Asp | Ser | Leu | Leu | Ala 805 | Leu | Leu | Lys | Lys | Ser 810 | Gin | Pro | Ala | Pro | Ile 815 | Gin |
<210> 93 <211> 816 <212> PRT <213> s. pneumoniae <400> 93
Cys Ser Tyr Glu Leu Gly Arg His Gin Ala Gly Gin Asp Lys Lys Glu 15 10 15
PL 206 576 B1
121
| Ser | Asn | Arg | Val 20 | Ala | Tyr | Ile | Asp | Gly 25 | Asp | Gin | Ala | Gly | Gin 30 | Lys | Ala |
| Glu | Asn | Leu 35 | Thr | Pro | Asp | Glu | Val 40 | Ser | Lys | Arg | Glu | Gly 45 | Ile | Asn | Ala |
| Glu | Gin 50 | Ile | Val | Ile | Lys | Ile 55 | Thr | Asp | Gin | Gly | Tyr 60 | Val | Thr | Ser | His |
| Gly 65 | Asp | His | Tyr | His | Tyr 70 | Tyr | Asn | Gly | Lys | Val 75 | Pro | Tyr | Asp | Ala | Ile 80 |
| Ile | Ser | Glu | Glu | Leu 85 | Leu | Met | Lys | Asp | Pro 90 | Asn | Tyr | Gin | Leu | Lys 95 | Asp |
| Ser | Asp | Ile | Val 100 | Asn | Glu | Ile | Lys | Gly 105 | Gly | Tyr | Val | Ile | Lys 110 | Val | Asn |
| Gly | Lys | Tyr 115 | Tyr | Val | Tyr | Leu | Lys 120 | Asp | Ala | Ala | His | Ala 125 | Asp | Asn | Ile |
| Arg | Thr 130 | Lys | Glu | Glu | Ile | Lys 135 | Arg | Gin | Arg | Gin | Glu 140 | His | Ser | His | Asn |
| His 145 | Giy | Gly | Gly | Ser | Asn 150 | Asp | Gin | Ala | Val | Val 155 | Ala | Ala | Arg | Ala | Gin 160 |
| Gly | Arg | Tyr | Thr | Thr 165 | Asp | Asp | Gly | Tyr | Ile 170 | Phe | Asn | Ala | Ser | Asp 175 | Ile |
| Ile | Glu | Asp | Thr 180 | Gly | Asp | Ala | Tyr | Ile 185 | Val | Pro | His | Gly | Asn 190 | His | Phe |
| His | Tyr | Ile 195 | Pro | Lys | Ser | Asp | Leu 200 | Ser | Ala | Ser | Glu | Leu 205 | Ala | Ala | Ala |
| Gin | Ala 210 | Tyr | Trp | Asn | Gly | Lys 215 | Gin | Gly | Ser | Arg | Pro 220 | Ser | Ser | Ser | Ser |
| Ser 225 | His | Asn | Ala | Asn | Pro 230 | Ala | Gin | Pro | Arg | Leu 235 | Ser | Glu | Asn | His | Asn 240 |
| Leu | Thr | Val | Thr | Pro 245 | Thr | Tyr | His | Gin | Asn 250 | Gin | Gly | Glu | Asn | Ile 255 | Ser |
| Ser | Leu | Leu | Arg 260 | Glu | Leu | Tyr | Ala | Lys 265 | Pro | Leu | Ser | Glu | Arg 270 | His | Val |
| Glu | Ser | Asp 275 | Gly | Leu | Ile | Phe | Asp 280 | Pro | Ala | Gin | Ile | Thr 285 | Ser | Arg | Thr |
| Ala | Arg 290 | Gly | Val | Ala | Val | Pro 295 | His | Gly | Asn | His | Tyr 300 | His | Phe | Ile | Pro |
| Tyr 305 | Glu | Gin | Met | Ser | Glu 310 | Leu | Glu | Glu | Arg | Ile 315 | Ala | Arg | Ile | Ile | Pro 320 |
| Leu | Arg | Tyr | Arg | Ser 325 | Asn | His | Trp | Val | Pro 330 | Asp | Ser | Arg | Pro | Glu 335 | Gin |
| Pro | Ser | Pro | Gin 340 | Pro | Ser | Pro | Ser | Pro 345 | Gin | Pro | Ala | Pro | Asn 350 | Pro | Gin |
| Pro | Ala | Pro 355 | Ser | Asn | Pro | Ile | Asp 360 | Glu | Lys | Leu | Val | Lys 365 | Glu | Ala | Val |
| Arg | Lys 370 | Val | Gly | Asp | Gly | Tyr 375 | Val | Phe | Glu | Glu | Asn 380 | Gly | Val | Ser | Arg |
| Tyr 385 | Ile | Pro | Ala | Lys | Asp 390 | Leu | Ser | Ala | Glu | Thr 395 | Ala | Ala | Gly | Ile | Asp 400 |
| Ser | Lys | Leu | Ala | Lys 405 | Gin | Glu | Ser | Leu | Ser 410 | His | Lys | Leu | Gly | Thr 415 | Lys |
| Lys | Thr | Asp | Leu 420 | Pro | Ser | Ser | Asp | Arg 425 | Glu | Phe | Tyr | Asn | Lys 430 | Ala | Tyr |
| Asp | Leu | Leu 435 | Ala | Arg | Ile | His | Gin 440 | Asp | Leu | Leu | Asp | Asn 445 | Lys | Gly | Arg |
| Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp |
450 455 460
122
PL 206 576 B1
| Val | Ser Ser Asp | Lys Val | Lys | Leu | Val Glu Asp | Ile | Leu | Ala | Phe | Leu |
| 465 | 470 | 475 | 480 | |||||||
| Ala | Pro Ile Arg | His Pro 485 | Glu | Arg | Leu Gly Lys 490 | Pro | Asn | Ser | Gin 495 | Ile |
| Thr | Tyr Thr Asp 500 | Asp Glu | Ile | Gin | Val Ala Lys 505 | Leu | Ala | Gly 510 | Lys | Tyr |
| Thr | Thr Glu Asp 515 | Gly Tyr | Ile | Phe 520 | Asp Pro Arg | Asp | Ile 525 | Thr | Ser | Asp |
| Glu | Gly Asp Ala 530 | Tyr Val | Thr 535 | Pro | His Met Thr | His 540 | Ser | His | Trp | Ile |
| Lys 545 | Lys Asp Ser | Leu Ser 550 | Glu | Ala | Glu Arg Ala 555 | Ala | Ala | Gin | Ala | Tyr 560 |
| Ala | Lys Glu Lys | Gly Leu 565 | Thr | Pro | Pro Ser Thr 570 | Asp | His | Gin | Asp 575 | Ser |
| Gly | Asn Thr Glu 580 | Ala Lys | Gly | Ala | Glu Ala Ile 585 | Tyr | Asn | Arg 590 | Val | Lys |
| Ala | Ala Lys Lys 595 | Val Pro | Leu | Asp 600 | Arg Met Pro | Tyr | Asn 605 | Leu | Gin | Tyr |
| Thr | Val Glu Val 610 | Lys Asn | Gly 615 | Ser | Leu Ile Ile | Pro 620 | His | Tyr | Asp | His |
| Tyr 625 | His Asn Ile | Lys Phe 630 | Glu | Trp | Phe Asp Glu 635 | Gly | Leu | Tyr | Glu | Ala 640 |
| Pro | Lys Gly Tyr | Thr Leu 645 | Glu | Asp | Leu Leu Ala 650 | Thr | Val | Lys | Tyr 655 | Tyr |
| Val | Glu His Pro 660 | Asn Glu | Arg | Pro | His Ser Asp 665 | Asn | Gly | Phe 670 | Gly | Asn |
| Ala | Ser Asp His 675 | Val Arg | Lys | Asn 680 | Lys Ala Asp | Gin | Asp 685 | Ser | Lys | Pro |
| Asp | Glu Asp Lys 690 | Gly His | Asp 695 | Glu | Val Ser Glu | Pro 700 | Thr | His | Pro | Glu |
| Ser 705 | Asp Glu Lys | Glu Asn 710 | His | Ala | Gly Leu Asn 715 | Pro | Ser | Ala | Asp | Asn 720 |
| Leu | Tyr Lys Pro | Ser Thr 725 | Asp | Thr | Glu Glu Thr 730 | Glu | Glu | Glu | Ala 735 | Glu |
| Asp | Thr Thr Asp 740 | Glu Ala | Glu | Ile | Pro Gin Val 745 | Glu | His | Ser 750 | Val | Ile |
| Asn | Ala Lys Ile 755 | Ala Asp | Ala | Glu 760 | Ala Leu Leu | Glu | Lys 765 | Val | Thr | Asp |
| Pro | Ser Ile Arg 770 | Gin Asn | Ala 775 | Met | Glu Thr Leu | Thr 780 | Gly | Leu | Lys | Ser |
| Ser 785 | Leu Leu Leu | Gly Thr 790 | Lys | Asp | Asn Asn Thr 795 | Ile | Ser | Ala | Glu | Val 800 |
| Asp | Ser Leu Leu Ala Leu Leu 805 <210> 94 <211> 816 <212> PRT <213> S. pneumoniae <400> 94 | Lys | Lys Ser Gin 810 | Pro | Ala | Pro | Ile 815 | Gin | ||
| Cys 1 | Ser Tyr Glu | Leu Gly 5 | Arg | His | Gin Ala Gly 10 | Gin | Asp | Lys | Lys 15 | Glu |
| Ser | Asn Arg Val 20 | Ala Tyr | Ile | Asp | Gly Asp Gin 25 | Ala | Gly | Gin 30 | Lys | Ala |
| Glu | Asn Leu Thr 35 | Pro Asp | Glu | Val 40 | Ser Lys Arg | Glu | Gly 45 | Ile | Asn | Ala |
PL 206 576 B1
123
| Glu | Gin 50 | Ile Val | Ile Lys | Ile Thr Asp Gin Gly Tyr Val | Thr | Ser His | |||||||||
| 55 | 60 | ||||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | Arg | Gly | Asn | His | Phe |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Gin | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | Arg | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin |
| 340 | 345 | 350 | |||||||||||||
| Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val |
| 355 | 360 | 365 | |||||||||||||
| Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 425 | 430 | |||||||||||||
| Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg |
| 435 | 440 | 445 | |||||||||||||
| Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp |
| 450 | 455 | 460 | |||||||||||||
| Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Glu | Asp | Ile | Leu | Ala | Phe | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ser | Gin | Ile |
| 485 | 490 | 495 |
124
PL 206 576 B1
| Thr | Tyr | Thr | Asp 500 | Asp | Glu | Ile | Gin | Val 505 | Ala | Lys | Leu | Ala | Gly 510 | Lys | Tyr |
| Thr | Thr | Glu 515 | Asp | Gly | Tyr | Ile | Phe 520 | Asp | Pro | Arg | Asp | Ile 525 | Thr | Ser | Asp |
| Glu | Gly 530 | Asp | Ala | Tyr | Val | Thr 535 | Pro | His | Met | Thr | His 540 | Ser | His | Trp | Ile |
| Lys 545 | Lys | Asp | Ser | Leu | Ser 550 | Glu | Ala | Glu | Arg | Ala 555 | Ala | Ala | Gin | Ala | Tyr 560 |
| Ala | Lys | Glu | Lys | Gly 565 | Leu | Thr | Pro | Pro | Ser 570 | Thr | Asp | His | Gin | Asp 575 | Ser |
| Gly | Asn | Thr | Glu 580 | Ala | Lys | Gly | Ala | Glu 585 | Ala | Ile | Tyr | Asn | Arg 590 | Val | Lys |
| Ala | Ala | Lys 595 | Lys | Val | Pro | Leu | Asp 600 | Arg | Met | Pro | Tyr | Asn 605 | Leu | Gin | Tyr |
| Thr | Val 610 | Glu | Val | Lys | Asn | Gly 615 | Ser | Leu | Ile | Ile | Pro 620 | His | Tyr | Asp | His |
| Tyr 625 | His | Asn | Ile | Lys | Phe 630 | Glu | Trp | Phe | Asp | Glu 635 | Gly | Leu | Tyr | Glu | Ala 640 |
| Pro | Lys | Gly | Tyr | Thr 645 | Leu | Glu | Asp | Leu | Leu 650 | Ala | Thr | Val | Lys | Tyr 655 | Tyr |
| Val | Glu | His | Pro 660 | Asn | Glu | Arg | Pro | His 665 | Ser | Asp | Asn | Gly | Phe 670 | Gly | Asn |
| Ala | Ser | Asp 675 | His | Val | Arg | Lys | Asn 680 | Lys | Ala | Asp | Gin | Asp 685 | Ser | Lys | Pro |
| Asp | Glu 690 | Asp | Lys | Gly | His | Asp 695 | Glu | Val | Ser | Glu | Pro 700 | Thr | His | Pro | Glu |
| Ser 705 | Asp | Glu | Lys | Glu | Asn 710 | His | Ala | Gly | Leu | Asn 715 | Pro | Ser | Ala | Asp | Asn 720 |
| Leu | Tyr | Lys | Pro | Ser 725 | Thr | Asp | Thr | Glu | Glu 730 | Thr | Glu | Glu | Glu | Ala 735 | Glu |
| Asp | Thr | Thr | Asp 740 | Glu | Ala | Glu | Ile | Pro 745 | Gin | Val | Glu | His | Ser 750 | Val | Ile |
| Asn | Ala | Lys 755 | Ile | Ala | Asp | Ala | Glu 760 | Ala | Leu | Leu | Glu | Lys 765 | Val | Thr | Asp |
| Pro | Ser 770 | Ile | Arg | Gin | Asn | Ala 775 | Met | Glu | Thr | Leu | Thr 780 | Gly | Leu | Lys | Ser |
| Ser 785 | Leu | Leu | Leu | Gly | Thr 790 | Lys | Asp | Asn | Asn | Thr 795 | Ile | Ser | Ala | Glu | Val 800 |
| Asp | Ser | Leu | Leu | Ala 805 | Leu | Leu | Lys | Lys | Ser 810 | Gin | Pro | Ala | Pro | Ile 815 | Gin |
<210> 95 <211> 834 <212> PRT <213> Ξ. pneumoniae <400> 95
| Cys 1 | Ser | Tyr | Glu | Leu 5 | Gly | Arg | His | Gin | Ala 10 | Gly | Gin | Val | Lys | Lys 15 | Glu |
| Ser | Asn | Arg | Val 20 | Ser | Tyr | Ile | Asp | Gly 25 | Asp | Gin | Ala | Gly | Gin 30 | Lys | Ala |
| Glu | Asn | Leu 35 | Thr | Pro | Asp | Glu | Val 40 | Ser | Lys | Arg | Glu | Gly 45 | Ile | Asn | Ala |
| Glu | Gin 50 | Ile | Val | Ile | Lys | Ile 55 | Thr | Asp | Gin | Gly | Tyr 60 | Val | Thr | Ser | His |
| Gly 65 | Asp | His | Tyr | His | Tyr 70 | Tyr | Asn | Gly | Lys | Val 75 | Pro | Tyr | Asp | Ala | Ile 80 |
PL 206 576 B1
125
| Ile | Ser | Glu | Glu | Leu Leu Met 85 | Lys | Asp | Pro Asn Tyr Gin Leu Lys Asp | ||||||||
| 90 | 95 | ||||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asp |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | Arg | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | Val | Ala | Ala | Ala | Arg | Ala | Gin | Gly |
| 145 | 150 | 155 | 160 | ||||||||||||
| Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile | Ile |
| 165 | 170 | 175 | |||||||||||||
| Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asp | His | Tyr | His |
| 180 | 185 | 190 | |||||||||||||
| Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Gin |
| 195 | 200 | 205 | |||||||||||||
| Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser | Ser |
| 245 | 250 | 255 | |||||||||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala |
| 275 | 280 | 285 | |||||||||||||
| Asn | Gly | Val | Ala | Val | Pro | His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Ser | Gin | Leu | Ser | Pro | Leu | Glu | Glu | Lys | Leu | Ala | Arg | Ile | Ile | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin | Pro |
| 325 | 330 | 335 | |||||||||||||
| Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly |
| 370 | 375 | 380 | |||||||||||||
| Val | Pro | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu |
| 405 | 410 | 415 | |||||||||||||
| Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn |
| 435 | 440 | 445 | |||||||||||||
| Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 450 | 455 | 460 | |||||||||||||
| Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 485 | 490 | 495 | |||||||||||||
| Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
| 500 | 505 | 510 | |||||||||||||
| Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile |
| 515 | 520 | 525 |
126
PL 206 576 B1
| Thr Ser 530 | Asp Glu Gly | Asp Ala 535 | Tyr | Val | Thr | Pro | His 540 | Met | Thr | His | Ser | ||||
| His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 565 | 570 | 575 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn |
| 580 | 585 | 590 | |||||||||||||
| Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn |
| 595 | 600 | 605 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
| 625 | 630 | 635 | 640 | ||||||||||||
| Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val |
| 645 | 650 | 655 | |||||||||||||
| Lys | Tyr | Tyr | val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly |
| 660 | 665 | 670 | |||||||||||||
| Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | Ala |
| 675 | 680 | 685 | |||||||||||||
| Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Asn | Glu | Glu | Lys | Pro | Gin | Thr | Glu |
| 690 | 695 | 700 | |||||||||||||
| Lys | Pro | Glu | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | Ser | Glu | Pro | Thr | His |
| 705 | 710 | 715 | 720 | ||||||||||||
| Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Val | Gly | Leu | Asn | Pro | Ser | Ala |
| 725 | 730 | 735 | |||||||||||||
| Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu |
| 740 | 745 | 750 | |||||||||||||
| Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | ile | Pro | Gin | Val | Glu | Tyr | Ser |
| 755 | 760 | 765 | |||||||||||||
| Val | Ile | Asn | Ala | Lys | Ile | Ala | Glu | Ala | Glu | Ala | Leu | Leu | Glu | Lys | Val |
| 770 | 775 | 780 | |||||||||||||
| Thr | Asp | Ser | Ser | Ile | Arg | Gin | Asn | Ala | Val | Glu | Thr | Leu | Thr | Giy | Leu |
| 785 | 790 | 795 | 800 | ||||||||||||
| Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala |
| 805 | 810 | 815 | |||||||||||||
| Glu | val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro |
| 820 | 825 | 830 | |||||||||||||
| Ile | Gin |
| <210> 96 <211> 811 <212> PRT | ||||||||||||||
| <213> | S. i | pneumoniae | ||||||||||||
| <400> | 96 | |||||||||||||
| Cys | Ser Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Gly | Gin | Asp | Lys | Lys | Glu |
| 1 | 5 | 10 | 15 | |||||||||||
| Ser | Asn Arg | Val | Ala | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | ||||||||||||
| Glu | Asn Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | ||||||||||||
| Glu | Gin Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | ||||||||||||
| Gly | Asp His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
70 75 80
PL 206 576 B1
127
| Ile | Ser Glu | Glu Leu Leu 85 | Met | Lys Asp | Pro Asn Tyr Gin Leu Lys | Asp | |||||||||
| 90 | 95 | ||||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asn | His | Phe |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Gin | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin |
| 340 | 345 | 350 | |||||||||||||
| Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val |
| 355 | 360 | 365 | |||||||||||||
| Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 425 | 430 | |||||||||||||
| Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg |
| 435 | 440 | 445 | |||||||||||||
| Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp |
| 450 | 455 | 460 | |||||||||||||
| Val | Ser | Ser | Asp | Lys | Val | hys | Leu | Val | Glu | Asp | Ile | Leu | Ala | Phe | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ser | Gin | Ile |
| 485 | 490 | 495 | |||||||||||||
| Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr |
| 500 | 505 | 510 | |||||||||||||
| Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp |
| 515 | 520 | 525 |
128
PL 206 576 B1
| Glu Gly Asp 530 | Ala | Tyr | Val | Thr Pro His Met Thr His | Ser | His | Trp | Ile | |||||||
| 535 | 540 | ||||||||||||||
| Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
| 565 | 570 | 575 | |||||||||||||
| Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
| 580 | 585 | 590 | |||||||||||||
| Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
| 595 | 600 | 605 | |||||||||||||
| Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
| 645 | 650 | 655 | |||||||||||||
| Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn |
| 660 | 665 | 670 | |||||||||||||
| Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro |
| 675 | 680 | 685 | |||||||||||||
| Asp | Glu | Asp | Lys | Gly | His | Asp | Glu | Val | Ser | Glu | Pro | Thr | His | Pro | Glu |
| 690 | 695 | 700 | |||||||||||||
| Ser | ASP | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn |
| 705 | 710 | 715 | 720 | ||||||||||||
| Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu |
| 725 | 730 | 735 | |||||||||||||
| Asp | Thr | Thr | Asp | Glu | Ala | Glu | He | Pro | Gin | Val | Glu | His | Ser | Val | Ile |
| 740 | 745 | 750 | |||||||||||||
| Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp |
| 755 | 760 | 765 | |||||||||||||
| Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
| 770 | 775 | 780 | |||||||||||||
| Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
| 785 | 790 | 795 | 800 | ||||||||||||
| Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys | |||||
| 805 | 810 |
<210> 97 <211> 811 <212> PRT <213> S. pneumoniae <400> 97
| Cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Gly | Gin | Asp | Lys | Lys | Glu |
| 1 | 5 | 10 | 15 | ||||||||||||
| Ser | Asn | Arg | Val | Ala | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn |
| 100 | 105 | 110 |
PL 206 576 B1
129
| Gly | Lys | Tyr Tyr 115 | Gly | Tyr Leu Lys 120 | Asp Ala Ala | His | Ala 125 | Asp | Asn | Ile | |||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 | |||||||||||||
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asn | His | Phe |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Gin | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin |
| 340 | 345 | 350 | |||||||||||||
| Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val |
| 355 | 360 | 365 | |||||||||||||
| Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 425 | 430 | |||||||||||||
| Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg |
| 435 | 440 | 445 | |||||||||||||
| Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp |
| 450 | 455 | 460 | |||||||||||||
| Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Glu | Asp | Ile | Leu | Ala | Phe | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ser | Gin | Ile |
| 485 | 490 | 495 | |||||||||||||
| Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr |
| 500 | 505 | 510 | |||||||||||||
| Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp |
| 515 | 520 | 525 | |||||||||||||
| Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | Ile |
| 530 | 535 | 540 | |||||||||||||
| Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
545 550 555 560
130
PL 206 576 B1
| Ala Lys | Glu | Lys | Gly 565 | Leu | Thr Pro Pro | Ser Thr 570 | Asp | His | Gin | Asp 575 | Ser | ||||
| Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
| 580 | 585 | 590 | |||||||||||||
| Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
| 595 | 600 | 605 | |||||||||||||
| Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
| 645 | 650 | 655 | |||||||||||||
| Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn |
| 660 | 665 | 670 | |||||||||||||
| Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro |
| 675 | 680 | 685 | |||||||||||||
| Asp | Glu | Asp | Lys | Gly | His | Asp | Glu | Val | Ser | Glu | Pro | Thr | His | Pro | Glu |
| 690 | 695 | 700 | |||||||||||||
| Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn |
| 705 | 710 | 715 | 720 | ||||||||||||
| Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu |
| 725 | 730 | 735 | |||||||||||||
| Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gin | Val | Glu | His | Ser | Val | Ile |
| 740 | 745 | 750 | |||||||||||||
| Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp |
| 755 | 760 | 765 | |||||||||||||
| Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
| 770 | 775 | 780 | |||||||||||||
| Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
| 785 | 790 | 795 | 800 | ||||||||||||
| Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys | |||||
| 805 | 810 |
<210> 98 <211> 811 <212> PRT <213> S. pneumoniae <400> 98
| Cys 1 | Ser Tyr Glu Leu 5 | Gly Arg | His Gin | Ala Gly Gin Asp Lys 10 | Lys 15 | Glu | |||||||||
| Ser | Asn | Arg | Val | Ala | Tyr | Ile | Asp | Gly | Asp | Gin | Ala | Gly | Gin | Lys | Ala |
| 20 | 25 | 30 | |||||||||||||
| Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly | Ile | Asn | Ala |
| 35 | 40 | 45 | |||||||||||||
| Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His |
| 50 | 55 | 60 | |||||||||||||
| Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp | Ala | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp |
| 85 | 90 | 95 | |||||||||||||
| Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | Ile | Lys | Val | Asn |
| 100 | 105 | 110 | |||||||||||||
| Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | Ile |
| 115 | 120 | 125 | |||||||||||||
| Arg | Thr | Lys | Glu | Glu | Ile | Lys | Arg | Gin | Lys | Gin | Glu | His | Ser | His | Asn |
| 130 | 135 | 140 |
PL 206 576 B1
131
| His | Gly | Gly | Gly | Ser | Asn | Asp | Gin | Ala | Val | Val | Ala | Ala | Arg | Ala | Gin |
| 145 | 150 | 155 | 160 | ||||||||||||
| Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser | Asp | Ile |
| 165 | 170 | 175 | |||||||||||||
| Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His | Gly | Asn | His | Phe |
| 180 | 185 | 190 | |||||||||||||
| His | Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala |
| 195 | 200 | 205 | |||||||||||||
| Gin | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| Ser | His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn |
| 225 | 230 | 235 | 240 | ||||||||||||
| Leu | Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser |
| 245 | 250 | 255 | |||||||||||||
| Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val |
| 260 | 265 | 270 | |||||||||||||
| Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
| 275 | 280 | 285 | |||||||||||||
| Ala | Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro |
| 290 | 295 | 300 | |||||||||||||
| Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin |
| 325 | 330 | 335 | |||||||||||||
| Pro | Ser | Pro | Gin | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin |
| 340 | 345 | 350 | |||||||||||||
| Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val |
| 355 | 360 | 365 | |||||||||||||
| Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg |
| 370 | 375 | 380 | |||||||||||||
| Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Thr | Lys |
| 405 | 410 | 415 | |||||||||||||
| Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr |
| 420 | 425 | 430 | |||||||||||||
| Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg |
| 435 | 440 | 445 | |||||||||||||
| Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp |
| 450 | 455 | 460 | |||||||||||||
| Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Glu | Asp | Ile | Leu | Ala | Phe | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ser | Gin | Ile |
| 485 | 490 | 495 | |||||||||||||
| Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr |
| 500 | 505 | 510 | |||||||||||||
| Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp |
| 515 | 520 | 525 | |||||||||||||
| Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | Ile |
| 530 | 535 | 540 | |||||||||||||
| Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
| 565 | 570 | 575 | |||||||||||||
| Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
580 585 590
132
PL 206 576 B1
| Ala | Ala Lys Lys Val 595 | Pro | Leu | Asp Arg Met 600 | Pro Tyr Asn Leu Gin 605 | Tyr |
| Thr | Val Glu Val Lys | Asn | Gly | Ser Leu Ile | Ile Pro His Tyr Asp | His |
| 610 | 615 | 620 | ||||
| Tyr | His Asn Ile Lys | Phe | Glu | Trp Phe Asp | Glu Gly Leu Tyr Glu | Ala |
| 625 | 630 | 635 | 640 | |||
| Pro | Lys Gly Tyr Thr | Leu | Glu | Asp Leu Leu | Ala Thr Val Lys Tyr | Tyr |
| 645 | 650 | 655 | ||||
| Val | Glu His Pro Asn | Glu | Arg | Pro His Ser | Asp Asn Gly Phe Gly | Asn |
| 660 | 665 | 670 | ||||
| Ala | Ser Asp His Val | Arg | Lys | Asn Lys Ala | Asp Gin Asp Ser Lys | Pro |
| 675 | 680 | 685 | ||||
| Asp | Glu Asp Lys Gly | His | Asp | Glu Val Ser | Glu Pro Thr His Pro | Glu |
| 690 | 695 | 700 | ||||
| Ser | Asp Glu Lys Glu | Asn | His | Ala Gly Leu | Asn Pro Ser Ala Asp | Asn |
| 705 | 710 | 715 | 720 | |||
| Leu | Tyr Lys Pro Ser | Thr | Asp | Thr Glu Glu | Thr Glu Glu Glu Ala | Glu |
| 725 | 730 | 735 | ||||
| Asp | Thr Thr Asp Glu | Ala | Glu | Ile Pro Gin | Val Glu His Ser Val | Ile |
| 740 | 745 | 750 | ||||
| Asn | Ala Lys Ile Ala | Asp | Ala | Glu Ala Leu | Leu Glu Lys Val Thr | Asp |
| 755 | 760 | 765 | ||||
| Pro | Ser Ile Arg Gin | Asn | Ala | Met Glu Thr | Leu Thr Gly Leu Lys | Ser |
| 770 | 775 | 780 | ||||
| Ser | Leu Leu Leu Gly | Thr | Lys | Asp Asn Asn | Thr Ile Ser Ala Glu | Val |
| 785 | 790 | 795 | 800 | |||
| Asp | Ser Leu Leu Ala | Leu | Leu | Lys Glu Ser | Lys | |
| 805 | 810 | |||||
| <210> 99 | ||||||
| <211> 811 | ||||||
| <212> PRT | ||||||
| <213> S. pneumoniae | ||||||
| <400> 99 | ||||||
| Cys | Ser Tyr Glu Leu | Gly | Arg | His Gin Ala | Gly Gin Val Lys Lys | Glu |
| 1 | 5 | 10 | 15 | |||
| Ser | Asn Arg Val Ser | Tyr | Ile | Asp Gly Asp | Gin Ala Gly Gin Lys | Ala |
| 20 | 25 | 30 | ||||
| Glu | Asn Leu Thr Pro | Asp | Glu | Val Ser Lys | Arg Glu Gly Ile Asn | Ala |
| 35 | 40 | 45 | ||||
| Glu | Gin Ile Val Ile | Lys | Ile | Thr Asp Gin | Gly Tyr Val Thr Ser | His |
| 50 | 55 | 60 | ||||
| Gly | Asp His Tyr His | Tyr | Tyr | Asn Gly Lys | Val Pro Tyr Asp Ala | Ile |
| 65 | 70 | 75 | 80 | |||
| Ile | Ser Glu Glu Leu | Leu | Met | Lys Asp Pro | Asn Tyr Gin Leu Lys | Asp |
| 85 | 90 | 95 | ||||
| Ser | Asp Ile Val Asn | Glu | Ile | Lys Gly Gly | Tyr Val Ile Lys Val | Asp |
| 100 | 105 | 110 | ||||
| Gly | Lys Tyr Tyr Val | Tyr | Leu | Lys Asp Ala | Ala His Ala Asp Asn | Ile |
| 115 | 120 | 125 | ||||
| Arg | Thr Lys Glu Glu | Ile | Lys | Arg Gin Lys | Gin Glu Arg Ser His | Asn |
| 130 | 135 | 140 | ||||
| His | Asn Ser Arg Ala | Asp | Asn | Ala Val Ala | Ala Ala Arg Ala Gin | Gly |
| 145 | 150 | 155 | 160 | |||
| Arg | Tyr Thr Thr Asp | Asp | Gly | Tyr Ile Phe | Asn Ala Ser Asp Ile | Ile |
165 170 175
PL 206 576 B1
133
| Glu Asp Thr Gly Asp | Ala Tyr | Ile | Val 185 | Pro His Gly Asp His 190 | Tyr | His | |||||||||
| 180 | |||||||||||||||
| Tyr | Ile | Pro | Lys | Ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Gin |
| 195 | 200 | 205 | |||||||||||||
| Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser | Ser | Ser | Ser |
| 210 | 215 | 220 | |||||||||||||
| His | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser | Ser |
| 245 | 250 | 255 | |||||||||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala |
| 275 | 280 | 285 | |||||||||||||
| Asn | Gly | Val | Ala | Val | Pro | His | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Ser | Gin | Leu | Ser | Pro | Leu | Glu | Glu | Lys | Leu | Ala | Arg | Ile | Ile | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin | Pro |
| 325 | 330 | 335 | |||||||||||||
| Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly |
| 370 | 375 | 380 | |||||||||||||
| Val | Pro | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu |
| 405 | 410 | 415 | |||||||||||||
| Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn |
| 435 | 440 | 445 | |||||||||||||
| Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 450 | 455 | 460 | |||||||||||||
| Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 485 | 490 | 495 | |||||||||||||
| Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
| 500 | 505 | 510 | |||||||||||||
| Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile |
| 515 | 520 | 525 | |||||||||||||
| Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser |
| 530 | 535 | 540 | |||||||||||||
| His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 565 | 570 | 575 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn |
| 580 | 585 | 590 | |||||||||||||
| Arg | val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn |
| 595 | 600 | 605 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His |
| 610 | 615 | 620 |
134
PL 206 576 B1
| Tyr | Asp His Tyr His Asn Ile Lys | Phe Glu Trp | Phe Asp Glu Gly Leu |
| 625 | 630 | 635 | 640 |
| Tyr | Glu Ala Pro Lys Gly Tyr Ser | Leu Glu Asp | Leu Leu Ala Thr Val |
| 645 | 650 | 655 | |
| Lys | Tyr Tyr Val Glu His Pro Asn | Glu Arg Pro | His Ser Asp Asn Gly |
| 660 | 665 | 670 | |
| Phe | Gly Asn Ala Ser Asp His Val | Gin Arg Asn | Lys Asn Gly Gin Ala |
| 675 680 | 685 | ||
| Asp | Thr Asn Gin Thr Glu Lys Pro | Asn Glu Glu | Lys Pro Gin Thr Glu |
| 690 695 | 700 | ||
| Lys | Pro Glu Glu Glu Thr Pro Arg | Glu Glu Lys | Pro Gin Ser Glu Lys |
| 705 | 710 | 715 | 720 |
| Pro | Glu Ser Pro Lys Pro Thr Glu | Glu Pro Glu | Glu Glu Ser Pro Glu |
| 725 | 730 | 735 | |
| Glu | Ser Pro Glu Glu Ser Glu Glu | Pro Gin Val | Glu Thr Glu Lys Val |
| 740 | 745 | 750 | |
| Lys | Glu Lys Leu Arg Glu Ala Glu | Asp Leu Leu | Gly Lys Ile Gin Asn |
| 755 760 | 765 | ||
| Pro | Ile Ile Lys Ser Asn Ala Lys | Glu Thr Leu | Thr Gly Leu Lys Asn |
| 770 775 | 780 | ||
| Asn | Leu Leu Phe Gly Thr Gin Asp | Asn Asn Thr | Ile Met Ala Glu Ala |
| 785 | 790 | 795 | 800 |
| Glu | Lys Leu Leu Ala Leu Leu Lys | Glu Ser Lys | |
| 805 | 810 | ||
| <210> 100 | |||
| <211> 805 | |||
| <212> PRT | |||
| <213> S. pneumoniae | |||
| <400> 100 | |||
| Cys | Ser Tyr Glu Leu Gly Arg His | Gin Ala Gly | Gin Asp Lys Lys Glu |
| 1 | 5 | 10 | 15 |
| Ser | Asn Arg Val Ala Tyr Ile Asp | Gly Asp Gin | Ala Gly Gin Lys Ala |
| 20 | 25 | 30 | |
| Glu | Asn Leu Thr Pro Asp Glu Val | Ser Lys Arg | Glu Gly Ile Asn Ala |
| 35 40 | 45 | ||
| Glu | Gin Ile Val Ile Lys Ile Thr | Asp Gin Gly | Tyr Val Thr Ser His |
| 50 55 | 60 | ||
| Gly | Asp His Tyr His Tyr Tyr Asn | Gly Lys Val | Pro Tyr Asp Ala Ile |
| 65 | 70 | 75 | 80 |
| Ile | Ser Glu Glu Leu Leu Met Lys | Asp Pro Asn | Tyr Gin Leu Lys Asp |
| 85 | 90 | 95 | |
| Ser | Asp Ile Val Asn Glu Ile Lys | Gly Gly Tyr | Val Ile Lys Val Asn |
| 100 | 105 | 110 | |
| Gly | Lys Tyr Tyr Val Tyr Leu Lys | Asp Ala Ala | His Ala Asp Asn Ile |
| 115 120 | 125 | ||
| Arg | Thr Lys Glu Glu Ile Lys Arg | Gin Lys Gin | Glu Arg Ser His Asn |
| 130 135 | 140 | ||
| His | Asn Ser Arg Ala Asp Asn Ala | Val Ala Ala | Ala Arg Ala Gin Gly |
| 145 | 150 | 155 | 160 |
| Arg | Tyr Thr Thr Asp Asp Gly Tyr | Ile Phe Asn | Ala Ser Asp Ile Ile |
| 165 | 170 | 175 | |
| Glu | Asp Thr Gly Asp Ala Tyr Ile | Val Pro His | Gly Asp His Tyr His |
| 180 | 185 | 190 | |
| Tyr | Ile Pro Lys Asn Glu Leu Ser | Ala Ser Glu | Leu Ala Ala Ala Glu |
| 195 200 | 205 |
PL 206 576 B1
135
| Ala Tyr Trp Asn Gly Lys Gin Gly Ser | Arg | Pro | Ser 220 | Ser | Ser | Ser | Ser | ||||||||
| 210 | 215 | ||||||||||||||
| Tyr | Asn | Ala | Asn | Pro | Ala | Gin | Pro | Arg | Leu | Ser | Glu | Asn | His | Asn | Leu |
| 225 | 230 | 235 | 240 | ||||||||||||
| Thr | Val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn | Ile | Ser | Ser |
| 245 | 250 | 255 | |||||||||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala |
| 275 | 280 | 285 | |||||||||||||
| Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro |
| 325 | 330 | 335 | |||||||||||||
| Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | Val | Arg | Lys | Val |
| 355 | 360 | 365 | |||||||||||||
| Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro |
| 370 | 375 | 380 | |||||||||||||
| Ala | Lys | Asp | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp |
| 405 | 410 | 415 | |||||||||||||
| Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu |
| 420 | 425 | 430 | |||||||||||||
| Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp |
| 435 | 440 | 445 | |||||||||||||
| Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser |
| 450 | 455 | 460 | |||||||||||||
| Asp | Lys | Val | Lys | Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile |
| 465 | 470 | 475 | 480 | ||||||||||||
| Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr |
| 485 | 490 | 495 | |||||||||||||
| Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu |
| 500 | 505 | 510 | |||||||||||||
| Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp |
| 515 | 520 | 525 | |||||||||||||
| Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp |
| 530 | 535 | 540 | |||||||||||||
| Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr |
| 565 | 570 | 575 | |||||||||||||
| Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys |
| 580 | 585 | 590 | |||||||||||||
| Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu |
| 595 | 600 | 605 | |||||||||||||
| Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn |
| 610 | 615 | 620 | |||||||||||||
| Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly |
| 625 | 630 | 635 | 640 | ||||||||||||
| Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His |
645 650 655
136
PL 206 576 B1
| Pro | Asn Glu | Arg 660 | Pro | His | Ser Asp Asn 665 | Gly | Phe Gly Asn Ala 670 | Ser | Asp | ||||||
| His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | Ala | Asp | Thr | Asn | Gin | Thr | Glu |
| 675 | 680 | 685 | |||||||||||||
| Lys | Pro | Asn | Glu | Glu | Lys | Pro | Gin | Thr | Glu | Lys | Pro | Glu | Glu | Glu | Thr |
| 690 | 695 | 700 | |||||||||||||
| Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys | Pro | Glu | Ser | Pro | Lys | Pro |
| 705 | 710 | 715 | 720 | ||||||||||||
| Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu | Glu | Ser | Pro | Glu | Glu | Ser |
| 725 | 730 | 735 | |||||||||||||
| Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Lys | Glu | Lys | Leu | Arg | Glu |
| 740 | 745 | 750 | |||||||||||||
| Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asn | Pro | Ile | Ile | Lys | Ser | Asn |
| 755 | 760 | 765 | |||||||||||||
| Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe | Gly | Thr |
| 770 | 775 | 780 | |||||||||||||
| Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu | Leu | Ala | Leu |
| 785 | 790 | 795 | 800 | ||||||||||||
| Leu | Lys | Glu | Ser | Lys | |||||||||||
| 805 |
<210> 101 <211> 807 <212> PRT <213> S. pneumoniae <400> 101
| Cys 1 | Ser | Tyr | Glu | Leu 5 | Gly | Arg | His | Gin | Ala 10 | Gly | Gin | Val | Lys | Lys 15 | Glu |
| Ser | Asn | Arg | Val 20 | Ser | Tyr | Ile | Asp | Gly 25 | Asp | Gin | Ala | Gly | Gin 30 | Lys | Ala |
| Glu | Asn | Leu 35 | Thr | Pro | Asp | Glu | Val 40 | Ser | Lys | Arg | Glu | Gly 45 | Ile | Asn | Ala |
| Glu | Gin 50 | Ile | Val | Ile | Lys | Ile 55 | Thr | Asp | Gin | Gly | Tyr 60 | Val | Thr | Ser | His |
| Gly 65 | Asp | His | Tyr | His | Tyr 70 | Tyr | Asn | Gly | Lys | Val 75 | Pro | Tyr | Asp | Ala | Ile 80 |
| Ile | Ser | Glu | Glu | Leu 85 | Leu | Met | Lys | Asp | Pro 90 | Asn | Tyr | Gin | Leu | Lys 95 | Asp |
| Ser | Asp | Ile | Val 100 | Asn | Glu | Ile | Lys | Gly 105 | Gly | Tyr | Val | Ile | Lys 110 | Val | Asp |
| Gly | Lys | Tyr 115 | Tyr | val | Tyr | Leu | Lys 120 | Asp | Ala | Ala | His | Ala 125 | Asp | Asn | Ile |
| Arg | Thr 130 | Lys | Glu | Glu | Ile | Lys 135 | Arg | Gin | Lys | Gin | Glu 140 | Arg | Ser | His | Asn |
| His 145 | Asn | Ser | Arg | Ala | Asp 150 | Asn | Ala | Val | Ala | Ala 155 | Ala | Arg | Ala | Gin | Gly 160 |
| Arg | Tyr | Thr | Thr | Asp 165 | Asp | Gly | Tyr | Ile | Phe 170 | Asn | Ala | Ser | Asp | Ile 175 | Ile |
| Glu | Asp | Thr | Gly 180 | Asp | Ala | Tyr | Ile | Val 185 | Pro | His | Gly | Asn | His 190 | Phe | His |
| Tyr | Ile | Pro 195 | Lys | Ser | Asp | Leu | Ser 200 | Ala | Ser | Glu | Leu | Ala 205 | Ala | Ala | Gin |
| Ala | Tyr 210 | Trp | Asn | Gly | Lys | Gin 215 | Gly | Ser | Arg | Pro | Ser 220 | Ser | Ser | Ser | Ser |
| His 225 | Asn | Ala | Asn | Pro | Ala 230 | Gin | Pro | Arg | Leu | Ser 235 | Glu | Asn | His | Asn | Leu 240 |
PL 206 576 B1
137
| Thr | Val | Thr | Pro | Thr 245 | Tyr | His Gin Asn Gin Gly Glu Asn 250 | Ile | Ser 255 | Ser | ||||||
| Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | Ser | Glu | Arg | His | Val | Glu |
| 260 | 265 | 270 | |||||||||||||
| Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala |
| 275 | 280 | 285 | |||||||||||||
| Arg | Gly | Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Ser | Gin | Met | Ser | Glu | Leu | Glu | Glu | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu |
| 305 | 310 | 315 | 320 | ||||||||||||
| Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Gin | Pro |
| 325 | 330 | 335 | |||||||||||||
| Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Ser | Ala | Pro |
| 340 | 345 | 350 | |||||||||||||
| Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys |
| 355 | 360 | 365 | |||||||||||||
| Glu | Val | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Lys | Asn | Gly |
| 370 | 375 | 380 | |||||||||||||
| Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala |
| 385 | 390 | 395 | 400 | ||||||||||||
| Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu |
| 405 | 410 | 415 | |||||||||||||
| Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn |
| 420 | 425 | 430 | |||||||||||||
| Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn |
| 435 | 440 | 445 | |||||||||||||
| Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg |
| 450 | 455 | 460 | |||||||||||||
| Leu | Glu | Asp | Val | Pro | Ser | Asp | Lys | val | Lys | Leu | Val | Asp | Asp | Ile | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn |
| 485 | 490 | 495 | |||||||||||||
| Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
| 500 | 505 | 510 | |||||||||||||
| Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp | Ile |
| 515 | 520 | 525 | |||||||||||||
| Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met | Thr | His | Ser |
| 530 | 535 | 540 | |||||||||||||
| His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
| 565 | 570 | 575 | |||||||||||||
| Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn |
| 580 | 585 | 590 | |||||||||||||
| Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn |
| 595 | 600 | 605 | |||||||||||||
| Leu | Gin | Tyr | Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | He | Pro | His |
| 610 | 615 | 620 | |||||||||||||
| Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
| 625 | 630 | 635 | 640 | ||||||||||||
| Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val |
| 645 | 650 | 655 | |||||||||||||
| Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly |
| 660 | 665 | 670 | |||||||||||||
| Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Gin | Arg | Asn | Lys | Asn | Gly | Gin | Ala |
| 675 | 680 | 685 |
138
PL 206 576 B1
| Asp | Thr 690 | Asn | Gin | Thr Glu Lys 695 | Pro | Ser Glu Glu | Lys 700 | Pro | Gin | Thr | Glu | ||||
| Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu | Lys |
| 705 | 710 | 715 | 720 | ||||||||||||
| Pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu |
| 725 | 730 | 735 | |||||||||||||
| Glu | Ser | Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys | Leu |
| 740 | 745 | 750 | |||||||||||||
| Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | Ile | Ile | Lys |
| 755 | 760 | 765 | |||||||||||||
| Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe |
| 770 | 775 | 780 | |||||||||||||
| Gly | Thr | Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu | Leu |
| 785 | 790 | 795 | 800 | ||||||||||||
| Ala | Leu | Leu | Lys | Glu | Ser | Lys | |||||||||
| 805 |
<210> 102 <211> 821 <212> PRT <213> S. pneumoniae <400> 102
| Cys 1 | Ala | Tyr | Glu | Leu 5 | Gly | Leu | His | Gin | Ala 10 | Gin | Thr | Val | Lys | Glu 15 | Asn |
| Asn | Arg | Val | Ser 20 | Tyr | Ile | Asp | Gly | Lys 25 | Gin | Ala | Thr | Gin | Lys 30 | Thr | Glu |
| Asn | Leu | Thr 35 | Pro | Asp | Glu | Val | Ser 40 | Lys | Arg | Glu | Gly | Ile 45 | Asn | Ala | Glu |
| Gin | Ile 50 | Val | Ile | Lys | Ile | Thr 55 | Asp | Gin | Gly | Tyr | Val 60 | Thr | Ser | His | Gly |
| Asp 65 | His | Tyr | His | Tyr | Tyr 70 | Asn | Gly | Lys | Val | Pro 75 | Tyr | Asp | Ala | Ile | Ile 80 |
| Ser | Glu | Glu | Leu | Leu 85 | Met | Lys | Asp | Pro | Asn 90 | Tyr | Gin | Leu | Lys | Asp 95 | Ser |
| Asp | Ile | Val | Asn 100 | Glu | Ile | Lys | Gly | Gly 105 | Tyr | Val | ile | Lys | Val 110 | Asn | Gly |
| Lys | Tyr | Tyr 115 | Val | Tyr | Leu | Lys | Asp 120 | Ala | Ala | His | Ala | Asp 125 | Asn | Val | Arg |
| Thr | Lys 130 | Glu | Glu | Ile | Asn | Arg 135 | Gin | Lys | Gin | Glu | His 140 | Ser | Gin | His | Arg |
| Glu 145 | Gly | Gly | Thr | Ser | Ala 150 | Asn | Asp | Gly | Ala | Val 155 | Ala | Phe | Ala | Arg | Ser 160 |
| Gin | Gly | Arg | Tyr | Thr 165 | Thr | Asp | Asp | Gly | Tyr 170 | Ile | Phe | Asn | Ala | Ser 175 | Asp |
| Ile | Ile | Glu | Asp 180 | Thr | Gly | Asp | Ala | Tyr 185 | Ile | Val | Pro | His | Gly 190 | Asp | His |
| Tyr | His | Tyr 195 | Ile | Pro | Lys | Asn | Glu 200 | Leu | Ser | Ala | Ser | Glu 205 | Leu | Ala | Ala |
| Ala | Glu 210 | Ala | Phe | Leu | Ser | Gly 215 | Arg | Glu | Asn | Leu | Ser 220 | Asn | Leu | Arg | Thr |
| Tyr 225 | Arg | Arg | Gin | Asn | Ser 230 | Asp | Asn | Thr | Pro | Arg 235 | Thr | Asn | Trp | Val | Pro 240 |
| Ser | Val | Ser | Asn | Pro 245 | Gly | Thr | Thr | Asn | Thr 250 | Asn | Thr | Ser | Asn | Asn 255 | Ser |
| Asn | Thr | Asn | Ser 260 | Gin | Ala | Ser | Gin | Ser 265 | Asn | Asp | Ile | Asp | Ser 270 | Leu | Leu |
PL 206 576 B1
139
| Lys Gin Leu Tyr | Lys | Leu Pro Leu Ser Gin Arg His Val | Glu | Ser | Asp | ||||||||||
| 275 | 280 | 285 | |||||||||||||
| Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr | Ala | Arg | Gly |
| 290 | 295 | 300 | |||||||||||||
| Val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr | Glu | Gin |
| 305 | 310 | 315 | 320 | ||||||||||||
| Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro | Leu | Arg | Tyr |
| 325 | 330 | 335 | |||||||||||||
| Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu | Pro | Ser | Pro |
| 340 | 345 | 350 | |||||||||||||
| Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn | Pro |
| 355 | 360 | 365 | |||||||||||||
| Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala |
| 370 | 375 | 380 | |||||||||||||
| Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | Val | Ser |
| 385 | 390 | 395 | 400 | ||||||||||||
| Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile |
| 405 | 410 | 415 | |||||||||||||
| Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys | Leu | Gly | Ala |
| 420 | 425 | 430 | |||||||||||||
| Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala |
| 435 | 440 | 445 | |||||||||||||
| Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly |
| 450 | 455 | 460 | |||||||||||||
| Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys |
| 465 | 470 | 475 | 480 | ||||||||||||
| Asp | Val | Ser | Ser | Asp 485 | Lys | Val | Lys | Leu | Val 490 | Asp | Asp | Ile | Leu | Ala 495 | Phe |
| Leu | Ala | Pro | Ile 500 | Arg | His | Pro | Glu | Arg 505 | Leu | Gly | Lys | Pro | Asn 510 | Ala | Gin |
| Ile | Thr | Tyr 515 | Thr | Asp | Asp | Glu | Ile 520 | Gin | Val | Ala | Lys | Leu 525 | Ala | Gly | Lys |
| Tyr | Thr 530 | Thr | Glu | Asp | Gly | Tyr 535 | Ile | Phe | Asp | Pro | Arg 540 | Asp | ile | Thr | Ser |
| Asp 545 | Glu | Gly | Asp | Ala | Tyr 550 | Val | Thr | Pro | His | Met 555 | Thr | His | Ser | His | Trp 560 |
| Ile | Lys | Lys | Asp | Ser 565 | Leu | Ser | Glu | Ala | Glu 570 | Arg | Ala | Ala | Ala | Gin 575 | Ala |
| Tyr | Ala | Lys | Glu 580 | Lys | Gly | Leu | Thr | Pro 585 | Pro | Ser | Thr | Asp | His 590 | Gin | Asp |
| Ser | Gly | Asn 595 | Thr | Glu | Ala | Lys | Gly 600 | Ala | Glu | Ala | Ile | Tyr 605 | Asn | Arg | Val |
| Lys | Ala 610 | Ala | Lys | Lys | Val | Pro 615 | Leu | Asp | Arg | Met | Pro 620 | Tyr | Asn | Leu | Gin |
| Tyr 625 | Thr | Val | Glu | Val | Lys 630 | Asn | Gly | Ser | Leu | Ile 635 | Ile | Pro | His | Tyr | Asp 640 |
| His | Tyr | His | Asn | Ile 645 | Lys | Phe | Glu | Trp | Phe 650 | Asp | Glu | Gly | Leu | Tyr 655 | Glu |
| Ala | Pro | Lys | Gly 660 | Tyr | Thr | Leu | Glu | Asp 665 | Leu | Leu | Ala | Thr | Val 670 | Lys | Tyr |
| Tyr | Val | Glu 675 | His | Pro | Asn | Glu | Arg 680 | Pro | His | Ser | Asp | Asn 685 | Gly | Phe | Gly |
| Asn | Ala 690 | Ser | Asp | His | Val | Gin 695 | Arg | Asn | Lys | Asn | Gly 700 | Gin | Ala | Asp | Thr |
| Asn 705 | Gin | Thr | Glu | Lys | Pro 710 | Ser | Glu | Glu | Lys | Pro 715 | Gin | Thr | Glu | Lys | Pro 720 |
140
PL 206 576 B1
| Glu Glu Glu Thr Pro | Arg Glu | Glu Lys | Pro Gin Ser Glu 730 | Lys | Pro 735 | Glu | |||||||||
| 725 | |||||||||||||||
| Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro | Glu | Glu | Ser |
| 740 | 745 | 750 | |||||||||||||
| Glu | Glu | Pro | Gin | Val | Glu | Thr | Glu | Lys | Val | Glu | Glu | Lys | Leu | Arg | Glu |
| 755 | 760 | 765 | |||||||||||||
| Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | Ile | Ile | Lys | Ser | Asn |
| 770 | 775 | 780 | |||||||||||||
| Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu | Phe | Gly | Thr |
| 785 | 790 | 795 | 800 | ||||||||||||
| Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu | Leu | Ala | Leu |
| 805 | 810 | 815 | |||||||||||||
| Leu | Lys | Glu | Ser | Lys | |||||||||||
| 820 |
Zastrzeżenia patentowe
Claims (25)
1. Izolowany polinukleotyd wybrany spośród (a) izolowanego polinukleotydu kodującego polipeptyd zawierają cy sekwencję aminokwasów identyczną w co najmniej 95% z sekwencją aminokwasów nr 4, 14, 58, 60, 62, 63, 73, 74, 77 lub 79, przy czym polipeptyd ten jest zdolny do wytwarzania przeciwciała wykazującego specyficzność wiązania wobec polipeptydu zawierającego sekwencję aminokwasów nr 4 lub 14, oraz polipeptyd ten jest zdolny do wywoływania u osobnika reakcji immunologicznej na paciorkowce;
(b) izolowanego polinukleotydu kodującego polipeptyd zawierający sekwencję aminokwasów nr 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79;
(c) izolowanego polinukleotydu zawierają cego sekwencję nukleotydową identyczną w co najmniej 95% z sekwencją nukleotydową nr 3, 12 lub 13, przy czym polinukleotyd ten koduje polipeptyd zdolny do wytwarzania przeciwciała wykazującego specyficzność wiązania wobec polipeptydu zawierającego sekwencję aminokwasów nr 4 lub 14, oraz ten izolowany polipeptyd jest zdolny do wywoływania u osobnika reakcji immunologicznej na paciorkowce;
(d) izolowanego polinukleotydu zawierają cego sekwencję nukleotydową nr 3, 12 lub 13; lub (e) izolowanego polinukleotydu komplementarnego z polinukleotydem określonym w którymkolwiek z punktów (a)-(d) powyżej.
2. Polinukleotyd według zastrzeżenia 1, znamienny tym, że ma postać DNA.
3. Polinukleotyd według zastrzeżenia 1, znamienny tym, że ma postać RNA.
4. Wektor zawierający polinukleotyd określony w zastrzeżeniu 1, znamienny tym, że ten polinukleotyd jest funkcjonalnie połączony z regionem kontroli ekspresji.
5. Komórka gospodarza transfekowana lub transformowana za pomocą wektora okreś lonego w zastrzeż eniu 4.
6. Sposób wytwarzania polipeptydu kodowanego przez polinukleotyd określony w zastrzeżeniu 1, znamienny tym, że obejmuje hodowlę komórek gospodarza określonych w zastrzeżeniu 5 w warunkach odpowiednich do uzyskania ekspresji tego polipeptydu.
7. Sposób według zastrzeżenia 6, znamienny tym, że ponadto obejmuje izolowanie polipeptydu z hodowli komórek gospodarza.
8. Sposób według zastrzeżenia 6, znamienny tym, że polipeptyd jest polipeptydem rekombinowanym.
9. Izolowany polipeptyd zawierają cy (a) sekwencję aminokwasów identyczną w co najmniej 95% z sekwencją aminokwasów nr 4, 14, 58, 60, 63, 73, 74, 77 lub 79, przy czym ten izolowany polipeptyd jest zdolny do wytwarzania przeciwciała wykazującego specyficzność wiązania wobec polipeptydu zawierającego sekwencję aminokwasów nr 4 lub 14, oraz polipeptyd ten jest zdolny do wywoływania u osobnika reakcji immunologicznej na paciorkowce; lub (b) sekwencję aminokwasów nr 4, 14, 58, 60, 62, 63, 68, 72, 73, 74, 77 lub 79.
10. Izolowany polipeptyd według zastrzeżenia 9, znamienny tym, że z sekwencji nr 4 lub 14 usunięta jest N-terminalna reszta metioninowa.
11. Izolowany polipeptyd według zastrzeżenia 9, znamienny tym, że z sekwencji nr 4 lub 14 usunięta jest wydzielnicza sekwencja aminokwasów.
PL 206 576 B1
141
12. Izolowany polipeptyd według zastrzeżenia 9 albo 10, albo 11, znamienny tym, że izolowany polipeptyd jest przyłączony do sacharydu.
13. Izolowany polipeptyd według zastrzeżenia 9, znamienny tym, że paciorkowiec jest wybrany spośród Streptococcus pneumoniae, grupy A Streptococcus (Streptococcus pyogenes), grupy B Streptococcus (Streptococcus agalactiae), Streptococcus dysgalactiae, lub Streptococcus uberis.
14. Izolowany polipeptyd według zastrzeżenia 9, znamienny tym, że paciorkowcem jest Streptococcus pneumoniae.
15. Chimeryczny polipeptyd wybrany spośród (a) chimerycznego polipeptydu zawierającego dwa lub większą liczbę polipeptydów, przy czym sekwencja aminokwasów każdego z dwóch lub większej liczby peptydów zawiera sekwencję aminokwasów wybraną spośród sekwencji nr 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79, zaś dwa lub większa liczba polipeptydów jest połączona z utworzeniem chimerycznego polipeptydu;
(b) chimerycznego polipeptydu zawierającego dwa lub większą liczbę polipeptydów, przy czym sekwencja aminokwasów każdego z dwóch lub większej liczby peptydów zawiera sekwencję aminokwasów wybraną spośród sekwencji nr 58, 60, 62, 67, 68, 72, 74 lub 77, zaś dwa lub większa liczba polipeptydów jest połączona z utworzeniem chimerycznego polipeptydu;
(c) chimerycznego polipeptydu o wzorze (I):
A-(B)m-(C)n-D (I) w którym: m oznacza 0 lub 1, n oznacza 0 lub 1,
A jest wybrane spoś ród sekwencji nr: 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79;
B jest wybrane spoś ród sekwencji nr: 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79;
C jest wybrane spoś ród sekwencji nr: 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79; oraz
D jest wybrane spoś ród sekwencji nr: 4, 14, 58, 60, 62, 63, 67, 68, 72, 73, 74, 77 lub 79; lub (d) chimerycznego polipeptydu o wzorze (I):
A-(B)m-(C)n-D (I) w którym: m oznacza 0 lub 1, n oznacza 0 lub 1,
A jest wybrane spoś ród sekwencji nr: 58, 60, 62, 67, 68, 72, 74 lub 77;
B jest wybrane spoś ród sekwencji nr: 58, 60, 62, 67, 68, 72, 74 lub 77;
C jest wybrane spoś ród sekwencji nr: 58, 60, 62, 67, 68, 72, 74 lub 77; oraz
D jest wybrane spoś ród sekwencji nr: 58, 60, 62, 67, 68, 72, 74 lub 77.
16. Chimeryczny polipeptyd według zastrzeżenia 15, znamienny tym, że izolowany polipeptyd jest przyłączony do sacharydu.
17. Kompozycja do szczepionek, znamienna tym, że zawiera (a) skuteczną profilaktycznie lub terapeutycznie ilość polipeptydu określonego w którymkolwiek z zastrzeż eń 9-14, oraz farmaceutycznie akceptowalny nośnik lub rozcieńczalnik; lub (b) skuteczną profilaktycznie lub terapeutycznie ilość chimerycznego polipeptydu określonego w zastrzeżeniu 15 lub 16, oraz farmaceutycznie akceptowalny nośnik lub rozcieńczalnik.
18. Kompozycja do szczepionek według zastrzeżenia 17, znamienna tym, że zawiera ponadto farmaceutycznie akceptowalny adiuwant.
19. Kompozycja do szczepionek według zastrzeżenia 17 albo 18 do zastosowania w zapobieganiu lub leczeniu zakażenia osobnika paciorkowcem.
20. Zastosowanie kompozycji określonej w zastrzeżeniu 17 albo 18 do wytwarzania leku do leczenia lub zapobiegania zakażeniu osobnika paciorkowcem.
21. Zastosowanie według zastrzeżenia 20, znamienne tym, że zakażenie paciorkowcem obejmuje zapalenie opon, zapalenie ucha środkowego, bakteriemię lub zapalenie płuc.
22. Zastosowanie według zastrzeżenia 20, znamienne tym, że osobnikiem jest ssak.
23. Zastosowanie według zastrzeżenia 20, znamienne tym, że osobnikiem jest człowiek.
24. Zastosowanie według zastrzeżenia 20, znamienne tym, że zakażenie paciorkowcem jest wywołane przez Streptococcus pneumoniae, grupę A paciorkowców (Streptococcus pyogenes), grupę B paciorkowców (Streptococcus agalactiae), Streptococcus dysgalactiae lub Streptococcus uberis.
25. Zastosowanie według zastrzeżenia 20, znamienne tym, że zakażenie paciorkowcem jest wywołane przez Streptococcus pneumoniae.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11380098P | 1998-12-23 | 1998-12-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL349777A1 PL349777A1 (en) | 2002-09-09 |
| PL206576B1 true PL206576B1 (pl) | 2010-08-31 |
Family
ID=22351610
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL382437A PL205041B1 (pl) | 1998-12-23 | 1999-12-20 | Izolowany polinukleotyd, wektor zawierający izolowany polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca polipeptyd oraz jej zastosowanie w leczeniu lub zapobieganiu zakażeniu osobnika paciorkowcem |
| PL382438A PL204073B1 (pl) | 1998-12-23 | 1999-12-20 | Izolowany polinukleotyd, wektor zawierający ten polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, kompozycja do szczepionek zawierająca ten polipeptyd, zastosowanie tej kompozycji w leczeniu lub zapobieganiu zakażeniom paciorkowcem, sposób diagnozowania zakażenia paciorkowcem, sposób wykrywania przeciwciała specyficznie wiążącego się z antygenem paciorkowca, sposób wykrywania obecności paciorkowców w próbce biologicznej |
| PL349777A PL206576B1 (pl) | 1998-12-23 | 1999-12-20 | Izolowany polinukleotyd, wektor zawierający ten polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca izolowany polipeptyd lub chimeryczny polipeptyd oraz terapeutyczne zastosowanie tej kompozycji w zakażeniach paciorkowcem |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL382437A PL205041B1 (pl) | 1998-12-23 | 1999-12-20 | Izolowany polinukleotyd, wektor zawierający izolowany polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca polipeptyd oraz jej zastosowanie w leczeniu lub zapobieganiu zakażeniu osobnika paciorkowcem |
| PL382438A PL204073B1 (pl) | 1998-12-23 | 1999-12-20 | Izolowany polinukleotyd, wektor zawierający ten polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, kompozycja do szczepionek zawierająca ten polipeptyd, zastosowanie tej kompozycji w leczeniu lub zapobieganiu zakażeniom paciorkowcem, sposób diagnozowania zakażenia paciorkowcem, sposób wykrywania przeciwciała specyficznie wiążącego się z antygenem paciorkowca, sposób wykrywania obecności paciorkowców w próbce biologicznej |
Country Status (29)
| Country | Link |
|---|---|
| EP (2) | EP1141306B1 (pl) |
| JP (2) | JP4761623B2 (pl) |
| KR (4) | KR100802198B1 (pl) |
| CN (3) | CN101134775A (pl) |
| AP (1) | AP2001002199A0 (pl) |
| AR (1) | AR029322A1 (pl) |
| AT (1) | ATE394489T1 (pl) |
| AU (1) | AU1764900A (pl) |
| BR (1) | BR9916477A (pl) |
| CA (1) | CA2356836C (pl) |
| CL (1) | CL2009002037A1 (pl) |
| CY (3) | CY1108223T1 (pl) |
| CZ (2) | CZ303675B6 (pl) |
| DE (1) | DE69938670D1 (pl) |
| DK (3) | DK2261358T3 (pl) |
| EA (1) | EA007409B1 (pl) |
| ES (3) | ES2480417T3 (pl) |
| HU (1) | HU229664B1 (pl) |
| IL (3) | IL143905A0 (pl) |
| MX (1) | MXPA01006427A (pl) |
| NO (1) | NO330800B1 (pl) |
| NZ (1) | NZ512574A (pl) |
| OA (1) | OA11736A (pl) |
| PL (3) | PL205041B1 (pl) |
| PT (3) | PT1950302E (pl) |
| TR (2) | TR200102497T2 (pl) |
| UY (1) | UY25877A1 (pl) |
| WO (1) | WO2000039299A2 (pl) |
| ZA (1) | ZA200105114B (pl) |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2321106C (en) | 1998-02-20 | 2013-07-23 | Biochem Pharma Inc. | Group b streptococcus antigens |
| EP1801218A3 (en) * | 1998-07-27 | 2007-10-10 | Sanofi Pasteur Limited | Nucleic acids and proteins from streptococcus pneumoniae |
| US20030134407A1 (en) | 1998-07-27 | 2003-07-17 | Le Page Richard William Falla | Nucleic acids and proteins from Streptococcus pneumoniae |
| EP1140157B1 (en) * | 1998-12-21 | 2009-02-18 | MedImmune, Inc. | Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
| KR100802198B1 (ko) * | 1998-12-23 | 2008-02-11 | 샤이어 바이오켐 인코포레이티드 | 신규한 스트렙토코커스 항원 |
| US6866855B2 (en) | 2000-06-12 | 2005-03-15 | University Of Saskatchewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
| DK1294771T3 (da) | 2000-06-12 | 2008-12-15 | Univ Saskatchewan | Kimært GapC-protein fra Streptococcus og anvendelse deraf til vaccinering og diagnosticering |
| US6833134B2 (en) | 2000-06-12 | 2004-12-21 | University Of Saskacthewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
| CA2413450C (en) | 2000-06-20 | 2014-02-18 | Shire Biochem Inc. | Streptococcus antigens |
| US7074415B2 (en) | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
| WO2002079475A2 (en) * | 2001-03-30 | 2002-10-10 | Shire Biochem Inc. | Streptococcus pyogenes antigens and corresponding dna fragments |
| BR0210875A (pt) | 2001-07-06 | 2004-06-22 | Shire Biochem Inc | Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes |
| GB0130228D0 (en) * | 2001-12-18 | 2002-02-06 | Hansa Medica Ab | Protein |
| EP1456231A2 (en) * | 2001-12-20 | 2004-09-15 | Shire Biochem Inc. | Streptococcus antigens |
| EP2287315A1 (en) * | 2003-03-04 | 2011-02-23 | Intercell AG | Streptococcus pyogenes antigens |
| EP2311988A1 (en) * | 2003-04-15 | 2011-04-20 | Intercell AG | S. pneumoniae antigens |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| KR101515078B1 (ko) | 2005-12-22 | 2015-04-24 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
| CA2690708A1 (en) | 2007-06-26 | 2008-12-31 | Glaxosmithkline Biologicals S.A. | Vaccine |
| WO2009012588A1 (en) * | 2007-07-23 | 2009-01-29 | Sanofi Pasteur Limited | Immunogenic polypeptides and monoclonal antibodies |
| ES2553113T3 (es) | 2008-04-16 | 2015-12-04 | Glaxosmithkline Biologicals S.A. | Vacuna |
| CN102223876A (zh) | 2008-09-26 | 2011-10-19 | 纳米生物公司 | 纳米乳剂治疗性组合物及其使用方法 |
| US20120052088A1 (en) | 2009-04-30 | 2012-03-01 | Coley Pharmaceutical Group, Inc. | Pneumococcal vaccine and uses thereof |
| WO2010132833A1 (en) | 2009-05-14 | 2010-11-18 | The Regents Of The University Of Michigan | Streptococcus vaccine compositions and methods of using the same |
| WO2011027257A2 (en) | 2009-09-03 | 2011-03-10 | Pfizer Vaccines Llc | Pcsk9 vaccine |
| GB201003920D0 (en) * | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
| MX2013006255A (es) | 2010-12-03 | 2015-08-05 | Sanofi Pasteur Ltd | Composicion para inmunizacion contra streptococcus pneumoniae. |
| WO2012100233A1 (en) * | 2011-01-20 | 2012-07-26 | Genocea Biosciences, Inc. | Vaccines and compositions against streptococcus pneumoniae |
| WO2012131504A1 (en) | 2011-03-02 | 2012-10-04 | Pfizer Inc. | Pcsk9 vaccine |
| CN103533953A (zh) | 2011-05-17 | 2014-01-22 | 葛兰素史密丝克莱恩生物有限公司 | 针对肺炎链球菌的疫苗 |
| ES2642184T3 (es) * | 2012-01-05 | 2017-11-15 | Deutsches Krebsforschungszentrum | Péptidos para su uso en el tratamiento y diagnóstico de cánceres positivos a IDH1 R132H |
| EP2931743A4 (en) * | 2012-12-14 | 2016-08-03 | Sanofi Pasteur Ltd | METHOD FOR ASSESSING IMMUNOGENICITY |
| BR112016015835B1 (pt) | 2014-01-21 | 2023-12-26 | Pfizer Inc | Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae |
| US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| PL3096786T3 (pl) | 2014-01-21 | 2021-11-08 | Pfizer Inc. | Polisacharydy otoczkowe streptococcus pneumoniae i ich koniugaty |
| CN110859957B (zh) | 2014-01-21 | 2024-04-12 | 辉瑞公司 | 包含缀合荚膜糖抗原的免疫原性组合物及其用途 |
| ES2701169T3 (es) | 2014-02-14 | 2019-02-21 | Pfizer | Conjugados glucoproteicos inmunogénicos |
| HUE062499T2 (hu) | 2015-01-15 | 2023-11-28 | Pfizer | Pneumococcus-vakcinákban történõ alkalmazásra szolgáló immunogén készítmények |
| KR102225282B1 (ko) | 2015-07-21 | 2021-03-10 | 화이자 인코포레이티드 | 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도 |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
| JP6884145B2 (ja) | 2015-11-20 | 2021-06-09 | ファイザー・インク | 肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物 |
| GB201610599D0 (en) | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
| BR112019014833A2 (pt) | 2017-01-20 | 2020-04-14 | Pfizer | composições imunogênicas para uso em vacinas pneumococais |
| GB201711635D0 (en) | 2017-07-19 | 2017-08-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| US11260119B2 (en) | 2018-08-24 | 2022-03-01 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
| CA3120922A1 (en) | 2018-12-12 | 2020-06-18 | Pfizer Inc. | Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof |
| JP7239509B6 (ja) | 2019-02-22 | 2023-03-28 | ファイザー・インク | 細菌多糖類を精製するための方法 |
| WO2020208502A1 (en) | 2019-04-10 | 2020-10-15 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof |
| PH12022550110A1 (en) | 2019-07-31 | 2022-12-12 | Sk Bioscience Co Ltd | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same |
| US20230000966A1 (en) | 2019-11-01 | 2023-01-05 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
| CN119371566A (zh) | 2020-02-21 | 2025-01-28 | 辉瑞公司 | 糖类的纯化 |
| BR112022014555A2 (pt) | 2020-02-23 | 2022-09-20 | Pfizer | Composições de escherichia coli e métodos das mesmas. |
| WO2022084852A1 (en) | 2020-10-22 | 2022-04-28 | Pfizer Inc. | Methods for purifying bacterial polysaccharides |
| US12138302B2 (en) | 2020-10-27 | 2024-11-12 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
| PE20231934A1 (es) | 2020-10-27 | 2023-12-01 | Pfizer | Composiciones de escherichia coli y metodos de las mismas |
| CA3200602A1 (en) | 2020-11-04 | 2022-05-12 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
| US12357681B2 (en) | 2020-12-23 | 2025-07-15 | Pfizer Inc. | E. coli FimH mutants and uses thereof |
| JP2024517780A (ja) | 2021-05-03 | 2024-04-23 | ファイザー・インク | 細菌およびベータコロナウイルス感染症に対するワクチン接種 |
| WO2022234416A1 (en) | 2021-05-03 | 2022-11-10 | Pfizer Inc. | Vaccination against pneumoccocal and covid-19 infections |
| JP2024521847A (ja) | 2021-05-28 | 2024-06-04 | ファイザー・インク | コンジュゲート化莢膜糖抗原を含む免疫原性組成物およびその使用 |
| MX2023013434A (es) | 2021-05-28 | 2023-12-12 | Pfizer | Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos. |
| CA3247998A1 (en) | 2022-01-13 | 2023-07-20 | Pfizer Inc. | Immunogenic compositions based on conjugated capsular saccharidic antigens and their uses |
| WO2023161817A1 (en) | 2022-02-25 | 2023-08-31 | Pfizer Inc. | Methods for incorporating azido groups in bacterial capsular polysaccharides |
| CA3256617A1 (en) | 2022-05-11 | 2023-11-16 | Pfizer Inc. | PROCESS FOR PRODUCING VACCINE FORMULATIONS WITH PRESERVATIVES |
| WO2024084397A1 (en) | 2022-10-19 | 2024-04-25 | Pfizer Inc. | Vaccination against pneumoccocal and covid-19 infections |
| WO2024110827A1 (en) | 2022-11-21 | 2024-05-30 | Pfizer Inc. | Methods for preparing conjugated capsular saccharide antigens and uses thereof |
| EP4622665A2 (en) | 2022-11-22 | 2025-10-01 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| AU2023403045A1 (en) | 2022-12-01 | 2025-06-12 | Pfizer Inc. | Pneumococcal conjugate vaccine formulations |
| WO2024166008A1 (en) | 2023-02-10 | 2024-08-15 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| PE20252774A1 (es) | 2023-03-30 | 2025-12-22 | Pfizer | Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y usos de estos |
| AU2024255922A1 (en) | 2023-04-14 | 2025-10-30 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| WO2024224266A1 (en) | 2023-04-24 | 2024-10-31 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| KR20260015203A (ko) | 2023-05-19 | 2026-02-02 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 호흡기 세포융합 바이러스 및 스트렙토코쿠스 뉴모니아에 감염에 대한 면역 반응을 유발하는 방법 |
| TW202527906A (zh) | 2023-09-14 | 2025-07-16 | 美商輝瑞股份有限公司 | 包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途 |
| WO2025133971A1 (en) | 2023-12-23 | 2025-06-26 | Pfizer Inc. | Improved methods for producing bacterial capsular saccharide glycoconjugates |
| WO2025186705A2 (en) | 2024-03-06 | 2025-09-12 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| WO2025191415A1 (en) | 2024-03-11 | 2025-09-18 | Pfizer Inc. | Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof |
| WO2025219908A2 (en) | 2024-04-19 | 2025-10-23 | Pfizer Inc. | Media and fermentation methods for polysaccharide production in bacterial cell culture |
| WO2025219904A1 (en) | 2024-04-19 | 2025-10-23 | Pfizer Inc. | Improved methods for producing glycoconjugates by reductive amination in aprotic solvent |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431739A (en) | 1979-11-05 | 1984-02-14 | Genentech, Inc. | Transformant bacterial culture capable of expressing heterologous protein |
| US4425437A (en) | 1979-11-05 | 1984-01-10 | Genentech, Inc. | Microbial polypeptide expression vehicle |
| US4338397A (en) | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
| HU217582B (hu) * | 1993-03-19 | 2000-02-28 | Gunnar Lindahl | Streptococcus B csoportba tartozó törzsek elleni immunitást biztosító, Rib fehérjenevű felületi protein, eljárás a protein tisztítására, reagenskészlet és gyógyszerkészítmény |
| EA199800046A1 (ru) * | 1995-06-07 | 1998-06-25 | Байокем Вэксинс Инк. | Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента |
| US5882896A (en) * | 1996-09-24 | 1999-03-16 | Smithkline Beecham Corporation | M protein |
| US5928895A (en) * | 1996-09-24 | 1999-07-27 | Smithkline Beecham Corporation | IgA Fc binding protein |
| JP4469026B2 (ja) * | 1996-10-31 | 2010-05-26 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | Streptococcus pneumoniaeの抗原およびワクチン |
| AU9510598A (en) * | 1997-09-24 | 1999-04-12 | American Cyanamid Company | Human complement c3-degrading proteinase from (streptococcus pneumoniae) |
| WO1999053940A1 (en) * | 1998-04-23 | 1999-10-28 | Uab Research Foundation | PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR |
| ATE361365T1 (de) * | 1998-07-27 | 2007-05-15 | Sanofi Pasteur Ltd | Streptococcus pneumoniae proteine und nukleinsäuren |
| CN1318103A (zh) * | 1998-07-27 | 2001-10-17 | 微生物技术有限公司 | 肺炎链球菌的核酸和蛋白质 |
| EP1115875A1 (en) * | 1998-09-24 | 2001-07-18 | Regents Of The University Of Minnesota | Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| EP1140157B1 (en) * | 1998-12-21 | 2009-02-18 | MedImmune, Inc. | Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| KR100802198B1 (ko) * | 1998-12-23 | 2008-02-11 | 샤이어 바이오켐 인코포레이티드 | 신규한 스트렙토코커스 항원 |
-
1999
- 1999-12-20 KR KR1020017007963A patent/KR100802198B1/ko not_active Expired - Fee Related
- 1999-12-20 CN CNA2007101481600A patent/CN101134775A/zh active Pending
- 1999-12-20 TR TR2001/02497T patent/TR200102497T2/xx unknown
- 1999-12-20 EP EP99960748A patent/EP1141306B1/en not_active Expired - Lifetime
- 1999-12-20 ES ES10180372.4T patent/ES2480417T3/es not_active Expired - Lifetime
- 1999-12-20 IL IL14390599A patent/IL143905A0/xx unknown
- 1999-12-20 EA EA200100565A patent/EA007409B1/ru not_active IP Right Cessation
- 1999-12-20 TR TR2002/00633T patent/TR200200633T2/xx unknown
- 1999-12-20 CN CNB2005100037492A patent/CN100398653C/zh not_active Expired - Fee Related
- 1999-12-20 DK DK10180372.4T patent/DK2261358T3/da active
- 1999-12-20 DE DE69938670T patent/DE69938670D1/de not_active Expired - Lifetime
- 1999-12-20 AP APAP/P/2001/002199A patent/AP2001002199A0/en unknown
- 1999-12-20 AT AT99960748T patent/ATE394489T1/de active
- 1999-12-20 ES ES08155317T patent/ES2400280T3/es not_active Expired - Lifetime
- 1999-12-20 CZ CZ20012161A patent/CZ303675B6/cs not_active IP Right Cessation
- 1999-12-20 EP EP10180372.4A patent/EP2261358B1/en not_active Expired - Lifetime
- 1999-12-20 PL PL382437A patent/PL205041B1/pl unknown
- 1999-12-20 MX MXPA01006427A patent/MXPA01006427A/es not_active IP Right Cessation
- 1999-12-20 PL PL382438A patent/PL204073B1/pl not_active IP Right Cessation
- 1999-12-20 CA CA2356836A patent/CA2356836C/en not_active Expired - Fee Related
- 1999-12-20 KR KR1020087008264A patent/KR101170203B1/ko not_active Expired - Fee Related
- 1999-12-20 JP JP2000591190A patent/JP4761623B2/ja not_active Expired - Fee Related
- 1999-12-20 DK DK99960748T patent/DK1141306T3/da active
- 1999-12-20 CZ CZ20100674A patent/CZ302790B6/cs not_active IP Right Cessation
- 1999-12-20 BR BR9916477-9A patent/BR9916477A/pt active Search and Examination
- 1999-12-20 PL PL349777A patent/PL206576B1/pl unknown
- 1999-12-20 ES ES99960748T patent/ES2306528T3/es not_active Expired - Lifetime
- 1999-12-20 AU AU17649/00A patent/AU1764900A/en not_active Abandoned
- 1999-12-20 OA OA1200100165A patent/OA11736A/en unknown
- 1999-12-20 HU HU0104774A patent/HU229664B1/hu not_active IP Right Cessation
- 1999-12-20 PT PT81553174T patent/PT1950302E/pt unknown
- 1999-12-20 WO PCT/CA1999/001218 patent/WO2000039299A2/en not_active Ceased
- 1999-12-20 PT PT99960748T patent/PT1141306E/pt unknown
- 1999-12-20 KR KR1020067025282A patent/KR100891398B1/ko not_active Expired - Fee Related
- 1999-12-20 CN CNB998149047A patent/CN1191362C/zh not_active Expired - Fee Related
- 1999-12-20 KR KR1020107009285A patent/KR101078919B1/ko not_active Expired - Fee Related
- 1999-12-20 PT PT101803724T patent/PT2261358E/pt unknown
- 1999-12-20 NZ NZ512574A patent/NZ512574A/xx not_active IP Right Cessation
- 1999-12-20 DK DK08155317.4T patent/DK1950302T3/da active
- 1999-12-23 AR ARP990106746A patent/AR029322A1/es not_active Application Discontinuation
- 1999-12-23 UY UY25877A patent/UY25877A1/es unknown
-
2001
- 2001-06-19 NO NO20013045A patent/NO330800B1/no not_active IP Right Cessation
- 2001-06-21 IL IL143905A patent/IL143905A/en not_active IP Right Cessation
- 2001-06-21 ZA ZA200105114A patent/ZA200105114B/en unknown
-
2008
- 2008-07-29 CY CY20081100787T patent/CY1108223T1/el unknown
- 2008-09-21 IL IL194230A patent/IL194230A/en not_active IP Right Cessation
-
2009
- 2009-11-05 CL CL2009002037A patent/CL2009002037A1/es unknown
-
2010
- 2010-02-09 JP JP2010026521A patent/JP5039802B2/ja not_active Expired - Fee Related
-
2012
- 2012-12-27 CY CY20121101268T patent/CY1114722T1/el unknown
-
2014
- 2014-07-16 CY CY20141100536T patent/CY1115340T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL206576B1 (pl) | Izolowany polinukleotyd, wektor zawierający ten polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca izolowany polipeptyd lub chimeryczny polipeptyd oraz terapeutyczne zastosowanie tej kompozycji w zakażeniach paciorkowcem | |
| JP5051959B2 (ja) | ストレプトコッカス抗原 | |
| US8211437B2 (en) | Streptococcus antigens | |
| US20060177465A1 (en) | Streptococcus antigens | |
| AU2008229967B2 (en) | Novel streptococcus antigens | |
| EP1950302B1 (en) | Streptococcus antigens | |
| HK1118575B (en) | Streptococcus antigens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification |